data_2mdt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mdt _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.15 152.28 22.47 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.12 107.2 8.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' HD11 ' A' ' 83' ' ' LEU . 43.5 t -92.35 132.68 36.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.1 mt -98.32 131.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.573 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.18 149.82 42.1 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -54.45 -26.29 44.03 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.268 2.646 . . . . 0.0 113.483 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.5 m -63.31 -14.97 55.66 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.08 5.49 48.61 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 0.0 111.535 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 6.5 m-30 -68.09 149.91 49.05 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.17 5.2 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 60.2 mtpt -105.66 19.93 19.74 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.915 0.864 . . . . 0.0 109.603 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.71 -30.41 69.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.796 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.92 -41.28 68.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.845 0.831 . . . . 0.0 109.035 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 12' ' ' LYS . 17.8 mp0 -58.62 -57.27 13.72 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.824 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 pt -63.04 -43.74 99.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.99 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 48' ' ' ARG . 4.8 mp -61.46 -54.31 45.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.637 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.14 -29.65 64.23 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 123.522 0.514 . . . . 0.0 114.14 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -81.79 -61.25 1.97 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.175 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 39.9 t-20 -77.84 -53.39 7.54 Favored 'General case' 0 C--O 1.253 1.268 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.424 -170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 8.1 mtmp? 59.65 -162.17 0.25 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 66.91 -15.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -97.79 163.8 12.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.432 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -97.82 95.78 7.77 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 172.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CB ' HG22 ' A' ' 50' ' ' VAL . 97.8 m-85 -74.8 135.32 41.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.3 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.09 138.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.616 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.68 159.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.603 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 p -100.03 171.46 7.82 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -45.51 84.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.283 1.033 . . . . 0.0 110.995 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.12 -26.55 61.27 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.75 -57.2 17.12 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.176 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.0 m -60.38 -34.96 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.988 0.394 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 49.7 m -65.6 -33.52 76.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.056 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -65.79 -40.2 91.72 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . . . -67.28 -42.55 83.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.1 mm -62.62 -47.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.256 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HB3' ' HZ1' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -66.85 -39.48 87.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -81.69 -28.5 33.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.888 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.54 41.04 4.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.207 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.64 151.64 5.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.84 92.95 5.54 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.442 1.115 . . . . 0.0 111.489 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -89.57 -17.68 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.317 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.59 -33.72 76.57 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 m -61.72 -30.12 70.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.233 0.54 . . . . 0.0 110.955 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -76.96 -50.17 13.81 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.68 -38.38 84.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.915 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.44 -39.17 75.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.712 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.445 ' HB2' HD22 ' A' ' 17' ' ' LEU . 94.9 mtt180 -89.42 -14.81 34.64 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.208 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.77 16.64 3.3 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.735 -1.221 . . . . 0.0 115.106 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG22 ' CB ' ' A' ' 25' ' ' PHE . 60.7 t -73.03 123.41 27.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 pt -93.99 150.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.75 118.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -116.09 126.47 53.78 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.357 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.391 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.581 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -79.36 161.67 25.57 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.759 2.306 . . . . 0.0 111.853 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -53.32 -40.65 64.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -63.35 -38.4 91.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.56 -38.26 62.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -58.12 -48.04 81.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.075 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.603 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.8 tt0 -60.92 -38.13 84.69 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.563 0.345 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.62 74.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.946 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.61 -45.22 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.451 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.497 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 16.6 mmt -60.96 -45.16 95.84 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.39 -35.94 76.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 120.827 0.346 . . . . 0.0 110.972 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.51 -33.61 74.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.898 0.38 . . . . 0.0 110.539 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -69.52 -46.57 66.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -49.2 -56.8 8.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.08 1.352 . . . . 0.0 111.431 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.51 -16.64 36.33 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.392 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.65 68.44 0.75 Allowed 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.74 179.26 4.02 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.674 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.11 129.96 36.33 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 4' ' ' VAL . 42.5 tp -108.34 123.78 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.267 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.13 110.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.57 139.29 38.58 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.01 -29.3 14.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.206 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 130.16 39.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.93 0.395 . . . . 0.0 110.674 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -55.18 -42.51 73.31 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.94 1.296 . . . . 0.0 112.644 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.48 -34.12 31.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.156 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.39 -45.71 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.24 -51.64 70.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.897 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.86 68.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 49.2 tptt -71.94 -42.87 66.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.388 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.66 74.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.998 0.427 . . . . 0.0 110.209 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.79 -38.35 90.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.554 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.431 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 50.3 mt-10 -57.39 -43.22 83.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.84 -11.35 60.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.017 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.3 15.92 31.28 Favored Glycine 0 CA--C 1.5 -0.868 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.268 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.1 131.43 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -80.82 89.98 5.85 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.503 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.3 128.1 38.02 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.325 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.68 157.05 78.09 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 123.578 0.549 . . . . 0.0 111.083 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.81 156.39 52.91 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.611 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 40.7 mt -55.8 -44.46 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 12' ' ' LYS . 2.7 mp0 -67.64 -24.29 65.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.93 -28.77 35.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.21 -35.22 79.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 86.0 mt -72.93 -31.66 64.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.046 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -26.94 62.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.877 0.37 . . . . 0.0 110.866 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.317 -0.848 0 CA-C-O 121.382 0.61 . . . . 0.0 110.611 179.017 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.2 156.38 19.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.73 110.31 9.74 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.4 t -95.08 129.83 44.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.109 0.48 . . . . 0.0 110.068 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.98 129.76 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.127 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.7 m -90.39 152.63 45.73 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.0 Cg_exo -57.58 -24.79 64.01 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 123.204 2.603 . . . . 0.0 114.068 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -70.16 -17.67 63.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.12 0.486 . . . . 0.0 111.505 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.403 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -95.95 9.08 41.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.5 m-30 -66.7 144.34 56.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.884 0.373 . . . . 0.0 111.709 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.8 -36.08 2.49 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.929 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -87.91 -12.63 44.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 14' ' ' LYS . 2.9 pp -62.34 -24.3 67.26 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.109 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 13' ' ' LEU . 48.7 mtmt -75.02 -25.8 59.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.284 0.564 . . . . 0.0 110.029 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -76.08 -45.64 33.01 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.658 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -64.27 -37.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.205 0.526 . . . . 0.0 110.391 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 48' ' ' ARG . 47.9 tp -65.69 -55.16 18.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.252 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.53 -19.22 78.32 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.004 0.762 . . . . 0.0 115.004 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -105.42 -3.5 22.51 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.717 -0.872 . . . . 0.0 113.05 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -125.94 -59.36 1.34 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.009 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 61.92 178.72 0.12 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.634 1.174 . . . . 0.0 114.088 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 m120 74.34 -15.01 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.945 1.698 . . . . 0.0 114.814 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -80.43 152.9 28.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tpmt? -93.0 96.83 10.33 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.83 127.85 34.16 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.722 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.42 130.43 74.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.562 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.98 144.77 23.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.58 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 22.8 p -81.85 169.68 16.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 p -72.27 -39.92 68.01 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.1 mt -70.09 -28.76 65.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.075 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.11 -53.01 36.05 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.806 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.0 m -61.25 -41.65 90.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.097 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.5 m -63.58 -37.59 87.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -66.53 -39.33 88.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.55 77.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.487 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.9 mm -57.46 -51.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.07 0.548 . . . . 0.0 111.4 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 33' ' ' SER . 18.0 ptpt -69.8 -23.4 63.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -90.72 -23.03 20.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.046 0.451 . . . . 0.0 111.217 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 31.48 11.7 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.761 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 77.8 mt -92.14 138.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.55 88.25 0.93 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.743 1.258 . . . . 0.0 111.883 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.5 tp -86.96 -19.76 7.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.907 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.9 -41.29 91.3 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.945 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -57.71 -35.57 70.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.656 0.782 . . . . 0.0 110.952 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -50.2 13.57 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.332 0.586 . . . . 0.0 109.765 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.9 mt -58.51 -41.71 86.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.865 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -48.53 81.28 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.705 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HB2' HD22 ' A' ' 17' ' ' LEU . 76.4 mtt180 -74.57 -8.56 56.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.61 13.27 3.85 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 118.776 -1.678 . . . . 0.0 114.676 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.95 122.44 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -101.55 154.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.454 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 t -100.35 128.63 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -133.33 141.86 48.15 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.935 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.427 -1.598 0 CA-C-O 120.63 0.252 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.93 155.59 67.07 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 122.664 2.243 . . . . 0.0 110.037 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -62.4 -33.0 73.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.256 6.3 p90 -62.35 -39.27 92.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.99 -42.4 73.11 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.0 m -67.08 -29.86 69.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.522 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.58 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.1 tt0 -66.55 -40.37 89.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.39 84.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.2 mt -54.75 -50.64 58.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.8 mmt -71.66 -31.65 67.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.33 -35.02 69.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.62 72.95 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.508 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -70.25 -48.22 57.84 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.33 -44.15 92.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.23 -17.9 35.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.203 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 61.1 66.89 0.84 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 123.028 1.394 . . . . 0.0 107.4 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.56 178.16 4.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 113.156 -1.838 . . . . 0.0 111.229 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -89.53 121.13 31.45 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.11 127.09 42.74 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.177 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.3 mt -111.91 117.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.896 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.7 153.48 43.41 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.453 ' OE1' ' HB ' ' A' ' 104' ' ' ILE . 6.7 mm-40 -101.04 -17.63 16.63 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.17 127.91 40.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -69.43 -24.61 63.84 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.09 -35.27 31.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.03 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.54 -49.95 81.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.9 -47.82 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.689 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.531 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -62.22 -50.43 71.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.577 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tmtt? -60.26 -43.84 95.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.333 0.587 . . . . 0.0 109.443 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.58 98.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.021 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 35.7 ttmt -69.98 -31.2 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.602 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt-10 -63.54 -34.58 78.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 109.52 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 86.5 mt -80.35 -11.14 59.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.179 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.34 12.48 26.92 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.887 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 40.4 t -98.54 127.75 50.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.17 91.03 4.91 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.663 0.744 . . . . 0.0 109.545 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.32 137.42 38.77 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.574 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.99 153.58 67.43 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.182 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 27.5 Cg_exo -63.59 155.45 62.85 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.443 2.095 . . . . 0.0 111.112 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' ' OE1' ' A' ' 86' ' ' GLU . 7.4 mt -55.7 -43.52 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.93 -19.33 61.28 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.87 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 12.6 mm-40 -77.34 -33.48 55.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.4 -41.79 88.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.3 -46.5 88.39 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.3 -22.39 66.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.546 0.738 . . . . 0.0 112.68 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 121.526 0.679 . . . . 0.0 110.756 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.245 0.837 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -87.75 147.56 25.13 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.2 10.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.57 132.65 36.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mm -95.41 130.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.329 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.6 m -90.22 152.5 45.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -57.04 -12.39 9.57 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 123.528 2.819 . . . . 0.0 113.977 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -81.97 -9.39 59.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.924 0.49 . . . . 0.0 111.172 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.4 13.66 33.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 111.801 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HB3' HG22 ' A' ' 40' ' ' ILE . 23.2 m-30 -76.67 152.43 35.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.489 0.661 . . . . 0.0 111.071 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 -36.01 3.55 Favored Glycine 0 C--N 1.313 -0.709 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.36 -1.57 47.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.723 0.773 . . . . 0.0 109.295 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.4 tp -53.62 -38.64 64.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.669 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.36 -41.43 63.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.135 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.42 -50.87 61.94 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.278 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.18 -40.51 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 121.156 0.503 . . . . 0.0 111.434 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 48' ' ' ARG . 51.5 tp -66.25 -48.42 70.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.297 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 -33.17 25.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 114.251 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 t -76.38 -46.33 27.85 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 116.925 0.362 . . . . 0.0 110.972 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -92.0 -47.58 7.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.909 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 58.55 -142.46 0.66 Allowed 'General case' 0 C--N 1.362 1.137 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.3 t30 68.68 -14.2 0.29 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 166.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -123.9 157.55 34.0 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 110.49 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -92.93 98.4 11.34 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -75.37 130.61 39.29 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.568 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.77 134.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.106 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -117.9 152.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.3 p -91.28 170.58 9.87 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.959 0.409 . . . . 0.0 111.779 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -37.99 87.57 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.886 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.15 -20.39 55.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.158 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.93 -51.41 19.1 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.8 m -63.14 -39.28 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 p -70.4 -34.94 73.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.446 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -65.01 -38.19 90.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.67 75.24 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.548 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 32' ' ' VAL . 37.1 mm -58.31 -49.93 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.89 0.476 . . . . 0.0 111.808 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.532 ' HZ2' ' HB3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -68.64 -27.06 65.66 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -91.78 -5.9 52.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.95 57.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.304 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 10' ' ' PHE . 69.3 mt -100.88 146.83 8.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.96 85.69 0.99 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.036 0.446 . . . . 0.0 111.288 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.1 tp -90.38 -24.42 5.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.83 -41.19 97.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.131 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 8.4 t -72.52 -26.41 61.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.207 0.527 . . . . 0.0 109.74 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.77 -47.63 29.9 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 84.7 mt -57.77 -44.05 85.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.044 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.76 -47.77 70.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.031 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB2' HD23 ' A' ' 17' ' ' LEU . 68.4 mtt180 -84.53 1.62 44.92 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.96 7.37 6.04 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 118.786 -1.673 . . . . 0.0 116.324 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.4 t -81.44 127.73 39.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 118.148 0.974 . . . . 0.0 108.722 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -102.48 159.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.4 p -114.88 137.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -141.05 139.82 34.16 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.247 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.15 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.05 170.24 12.09 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 123.098 2.532 . . . . 0.0 111.762 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.76 66.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.269 42.1 p90 -72.75 -43.77 62.47 Favored 'General case' 0 C--O 1.255 1.391 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.33 -33.07 55.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.607 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.3 m -66.38 -28.2 68.45 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.299 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.4 tt0 -66.13 -40.02 90.32 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.23 87.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.901 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.2 -46.09 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.783 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.446 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 3.6 mmt -63.46 -42.75 98.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.41 -35.06 65.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.477 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.85 88.46 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -66.22 -42.02 89.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.23 0.612 . . . . 0.0 109.899 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.91 -42.53 94.66 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.977 0.911 . . . . 0.0 111.251 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.35 -10.65 51.61 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.599 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.95 39.63 19.93 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -175.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.17 178.65 5.93 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.574 -1.648 . . . . 0.0 112.689 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.99 125.62 35.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 47.0 tp -102.49 123.25 45.9 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.046 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.49 113.69 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.07 160.07 40.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.754 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.52 -29.48 7.16 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.5 138.78 37.65 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.775 -0.77 . . . . 0.0 113.021 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -46.19 -55.49 7.03 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 126.833 2.053 . . . . 0.0 110.931 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.92 -37.58 64.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.964 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.81 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.47 0.481 . . . . 0.0 110.399 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -45.31 96.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.124 0.488 . . . . 0.0 109.857 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -64.56 -40.24 95.2 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.797 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 2.5 tmtm? -68.68 -39.28 80.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.322 0.582 . . . . 0.0 109.684 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.64 85.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.69 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -66.4 -35.07 79.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.405 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.6 mt-10 -58.13 -40.91 82.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.463 0.705 . . . . 0.0 110.187 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.06 -11.05 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.639 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.79 47.47 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.468 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.11 139.15 18.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.5 90.3 6.23 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.632 0.73 . . . . 0.0 110.694 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -103.6 131.17 50.98 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.498 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.6 154.95 79.9 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 123.458 0.474 . . . . 0.0 111.309 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.9 Cg_exo -70.07 160.5 49.41 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.664 2.243 . . . . 0.0 111.373 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.9 -43.69 89.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.7 -24.95 67.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -45.4 62.29 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -43.53 95.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.301 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.46 -40.22 93.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.899 0.48 . . . . 0.0 111.205 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 -21.73 63.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.783 -178.034 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 C--O 1.239 0.506 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.57 154.46 20.6 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 120.891 0.377 . . . . 0.0 110.755 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -135.69 111.2 9.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.57 130.27 41.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.29 127.73 47.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.104 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -93.7 153.44 41.14 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.87 -20.78 13.82 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 123.521 2.814 . . . . 0.0 114.571 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -64.0 -29.86 70.98 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 120.621 0.248 . . . . 0.0 110.684 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.87 11.28 16.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -74.26 148.68 41.28 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.169 0.509 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 -35.65 3.29 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -90.0 -7.43 54.0 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.1 tp -45.15 -39.4 6.07 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 128.281 2.632 . . . . 0.0 112.36 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.82 -28.98 60.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -71.7 -48.82 44.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.565 0.221 . . . . 0.0 110.914 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.464 ' CG2' HG23 ' A' ' 104' ' ' ILE . 21.5 pt -64.32 -38.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.498 0.666 . . . . 0.0 111.133 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 48' ' ' ARG . 41.7 tp -73.7 -49.68 24.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.209 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.71 -33.05 28.53 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 114.596 0.599 . . . . 0.0 114.596 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -86.12 -30.65 22.37 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.791 0.796 . . . . 0.0 112.256 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -103.83 -57.73 1.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.193 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 23' ' ' TYR . 5.0 mmpt? 56.95 -137.1 1.04 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 21' ' ' LYS . 34.5 t30 70.19 -14.95 0.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.906 0.882 . . . . 0.0 112.991 171.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 21' ' ' LYS . 98.6 m-85 -129.84 159.8 35.46 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -96.01 102.98 14.84 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 92.4 m-85 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.571 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.67 139.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.514 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -128.4 153.8 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.502 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 22.8 p -100.07 175.71 5.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -39.24 87.56 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.32 -20.5 60.78 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.373 0.606 . . . . 0.0 110.064 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.46 -54.9 5.83 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.842 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -60.54 -38.81 79.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -66.51 -36.49 82.85 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.446 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -69.27 -39.85 78.13 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.29 83.15 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.88 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.3 mm -65.5 -52.86 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.884 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.06 -27.85 67.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -90.45 -0.36 57.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.44 95.95 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.443 -0.408 . . . . 0.0 112.837 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -94.52 148.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.93 83.1 0.66 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.738 0.78 . . . . 0.0 111.076 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -23.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.561 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -66.67 -37.86 85.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 t -65.85 -33.83 76.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.45 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.34 -51.42 44.72 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 91.8 mt -54.88 -46.93 74.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.855 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.38 -43.43 96.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.702 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HB2' HD23 ' A' ' 17' ' ' LEU . 98.7 mtt180 -78.89 0.51 27.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.82 3.19 7.74 Favored Glycine 0 N--CA 1.458 0.144 0 C-N-CA 119.24 -1.457 . . . . 0.0 115.665 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 60.2 t -82.22 127.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 117.827 0.814 . . . . 0.0 109.438 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.4 pt -104.49 144.76 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 6.3 p -97.42 120.98 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -122.92 126.36 47.11 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.768 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.355 -179.378 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 120.146 0.022 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.74 161.39 24.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.409 2.739 . . . . 0.0 114.578 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.43 -33.04 69.24 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.432 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.273 6.7 p90 -61.52 -32.48 72.53 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -79.35 -36.65 39.07 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.505 176.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 74' ' ' MET . 14.6 m -54.72 -51.73 64.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.722 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.7 tt0 -61.38 -43.53 98.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.185 0.303 . . . . 0.0 110.595 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.83 -51.4 69.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.338 0.59 . . . . 0.0 110.286 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.55 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.417 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 70' ' ' SER . 6.5 mmt -68.25 -38.44 81.81 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.868 -0.52 . . . . 0.0 111.196 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.33 -38.06 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.614 0.721 . . . . 0.0 109.71 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.76 73.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.115 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -71.87 -43.46 65.43 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.703 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.94 -30.53 67.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.652 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.91 -15.01 26.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 t30 55.2 61.97 2.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.99 -177.57 3.4 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.662 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.3 mt -90.0 147.82 23.45 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.62 133.73 55.67 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.359 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.1 mt -111.21 117.87 56.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.89 154.51 40.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.912 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.94 -37.26 12.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.328 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.16 130.67 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.196 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -62.59 -35.42 79.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.826 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -76.6 -36.6 57.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.124 0.42 . . . . 0.0 109.969 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.36 -44.85 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.96 -45.1 95.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.111 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.6 t30 -57.73 -52.88 63.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.346 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -56.76 -43.08 80.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.696 0.799 . . . . 0.0 110.756 -178.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.3 -47.53 76.3 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.114 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -69.81 -27.61 65.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.513 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.1 mt-10 -70.6 -23.27 62.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 110.472 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.59 -18.39 33.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.523 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.2 11.99 18.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.104 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.79 131.32 46.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -78.17 95.91 5.06 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.288 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.78 130.01 42.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.892 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.45 153.55 80.47 Favored Pre-proline 0 C--N 1.29 -2.0 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.76 164.27 29.97 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.21 1.94 . . . . 0.0 111.711 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 64.1 mt -65.75 -43.93 93.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.65 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -66.49 -25.29 66.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.841 0.353 . . . . 0.0 111.448 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -41.78 66.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.254 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.21 -39.22 93.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 92.7 mt -65.23 -45.25 85.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.512 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.12 71.37 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.686 0.794 . . . . 0.0 112.547 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.327 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 C--O 1.248 0.993 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -89.51 154.72 19.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 120.901 0.381 . . . . 0.0 110.003 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.55 110.43 9.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.5 t -91.92 129.33 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 HG22 ' CD2' ' A' ' 13' ' ' LEU . 65.0 mt -93.1 128.01 44.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -93.15 138.5 23.16 Favored Pre-proline 0 N--CA 1.419 -2.023 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 22.7 Cg_exo -39.03 -31.7 0.28 Allowed 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 125.047 3.832 . . . . 0.0 117.003 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 p -65.96 -22.49 66.48 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.606 0.639 . . . . 0.0 112.238 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 10.27 21.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.517 0.727 . . . . 0.0 112.069 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-30 -68.44 152.67 45.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.397 0.618 . . . . 0.0 112.605 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.17 -34.11 4.07 Favored Glycine 0 N--CA 1.46 0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.783 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.21 7.07 44.75 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.015 0.912 . . . . 0.0 109.322 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 5' ' ' ILE . 76.1 mt -51.51 -49.44 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 110.636 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.07 -20.47 63.22 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.654 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.19 -55.65 6.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.53 -42.39 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 48' ' ' ARG . 3.4 mp -54.82 -51.92 64.31 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.577 0.751 . . . . 0.0 111.702 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.36 -33.13 29.32 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.057 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 m -71.89 -38.24 70.0 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.709 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -102.65 -59.35 1.72 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.623 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.46 -168.13 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 71.36 -13.39 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -107.14 143.95 34.57 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -88.83 103.91 16.43 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CB ' HG21 ' A' ' 50' ' ' VAL . 94.5 m-85 -74.94 138.55 42.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.706 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.84 135.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.04 153.9 32.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.3 p -94.98 172.02 8.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 120.934 0.397 . . . . 0.0 111.466 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -65.81 -44.22 86.3 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.38 -25.24 63.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.62 -52.6 28.99 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.9 m -61.5 -36.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.977 0.389 . . . . 0.0 110.835 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -67.37 -38.87 85.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -64.99 -38.5 91.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.952 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.43 -51.1 68.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.181 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 32' ' ' VAL . 50.3 mm -55.82 -50.5 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.607 0.567 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -71.2 -21.51 62.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -95.05 -4.44 46.43 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.365 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.21 54.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.109 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -103.24 133.15 47.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -76.01 108.25 8.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.23 1.014 . . . . 0.0 111.58 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.9 tp -98.8 -22.47 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.47 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.75 -27.44 66.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.391 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.641 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.2 t -70.38 -31.79 69.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -47.7 38.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 81.9 mt -54.7 -43.55 72.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.315 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.43 -33.94 74.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.443 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 44' ' ' SER . 33.7 mtt180 -85.49 -4.16 59.08 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.864 -0.735 . . . . 0.0 112.201 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.81 17.74 2.77 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.437 -1.364 . . . . 0.0 114.447 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' CB ' ' A' ' 25' ' ' PHE . 59.3 t -89.24 124.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.3 pt -99.11 161.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.4 127.19 61.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -132.44 125.31 30.43 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.883 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.634 175.491 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -82.54 151.35 15.11 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.086 1.858 . . . . 0.0 111.505 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.98 -30.09 71.32 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -63.12 -32.71 74.15 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.495 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.3 mt-10 -89.6 -24.96 21.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.736 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 t -62.3 -40.05 95.01 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -57.23 -47.46 81.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.136 0.974 . . . . 0.0 108.598 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.12 87.13 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.219 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 69' ' ' GLU . 65.5 mt -59.98 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.485 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 15.2 mmt -63.95 -40.55 96.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.051 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.56 -40.59 84.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.68 70.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -77.22 -42.36 37.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.729 0.811 . . . . 0.0 110.212 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.48 -49.04 79.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.423 1.089 . . . . 0.0 110.102 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.73 -18.96 28.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.917 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 59.08 68.96 0.76 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.85 -177.21 3.35 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.468 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.01 137.75 33.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.66 116.12 31.38 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.136 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.43 110.29 23.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -137.49 146.83 44.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.223 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.1 -22.79 16.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.08 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.52 124.71 31.7 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -74.36 -16.45 60.9 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -81.19 -35.42 31.4 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.447 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.79 -44.34 97.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.709 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.79 -51.83 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.459 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 10.0 t30 -59.29 -46.13 89.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.35 -49.67 76.39 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 124.393 1.077 . . . . 0.0 110.202 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.16 79.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.051 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 38.0 ttmt -64.95 -34.98 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.9 mt-10 -61.61 -34.31 75.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.502 0.668 . . . . 0.0 109.811 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.8 -1.53 52.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.554 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.84 58.25 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.45 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 65.2 t -96.96 141.95 14.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -89.16 97.93 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.293 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.9 131.27 46.86 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.78 151.27 65.48 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 123.567 0.542 . . . . 0.0 111.013 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 6.8 Cg_exo -71.86 166.04 30.73 Favored 'Trans proline' 0 C--O 1.253 1.274 0 C-N-CA 122.226 1.951 . . . . 0.0 111.095 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 45.5 mt -58.46 -40.52 78.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -63.55 -23.04 67.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.871 0.367 . . . . 0.0 111.785 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 34.2 mm-40 -78.1 -35.15 49.61 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.18 -37.22 75.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.1 mt -64.52 -40.56 95.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 109.8 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.89 -18.45 62.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.395 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.554 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.82 144.72 26.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.752 0.31 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -129.73 109.88 11.32 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 41.0 t -92.61 133.88 32.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.85 121.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.78 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -82.63 149.3 60.29 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.575 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 52.0 Cg_exo -56.47 -15.75 16.33 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.604 2.869 . . . . 0.0 114.861 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 p -71.92 -20.78 61.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.0 111.261 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.67 11.82 31.98 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.637 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.584 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 8.7 m-30 -65.94 147.61 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.86 -34.69 3.83 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.973 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.0 mmmt -90.07 -1.09 57.9 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.583 0.353 . . . . 0.0 111.29 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.584 ' CD1' ' HA ' ' A' ' 10' ' ' PHE . 7.9 mp -54.25 -35.77 62.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.429 0.633 . . . . 0.0 111.401 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -38.52 88.4 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.836 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.33 -38.95 33.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.4 pt -67.02 -35.26 74.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 13' ' ' LEU . 5.0 mp -57.23 -55.52 33.73 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.747 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.38 -33.35 53.42 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -76.98 -40.28 47.38 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.089 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.87 -52.67 3.25 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.545 -1.262 . . . . 0.0 111.803 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 59.51 -178.97 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 73.01 -14.64 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.59 1.556 . . . . 0.0 112.869 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -89.42 148.35 23.52 Favored 'General case' 0 CA--C 1.492 -1.281 0 O-C-N 121.75 -0.594 . . . . 0.0 109.398 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -91.94 98.29 11.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.6 m-85 -74.81 125.35 28.61 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.897 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.6 t -118.94 136.28 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.07 144.04 39.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -81.62 169.58 16.86 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.395 0.617 . . . . 0.0 112.565 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 p -67.62 -36.47 80.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.79 -31.0 70.57 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.54 -50.55 42.62 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.247 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.3 m -61.74 -40.53 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 117.369 0.585 . . . . 0.0 112.007 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -69.89 -39.26 76.36 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.51 0.195 . . . . 0.0 110.617 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.05 -42.3 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.04 61.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.7 mm -53.85 -51.37 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.968 0.507 . . . . 0.0 112.085 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -67.86 -22.15 65.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -95.89 -3.9 44.52 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.84 34.97 55.34 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.877 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.17 137.18 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.08 94.07 1.87 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.2 tp -101.86 -20.34 5.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.82 -41.83 97.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.268 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.5 m -71.02 -24.91 62.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.999 0.428 . . . . 0.0 111.058 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.98 -47.36 59.34 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 85.3 mt -56.32 -40.27 74.14 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.234 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.58 -39.42 87.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.803 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 44' ' ' SER . 95.8 mtt180 -83.34 -1.9 54.44 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.96 2.54 7.19 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 114.714 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 65.5 t -76.05 120.33 25.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -97.95 140.42 18.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.233 0.54 . . . . 0.0 110.55 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -91.44 119.23 38.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -148.08 138.8 23.06 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.99 0.424 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.108 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.99 159.03 53.77 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.71 2.273 . . . . 0.0 109.888 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -62.7 -40.14 96.2 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -58.68 -37.62 76.43 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -71.03 -40.17 71.88 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 74' ' ' MET . 19.2 m -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.61 -37.81 87.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.37 89.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.555 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.27 -45.43 89.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.462 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 7.8 mmt -60.83 -45.54 94.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.699 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.39 -39.65 84.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 110.27 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.47 71.55 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.93 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -75.42 -27.07 58.85 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.596 0.758 . . . . 0.0 110.537 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 74' ' ' MET . 31.9 mm-40 -77.04 -42.85 36.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.479 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.26 -9.23 42.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.23 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t30 55.73 57.25 5.38 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.12 175.01 6.25 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.747 -170.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.06 121.63 30.69 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 tp -101.9 121.11 41.5 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.072 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.84 110.25 28.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.5 147.66 34.84 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.252 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -95.97 -26.24 15.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.254 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.89 131.22 37.4 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.069 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.54 -33.75 74.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -76.39 -30.75 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.11 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.301 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.69 -47.14 86.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.13 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -58.07 -54.75 43.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.251 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -61.24 -44.93 96.46 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.593 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.7 98.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 37.9 ttmt -68.94 -28.09 66.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.9 mt-10 -64.4 -33.52 76.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.39 -3.86 57.94 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.092 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.36 59.92 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.537 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.6 t -81.64 135.08 25.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.03 96.17 8.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.672 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 133.7 51.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.502 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.74 156.48 62.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.333 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.4 Cg_exo -72.93 162.4 41.12 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.322 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.432 HD13 ' HB2' ' A' ' 12' ' ' LYS . 69.3 mt -55.98 -44.68 79.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -72.0 -16.53 62.07 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.83 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.28 -27.63 27.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.743 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.86 -38.2 79.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.5 -14.57 60.84 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.517 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.79 -35.44 14.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.444 -0.765 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.587 -178.533 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -87.89 155.58 19.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.275 0.56 . . . . 0.0 110.816 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -138.1 110.4 7.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -92.84 128.95 44.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.92 126.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 t -91.74 145.7 31.64 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 84.5 Cg_exo -50.85 -28.22 22.86 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 123.954 3.102 . . . . 0.0 115.103 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 p -60.56 -34.45 74.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.23 12.15 7.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.508 0.723 . . . . 0.0 112.825 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 10.5 m-30 -67.99 165.83 17.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.726 0.774 . . . . 0.0 112.754 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.73 -35.3 3.07 Favored Glycine 0 C--O 1.215 -1.081 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.214 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -113.13 14.78 19.55 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.659 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.29 -35.17 79.45 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.314 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -67.05 -40.68 87.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.7 -51.5 64.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.633 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.3 pt -60.31 -39.48 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.9 0.381 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -65.71 -48.32 72.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.065 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.19 -33.75 43.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -86.21 -36.23 19.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.488 0.644 . . . . 0.0 111.627 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.5 -53.96 4.68 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.945 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 59.16 -174.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.364 0.602 . . . . 0.0 111.364 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 -13.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.809 1.244 . . . . 0.0 114.011 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.8 154.57 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.3 tpmt? -91.66 97.97 11.35 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.3 m-85 -74.81 129.36 37.55 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.49 138.06 51.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.973 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -126.46 152.47 34.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 41.9 p -90.88 169.32 11.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.108 -0.37 . . . . 0.0 111.246 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.3 p -67.83 -41.84 82.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.482 0.658 . . . . 0.0 109.687 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.61 -34.43 78.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.139 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.7 -57.66 16.65 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.998 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 36' ' ' ILE . 29.3 m -59.73 -39.34 79.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 27.0 m -66.11 -36.22 82.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.76 0.314 . . . . 0.0 111.118 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -69.21 -40.13 78.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.65 84.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.773 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.2 mm -57.37 -57.68 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.223 0.327 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.7 ptpp? -65.07 -24.37 67.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 t -93.96 -8.2 40.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.371 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.84 34.34 43.33 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.665 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 10' ' ' PHE . 84.2 mt -91.54 143.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.76 95.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 111.195 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.05 -28.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.32 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.07 -39.82 94.91 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 5.5 m -67.67 -30.88 70.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.292 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.1 -51.05 42.59 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -38.11 85.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 44' ' ' SER . 10.6 t70 -52.77 -45.51 67.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.631 1.172 . . . . 0.0 112.051 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -82.78 -9.81 59.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.416 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.11 19.09 4.42 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.257 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.9 t -73.13 132.18 33.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.66 145.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.639 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.0 t -96.11 132.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' THR . 23.3 ttm180 -153.25 138.65 17.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.07 147.25 91.63 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 122.527 2.152 . . . . 0.0 110.174 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.59 -34.7 77.53 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.296 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.252 10.4 p90 -64.08 -35.85 82.08 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.705 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 73' ' ' ILE . 72.0 mm-40 -71.97 -40.3 68.71 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 74' ' ' MET . 35.8 m -61.5 -38.19 86.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.922 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -58.78 -44.39 90.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.82 97.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 69' ' ' GLU . 64.2 mt -59.63 -46.21 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.03 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.473 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 13.4 mmt -62.86 -45.17 93.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.625 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.42 -40.44 89.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 120.848 0.356 . . . . 0.0 110.606 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.69 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.203 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.52 -38.45 68.06 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.628 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -49.77 46.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.827 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.08 -14.11 58.09 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.021 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.6 m120 60.44 65.83 1.01 Allowed 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.871 1.32 . . . . 0.0 108.48 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.56 171.43 8.37 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 113.206 -1.815 . . . . 0.0 110.04 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -84.54 133.33 34.45 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -101.94 116.38 32.57 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.015 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.4 mt -96.34 110.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -134.49 154.99 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.59 -31.0 11.05 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.04 122.34 25.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.148 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 10.8 mptt -69.42 -25.96 64.39 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.63 -29.82 33.05 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.6 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.24 -49.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.77 -44.32 81.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.208 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -55.33 -56.0 25.05 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.354 1.462 . . . . 0.0 111.412 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.96 86.33 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -76.54 -18.61 58.6 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.97 -28.24 68.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.58 -18.48 33.22 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.93 13.64 15.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.969 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.74 127.97 46.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -76.41 89.89 3.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.726 0.774 . . . . 0.0 109.484 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.99 129.31 43.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.174 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.22 148.74 67.67 Favored Pre-proline 0 C--N 1.291 -1.96 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.14 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.3 Cg_exo -68.84 167.76 22.25 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.72 2.28 . . . . 0.0 111.68 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.64 -50.05 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.097 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.76 -36.58 72.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 56.6 mm-40 -69.51 -37.82 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.524 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.92 -44.54 84.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.37 -43.44 92.86 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.31 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.74 -27.42 69.19 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.138 0.575 . . . . 0.0 111.78 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 121.303 0.573 . . . . 0.0 110.632 -178.454 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -87.75 160.14 18.19 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.947 0.403 . . . . 0.0 110.406 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.28 114.95 11.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.15 131.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.185 0.517 . . . . 0.0 109.778 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.1 mt -97.49 130.24 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -94.57 149.02 35.89 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 88.2 Cg_exo -50.96 -27.37 20.89 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.657 2.905 . . . . 0.0 114.94 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -64.25 -24.53 67.7 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 120.975 0.417 . . . . 0.0 112.061 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 6.52 43.2 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.643 0.377 . . . . 0.0 111.688 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 15.1 m-30 -68.76 154.33 42.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -34.47 3.48 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.016 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -98.95 11.87 37.64 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.004 0.907 . . . . 0.0 109.662 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.71 -36.37 74.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.296 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.741 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.17 -59.2 2.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.578 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.6 pt -57.18 -45.59 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.97 -42.6 84.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.331 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.89 -33.16 34.28 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.593 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 m -77.27 -45.89 24.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.883 0.373 . . . . 0.0 111.507 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -93.9 -58.41 2.26 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.254 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 57.69 -146.32 0.55 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.0 -14.02 0.25 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -117.77 157.48 26.47 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -90.63 102.67 15.42 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -75.06 120.38 20.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.843 0.83 . . . . 0.0 110.545 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.31 133.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.653 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.39 153.6 28.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.564 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 24.7 p -90.75 170.55 10.03 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -67.96 -38.64 83.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.943 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -73.04 -29.74 63.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.31 -56.18 25.0 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.578 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.9 m -60.82 -38.39 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.735 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 44.3 t -64.45 -40.33 95.51 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.811 0.339 . . . . 0.0 110.627 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.88 -38.92 87.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.91 86.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.379 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.2 mm -55.3 -56.81 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.6 0.562 . . . . 0.0 111.337 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 33' ' ' SER . 14.4 pttm -66.49 -30.27 70.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -87.41 -0.73 57.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.545 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.58 95.49 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.07 147.8 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 123.566 0.746 . . . . 0.0 109.18 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.2 89.25 0.64 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.153 0.502 . . . . 0.0 110.922 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -102.84 -32.65 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -60.56 -39.29 87.43 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -30.62 71.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.274 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.95 -48.6 23.6 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.57 -41.93 95.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.249 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.68 -21.73 64.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.609 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -92.9 -7.95 44.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.94 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 5.82 6.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 115.248 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.63 129.72 36.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.149 0.974 . . . . 0.0 108.848 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.1 pt -104.88 152.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.18 124.35 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -122.41 124.76 44.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 171.345 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.512 -0.498 0 CA-C-O 119.84 -0.124 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.84 153.66 76.84 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.981 1.788 . . . . 0.0 109.601 173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.85 -32.92 74.84 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -60.36 -40.46 90.86 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.58 -40.99 69.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -63.66 -37.88 89.03 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.325 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.564 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.7 tt0 -61.75 -40.83 96.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.06 89.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.511 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.19 -44.32 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.505 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 12.6 mmt -64.51 -40.05 94.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.67 -38.03 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.088 0.47 . . . . 0.0 110.067 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.18 -32.52 74.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -73.67 -35.96 65.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.313 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.95 -46.71 67.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.672 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.87 -17.77 39.75 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.03 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.54 69.19 0.7 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.21 176.18 7.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.721 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -85.86 134.49 33.9 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -101.97 122.62 44.4 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.459 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.36 113.47 36.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.22 159.54 42.49 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.95 -24.54 11.58 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.65 135.71 33.3 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.594 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -59.49 -38.52 81.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.078 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.38 -34.11 67.71 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.95 -53.08 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.625 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.3 -43.13 85.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.098 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -70.73 -41.65 71.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 40.3 tptt -65.87 -39.78 91.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.094 0.473 . . . . 0.0 110.311 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.47 98.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.08 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -71.74 -20.44 61.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.516 ' OE1' ' HD2' ' A' ' 93' ' ' LYS . 42.3 mt-10 -72.93 -31.8 64.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.27 -14.53 57.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.535 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.26 44.82 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.954 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.97 133.81 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -79.85 93.47 5.64 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.45 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.61 130.14 41.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.578 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.21 139.2 34.16 Favored Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.479 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 25.6 Cg_exo -61.28 159.98 28.8 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.321 2.014 . . . . 0.0 110.453 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 45.6 mt -56.09 -40.54 64.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -30.07 70.99 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.89 -33.57 59.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.782 0.325 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.51 -43.39 80.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 85.7 mt -63.43 -42.59 98.7 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.01 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.0 110.877 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.443 -0.779 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.467 178.513 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -86.77 146.04 26.4 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -130.91 113.55 14.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.74 134.57 30.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -95.97 128.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 85' ' ' ALA . 1.4 t -82.47 144.4 49.46 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.355 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 Cg_exo -58.07 -26.76 76.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.91 2.407 . . . . 0.0 112.452 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.411 ' HG ' ' CD ' ' A' ' 69' ' ' GLU . 49.0 m -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.151 0.5 . . . . 0.0 110.547 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.82 -0.1 49.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.615 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 16.3 m-30 -63.2 153.01 35.89 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.426 0.631 . . . . 0.0 112.362 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.59 -35.38 3.5 Favored Glycine 0 C--N 1.31 -0.915 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.166 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -99.05 3.67 46.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.76 1.267 . . . . 0.0 108.397 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.4 -34.92 78.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.038 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -61.66 -34.35 75.57 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.232 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.82 -62.66 1.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.822 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.446 ' CG2' HG21 ' A' ' 104' ' ' ILE . 29.9 pt -53.43 -40.37 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.5 -54.88 33.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.152 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.77 -30.47 13.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.175 -1.012 . . . . 0.0 114.134 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -78.54 -29.62 46.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 122.429 -0.454 . . . . 0.0 110.911 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -114.81 -55.04 2.52 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.913 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 51.6 tttp 58.01 -140.19 0.79 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 66.4 t30 69.93 -13.36 0.42 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 124.793 1.237 . . . . 0.0 113.949 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.54 161.22 18.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.695 -0.628 . . . . 0.0 109.737 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.95 102.35 14.71 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.49 124.04 26.48 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.359 0.6 . . . . 0.0 111.446 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.86 134.61 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.025 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.3 tp -121.14 149.47 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 24.1 p -85.86 168.63 14.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.584 0.707 . . . . 0.0 112.506 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.76 95.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.291 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.93 -30.52 58.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.93 -54.65 35.77 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.947 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.2 m -60.56 -42.42 91.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.475 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 m -63.16 -41.79 99.32 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.859 0.362 . . . . 0.0 111.378 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.02 -43.43 98.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.307 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.199 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 32' ' ' VAL . 31.8 mm -59.25 -52.53 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.805 0.442 . . . . 0.0 111.088 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -12.89 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -98.48 -16.01 19.37 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.19 41.36 13.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.192 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.4 mt -100.41 157.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.86 83.74 0.11 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.905 0.482 . . . . 0.0 111.364 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.3 tp -107.13 -31.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -71.09 -37.44 72.42 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.882 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.9 m -65.29 -28.92 69.67 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.934 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.99 -50.08 13.97 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.75 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 80.5 mt -57.88 -40.74 80.98 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.806 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.89 -49.61 65.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.883 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -82.09 -0.62 45.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.04 0.68 8.17 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 118.609 -1.757 . . . . 0.0 115.026 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.48 126.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 pt -104.53 148.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -96.03 137.98 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' NE ' HD22 ' A' ' 79' ' ' LEU . 37.8 ttt85 -147.91 136.11 21.34 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.266 0.555 . . . . 0.0 111.499 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -1.982 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.525 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.53 161.25 46.69 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.396 2.064 . . . . 0.0 111.042 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -56.46 -40.18 74.41 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.746 0.818 . . . . 0.0 112.623 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -62.68 -36.59 83.39 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' CD ' ' HG ' ' A' ' 8' ' ' SER . 73.9 mm-40 -75.4 -37.62 60.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -59.93 -44.8 94.14 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.463 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.3 tt0 -61.94 -37.88 86.38 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.88 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.87 97.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.32 -44.1 83.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.385 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.471 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 23.2 mmt -60.92 -42.5 98.24 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.55 -40.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.134 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.02 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.295 0.569 . . . . 0.0 110.136 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.66 -44.07 74.88 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.439 1.096 . . . . 0.0 110.62 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -74.19 -27.22 60.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.072 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 HD22 ' NE ' ' A' ' 53' ' ' ARG . 93.1 mt -88.75 -19.13 26.44 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.06 48.86 6.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.98 176.92 5.93 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.819 -1.537 . . . . 0.0 112.243 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.94 128.03 36.14 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.2 tp -103.57 119.06 38.15 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.483 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.9 mt -94.58 110.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -126.11 173.45 9.2 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.0 -60.33 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.44 136.19 57.44 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.34 0.59 . . . . 0.0 111.232 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.34 -35.37 71.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.151 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.25 -31.07 54.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.111 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.39 -43.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.43 -49.52 82.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.739 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.16 -52.72 64.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.62 -33.23 75.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 -46.78 77.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.436 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.43 -20.94 61.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.82 -39.1 93.42 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.696 0.76 . . . . 0.0 109.176 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.57 -3.57 57.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.265 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.14 10.81 59.3 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.916 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.23 126.1 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.39 95.3 3.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.176 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.44 143.93 29.13 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.027 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -141.0 152.27 64.69 Favored Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 123.728 0.643 . . . . 0.0 110.445 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.94 159.45 53.23 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.54 1.493 . . . . 0.0 109.848 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.446 HG21 ' CG2' ' A' ' 16' ' ' ILE . 75.4 mt -54.89 -43.65 69.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.51 -32.38 54.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 120.954 0.406 . . . . 0.0 110.186 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.52 -37.9 71.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.2 -35.64 81.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 -9.22 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.249 0.547 . . . . 0.0 111.094 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.443 -0.82 0 CA-C-O 121.444 0.64 . . . . 0.0 109.735 176.623 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.244 0.767 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -87.42 155.67 19.92 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.79 109.15 9.45 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 83' ' ' LEU . 59.2 t -92.37 129.23 43.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.8 mt -96.96 133.99 36.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.573 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -91.7 147.13 34.46 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.521 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 45.5 Cg_exo -56.16 -21.45 35.48 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.219 2.613 . . . . 0.0 114.561 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -67.81 -25.67 65.69 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 122.094 -0.379 . . . . 0.0 111.729 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 19.57 8.83 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.025 0.53 . . . . 0.0 111.866 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.1 m-30 -72.33 168.09 19.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 -34.87 3.38 Favored Glycine 0 C--O 1.217 -0.943 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.357 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 16' ' ' ILE . 13.4 mmmm -100.12 21.22 13.17 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.414 0.626 . . . . 0.0 110.098 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 -27.32 68.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.711 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -43.54 22.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -66.26 -46.24 77.73 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.457 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 12' ' ' LYS . 30.6 pt -64.88 -34.48 70.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.398 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 9.5 tp -66.65 -55.04 17.05 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.167 0.508 . . . . 0.0 109.671 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.4 -33.17 61.59 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.3 m -82.81 -48.1 11.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 117.358 0.579 . . . . 0.0 111.214 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.21 -59.07 2.29 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.668 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 75.1 tttt 59.7 -162.21 0.26 Allowed 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.448 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 43.1 m-80 73.86 -0.51 3.34 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 170.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -123.18 152.42 41.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.13 104.34 16.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -74.69 131.27 40.73 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.689 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 58.6 t -127.76 138.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.331 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.27 150.59 30.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -84.01 163.15 20.1 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.14 0.495 . . . . 0.0 111.415 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -62.56 -34.37 76.8 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.351 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.06 -32.64 63.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.03 67.51 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.108 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.9 m -61.35 -39.34 82.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.717 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -65.32 -37.54 87.41 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.693 0.282 . . . . 0.0 111.085 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.23 -42.23 88.96 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.446 0.641 . . . . 0.0 109.471 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.64 90.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.774 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' VAL . 40.8 mm -61.27 -50.58 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.572 0.349 . . . . 0.0 111.043 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -64.73 -35.78 82.18 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.3 t -80.45 -28.33 37.68 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.59 40.91 6.62 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.6 mt -95.77 149.04 4.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.14 91.72 0.23 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.725 0.774 . . . . 0.0 111.725 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.2 tp -109.59 -27.55 2.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.186 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.96 -48.21 77.35 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.332 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.593 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 3.1 m -72.77 -27.8 62.22 Favored 'General case' 0 C--O 1.204 -1.303 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -44.89 90.38 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.1 mt -60.1 -44.14 95.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.641 176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.94 -38.01 84.33 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.749 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 44' ' ' SER . 72.5 mtt85 -67.27 -19.8 65.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.71 4.11 6.88 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.85 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 61.9 t -75.98 119.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 pt -98.29 150.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 0.0 111.647 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.45 135.47 27.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -132.56 135.61 46.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -66.43 145.15 76.23 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.245 1.963 . . . . 0.0 109.958 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.51 -38.94 89.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -33.49 75.74 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -73.98 -40.77 62.74 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.9 m -60.96 -40.41 93.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.646 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.67 -38.22 90.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.768 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.78 -46.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.662 0.601 . . . . 0.0 110.092 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.491 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 8.7 mmt -61.77 -49.55 75.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.77 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.57 -41.49 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -41.55 98.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.552 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -65.36 -46.31 80.68 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.696 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.75 -43.88 97.4 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.218 0.607 . . . . 0.0 109.517 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.0 -15.99 54.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.343 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.34 43.61 4.64 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.58 178.93 5.02 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.237 -1.801 . . . . 0.0 112.288 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.0 135.21 33.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 4' ' ' VAL . 45.0 tp -111.09 122.29 47.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.495 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mt -103.13 110.21 29.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.72 155.17 48.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -108.47 -25.4 10.97 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -75.76 129.55 37.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.755 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -50.85 -50.32 57.07 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 124.683 1.24 . . . . 0.0 112.611 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.47 -27.49 34.57 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.562 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.21 -47.77 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.06 -43.86 97.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.785 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 4.4 t30 -61.56 -47.77 84.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.873 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -66.41 -36.54 83.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.124 0.487 . . . . 0.0 111.1 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.31 84.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.498 0.666 . . . . 0.0 109.871 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -72.76 -26.26 61.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 51.6 mt-10 -63.8 -36.72 84.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.101 0.56 . . . . 0.0 110.23 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.49 -18.96 43.33 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.97 27.54 6.57 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.033 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -98.27 141.17 16.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -81.17 90.75 6.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.72 0.771 . . . . 0.0 109.5 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.0 131.04 54.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.124 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -143.09 157.16 61.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 123.782 0.677 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.17 167.33 27.62 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.661 2.241 . . . . 0.0 111.981 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 79.4 mt -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.223 1.009 . . . . 0.0 113.274 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.44 -38.05 89.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 111.462 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.6 -31.19 64.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.476 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.44 -39.7 94.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 79.5 mt -68.26 -19.29 64.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.21 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.63 2.41 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.317 -0.838 0 O-C-N 121.921 -0.487 . . . . 0.0 112.007 -178.815 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.71 149.29 24.32 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.23 111.28 10.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 61.8 t -92.67 129.85 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mt -95.3 125.77 47.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.884 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -92.42 141.21 24.54 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -38.84 -32.2 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 125.074 3.849 . . . . 0.0 116.98 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.6 p -64.75 -22.97 67.1 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.754 0.706 . . . . 0.0 112.053 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.44 11.51 25.94 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.381 0.672 . . . . 0.0 111.411 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 12' ' ' LYS . 11.3 m-30 -76.28 159.63 30.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.359 0.6 . . . . 0.0 112.238 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.3 -34.97 2.2 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.403 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 10' ' ' PHE . 58.7 mtpt -96.3 13.12 28.66 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.939 0.876 . . . . 0.0 109.433 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -54.73 -39.21 68.03 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.216 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -73.13 -21.0 60.81 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.98 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -74.53 -58.39 3.32 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.34 -48.91 85.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 48' ' ' ARG . 57.6 tp -66.72 -45.96 77.01 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.941 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.16 48.75 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.292 -0.956 . . . . 0.0 114.061 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -84.79 -27.22 27.0 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.384 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -109.07 -59.1 1.94 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 119.629 -0.828 . . . . 0.0 112.089 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 59.06 -155.86 0.35 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 70.7 -15.32 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 124.847 1.259 . . . . 0.0 113.896 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -104.98 153.6 21.22 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -91.82 97.5 11.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -74.6 125.66 29.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.509 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 53.1 t -121.26 135.19 62.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.438 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.1 tt -123.45 154.38 29.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.521 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 20.4 p -89.86 167.93 12.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -45.57 92.45 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.719 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.67 -21.87 61.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -56.68 8.75 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.691 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.7 m -58.58 -38.33 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 117.323 0.561 . . . . 0.0 111.156 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -67.21 -35.05 78.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.91 -40.1 87.57 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.07 78.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.456 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' VAL . 42.7 mm -55.4 -51.15 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.999 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -12.35 61.44 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -106.78 -0.56 23.36 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.02 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.59 29.2 68.11 Favored Glycine 0 C--O 1.242 0.601 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.221 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.93 129.91 37.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.97 111.75 6.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.077 0.942 . . . . 0.0 111.049 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -116.77 -16.98 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.73 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 122.314 -0.241 . . . . 0.0 111.222 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -63.22 -32.18 73.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.14 58.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.39 -43.17 99.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.465 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.26 -43.18 74.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.695 1.198 . . . . 0.0 111.978 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.434 ' HB2' HD22 ' A' ' 17' ' ' LEU . 81.6 mtt180 -77.12 -13.59 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.26 13.38 3.56 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.265 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -81.3 133.13 29.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.2 pt -110.52 154.57 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.676 0.274 . . . . 0.0 110.593 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.2 p -107.92 136.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -127.34 133.18 50.11 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 -178.405 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 120.304 0.097 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.93 140.29 37.95 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.465 2.11 . . . . 0.0 110.688 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -45.38 -45.39 12.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.804 1.241 . . . . 0.0 113.139 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -61.17 -34.57 75.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.83 -28.23 21.76 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -64.08 -38.69 91.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.929 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.521 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.5 tt0 -62.0 -40.82 96.96 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.7 80.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.917 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.99 -45.28 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.907 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.488 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 3.7 mmt -62.55 -44.48 96.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 -177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.72 -38.4 82.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.939 0.399 . . . . 0.0 110.746 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.43 80.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.589 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -69.84 -39.43 76.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.482 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 74' ' ' MET . 12.8 mm-40 -60.09 -49.89 75.87 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.485 0.659 . . . . 0.0 111.208 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.61 -16.83 46.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.343 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 60.73 56.09 3.08 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.05 177.76 4.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.031 -1.895 . . . . 0.0 111.649 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.38 134.69 34.4 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 34.5 tp -109.19 128.71 55.25 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.452 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.1 mt -106.89 113.09 42.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.56 146.57 32.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.63 -23.52 15.44 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.13 123.94 27.47 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.768 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.56 -38.12 80.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.805 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.57 -31.29 47.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.515 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.5 t -62.9 -46.53 96.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.26 -49.56 81.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.01 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -56.14 -48.74 75.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.258 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 2.2 tmtm? -65.55 -45.9 81.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.013 0.435 . . . . 0.0 110.351 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.06 82.84 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -57.82 -42.64 84.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.439 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.9 mt-10 -60.39 -35.57 76.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.76 0.824 . . . . 0.0 111.091 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 81.6 mt -77.54 -5.61 50.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.523 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.77 7.22 63.11 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.04 128.22 44.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -82.45 97.95 8.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.616 -1.233 . . . . 0.0 110.307 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.44 127.46 37.94 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.227 174.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 102' ' ' ILE . 2.6 pp -132.61 146.65 62.32 Favored Pre-proline 0 C--N 1.28 -2.449 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.293 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 40.3 Cg_endo -71.42 167.65 25.73 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.421 2.081 . . . . 0.0 111.065 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 63.2 mt -60.18 -40.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.11 -29.56 69.9 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.283 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.2 -32.59 63.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.968 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.39 -34.88 76.82 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 93.2 mt -65.9 -40.73 91.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.185 0.517 . . . . 0.0 109.948 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.57 -25.42 63.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.317 0.579 . . . . 0.0 110.811 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.751 178.679 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -87.88 150.2 23.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.77 108.56 10.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -92.12 128.44 43.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 109.705 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.0 mt -93.94 124.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.716 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -87.2 149.01 46.28 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -59.05 -19.34 48.19 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.355 2.703 . . . . 0.0 114.4 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 p -69.1 -19.25 64.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.979 0.418 . . . . 0.0 110.941 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.49 13.52 33.06 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.282 0.633 . . . . 0.0 110.963 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.2 m-30 -71.44 153.87 41.94 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.18 -33.1 4.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.057 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.42 11.99 35.83 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.078 0.466 . . . . 0.0 111.653 -175.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.47 -32.01 69.85 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.773 0.796 . . . . 0.0 108.864 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.11 -39.68 87.06 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.319 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.46 -56.29 8.91 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.0 pt -58.62 -37.63 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.0 tp -72.94 -47.62 43.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.222 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -31.57 31.67 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.34 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -87.72 -22.51 24.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -114.84 -55.77 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.501 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 21' ' ' LYS . 8.6 mtpm? 60.78 -142.04 0.52 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -171.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 70.77 -13.86 0.46 Allowed 'General case' 0 N--CA 1.518 2.933 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.98 156.4 43.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -89.02 102.4 15.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -74.71 126.9 31.87 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.344 0.592 . . . . 0.0 110.027 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.3 t -115.69 126.66 73.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.263 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -113.89 145.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.246 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -84.79 160.44 20.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -44.22 97.43 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.968 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.78 -32.21 73.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.634 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.8 77.4 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.705 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.7 m -62.82 -41.56 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.599 0.699 . . . . 0.0 111.659 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -64.72 -36.4 84.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -67.75 -43.16 80.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.64 85.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 32' ' ' VAL . 44.2 mm -64.75 -52.67 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HZ2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -67.64 -32.53 73.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -88.54 -11.77 44.72 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.09 18.02 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.86 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.3 mt -97.0 142.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -67.73 112.66 4.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.046 0.45 . . . . 0.0 110.705 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.62 -26.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.516 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.13 -35.62 78.4 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.659 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.7 p -65.28 -38.86 91.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.485 0.66 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -52.09 63.95 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.596 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.67 -39.78 85.6 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.466 0.65 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.5 -38.42 84.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.467 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.6 mtt180 -87.04 3.48 45.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.36 2.24 7.64 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 118.73 -1.7 . . . . 0.0 115.771 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 92.6 t -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -105.62 157.34 6.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.2 p -105.86 128.13 60.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.129 0.49 . . . . 0.0 110.768 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.89 137.4 52.83 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.407 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.83 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.05 169.1 5.13 Favored 'Trans proline' 0 C--O 1.256 1.385 0 C-N-CA 122.96 2.44 . . . . 0.0 112.238 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.21 -48.53 70.92 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.501 0.72 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -63.22 -31.21 72.3 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -75.71 -42.39 50.97 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -61.57 -39.98 93.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.123 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -54.03 -50.2 67.22 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.572 1.149 . . . . 0.0 109.234 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.01 -48.97 77.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.611 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.05 -45.56 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.934 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 29.8 mmt -65.09 -38.31 90.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.68 -43.37 96.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.41 77.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.67 -39.25 80.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.631 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.64 -48.83 36.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.289 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.09 -21.55 50.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.56 69.08 0.47 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.05 170.7 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.492 -172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.27 122.86 30.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 36.8 tp -99.59 125.75 45.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.18 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.54 113.86 43.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.85 145.54 36.35 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.896 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -95.77 -29.32 14.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -83.71 124.09 30.51 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.858 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.51 -36.53 6.81 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 125.892 1.677 . . . . 0.0 114.402 179.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 23.9 t70 -79.72 -33.82 40.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.363 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.93 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.66 -46.46 93.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.916 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.3 t30 -59.54 -51.6 69.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.1 mmmt -63.01 -41.68 99.64 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.03 88.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.464 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.53 -26.18 65.3 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.026 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.2 mt-10 -69.3 -28.74 66.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.189 0.519 . . . . 0.0 109.852 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.44 0.03 56.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.703 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.77 8.76 65.01 Favored Glycine 0 C--O 1.241 0.54 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.66 128.92 43.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.25 92.69 6.38 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.157 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.56 132.41 44.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.759 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.96 155.95 76.05 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.8 Cg_exo -70.76 160.65 48.73 Favored 'Trans proline' 0 C--O 1.256 1.409 0 C-N-CA 121.999 1.799 . . . . 0.0 110.868 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.456 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.8 mt -54.76 -42.9 64.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 123.651 0.78 . . . . 0.0 111.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -63.13 -36.72 84.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.13 -33.06 69.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.975 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.95 -47.95 75.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.8 mt -63.0 -33.33 75.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.056 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.64 59.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.244 0.766 0 CA-C-O 121.328 0.585 . . . . 0.0 110.885 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 C--O 1.245 0.863 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.64 153.0 21.72 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.0 109.69 10.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.61 128.54 44.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.61 123.48 43.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 m -83.93 148.59 54.33 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.617 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 77.3 Cg_exo -53.32 -11.25 1.71 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 124.13 3.22 . . . . 0.0 114.679 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -64.25 -47.36 79.91 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.7 20.33 0.95 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.54 -171.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.617 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 4.3 m-30 -70.6 147.77 48.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.084 0.469 . . . . 0.0 111.175 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -34.32 3.53 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.58 -0.77 57.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.606 1.162 . . . . 0.0 109.605 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -47.52 -48.68 27.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.493 1.517 . . . . 0.0 111.999 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -75.12 -22.78 57.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.434 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -75.38 -52.37 10.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.417 ' CG2' HG23 ' A' ' 104' ' ' ILE . 23.7 pt -63.57 -41.45 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 48' ' ' ARG . 59.9 tp -65.38 -54.97 21.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.518 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.1 -33.6 56.78 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.225 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -79.35 -55.64 4.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.849 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -75.67 -59.06 2.92 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.017 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 60.09 -156.73 0.34 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 t30 73.11 -13.97 0.65 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.257 1.023 . . . . 0.0 113.38 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -116.35 155.16 28.94 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -90.85 101.92 14.68 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' HB2' HG21 ' A' ' 50' ' ' VAL . 87.1 m-85 -74.66 133.72 42.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.63 140.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.304 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -126.42 154.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.7 p -99.92 177.9 4.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -47.46 79.54 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 124.685 1.194 . . . . 0.0 112.133 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.61 -24.05 56.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.92 -56.42 22.67 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.044 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.2 m -61.42 -34.59 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 117.049 0.425 . . . . 0.0 111.379 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 m -67.93 -37.34 81.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.114 0.483 . . . . 0.0 110.665 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -69.24 -35.07 75.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.88 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.16 88.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.4 mm -58.81 -53.13 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HZ1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -65.21 -29.48 70.29 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 -2.74 58.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.628 0.252 . . . . 0.0 111.558 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.3 41.23 53.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.667 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.66 137.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.43 88.63 3.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.259 1.028 . . . . 0.0 111.134 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -81.8 -22.72 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.333 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -32.38 72.74 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.143 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 m -65.42 -33.44 75.96 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.267 0.556 . . . . 0.0 110.875 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.58 -47.86 16.34 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.3 -42.83 82.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.38 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.52 -41.95 86.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.717 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.412 ' HB2' HD22 ' A' ' 17' ' ' LEU . 80.7 mtt85 -79.64 -2.6 43.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.64 24.08 4.48 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.923 -1.132 . . . . 0.0 114.771 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 25' ' ' PHE . 95.6 t -86.4 126.7 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 pt -100.47 151.02 5.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.378 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.1 t -99.52 123.25 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -121.3 125.59 47.42 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.204 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.136 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -64.68 148.38 90.24 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.398 2.066 . . . . 0.0 110.068 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -58.06 -42.22 85.03 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -61.77 -35.3 77.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -81.11 -27.26 35.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.221 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -70.51 -32.12 69.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.617 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.77 -46.81 86.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.14 73.95 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.7 0.625 . . . . 0.0 111.181 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.03 -47.67 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.918 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.455 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 1.9 mmt -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.058 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.81 -39.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 120.731 0.301 . . . . 0.0 110.664 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.042 0.449 . . . . 0.0 110.532 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -71.21 -43.74 66.77 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.88 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -50.89 65.22 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 109.787 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.7 -20.34 56.7 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.89 68.47 0.57 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 179.74 4.02 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.629 -172.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.93 133.15 36.39 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 30.8 tp -108.91 127.76 54.34 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.391 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.8 mt -105.72 115.65 47.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.2 157.55 44.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.626 0.25 . . . . 0.0 110.424 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.92 -43.71 6.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.957 0.408 . . . . 0.0 110.074 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.47 126.84 31.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.474 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -62.49 -28.0 69.52 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.714 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 -39.48 58.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.18 -51.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.21 -49.9 73.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.664 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 96' ' ' GLU 0.264 0.2 OUTLIER -64.9 -42.99 94.3 Favored 'General case' 0 C--O 1.205 -1.255 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.221 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.0 mtpp -63.22 -41.54 99.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.72 99.87 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.26 0.552 . . . . 0.0 109.764 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -72.77 -26.13 61.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.698 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.8 mt-10 -64.62 -37.19 86.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.1 mt -80.82 -15.71 55.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.656 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.31 5.49 28.27 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.083 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.5 t -94.36 130.34 43.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.9 96.7 5.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.086 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.41 133.69 43.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.44 155.26 72.05 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.49 0.493 . . . . 0.0 111.171 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 23.6 Cg_exo -67.91 162.87 37.86 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.519 2.146 . . . . 0.0 112.066 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.417 HG23 ' CG2' ' A' ' 16' ' ' ILE . 84.3 mt -57.66 -46.4 86.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 123.859 0.864 . . . . 0.0 111.597 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.31 -37.71 78.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.85 -39.58 87.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.37 -46.8 81.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.81 -39.59 85.56 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.197 0.599 . . . . 0.0 110.646 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.57 -16.29 60.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.724 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.318 -0.778 0 CA-C-O 120.909 0.385 . . . . 0.0 110.274 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.24 0.581 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.86 154.49 20.49 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.5 108.99 9.95 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.7 t -93.54 134.41 31.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mt -104.56 134.24 46.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -89.08 146.9 37.35 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 70.6 Cg_exo -52.65 -28.08 35.83 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.545 2.83 . . . . 0.0 114.328 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 p -61.75 -22.86 65.76 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.97 13.23 31.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.166 0.507 . . . . 0.0 111.445 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 3.6 m-30 -69.88 160.52 31.65 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -34.33 3.65 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.687 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HB2' HD12 ' A' ' 104' ' ' ILE . 28.6 mtpp -102.18 13.85 33.56 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.781 0.801 . . . . 0.0 110.382 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.4 mt -56.93 -40.74 76.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.572 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -65.92 -26.2 67.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.024 -1.443 . . . . 0.0 111.33 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.53 -49.15 9.52 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.74 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CG2' HG23 ' A' ' 104' ' ' ILE . 19.0 pt -63.38 -46.55 95.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 111.368 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.97 -43.18 79.59 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.853 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.36 -33.19 64.52 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.196 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.1 m -83.79 -45.32 13.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.63 -53.67 3.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 23' ' ' TYR . 11.4 mptt 58.68 -114.28 0.74 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -164.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 55.94 -15.31 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 21' ' ' LYS . 96.1 m-85 -132.17 166.25 22.24 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.4 -0.813 . . . . 0.0 109.233 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -98.28 105.51 17.67 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.26 139.69 42.71 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.8 t -131.05 140.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.373 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 tp -130.0 156.96 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -91.64 169.03 11.07 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.171 0.51 . . . . 0.0 111.779 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -41.68 95.16 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.279 1.032 . . . . 0.0 110.176 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.216 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 -52.06 19.57 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.404 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 36' ' ' ILE . 32.1 m -58.58 -38.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.434 0.617 . . . . 0.0 112.001 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 47.3 p -75.78 -22.46 56.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.046 0.451 . . . . 0.0 111.34 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -69.1 -40.88 78.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 42' ' ' ILE . . . -66.45 -43.11 86.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.0 mm -57.72 -52.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.736 0.648 . . . . 0.0 111.391 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.8 ptpp? -65.51 -25.05 67.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -100.34 -28.39 12.98 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.334 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.68 41.57 3.1 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.91 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -100.45 147.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.44 97.89 0.45 Allowed 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.896 0.379 . . . . 0.0 111.511 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.6 tp -108.12 -34.29 2.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.622 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.23 -48.35 80.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.842 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 t -62.56 -37.25 85.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.839 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.5 69.72 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 87.4 mt -57.67 -45.86 85.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.68 -41.54 97.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.93 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -74.06 -8.03 54.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.27 23.18 1.78 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.151 -1.499 . . . . 0.0 115.154 175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 62.6 t -98.39 119.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -99.45 155.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 110.991 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.91 135.29 33.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -122.32 125.08 45.19 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.82 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 120.355 0.121 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 158.05 55.98 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 122.72 2.28 . . . . 0.0 111.582 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -66.07 -27.91 68.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.985 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.262 5.1 p90 -62.01 -37.09 83.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.737 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -71.29 -38.68 71.77 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 m -63.17 -40.9 98.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.699 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -65.97 -35.37 80.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.21 91.8 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.15 -45.09 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.615 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.483 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 26.6 mmt -61.67 -45.16 95.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.77 -40.66 87.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 120.876 0.37 . . . . 0.0 110.73 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.05 69.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -79.85 -27.61 40.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.323 0.582 . . . . 0.0 110.348 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.25 -48.79 21.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.09 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.69 -12.86 55.31 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.596 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 57.19 63.3 1.93 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.97 -179.92 3.8 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 113.455 -1.702 . . . . 0.0 112.308 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.34 130.83 36.39 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 4' ' ' VAL . 44.1 tp -107.55 130.25 54.89 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.301 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -111.03 115.83 50.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.84 146.18 33.9 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.42 -29.0 15.2 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.634 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.37 123.15 24.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -73.17 -17.55 61.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.699 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 34.0 t70 -81.01 -33.18 33.83 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.8 t -60.45 -41.48 87.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.748 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 82.5 mt -59.59 -50.34 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.87 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.699 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.6 p-10 -68.6 -41.47 79.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.2 mmmt -59.23 -43.98 92.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.432 . . . . 0.0 111.542 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.56 96.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.236 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 91' ' ' ILE 0.312 17.4 ptpt -74.55 -18.51 60.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.8 mt-10 -67.4 -29.79 69.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.48 -7.5 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.487 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.07 -7.19 47.97 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.235 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.21 127.21 39.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.27 95.41 3.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.523 . . . . 0.0 110.147 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.35 132.53 44.61 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.232 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.27 153.97 78.44 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 123.566 0.542 . . . . 0.0 110.392 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.7 Cg_endo -76.25 166.99 26.69 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 121.962 1.775 . . . . 0.0 111.637 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' A' ' 12' ' ' LYS . 41.7 mt -54.74 -44.72 72.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.014 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.54 -25.81 60.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.221 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.21 -44.67 68.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.26 -38.95 93.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.556 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -22.75 64.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.311 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.26 0.552 . . . . 0.0 109.912 177.803 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -87.37 149.17 24.67 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -136.55 114.09 10.98 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.1 t -98.79 132.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -99.67 131.79 46.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.108 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -92.91 148.58 36.13 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 85.2 Cg_exo -53.8 -23.19 26.04 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.502 2.801 . . . . 0.0 114.505 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 p -65.21 -24.27 67.31 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.109 -0.369 . . . . 0.0 111.683 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.423 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . . . -91.44 7.74 39.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.108 0.48 . . . . 0.0 111.46 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 9.5 m-30 -66.81 157.55 32.67 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.81 -35.8 2.09 Favored Glycine 0 C--N 1.318 -0.449 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.208 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -93.59 12.29 25.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.344 1.068 . . . . 0.0 109.366 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.48 -38.66 81.43 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.834 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -58.74 -37.85 77.13 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.196 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -74.41 -59.45 2.72 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.722 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.477 ' CG2' HG22 ' A' ' 104' ' ' ILE . 24.9 pt -59.48 -43.84 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 48' ' ' ARG . 51.4 tp -68.73 -43.9 74.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.831 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.08 -33.15 15.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.492 -0.861 . . . . 0.0 114.893 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 m -81.31 -34.46 31.9 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 117.321 0.56 . . . . 0.0 111.436 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.0 -60.39 2.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 22' ' ' ASN . 4.2 tmmm? 59.83 141.88 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 CA-C-O 122.336 1.065 . . . . 0.0 112.537 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' N ' ' HD2' ' A' ' 21' ' ' LYS 0.31 14.4 t-20 81.58 63.84 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 125.509 1.523 . . . . 0.0 114.342 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -146.11 150.27 35.59 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 164.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -87.88 92.89 9.29 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.7 m-85 -74.33 126.43 30.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.131 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.87 133.17 67.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.974 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 tp -117.08 156.93 18.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.618 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.2 p -94.12 165.22 12.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -39.35 93.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.914 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.64 -33.28 66.51 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.48 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.5 -52.4 53.36 Favored Glycine 0 N--CA 1.446 -0.661 0 O-C-N 123.869 0.73 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.7 m -63.04 -39.97 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -65.34 -40.36 93.55 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.101 0.477 . . . . 0.0 110.271 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.52 -49.08 74.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.46 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.25 73.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.799 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.0 mm -59.71 -57.25 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.273 0.358 . . . . 0.0 110.934 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -26.31 63.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -81.37 -18.66 44.8 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.423 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.21 37.24 25.28 Favored Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.424 HG22 ' HB3' ' A' ' 10' ' ' PHE . 84.4 mt -101.35 140.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.7 98.54 0.07 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.574 0.75 . . . . 0.0 111.446 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.49 -30.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.14 -49.46 77.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 23.0 t -62.91 -34.39 77.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.709 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.9 63.02 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.4 mt -60.99 -39.89 91.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.955 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.24 -39.39 92.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.308 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 44' ' ' SER . 63.2 mtt180 -79.22 -7.22 58.08 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.35 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.06 12.09 4.06 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.995 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 90.2 t -82.58 131.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 pt -108.43 148.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 p -101.89 127.98 54.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 120.885 0.374 . . . . 0.0 111.257 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -118.52 154.24 32.87 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.322 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -174.499 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--O 1.243 0.757 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.06 150.28 60.04 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.246 1.964 . . . . 0.0 109.874 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.89 -28.91 62.49 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -64.64 -33.16 75.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.632 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.55 -44.62 50.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.6 m -59.7 -38.09 80.63 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.993 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.618 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 35.7 tt0 -63.74 -40.65 97.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.89 87.83 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.13 -46.05 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.181 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.463 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 28.6 mmt -64.82 -37.59 88.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.15 -36.43 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.234 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.62 -33.35 73.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.237 0.541 . . . . 0.0 110.306 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.68 -35.93 70.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.605 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.48 -52.29 41.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.674 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.44 -15.12 53.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.811 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.78 62.85 1.8 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -170.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 177.82 4.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.813 -1.994 . . . . 0.0 111.368 -171.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.15 126.09 35.68 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.0 tp -103.02 125.74 49.9 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.499 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -107.25 118.98 56.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -147.76 159.17 44.11 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mt-10 -103.43 -25.93 13.07 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.152 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.39 126.61 31.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.076 -173.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.43 -42.09 63.82 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 124.423 1.077 . . . . 0.0 112.705 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.5 -35.27 58.45 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.586 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.77 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.99 -48.42 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -68.64 -37.49 79.74 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 31.6 mmmt -67.19 -39.2 86.33 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.46 87.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -60.23 -42.39 95.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.341 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 52.9 mt-10 -55.82 -42.59 75.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.176 0.59 . . . . 0.0 111.097 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.72 -8.49 56.96 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.987 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.54 44.1 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.08 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.26 129.46 46.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.15 92.85 6.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.451 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.93 136.0 38.85 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.606 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.24 152.23 73.11 Favored Pre-proline 0 C--N 1.293 -1.885 0 O-C-N 123.376 0.423 . . . . 0.0 110.609 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 16.9 Cg_exo -68.73 160.27 50.24 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 121.968 1.779 . . . . 0.0 110.712 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.477 HG22 ' CG2' ' A' ' 16' ' ' ILE . 53.6 mt -54.78 -42.92 64.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 123.837 0.855 . . . . 0.0 111.728 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -63.07 -25.32 68.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.991 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.59 -34.84 46.51 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.828 0.346 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.88 -41.85 95.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.9 mt -64.14 -41.76 97.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.249 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.36 33.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.637 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.057 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.246 0.881 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.8 152.93 21.74 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.91 108.28 7.81 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 26' ' ' VAL . 46.6 t -92.85 131.65 39.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -97.72 132.39 42.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.41 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -92.84 149.39 37.7 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 Cg_exo -57.07 -15.17 16.76 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 123.441 2.761 . . . . 0.0 114.961 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -75.14 -22.03 58.4 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.769 -0.582 . . . . 0.0 111.099 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.21 10.11 25.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.484 0.659 . . . . 0.0 110.995 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.9 m-30 -72.08 156.3 39.35 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.498 0.666 . . . . 0.0 111.749 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -33.7 4.88 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.741 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 57.8 mtpt -106.46 18.54 21.8 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 122.405 1.098 . . . . 0.0 109.539 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.94 -39.5 94.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.696 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -68.6 -35.21 77.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.15 -175.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 -54.57 19.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.676 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.413 ' CG2' HG22 ' A' ' 104' ' ' ILE . 24.5 pt -57.77 -39.81 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 45' ' ' ALA . 4.1 mp -59.33 -55.05 39.64 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.764 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.93 -33.42 41.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.955 -1.117 . . . . 0.0 113.718 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -77.53 -15.49 59.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -122.42 -60.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.687 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 60.23 -171.45 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.308 0.643 . . . . 0.0 111.609 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.2 -14.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.677 1.991 . . . . 0.0 115.013 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -93.05 149.32 21.31 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -90.73 99.67 12.66 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.4 m-85 -74.71 131.42 40.84 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.636 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 4' ' ' VAL . 39.5 t -122.16 136.39 59.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.593 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.65 153.32 27.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.606 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 25.6 p -92.47 166.91 12.3 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.088 0.471 . . . . 0.0 112.007 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -41.09 99.03 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.443 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.45 -31.72 69.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -56.43 24.17 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.107 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -59.99 -40.74 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -63.77 -38.32 90.68 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.72 -39.6 76.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.671 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.06 -42.14 94.48 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.4 mm -56.34 -52.63 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 123.759 0.662 . . . . 0.0 110.951 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -21.79 61.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 m -88.74 -23.58 22.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.44 41.55 6.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.886 -1.15 . . . . 0.0 111.575 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.7 mt -103.22 153.53 5.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.85 83.25 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.118 0.485 . . . . 0.0 110.561 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -93.13 -27.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 -38.47 89.14 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.44 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.2 m -72.88 -24.45 60.85 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.421 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -76.77 -52.63 9.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.185 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.19 -40.35 81.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.689 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.48 -44.82 72.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.636 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 17' ' ' LEU . 53.5 mtt85 -81.65 -5.71 58.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.44 5.2 6.67 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 118.898 -1.62 . . . . 0.0 115.146 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.95 124.82 28.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.57 0.685 . . . . 0.0 109.167 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.79 149.82 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.931 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.03 120.39 45.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -113.14 126.51 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.025 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.062 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 93' ' ' LYS . 84.8 mt . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -59.03 148.11 86.92 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.738 2.292 . . . . 0.0 111.229 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.81 -44.37 77.8 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.204 1.002 . . . . 0.0 111.307 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -63.93 -34.69 78.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 73' ' ' ILE . 26.6 mm-40 -70.36 -39.92 74.34 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -63.15 -41.04 99.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.184 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.606 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -60.31 -39.6 87.56 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.33 83.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.48 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 69' ' ' GLU . 61.5 mt -58.18 -43.64 86.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.401 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 74' ' ' MET . 19.8 mmt -67.43 -38.68 84.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.093 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.2 -39.62 84.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.358 0.599 . . . . 0.0 110.209 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.66 71.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.118 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.69 -47.03 64.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.184 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.13 -39.07 79.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 111.328 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.19 -11.43 57.87 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.332 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.46 59.26 3.38 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.76 177.11 4.89 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.148 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.42 141.47 28.71 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.2 tp -105.72 124.66 49.93 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.815 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.08 110.77 25.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -138.96 147.48 42.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.06 -28.43 12.35 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 91' ' ' ILE . 19.6 t70 -76.06 122.47 24.29 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.02 -29.54 69.77 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.621 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 23.0 t70 -79.73 -39.27 31.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.5 -44.3 88.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.067 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 87' ' ' ASP . 96.7 mt -57.62 -49.91 79.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.621 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.4 p-10 -69.57 -42.94 73.83 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.223 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 32.2 mmmt -60.52 -41.99 95.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.425 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.54 92.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 5.2 ptmm? -71.33 -25.5 62.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.035 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 44.0 mt-10 -74.02 -30.34 62.39 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 174.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 95.2 mt -79.89 -12.45 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.248 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 12.78 16.43 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.601 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 44.6 t -108.48 132.14 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.98 97.47 6.07 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 118.904 -1.118 . . . . 0.0 109.727 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.3 129.3 41.02 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.781 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.14 143.49 49.35 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.034 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 33.2 Cg_exo -61.28 158.36 35.79 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.363 2.042 . . . . 0.0 110.947 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 9.5 mt -54.06 -40.47 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.39 -20.43 65.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -76.68 -31.8 57.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.886 0.85 . . . . 0.0 109.125 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.48 -32.72 66.44 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.018 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.3 mt -79.64 -48.55 13.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.172 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.08 63.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.846 0.355 . . . . 0.0 111.788 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.796 -178.22 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.502 -0.899 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.39 153.65 21.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.65 107.69 9.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' HD13 ' A' ' 83' ' ' LEU . 46.9 t -92.38 131.73 38.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.7 mt -97.26 128.77 48.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.328 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 m -88.51 149.58 44.66 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 49.1 Cg_exo -58.03 -21.75 51.9 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.105 2.537 . . . . 0.0 113.404 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 p -68.84 -19.35 64.26 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.93 16.44 19.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.264 0.554 . . . . 0.0 111.521 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.5 m-30 -75.5 156.45 35.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.95 -34.32 5.0 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.565 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 104' ' ' ILE . 1.2 mmmp? -98.38 15.54 24.4 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.75 -38.83 86.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.129 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.62 -36.41 80.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.805 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.85 -56.08 5.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.329 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.5 pt -58.24 -41.22 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 45' ' ' ALA . 36.7 tp -72.25 -52.86 14.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.234 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.63 -31.15 58.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.84 -0.695 . . . . 0.0 114.3 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.8 m -83.3 -39.31 20.98 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 117.652 0.726 . . . . 0.0 112.231 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -91.26 -59.55 2.12 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.225 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 23' ' ' TYR . 97.5 mttt 55.8 -152.53 0.37 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -173.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 t30 70.05 -14.28 0.39 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 125.013 1.325 . . . . 0.0 112.845 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' H ' ' C ' ' A' ' 21' ' ' LYS . 80.8 m-85 -115.5 160.17 20.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 123.135 0.574 . . . . 0.0 109.63 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.6 102.07 13.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.437 ' CB ' HG23 ' A' ' 50' ' ' VAL . 57.0 m-85 -75.41 136.66 40.73 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.71 139.62 51.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.442 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 10.2 tp -127.58 158.86 38.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -96.71 168.53 10.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 122.138 -0.351 . . . . 0.0 110.404 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.8 p -68.69 -39.06 80.72 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.09 -31.8 72.53 Favored 'General case' 0 C--O 1.214 -0.807 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.92 -54.06 36.15 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.496 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.6 m -62.93 -35.12 69.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.046 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -68.4 -38.75 81.58 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -63.06 -40.52 97.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.68 96.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.376 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.7 mm -60.07 -53.91 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -93.25 -9.87 37.57 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.502 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.82 37.81 60.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.655 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.91 140.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CG ' ' HG ' ' A' ' 44' ' ' SER . 6.8 t70 -64.06 108.94 1.66 Allowed 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.819 0.699 . . . . 0.0 112.367 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.3 tp -113.73 -9.38 12.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.494 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.21 -49.01 66.14 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.113 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.436 ' HG ' ' CG ' ' A' ' 41' ' ' ASP . 5.6 m -62.21 -26.5 68.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.703 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -69.58 -57.08 5.64 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.552 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.47 -39.74 80.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.906 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.97 -47.17 81.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.979 1.312 . . . . 0.0 112.804 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' HB2' HD21 ' A' ' 17' ' ' LEU . 72.5 mtt85 -91.25 4.05 53.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 6.06 6.59 Favored Glycine 0 CA--C 1.505 -0.534 0 C-N-CA 118.67 -1.729 . . . . 0.0 115.813 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 25' ' ' PHE . 57.8 t -81.03 120.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.653 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.4 p -98.02 128.28 49.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.186 0.517 . . . . 0.0 111.444 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -150.5 126.89 10.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.442 0 O-C-N 123.324 0.39 . . . . 0.0 110.617 -178.847 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.62 169.82 19.18 Favored 'Trans proline' 0 C--O 1.265 1.839 0 C-N-CA 123.05 2.5 . . . . 0.0 109.489 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -60.03 -42.74 95.06 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -55.26 -38.98 69.25 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.9 -40.92 71.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 0.0 109.685 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 m -73.79 -24.31 59.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.699 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.67 -45.11 95.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.71 87.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.752 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.4 -44.41 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.155 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.464 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 3.4 mmt -60.71 -48.61 81.02 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.145 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.7 -38.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.907 0.384 . . . . 0.0 110.612 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.9 84.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.398 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -71.13 -40.73 71.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.23 0.538 . . . . 0.0 109.885 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -63.92 -45.1 90.79 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.982 0.913 . . . . 0.0 111.363 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.18 -15.13 44.73 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.044 -0.41 . . . . 0.0 111.695 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 57.8 60.16 2.89 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.913 1.34 . . . . 0.0 107.661 -169.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.46 175.43 5.47 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.272 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.46 135.28 33.69 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 4' ' ' VAL . 41.5 tp -110.83 125.19 53.34 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.713 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -98.1 110.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.25 146.55 35.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.307 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -108.78 -20.53 13.03 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.103 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.432 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 10.5 t70 -79.2 132.79 36.63 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -63.04 -35.43 80.22 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.28 -28.41 34.69 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.658 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 87' ' ' ASP . 91.4 t -63.64 -49.89 80.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.0 mt -57.58 -47.21 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.982 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.0 t30 -63.12 -54.74 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.57 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 84.5 tttt -55.79 -51.26 68.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.52 1.128 . . . . 0.0 111.367 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.4 93.72 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.603 0.565 . . . . 0.0 111.258 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 21.2 ttmm -65.27 -38.77 91.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.112 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.1 mt-10 -62.7 -38.72 91.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.221 0.534 . . . . 0.0 109.762 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 81.8 mt -72.68 -13.2 61.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.437 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.14 5.39 37.81 Favored Glycine 0 CA--C 1.501 -0.803 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.358 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.3 t -92.83 137.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.59 96.34 10.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.092 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.81 127.02 42.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.83 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.24 152.83 78.92 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 26.3 Cg_exo -66.53 163.44 32.59 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.353 2.035 . . . . 0.0 112.181 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.474 HG23 ' CG2' ' A' ' 16' ' ' ILE . 72.3 mt -52.74 -43.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.543 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -65.64 -27.96 68.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.12 -32.13 56.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.135 0.493 . . . . 0.0 110.411 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.88 -40.81 75.45 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.98 -43.28 96.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.059 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.64 94.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.394 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.186 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -86.98 150.21 24.22 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -131.35 107.65 9.09 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 40.8 t -93.24 130.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.74 125.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.601 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -87.04 147.54 43.04 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 59.4 Cg_exo -53.17 -28.22 40.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.071 2.514 . . . . 0.0 113.971 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.3 m -60.53 -22.23 63.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.89 13.52 32.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.97 0.414 . . . . 0.0 111.382 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.8 m-30 -70.12 162.85 27.5 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.798 0.809 . . . . 0.0 112.604 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -33.88 3.63 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.153 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -95.98 14.24 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.671 0.789 . . . . 0.0 110.215 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -38.74 75.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.569 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -74.49 -26.98 60.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.141 0.496 . . . . 0.0 110.918 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.0 -46.67 20.38 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.728 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.6 pt -66.21 -39.65 84.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.301 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 45' ' ' ALA . 5.4 mp -65.24 -54.62 26.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.805 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.91 -31.3 75.21 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.635 -0.711 . . . . 0.0 114.147 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -88.63 -29.96 19.56 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -106.38 -59.24 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 118.34 -1.344 . . . . 0.0 113.64 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 56.07 -152.96 0.36 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -167.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 69.3 -15.0 0.29 Allowed 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 124.791 1.236 . . . . 0.0 113.566 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.73 149.09 32.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.85 98.08 11.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -75.0 129.6 37.92 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.065 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 52.0 t -125.01 138.0 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.172 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -130.87 142.38 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.489 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 23.2 p -82.7 165.12 20.23 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -38.24 78.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.8 -29.61 66.95 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.81 -54.09 33.44 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.399 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.0 m -60.82 -35.72 66.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.0 m -65.73 -42.24 91.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.74 -37.37 86.32 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.67 76.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.479 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.2 mm -59.33 -49.93 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.821 0.448 . . . . 0.0 111.201 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -98.12 -14.56 20.36 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 120.809 0.338 . . . . 0.0 111.607 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.55 35.31 20.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.155 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -92.32 146.54 6.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.74 88.3 5.21 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.889 1.328 . . . . 0.0 111.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 tp -88.72 -19.22 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.724 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.34 -49.36 76.4 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 125.908 1.683 . . . . 0.0 109.437 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -59.78 -30.92 69.22 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 111.226 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -75.21 -52.75 10.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.016 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.44 -39.33 79.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.95 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.01 -40.31 76.37 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.321 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 17' ' ' LEU . 45.5 mtt85 -82.98 -10.02 58.99 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.86 15.63 3.15 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.322 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.28 123.92 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -96.83 143.78 11.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.024 0.44 . . . . 0.0 110.871 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.9 t -87.9 136.81 22.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.69 126.59 43.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.809 176.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.534 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' ' OD2' ' A' ' 89' ' ' ASP . 59.4 mt . . . . . 0 C--O 1.235 0.338 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.71 166.12 28.95 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.389 2.059 . . . . 0.0 110.376 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -56.64 -36.03 69.02 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -62.83 -38.33 90.32 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' OE2' ' HB2' ' A' ' 7' ' ' PRO . 69.9 mm-40 -71.03 -36.16 72.27 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -62.04 -41.96 98.67 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.77 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -62.55 -36.85 83.94 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.16 78.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.109 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.78 -44.71 98.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.064 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 18.7 mmt -59.12 -45.96 89.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.19 -39.08 83.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-O 121.153 0.502 . . . . 0.0 110.131 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.03 66.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -75.2 -36.75 61.37 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.091 0.556 . . . . 0.0 110.477 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.58 -44.44 74.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.319 0.581 . . . . 0.0 111.536 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.84 -19.03 31.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.733 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.44 67.74 0.94 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -171.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.7 3.99 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.87 -170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 2.3 tm? -90.51 126.77 36.03 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -108.33 120.72 43.2 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.821 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.0 mt -94.21 112.14 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -145.02 139.71 27.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.878 0.37 . . . . 0.0 111.581 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.73 -22.69 16.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.606 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -87.67 132.95 33.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -51.17 -48.25 61.94 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 124.184 0.927 . . . . 0.0 113.07 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.62 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.4 t70 -69.4 -27.7 65.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 123.549 0.531 . . . . 0.0 111.374 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.03 -50.01 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.866 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.62 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.0 p-10 -70.57 -36.64 73.72 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -66.43 -40.97 89.83 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.468 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -67.89 -36.49 80.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.062 0.458 . . . . 0.0 109.827 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.78 -40.88 89.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.838 0.855 . . . . 0.0 109.233 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 62.6 mt-10 -63.18 -35.92 81.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.804 0.812 . . . . 0.0 110.787 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.12 -5.87 59.32 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.045 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.52 21.11 41.79 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.645 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.412 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 64.5 t -106.03 137.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -84.69 95.34 8.89 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.429 0.633 . . . . 0.0 110.966 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.68 131.23 45.01 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.882 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.95 155.45 76.3 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 122.686 0.394 . . . . 0.0 110.683 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.5 Cg_exo -71.7 162.03 43.37 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.151 1.901 . . . . 0.0 110.656 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.4 mt -54.21 -38.16 38.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 123.652 0.781 . . . . 0.0 112.71 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.23 -34.1 76.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.594 0.235 . . . . 0.0 110.945 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.85 -30.45 62.67 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.276 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.88 -38.79 89.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.76 -43.51 83.9 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.971 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.56 65.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.245 0.866 0 CA-C-O 121.637 0.732 . . . . 0.0 110.593 178.465 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.245 0.831 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -87.68 146.8 25.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.03 13.93 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.85 126.2 44.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt -93.12 125.7 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.885 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -89.48 152.22 47.08 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 82.6 Cg_exo -50.65 -27.95 21.06 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.461 2.774 . . . . 0.0 111.681 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -51.78 -36.42 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.864 1.266 . . . . 0.0 111.651 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 6.61 41.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.366 0.603 . . . . 0.0 111.625 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 10.0 m-85 -79.38 134.49 36.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.274 0.559 . . . . 0.0 111.323 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.14 -36.28 3.79 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 27.5 mtpp -110.36 15.74 22.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.92 -39.14 62.55 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.938 1.695 . . . . 0.0 110.877 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.94 -35.95 82.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.801 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.95 -53.39 21.07 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.648 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG2' HG21 ' A' ' 104' ' ' ILE . 25.9 pt -60.87 -41.13 87.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 48' ' ' ARG . 55.2 tp -69.35 -55.08 11.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.598 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.45 -34.12 12.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.743 -1.218 . . . . 0.0 114.694 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 m -84.4 -25.84 28.76 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 117.683 0.741 . . . . 0.0 112.015 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -97.55 -59.63 1.74 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.852 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 58.31 -140.82 0.74 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.07 -14.79 0.29 Allowed 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -135.5 162.23 33.24 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -93.47 108.42 20.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -79.06 125.97 30.1 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.852 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.63 134.64 60.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.114 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.5 tp -121.19 153.58 24.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.517 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 47.2 p -97.19 176.77 5.8 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.996 0.427 . . . . 0.0 111.929 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -42.57 85.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 123.686 0.794 . . . . 0.0 112.11 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.61 -24.47 56.52 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.59 -49.52 59.64 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.376 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.9 m -66.89 -32.07 56.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 m -65.96 -40.52 91.38 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.59 -44.54 93.34 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.732 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 32' ' ' VAL . 48.3 mm -64.14 -48.32 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.296 0.372 . . . . 0.0 111.039 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.65 -30.12 65.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.3 t -84.41 -28.2 27.08 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.976 0.417 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.43 34.64 6.93 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.154 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.4 mt -97.27 149.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.09 87.77 0.78 Allowed 'General case' 0 C--O 1.241 0.63 0 O-C-N 123.315 0.384 . . . . 0.0 111.406 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -86.11 -27.13 6.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.31 -45.32 93.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -66.37 -29.8 70.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.796 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -67.88 -51.29 49.85 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.51 -40.12 81.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.085 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.9 -38.83 89.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.17 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HB2' HD22 ' A' ' 17' ' ' LEU . 74.5 mtt180 -87.85 2.9 50.27 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.89 -2.5 7.96 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.43 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.1 t -72.61 132.79 32.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 117.79 0.795 . . . . 0.0 109.645 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.7 pt -111.39 142.91 22.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.267 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.46 116.41 41.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-O 121.332 0.587 . . . . 0.0 110.689 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -118.64 126.27 51.57 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.196 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 -176.191 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.5 145.75 92.33 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.077 1.851 . . . . 0.0 110.647 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.718 0.407 . . . . 0.0 111.602 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -64.4 -33.31 75.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.878 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.35 -37.19 63.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.2 m -64.46 -39.92 94.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.535 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.517 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.4 tt0 -63.42 -40.5 97.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.46 94.62 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.58 -45.45 94.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.207 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.461 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 4.3 mmt -60.79 -47.35 86.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.61 -37.97 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.031 0.443 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.44 -29.59 69.1 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.43 -34.06 36.38 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.13 0.572 . . . . 0.0 110.583 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -46.21 68.05 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.467 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.24 -20.81 43.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.794 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 56.93 64.39 1.66 Allowed 'General case' 0 C--O 1.247 0.924 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.61 -176.81 3.07 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.805 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.29 126.76 35.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -107.73 127.5 53.74 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.534 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mt -106.39 114.95 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -148.13 155.17 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.84 -35.5 9.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.78 118.88 12.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.545 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -74.57 -17.56 60.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.182 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.63 -39.18 24.84 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.3 t -59.78 -51.68 70.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.588 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.9 mt -54.1 -44.93 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.437 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.549 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.3 t30 -54.29 -52.21 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.752 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.79 -43.71 95.5 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.555 0.535 . . . . 0.0 110.752 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.55 97.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.035 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -70.71 -28.43 64.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.2 mt-10 -68.45 -28.98 67.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.14 0.495 . . . . 0.0 109.811 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.86 -11.83 58.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.655 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.85 14.17 35.05 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.51 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -86.83 90.89 8.47 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.91 132.85 49.77 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.362 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.74 157.82 64.03 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 123.972 0.795 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.3 Cg_exo -70.45 164.7 34.26 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 16' ' ' ILE . 33.9 mt -58.35 -46.93 89.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.327 53.7 mt-10 -76.03 -16.0 60.03 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.87 -35.03 38.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.83 -43.01 98.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.895 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.87 -34.66 78.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.164 0.507 . . . . 0.0 110.523 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.8 -4.42 43.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.363 0.602 . . . . 0.0 111.067 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.435 -1.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 177.404 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.248 0.977 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.43 147.04 25.6 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.56 110.93 11.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.1 t -94.6 133.11 36.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.06 129.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -85.91 144.39 39.19 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 84.6 Cg_exo -52.52 -18.03 7.69 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.786 2.991 . . . . 0.0 113.879 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 p -73.99 -20.13 60.43 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.04 0.448 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.96 12.04 33.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.524 . . . . 0.0 111.224 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-85 -73.11 153.97 40.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.36 -34.22 3.31 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -92.66 1.6 57.18 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 124.577 1.151 . . . . 0.0 109.713 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -51.4 -39.97 58.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.038 1.335 . . . . 0.0 111.949 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.88 -33.59 76.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.861 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.41 -49.13 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.997 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 pt -68.26 -43.44 84.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.891 0.377 . . . . 0.0 111.935 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.31 -48.56 56.05 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.83 -33.16 74.8 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.181 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 m -90.43 -15.1 31.55 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.439 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -114.64 -59.17 2.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 55.57 -155.21 0.28 Allowed 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 70.7 -13.97 0.45 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.99 148.33 34.03 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -85.87 96.47 9.79 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.2 m-85 -74.38 129.8 38.46 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.064 -176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.0 t -127.4 138.65 54.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.87 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 8.4 tp -123.7 160.21 27.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.566 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.8 p -99.62 165.48 11.59 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 120.835 0.35 . . . . 0.0 111.647 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.44 -36.66 84.89 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.919 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.96 -18.46 60.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.062 0.458 . . . . 0.0 110.014 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.24 -44.68 17.02 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 36' ' ' ILE . 20.2 m -66.64 -36.44 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.8 p -72.41 -31.96 65.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.535 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.63 -42.34 92.51 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.68 76.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.57 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.0 mm -59.15 -45.85 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.581 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.23 -26.53 62.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -103.46 4.08 35.65 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.52 37.92 85.88 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.354 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.09 155.92 4.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.41 129.6 35.12 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.69 -40.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.802 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.76 -31.52 72.21 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 122.159 -0.338 . . . . 0.0 111.01 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 m -57.72 -40.64 80.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 123.774 0.671 . . . . 0.0 109.922 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.15 60.08 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.808 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.6 mt -57.72 -45.11 86.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.058 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.37 -39.83 92.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.564 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.23 -3.79 41.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.85 7.43 5.59 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.017 -1.563 . . . . 0.0 115.862 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 63.6 t -86.78 138.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 pt -113.1 167.41 6.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 14.4 p -120.16 144.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.456 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -132.86 157.45 45.02 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.146 0.578 . . . . 0.0 110.241 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.162 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.666 -177.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.563 ' HB3' ' OE2' ' A' ' 69' ' ' GLU . 80.7 mt . . . . . 0 C--O 1.241 0.615 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.24 144.86 13.35 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.509 2.806 . . . . 0.0 113.588 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -46.91 -35.22 6.21 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.138 1.375 . . . . 0.0 114.106 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -58.62 -43.2 89.55 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.563 ' OE2' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -85.45 -26.66 26.21 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.973 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 m -63.45 -34.9 78.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.685 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.566 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.6 tt0 -64.47 -40.89 96.56 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.46 -45.0 95.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.38 -45.76 97.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.751 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.483 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 17.4 mmt -65.82 -39.42 90.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -66.46 -36.28 76.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-O 121.196 0.522 . . . . 0.0 109.848 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.74 72.2 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.52 -44.61 82.03 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.384 1.074 . . . . 0.0 110.219 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.83 -57.06 14.41 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.103 0.961 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.84 -13.6 57.42 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.087 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.47 64.74 1.4 Allowed 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -170.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.77 177.15 4.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.91 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.23 127.21 36.58 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 48.1 tp -108.23 122.83 47.75 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.635 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.8 115.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.08 144.0 32.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.648 0.261 . . . . 0.0 110.668 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -93.37 -25.58 17.63 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.81 123.82 29.71 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -73.33 -18.9 61.14 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -81.59 -33.25 31.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG22 ' OE1' ' A' ' 69' ' ' GLU . 95.8 t -61.18 -48.47 88.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 88.0 mt -56.65 -48.58 80.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.96 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 23.6 t30 -51.43 -58.85 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.622 1.169 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -65.87 -40.08 91.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.45 89.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 14.2 tppt? -57.77 -42.08 83.35 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.698 0.799 . . . . 0.0 109.655 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 41.0 mt-10 -67.3 -34.62 77.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.728 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -79.38 2.67 20.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.252 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.84 18.7 46.53 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.988 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 61.9 t -106.35 142.87 18.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -97.84 94.47 6.93 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.149 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -94.04 132.53 38.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.929 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.51 152.33 77.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 123.488 0.492 . . . . 0.0 110.691 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.0 Cg_exo -71.97 160.13 48.45 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.034 1.823 . . . . 0.0 110.27 175.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 mt -57.24 -36.88 53.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.02 -25.73 66.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.07 -30.8 62.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.464 0.649 . . . . 0.0 109.947 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.68 -42.39 67.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.16 -33.64 76.25 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.675 0.75 . . . . 0.0 110.786 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.33 69.34 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.831 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.028 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.15 152.28 22.47 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.12 107.2 8.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' HD11 ' A' ' 83' ' ' LEU . 43.5 t -92.35 132.68 36.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.1 mt -98.32 131.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.573 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.18 149.82 42.1 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -54.45 -26.29 44.03 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.268 2.646 . . . . 0.0 113.483 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.5 m -63.31 -14.97 55.66 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.08 5.49 48.61 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 0.0 111.535 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 6.5 m-30 -68.09 149.91 49.05 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.17 5.2 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 60.2 mtpt -105.66 19.93 19.74 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.915 0.864 . . . . 0.0 109.603 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.71 -30.41 69.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.796 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.92 -41.28 68.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.845 0.831 . . . . 0.0 109.035 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 12' ' ' LYS . 17.8 mp0 -58.62 -57.27 13.72 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.824 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 pt -63.04 -43.74 99.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.99 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD22 ' HB2' ' A' ' 48' ' ' ARG . 4.8 mp -61.46 -54.31 45.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.637 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.14 -29.65 64.23 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 123.522 0.514 . . . . 0.0 114.14 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -81.79 -61.25 1.97 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.175 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 39.9 t-20 -77.84 -53.39 7.54 Favored 'General case' 0 C--O 1.253 1.268 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.424 -170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 8.1 mtmp? 59.65 -162.17 0.25 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 66.91 -15.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -97.79 163.8 12.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.432 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -97.82 95.78 7.77 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 172.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CB ' HG22 ' A' ' 50' ' ' VAL . 97.8 m-85 -74.8 135.32 41.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.3 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.09 138.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.616 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.68 159.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.603 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 p -100.03 171.46 7.82 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -45.51 84.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.283 1.033 . . . . 0.0 110.995 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.12 -26.55 61.27 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.75 -57.2 17.12 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.176 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.0 m -60.38 -34.96 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.988 0.394 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 49.7 m -65.6 -33.52 76.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.056 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -65.79 -40.2 91.72 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' CE2' ' A' ' 10' ' ' PHE . . . -67.28 -42.55 83.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.1 mm -62.62 -47.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.256 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HB3' ' HZ1' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -66.85 -39.48 87.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -81.69 -28.5 33.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.888 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.54 41.04 4.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.207 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.64 151.64 5.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.84 92.95 5.54 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.442 1.115 . . . . 0.0 111.489 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -89.57 -17.68 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.317 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.59 -33.72 76.57 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 m -61.72 -30.12 70.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.233 0.54 . . . . 0.0 110.955 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -76.96 -50.17 13.81 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.68 -38.38 84.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.915 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.44 -39.17 75.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.712 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.445 ' HB2' HD22 ' A' ' 17' ' ' LEU . 94.9 mtt180 -89.42 -14.81 34.64 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.208 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.77 16.64 3.3 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.735 -1.221 . . . . 0.0 115.106 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG22 ' CB ' ' A' ' 25' ' ' PHE . 60.7 t -73.03 123.41 27.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 pt -93.99 150.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.75 118.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -116.09 126.47 53.78 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.357 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.83 132.61 56.12 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -87.56 158.9 18.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -69.33 -56.32 7.84 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -167.47 120.48 0.93 Allowed 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.949 1.3 . . . . 0.0 110.053 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -133.83 130.67 20.72 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.95 121.94 9.4 Favored 'Trans proline' 0 C--O 1.241 0.65 0 CA-C-N 120.252 1.126 . . . . 0.0 110.888 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -91.07 132.73 1.54 Allowed 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.869 2.379 . . . . 0.0 111.52 176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -114.09 107.97 16.37 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.554 -0.859 . . . . 0.0 108.694 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 m -156.13 144.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.82 -37.16 1.3 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.924 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.28 -34.9 12.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.53 0.681 . . . . 0.0 111.1 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -84.24 143.29 41.95 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.932 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -79.36 161.67 25.57 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.759 2.306 . . . . 0.0 111.853 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -53.32 -40.65 64.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -63.35 -38.4 91.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.56 -38.26 62.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.2 t -58.12 -48.04 81.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.075 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.603 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.8 tt0 -60.92 -38.13 84.69 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.563 0.345 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.62 74.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.946 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.61 -45.22 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.451 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.497 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 16.6 mmt -60.96 -45.16 95.84 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.39 -35.94 76.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 120.827 0.346 . . . . 0.0 110.972 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.51 -33.61 74.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.898 0.38 . . . . 0.0 110.539 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -69.52 -46.57 66.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -49.2 -56.8 8.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.08 1.352 . . . . 0.0 111.431 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.51 -16.64 36.33 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.392 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.65 68.44 0.75 Allowed 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.74 179.26 4.02 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.674 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.11 129.96 36.33 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 4' ' ' VAL . 42.5 tp -108.34 123.78 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.267 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.13 110.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.57 139.29 38.58 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.01 -29.3 14.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.206 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 130.16 39.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.93 0.395 . . . . 0.0 110.674 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -55.18 -42.51 73.31 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.94 1.296 . . . . 0.0 112.644 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.48 -34.12 31.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.156 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.39 -45.71 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.24 -51.64 70.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.897 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.07 -31.86 68.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 49.2 tptt -71.94 -42.87 66.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.388 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.66 74.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.998 0.427 . . . . 0.0 110.209 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.79 -38.35 90.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.554 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.431 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 50.3 mt-10 -57.39 -43.22 83.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.84 -11.35 60.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.017 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.3 15.92 31.28 Favored Glycine 0 CA--C 1.5 -0.868 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.268 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.1 131.43 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -80.82 89.98 5.85 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.503 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.3 128.1 38.02 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.325 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.68 157.05 78.09 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 123.578 0.549 . . . . 0.0 111.083 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.81 156.39 52.91 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.611 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 40.7 mt -55.8 -44.46 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 12' ' ' LYS . 2.7 mp0 -67.64 -24.29 65.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.93 -28.77 35.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.21 -35.22 79.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 86.0 mt -72.93 -31.66 64.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.046 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -26.94 62.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.877 0.37 . . . . 0.0 110.866 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.9 p -100.43 25.56 7.56 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.382 0.61 . . . . 0.0 110.611 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.5 t -74.38 1.48 11.59 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.018 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt 65.32 32.6 9.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.048 0.939 . . . . 0.0 111.303 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.68 -26.02 28.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.038 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 64.01 75.53 0.38 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.228 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -100.45 131.42 46.38 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.644 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -68.19 143.77 55.22 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -57.7 110.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -118.37 159.55 23.22 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.8 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.8 m80 . . . . . 0 C--N 1.296 -1.725 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.193 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.2 156.38 19.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.73 110.31 9.74 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.4 t -95.08 129.83 44.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.109 0.48 . . . . 0.0 110.068 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.98 129.76 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.127 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.7 m -90.39 152.63 45.73 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.0 Cg_exo -57.58 -24.79 64.01 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 123.204 2.603 . . . . 0.0 114.068 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -70.16 -17.67 63.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.12 0.486 . . . . 0.0 111.505 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.403 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -95.95 9.08 41.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.5 m-30 -66.7 144.34 56.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.884 0.373 . . . . 0.0 111.709 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.8 -36.08 2.49 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.929 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -87.91 -12.63 44.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 14' ' ' LYS . 2.9 pp -62.34 -24.3 67.26 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.109 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 13' ' ' LEU . 48.7 mtmt -75.02 -25.8 59.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.284 0.564 . . . . 0.0 110.029 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -76.08 -45.64 33.01 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.658 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.7 pt -64.27 -37.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.205 0.526 . . . . 0.0 110.391 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 48' ' ' ARG . 47.9 tp -65.69 -55.16 18.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.252 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.53 -19.22 78.32 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.004 0.762 . . . . 0.0 115.004 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -105.42 -3.5 22.51 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.717 -0.872 . . . . 0.0 113.05 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -125.94 -59.36 1.34 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.009 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 61.92 178.72 0.12 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.634 1.174 . . . . 0.0 114.088 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 m120 74.34 -15.01 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.945 1.698 . . . . 0.0 114.814 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -80.43 152.9 28.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tpmt? -93.0 96.83 10.33 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -74.83 127.85 34.16 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.722 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.3 t -120.42 130.43 74.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.562 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.98 144.77 23.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.58 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 22.8 p -81.85 169.68 16.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 p -72.27 -39.92 68.01 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.1 mt -70.09 -28.76 65.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.075 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.11 -53.01 36.05 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.806 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.0 m -61.25 -41.65 90.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.097 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 42.5 m -63.58 -37.59 87.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -66.53 -39.33 88.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.55 77.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.487 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.9 mm -57.46 -51.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.07 0.548 . . . . 0.0 111.4 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 33' ' ' SER . 18.0 ptpt -69.8 -23.4 63.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -90.72 -23.03 20.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.046 0.451 . . . . 0.0 111.217 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 31.48 11.7 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.761 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 77.8 mt -92.14 138.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.55 88.25 0.93 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.743 1.258 . . . . 0.0 111.883 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.5 tp -86.96 -19.76 7.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.907 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.9 -41.29 91.3 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.945 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -57.71 -35.57 70.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.656 0.782 . . . . 0.0 110.952 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -50.2 13.57 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.332 0.586 . . . . 0.0 109.765 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.9 mt -58.51 -41.71 86.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.865 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -48.53 81.28 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.705 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HB2' HD22 ' A' ' 17' ' ' LEU . 76.4 mtt180 -74.57 -8.56 56.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.61 13.27 3.85 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 118.776 -1.678 . . . . 0.0 114.676 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 72.7 t -82.95 122.44 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -101.55 154.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.454 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 t -100.35 128.63 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -133.33 141.86 48.15 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.935 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.79 157.03 17.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 29.2 t80 -80.63 117.1 21.04 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -93.51 -23.41 18.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.316 0.579 . . . . 0.0 112.061 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.589 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 20.4 t60 -80.37 169.29 17.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -80.98 130.91 61.38 Favored Pre-proline 0 C--N 1.318 -0.761 0 O-C-N 122.025 -0.422 . . . . 0.0 110.872 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.33 124.22 7.64 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.828 2.352 . . . . 0.0 114.392 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -75.24 172.57 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.606 2.87 . . . . 0.0 111.702 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.09 136.66 33.46 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.837 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.88 145.06 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.1 -52.37 0.29 Allowed Glycine 0 C--N 1.304 -1.222 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.609 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.52 -45.52 93.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.868 0.867 . . . . 0.0 111.919 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.1 mt -95.14 142.5 24.69 Favored Pre-proline 0 N--CA 1.427 -1.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.658 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.93 155.59 67.07 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 122.664 2.243 . . . . 0.0 110.037 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -62.4 -33.0 73.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.256 6.3 p90 -62.35 -39.27 92.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.99 -42.4 73.11 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.0 m -67.08 -29.86 69.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.522 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.58 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.1 tt0 -66.55 -40.37 89.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.39 84.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.2 mt -54.75 -50.64 58.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.646 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.565 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 11.8 mmt -71.66 -31.65 67.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.33 -35.02 69.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.62 72.95 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.508 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -70.25 -48.22 57.84 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.33 -44.15 92.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.23 -17.9 35.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.203 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 61.1 66.89 0.84 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 123.028 1.394 . . . . 0.0 107.4 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.56 178.16 4.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 113.156 -1.838 . . . . 0.0 111.229 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -89.53 121.13 31.45 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.11 127.09 42.74 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.177 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.3 mt -111.91 117.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.896 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.7 153.48 43.41 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' OE1' ' HB ' ' A' ' 104' ' ' ILE . 6.7 mm-40 -101.04 -17.63 16.63 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.17 127.91 40.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -69.43 -24.61 63.84 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.09 -35.27 31.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.03 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.54 -49.95 81.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.9 -47.82 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.689 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.531 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -62.22 -50.43 71.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.577 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tmtt? -60.26 -43.84 95.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.333 0.587 . . . . 0.0 109.443 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.58 98.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.021 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 35.7 ttmt -69.98 -31.2 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.602 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt-10 -63.54 -34.58 78.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 109.52 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 86.5 mt -80.35 -11.14 59.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.179 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.34 12.48 26.92 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.887 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 40.4 t -98.54 127.75 50.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.17 91.03 4.91 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.663 0.744 . . . . 0.0 109.545 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.32 137.42 38.77 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.574 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.99 153.58 67.43 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.182 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 27.5 Cg_exo -63.59 155.45 62.85 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.443 2.095 . . . . 0.0 111.112 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' ' OE1' ' A' ' 86' ' ' GLU . 7.4 mt -55.7 -43.52 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.93 -19.33 61.28 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.87 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 12.6 mm-40 -77.34 -33.48 55.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.4 -41.79 88.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.3 -46.5 88.39 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 112' ' ' LEU . . . -62.3 -22.39 66.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.546 0.738 . . . . 0.0 112.68 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.2 m -74.71 -7.77 54.34 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.526 0.679 . . . . 0.0 110.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.3 t -122.62 -35.99 2.99 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 31.5 mt -128.21 94.09 3.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.784 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -75.48 -32.75 60.68 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -99.59 122.34 42.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 167.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -70.38 79.18 0.55 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.628 0.771 . . . . 0.0 112.247 -171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -77.45 -42.51 35.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.854 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -75.94 119.02 19.33 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -103.63 128.57 50.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.04 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.245 0.837 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -87.75 147.56 25.13 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.39 110.2 10.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.57 132.65 36.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mm -95.41 130.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.329 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.6 m -90.22 152.5 45.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -57.04 -12.39 9.57 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 123.528 2.819 . . . . 0.0 113.977 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -81.97 -9.39 59.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.924 0.49 . . . . 0.0 111.172 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.4 13.66 33.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 111.801 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HB3' HG22 ' A' ' 40' ' ' ILE . 23.2 m-30 -76.67 152.43 35.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.489 0.661 . . . . 0.0 111.071 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 -36.01 3.55 Favored Glycine 0 C--N 1.313 -0.709 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.36 -1.57 47.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.723 0.773 . . . . 0.0 109.295 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.4 tp -53.62 -38.64 64.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.669 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.36 -41.43 63.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.135 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.42 -50.87 61.94 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.278 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.18 -40.51 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 121.156 0.503 . . . . 0.0 111.434 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 48' ' ' ARG . 51.5 tp -66.25 -48.42 70.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.297 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 -33.17 25.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 114.251 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 t -76.38 -46.33 27.85 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 116.925 0.362 . . . . 0.0 110.972 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -92.0 -47.58 7.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.909 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 58.55 -142.46 0.66 Allowed 'General case' 0 C--N 1.362 1.137 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.3 t30 68.68 -14.2 0.29 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 166.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -123.9 157.55 34.0 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 110.49 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -92.93 98.4 11.34 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -75.37 130.61 39.29 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.568 -176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -123.77 134.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.106 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -117.9 152.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.3 p -91.28 170.58 9.87 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.959 0.409 . . . . 0.0 111.779 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -37.99 87.57 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.886 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.15 -20.39 55.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.158 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.93 -51.41 19.1 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.8 m -63.14 -39.28 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 p -70.4 -34.94 73.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.446 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -65.01 -38.19 90.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.67 75.24 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.548 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 32' ' ' VAL . 37.1 mm -58.31 -49.93 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.89 0.476 . . . . 0.0 111.808 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.532 ' HZ2' ' HB3' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -68.64 -27.06 65.66 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -91.78 -5.9 52.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.95 57.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.304 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.401 HG22 ' HB3' ' A' ' 10' ' ' PHE . 69.3 mt -100.88 146.83 8.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.96 85.69 0.99 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.036 0.446 . . . . 0.0 111.288 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.1 tp -90.38 -24.42 5.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.83 -41.19 97.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.131 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 8.4 t -72.52 -26.41 61.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.207 0.527 . . . . 0.0 109.74 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.77 -47.63 29.9 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 84.7 mt -57.77 -44.05 85.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.044 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.76 -47.77 70.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.031 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HB2' HD23 ' A' ' 17' ' ' LEU . 68.4 mtt180 -84.53 1.62 44.92 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.96 7.37 6.04 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 118.786 -1.673 . . . . 0.0 116.324 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 92.4 t -81.44 127.73 39.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 118.148 0.974 . . . . 0.0 108.722 175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -102.48 159.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.4 p -114.88 137.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -141.05 139.82 34.16 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.31 152.15 21.7 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 57' ' ' HIS . 22.7 t80 -84.52 108.6 17.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -60.25 -34.85 74.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.353 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 m-70 -79.76 154.26 28.64 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 11.3 mptt -95.65 111.14 54.64 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.75 157.39 24.54 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.798 2.332 . . . . 0.0 112.459 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -82.52 171.72 12.0 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.936 1.757 . . . . 0.0 110.97 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.65 122.64 28.88 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.39 125.16 39.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.515 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.76 62.76 4.35 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.6 t30 178.81 -55.34 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.766 1.226 . . . . 0.0 108.542 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -107.59 141.14 22.38 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.494 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.05 170.24 12.09 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 123.098 2.532 . . . . 0.0 111.762 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -24.76 66.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.269 42.1 p90 -72.75 -43.77 62.47 Favored 'General case' 0 C--O 1.255 1.391 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.33 -33.07 55.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.607 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.3 m -66.38 -28.2 68.45 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.299 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.4 tt0 -66.13 -40.02 90.32 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.23 87.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.901 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.2 -46.09 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.783 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.446 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 3.6 mmt -63.46 -42.75 98.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.41 -35.06 65.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.477 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.85 88.46 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -66.22 -42.02 89.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.23 0.612 . . . . 0.0 109.899 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.91 -42.53 94.66 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.977 0.911 . . . . 0.0 111.251 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.35 -10.65 51.61 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.599 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.95 39.63 19.93 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -175.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.17 178.65 5.93 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.574 -1.648 . . . . 0.0 112.689 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.99 125.62 35.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 47.0 tp -102.49 123.25 45.9 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.046 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.49 113.69 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.07 160.07 40.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.754 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.52 -29.48 7.16 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.5 138.78 37.65 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.775 -0.77 . . . . 0.0 113.021 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -46.19 -55.49 7.03 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 126.833 2.053 . . . . 0.0 110.931 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.92 -37.58 64.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.964 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.81 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.47 0.481 . . . . 0.0 110.399 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -45.31 96.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.124 0.488 . . . . 0.0 109.857 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -64.56 -40.24 95.2 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.797 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 2.5 tmtm? -68.68 -39.28 80.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.322 0.582 . . . . 0.0 109.684 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.64 85.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.69 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -66.4 -35.07 79.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.405 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.6 mt-10 -58.13 -40.91 82.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.463 0.705 . . . . 0.0 110.187 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.06 -11.05 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.639 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.79 47.47 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.468 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.11 139.15 18.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.5 90.3 6.23 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.632 0.73 . . . . 0.0 110.694 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -103.6 131.17 50.98 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.498 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.6 154.95 79.9 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 123.458 0.474 . . . . 0.0 111.309 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.9 Cg_exo -70.07 160.5 49.41 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.664 2.243 . . . . 0.0 111.373 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.9 -43.69 89.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.7 -24.95 67.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -45.4 62.29 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -43.53 95.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.301 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.46 -40.22 93.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.899 0.48 . . . . 0.0 111.205 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 -21.73 63.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.3 m -92.16 12.17 23.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.783 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -80.06 91.1 5.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pp -158.04 162.18 38.1 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.256 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -89.14 -20.19 24.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 75.1 t60 74.36 12.21 4.01 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.457 1.103 . . . . 0.0 113.315 172.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 113' ' ' GLU . 21.1 p80 -117.0 -37.39 3.59 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.824 -1.172 . . . . 0.0 113.289 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 66.5 m80 69.38 -67.28 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.965 1.306 . . . . 0.0 109.962 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -152.56 135.44 15.51 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -88.34 -32.81 18.22 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 . . . . . 0 N--CA 1.421 -1.893 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.129 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 C--O 1.239 0.506 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.57 154.46 20.6 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 120.891 0.377 . . . . 0.0 110.755 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -135.69 111.2 9.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.57 130.27 41.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.29 127.73 47.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.104 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -93.7 153.44 41.14 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.87 -20.78 13.82 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 123.521 2.814 . . . . 0.0 114.571 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -64.0 -29.86 70.98 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 120.621 0.248 . . . . 0.0 110.684 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.87 11.28 16.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -74.26 148.68 41.28 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.169 0.509 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 -35.65 3.29 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -90.0 -7.43 54.0 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.1 tp -45.15 -39.4 6.07 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 128.281 2.632 . . . . 0.0 112.36 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.82 -28.98 60.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -71.7 -48.82 44.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.565 0.221 . . . . 0.0 110.914 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.464 ' CG2' HG23 ' A' ' 104' ' ' ILE . 21.5 pt -64.32 -38.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.498 0.666 . . . . 0.0 111.133 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD23 ' HB2' ' A' ' 48' ' ' ARG . 41.7 tp -73.7 -49.68 24.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.209 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 118' ' ' HIS . . . -81.71 -33.05 28.53 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 114.596 0.599 . . . . 0.0 114.596 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -86.12 -30.65 22.37 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.791 0.796 . . . . 0.0 112.256 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.441 ' CG ' ' HG ' ' A' ' 111' ' ' SER . 45.5 t-20 -103.83 -57.73 1.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.193 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 23' ' ' TYR . 5.0 mmpt? 56.95 -137.1 1.04 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.4 ' H ' ' HB3' ' A' ' 21' ' ' LYS . 34.5 t30 70.19 -14.95 0.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.906 0.882 . . . . 0.0 112.991 171.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' H ' ' C ' ' A' ' 21' ' ' LYS . 98.6 m-85 -129.84 159.8 35.46 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -96.01 102.98 14.84 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 92.4 m-85 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.571 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.67 139.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.514 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -128.4 153.8 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.502 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 22.8 p -100.07 175.71 5.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -39.24 87.56 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.32 -20.5 60.78 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.373 0.606 . . . . 0.0 110.064 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.46 -54.9 5.83 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.842 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -60.54 -38.81 79.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -66.51 -36.49 82.85 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.446 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -69.27 -39.85 78.13 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.29 83.15 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.88 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.3 mm -65.5 -52.86 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.884 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.06 -27.85 67.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -90.45 -0.36 57.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.44 95.95 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.443 -0.408 . . . . 0.0 112.837 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 62.7 mt -94.52 148.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.93 83.1 0.66 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.738 0.78 . . . . 0.0 111.076 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -23.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.561 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -66.67 -37.86 85.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 t -65.85 -33.83 76.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.45 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.34 -51.42 44.72 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 91.8 mt -54.88 -46.93 74.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.855 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.38 -43.43 96.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.702 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HB2' HD23 ' A' ' 17' ' ' LEU . 98.7 mtt180 -78.89 0.51 27.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.82 3.19 7.74 Favored Glycine 0 N--CA 1.458 0.144 0 C-N-CA 119.24 -1.457 . . . . 0.0 115.665 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 60.2 t -82.22 127.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 117.827 0.814 . . . . 0.0 109.438 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.4 pt -104.49 144.76 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 6.3 p -97.42 120.98 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -122.92 126.36 47.11 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.6 141.72 48.05 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.355 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.31 147.75 37.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -73.71 -40.93 63.23 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -158.03 100.63 1.73 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.346 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -136.46 101.59 9.92 Favored Pre-proline 0 C--N 1.292 -1.904 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.4 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.24 125.69 18.16 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 121.7 1.6 . . . . 0.0 108.938 172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.64 137.17 67.17 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.067 2.511 . . . . 0.0 113.356 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -95.35 109.11 21.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.43 159.97 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.507 0.67 . . . . 0.0 112.139 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.16 88.99 0.08 OUTLIER Glycine 0 C--N 1.29 -2.01 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.5 t30 80.05 -21.27 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.815 1.246 . . . . 0.0 111.183 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.0 mt -103.38 146.94 33.41 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.011 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.74 161.39 24.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.409 2.739 . . . . 0.0 114.578 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.43 -33.04 69.24 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.432 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.273 6.7 p90 -61.52 -32.48 72.53 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -79.35 -36.65 39.07 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.505 176.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 74' ' ' MET . 14.6 m -54.72 -51.73 64.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.722 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.7 tt0 -61.38 -43.53 98.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.185 0.303 . . . . 0.0 110.595 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.83 -51.4 69.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.338 0.59 . . . . 0.0 110.286 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.55 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.417 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 70' ' ' SER . 6.5 mmt -68.25 -38.44 81.81 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.868 -0.52 . . . . 0.0 111.196 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.33 -38.06 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.614 0.721 . . . . 0.0 109.71 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.76 73.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.115 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -71.87 -43.46 65.43 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.703 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.94 -30.53 67.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.652 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.91 -15.01 26.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 t30 55.2 61.97 2.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.99 -177.57 3.4 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.662 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.3 mt -90.0 147.82 23.45 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.62 133.73 55.67 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.359 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.1 mt -111.21 117.87 56.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.89 154.51 40.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.912 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.94 -37.26 12.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.328 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.16 130.67 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.196 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -62.59 -35.42 79.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.826 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -76.6 -36.6 57.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.124 0.42 . . . . 0.0 109.969 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.36 -44.85 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.96 -45.1 95.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.111 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.6 t30 -57.73 -52.88 63.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.346 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -56.76 -43.08 80.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.696 0.799 . . . . 0.0 110.756 -178.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.3 -47.53 76.3 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.114 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -69.81 -27.61 65.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.513 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.1 mt-10 -70.6 -23.27 62.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 110.472 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.59 -18.39 33.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.523 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.2 11.99 18.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.104 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.79 131.32 46.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -78.17 95.91 5.06 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.288 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.78 130.01 42.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.892 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.45 153.55 80.47 Favored Pre-proline 0 C--N 1.29 -2.0 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.76 164.27 29.97 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.21 1.94 . . . . 0.0 111.711 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 64.1 mt -65.75 -43.93 93.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.65 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -66.49 -25.29 66.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.841 0.353 . . . . 0.0 111.448 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -41.78 66.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.254 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.21 -39.22 93.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 92.7 mt -65.23 -45.25 85.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.512 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.12 71.37 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.686 0.794 . . . . 0.0 112.547 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 m -62.85 -26.85 68.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.441 ' HG ' ' CG ' ' A' ' 20' ' ' ASN . 9.1 m -103.25 99.15 8.99 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.629 0.728 . . . . 0.0 111.165 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -126.78 -41.0 1.86 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -28.93 68.19 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.493 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 111' ' ' SER . 35.0 m80 -81.72 74.12 8.73 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -105.98 151.62 24.39 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.5 t60 63.89 50.1 2.67 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.56 -75.75 0.48 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.878 -172.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 12.6 t-80 -85.92 -28.59 24.21 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 . . . . . 0 CA--C 1.479 -1.766 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 170.603 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 C--O 1.248 0.993 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -89.51 154.72 19.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 120.901 0.381 . . . . 0.0 110.003 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.55 110.43 9.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.5 t -91.92 129.33 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 HG22 ' CD2' ' A' ' 13' ' ' LEU . 65.0 mt -93.1 128.01 44.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -93.15 138.5 23.16 Favored Pre-proline 0 N--CA 1.419 -2.023 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 22.7 Cg_exo -39.03 -31.7 0.28 Allowed 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 125.047 3.832 . . . . 0.0 117.003 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 p -65.96 -22.49 66.48 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.606 0.639 . . . . 0.0 112.238 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.79 10.27 21.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.517 0.727 . . . . 0.0 112.069 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-30 -68.44 152.67 45.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.397 0.618 . . . . 0.0 112.605 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.17 -34.11 4.07 Favored Glycine 0 N--CA 1.46 0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.783 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.21 7.07 44.75 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.015 0.912 . . . . 0.0 109.322 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 5' ' ' ILE . 76.1 mt -51.51 -49.44 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 110.636 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.07 -20.47 63.22 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.654 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.19 -55.65 6.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.53 -42.39 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 48' ' ' ARG . 3.4 mp -54.82 -51.92 64.31 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.577 0.751 . . . . 0.0 111.702 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.36 -33.13 29.32 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.057 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 m -71.89 -38.24 70.0 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.709 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' CG ' ' HA ' ' A' ' 111' ' ' SER . 27.1 t-20 -102.65 -59.35 1.72 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.623 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.46 -168.13 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 71.36 -13.39 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -107.14 143.95 34.57 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -88.83 103.91 16.43 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CB ' HG21 ' A' ' 50' ' ' VAL . 94.5 m-85 -74.94 138.55 42.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.706 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.84 135.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.04 153.9 32.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.3 p -94.98 172.02 8.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 120.934 0.397 . . . . 0.0 111.466 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -65.81 -44.22 86.3 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.38 -25.24 63.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.62 -52.6 28.99 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.9 m -61.5 -36.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.977 0.389 . . . . 0.0 110.835 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -67.37 -38.87 85.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -64.99 -38.5 91.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.952 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.43 -51.1 68.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.181 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 32' ' ' VAL . 50.3 mm -55.82 -50.5 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.607 0.567 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -71.2 -21.51 62.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -95.05 -4.44 46.43 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.365 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.21 54.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.109 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -103.24 133.15 47.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -76.01 108.25 8.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.23 1.014 . . . . 0.0 111.58 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.9 tp -98.8 -22.47 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.47 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.75 -27.44 66.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.391 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.641 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.2 t -70.38 -31.79 69.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -47.7 38.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 81.9 mt -54.7 -43.55 72.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.315 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.43 -33.94 74.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.443 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 44' ' ' SER . 33.7 mtt180 -85.49 -4.16 59.08 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.864 -0.735 . . . . 0.0 112.201 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.81 17.74 2.77 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.437 -1.364 . . . . 0.0 114.447 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG21 ' CB ' ' A' ' 25' ' ' PHE . 59.3 t -89.24 124.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.3 pt -99.11 161.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.4 127.19 61.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -132.44 125.31 30.43 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.98 141.72 29.06 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.634 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 57' ' ' HIS . 40.0 t80 -79.26 108.73 12.98 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 m -65.56 -25.0 67.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 111.588 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . 59.6 m80 -80.21 166.09 21.76 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -93.24 118.35 67.68 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.63 141.46 31.07 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.966 2.444 . . . . 0.0 112.229 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.56 153.7 60.14 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.165 1.91 . . . . 0.0 110.768 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -85.74 119.42 26.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 65' ' ' LEU . 17.0 m -89.79 159.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.554 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.82 -69.44 1.39 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.949 -0.644 . . . . 0.0 114.236 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.06 -32.37 26.86 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 62' ' ' VAL . 72.2 mt -79.89 153.24 75.17 Favored Pre-proline 0 C--N 1.308 -1.211 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -82.54 151.35 15.11 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.086 1.858 . . . . 0.0 111.505 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.98 -30.09 71.32 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -63.12 -32.71 74.15 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.495 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.3 mt-10 -89.6 -24.96 21.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.736 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 t -62.3 -40.05 95.01 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -57.23 -47.46 81.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.136 0.974 . . . . 0.0 108.598 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.12 87.13 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.219 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 69' ' ' GLU . 65.5 mt -59.98 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.485 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 15.2 mmt -63.95 -40.55 96.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.051 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.56 -40.59 84.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.68 70.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -77.22 -42.36 37.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.729 0.811 . . . . 0.0 110.212 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.48 -49.04 79.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.423 1.089 . . . . 0.0 110.102 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.73 -18.96 28.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.917 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 59.08 68.96 0.76 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.85 -177.21 3.35 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.468 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.01 137.75 33.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.66 116.12 31.38 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.136 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.43 110.29 23.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -137.49 146.83 44.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.223 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.1 -22.79 16.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.08 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.52 124.71 31.7 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -74.36 -16.45 60.9 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -81.19 -35.42 31.4 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.447 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.79 -44.34 97.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.709 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.79 -51.83 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.459 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 10.0 t30 -59.29 -46.13 89.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.35 -49.67 76.39 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 124.393 1.077 . . . . 0.0 110.202 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.16 79.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.051 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 38.0 ttmt -64.95 -34.98 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.9 mt-10 -61.61 -34.31 75.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.502 0.668 . . . . 0.0 109.811 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.8 -1.53 52.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.554 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.84 58.25 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.45 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 65.2 t -96.96 141.95 14.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -89.16 97.93 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.293 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.9 131.27 46.86 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.78 151.27 65.48 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 123.567 0.542 . . . . 0.0 111.013 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 6.8 Cg_exo -71.86 166.04 30.73 Favored 'Trans proline' 0 C--O 1.253 1.274 0 C-N-CA 122.226 1.951 . . . . 0.0 111.095 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 45.5 mt -58.46 -40.52 78.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -63.55 -23.04 67.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.871 0.367 . . . . 0.0 111.785 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 34.2 mm-40 -78.1 -35.15 49.61 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.18 -37.22 75.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.1 mt -64.52 -40.56 95.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 109.8 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.89 -18.45 62.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.395 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 m -105.82 16.31 25.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.554 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.494 ' HA ' ' CG ' ' A' ' 20' ' ' ASN . 69.7 m -67.39 149.86 49.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.548 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt 75.99 66.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.754 1.221 . . . . 0.0 109.801 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.9 -28.34 36.0 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.87 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 73.64 96.04 0.07 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.037 0.935 . . . . 0.0 111.459 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -135.06 112.15 10.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.745 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -83.49 80.27 9.16 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.114 0.959 . . . . 0.0 108.54 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -128.14 142.92 51.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -65.62 -32.11 73.5 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.653 0.661 . . . . 0.0 112.014 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 174.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.82 144.72 26.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.752 0.31 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -129.73 109.88 11.32 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 41.0 t -92.61 133.88 32.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.85 121.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.78 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -82.63 149.3 60.29 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.575 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 52.0 Cg_exo -56.47 -15.75 16.33 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.604 2.869 . . . . 0.0 114.861 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 p -71.92 -20.78 61.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.0 111.261 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.67 11.82 31.98 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.637 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.584 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 8.7 m-30 -65.94 147.61 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.86 -34.69 3.83 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.973 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.0 mmmt -90.07 -1.09 57.9 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.583 0.353 . . . . 0.0 111.29 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.584 ' CD1' ' HA ' ' A' ' 10' ' ' PHE . 7.9 mp -54.25 -35.77 62.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.429 0.633 . . . . 0.0 111.401 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -38.52 88.4 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.836 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.33 -38.95 33.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.4 pt -67.02 -35.26 74.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 13' ' ' LEU . 5.0 mp -57.23 -55.52 33.73 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.747 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.38 -33.35 53.42 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -76.98 -40.28 47.38 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.089 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.87 -52.67 3.25 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.545 -1.262 . . . . 0.0 111.803 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 59.51 -178.97 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 73.01 -14.64 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.59 1.556 . . . . 0.0 112.869 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -89.42 148.35 23.52 Favored 'General case' 0 CA--C 1.492 -1.281 0 O-C-N 121.75 -0.594 . . . . 0.0 109.398 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -91.94 98.29 11.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.6 m-85 -74.81 125.35 28.61 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.897 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.6 t -118.94 136.28 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.07 144.04 39.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -81.62 169.58 16.86 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.395 0.617 . . . . 0.0 112.565 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 p -67.62 -36.47 80.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.79 -31.0 70.57 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.54 -50.55 42.62 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.247 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.3 m -61.74 -40.53 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 117.369 0.585 . . . . 0.0 112.007 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -69.89 -39.26 76.36 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.51 0.195 . . . . 0.0 110.617 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.05 -42.3 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.04 61.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.7 mm -53.85 -51.37 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.968 0.507 . . . . 0.0 112.085 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -67.86 -22.15 65.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -95.89 -3.9 44.52 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.84 34.97 55.34 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.877 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.17 137.18 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.08 94.07 1.87 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.2 tp -101.86 -20.34 5.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.82 -41.83 97.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.268 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.5 m -71.02 -24.91 62.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.999 0.428 . . . . 0.0 111.058 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.98 -47.36 59.34 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 85.3 mt -56.32 -40.27 74.14 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.234 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.58 -39.42 87.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.803 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 44' ' ' SER . 95.8 mtt180 -83.34 -1.9 54.44 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.96 2.54 7.19 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 114.714 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 65.5 t -76.05 120.33 25.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -97.95 140.42 18.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.233 0.54 . . . . 0.0 110.55 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -91.44 119.23 38.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -148.08 138.8 23.06 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.99 0.424 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.57 151.37 51.95 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.54 162.31 24.38 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 14.8 m -53.83 -56.81 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.579 ' HB2' ' O ' ' A' ' 56' ' ' SER . 7.8 t-80 156.75 136.49 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.979 1.312 . . . . 0.0 110.697 164.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.21 145.17 54.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.09 124.0 11.27 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 111.048 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.82 130.32 7.54 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.822 1.682 . . . . 0.0 112.469 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 61.7 tttp -96.66 109.47 22.1 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 m -150.87 162.79 3.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 123.888 0.875 . . . . 0.0 108.875 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -123.31 -54.71 0.2 Allowed Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.92 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -97.61 1.35 48.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.653 0.74 . . . . 0.0 110.82 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.0 mt -104.99 140.56 21.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.99 159.03 53.77 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.71 2.273 . . . . 0.0 109.888 173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -62.7 -40.14 96.2 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -58.68 -37.62 76.43 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -71.03 -40.17 71.88 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 74' ' ' MET . 19.2 m -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.61 -37.81 87.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.37 89.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.555 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.27 -45.43 89.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.462 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 7.8 mmt -60.83 -45.54 94.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.699 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.39 -39.65 84.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 110.27 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.47 71.55 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.93 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -75.42 -27.07 58.85 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.596 0.758 . . . . 0.0 110.537 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 74' ' ' MET . 31.9 mm-40 -77.04 -42.85 36.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.479 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.26 -9.23 42.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.23 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t30 55.73 57.25 5.38 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.12 175.01 6.25 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.747 -170.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.06 121.63 30.69 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 tp -101.9 121.11 41.5 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.072 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.84 110.25 28.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.5 147.66 34.84 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.252 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -95.97 -26.24 15.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.254 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.89 131.22 37.4 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.069 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.54 -33.75 74.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -76.39 -30.75 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.11 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.301 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.69 -47.14 86.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.13 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -58.07 -54.75 43.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.251 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 61' ' ' LYS . 1.3 tmtm? -61.24 -44.93 96.46 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.593 -173.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.7 98.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 37.9 ttmt -68.94 -28.09 66.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.9 mt-10 -64.4 -33.52 76.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.39 -3.86 57.94 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.092 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.36 59.92 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.537 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.6 t -81.64 135.08 25.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.03 96.17 8.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.672 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 133.7 51.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.502 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.74 156.48 62.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.333 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.4 Cg_exo -72.93 162.4 41.12 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.322 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.432 HD13 ' HB2' ' A' ' 12' ' ' LYS . 69.3 mt -55.98 -44.68 79.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -72.0 -16.53 62.07 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.83 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.28 -27.63 27.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.743 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.86 -38.2 79.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.5 -14.57 60.84 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.517 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.79 -35.44 14.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.7 m -91.45 11.47 23.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.587 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.8 p -80.98 -25.01 37.62 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.4 mt 60.37 83.1 0.14 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.859 -1.519 . . . . 0.0 113.608 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -26.97 50.92 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.02 0.914 . . . . 0.0 109.153 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -92.87 106.94 18.83 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -58.04 103.83 0.16 Allowed 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.637 0.585 . . . . 0.0 110.669 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 m170 66.64 118.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.537 1.135 . . . . 0.0 111.7 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -65.59 -35.92 82.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 70.77 -46.55 0.63 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.53 1.532 . . . . 0.0 113.537 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.198 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -87.89 155.58 19.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.275 0.56 . . . . 0.0 110.816 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -138.1 110.4 7.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -92.84 128.95 44.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.92 126.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 t -91.74 145.7 31.64 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 84.5 Cg_exo -50.85 -28.22 22.86 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 123.954 3.102 . . . . 0.0 115.103 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 p -60.56 -34.45 74.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.23 12.15 7.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.508 0.723 . . . . 0.0 112.825 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 10.5 m-30 -67.99 165.83 17.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.726 0.774 . . . . 0.0 112.754 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.73 -35.3 3.07 Favored Glycine 0 C--O 1.215 -1.081 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.214 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -113.13 14.78 19.55 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.659 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.29 -35.17 79.45 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.314 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -67.05 -40.68 87.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.7 -51.5 64.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.633 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.3 pt -60.31 -39.48 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.9 0.381 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -65.71 -48.32 72.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.065 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.19 -33.75 43.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -86.21 -36.23 19.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.488 0.644 . . . . 0.0 111.627 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.5 -53.96 4.68 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.945 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 59.16 -174.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.364 0.602 . . . . 0.0 111.364 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 -13.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.809 1.244 . . . . 0.0 114.011 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.8 154.57 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.3 tpmt? -91.66 97.97 11.35 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.3 m-85 -74.81 129.36 37.55 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.49 138.06 51.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.973 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -126.46 152.47 34.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 41.9 p -90.88 169.32 11.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.108 -0.37 . . . . 0.0 111.246 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.3 p -67.83 -41.84 82.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.482 0.658 . . . . 0.0 109.687 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.61 -34.43 78.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.139 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.7 -57.66 16.65 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.998 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 36' ' ' ILE . 29.3 m -59.73 -39.34 79.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 27.0 m -66.11 -36.22 82.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.76 0.314 . . . . 0.0 111.118 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -69.21 -40.13 78.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.65 84.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.773 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.2 mm -57.37 -57.68 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.223 0.327 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.7 ptpp? -65.07 -24.37 67.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 t -93.96 -8.2 40.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.371 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.84 34.34 43.33 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.665 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 10' ' ' PHE . 84.2 mt -91.54 143.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.76 95.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 111.195 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.05 -28.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.32 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.07 -39.82 94.91 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 5.5 m -67.67 -30.88 70.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.292 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.1 -51.05 42.59 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -38.11 85.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 44' ' ' SER . 10.6 t70 -52.77 -45.51 67.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.631 1.172 . . . . 0.0 112.051 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -82.78 -9.81 59.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.416 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.11 19.09 4.42 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.257 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 93.9 t -73.13 132.18 33.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.66 145.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.639 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.0 t -96.11 132.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' THR . 23.3 ttm180 -153.25 138.65 17.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -152.93 157.87 41.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 11.4 m-85 -71.84 147.07 47.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -74.15 -39.08 63.52 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -165.86 100.12 0.66 Allowed 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.605 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 5.7 tmtm? -137.43 110.71 8.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.47 121.76 2.67 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 CA-C-N 119.978 1.028 . . . . 0.0 111.463 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -91.6 132.12 1.35 Allowed 'Trans proline' 0 N--CA 1.438 -1.735 0 C-N-CA 122.998 2.465 . . . . 0.0 110.337 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.97 107.16 16.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.097 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.79 148.32 17.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.055 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.77 38.5 0.86 Allowed Glycine 0 C--N 1.283 -2.392 0 N-CA-C 106.658 -2.577 . . . . 0.0 106.658 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -158.0 -56.07 0.07 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.838 -1.181 . . . . 0.0 110.027 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt -83.72 141.85 41.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.163 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.07 147.25 91.63 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 122.527 2.152 . . . . 0.0 110.174 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.59 -34.7 77.53 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.296 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.252 10.4 p90 -64.08 -35.85 82.08 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.705 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 73' ' ' ILE . 72.0 mm-40 -71.97 -40.3 68.71 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 74' ' ' MET . 35.8 m -61.5 -38.19 86.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.922 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -58.78 -44.39 90.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.82 97.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 69' ' ' GLU . 64.2 mt -59.63 -46.21 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.03 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 13.4 mmt -62.86 -45.17 93.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.625 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.42 -40.44 89.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 120.848 0.356 . . . . 0.0 110.606 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.69 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.203 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.52 -38.45 68.06 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.628 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -49.77 46.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.827 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.08 -14.11 58.09 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.021 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.6 m120 60.44 65.83 1.01 Allowed 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.871 1.32 . . . . 0.0 108.48 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.56 171.43 8.37 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 113.206 -1.815 . . . . 0.0 110.04 -173.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -84.54 133.33 34.45 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -101.94 116.38 32.57 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.015 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.4 mt -96.34 110.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -134.49 154.99 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.59 -31.0 11.05 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.04 122.34 25.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.148 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 10.8 mptt -69.42 -25.96 64.39 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.63 -29.82 33.05 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.6 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -63.24 -49.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.77 -44.32 81.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.208 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -55.33 -56.0 25.05 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.354 1.462 . . . . 0.0 111.412 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.96 86.33 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -76.54 -18.61 58.6 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.97 -28.24 68.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.58 -18.48 33.22 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.93 13.64 15.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.969 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.74 127.97 46.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -76.41 89.89 3.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.726 0.774 . . . . 0.0 109.484 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.99 129.31 43.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.174 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.22 148.74 67.67 Favored Pre-proline 0 C--N 1.291 -1.96 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.14 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.3 Cg_exo -68.84 167.76 22.25 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.72 2.28 . . . . 0.0 111.68 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.64 -50.05 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.097 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.76 -36.58 72.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 56.6 mm-40 -69.51 -37.82 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.524 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.92 -44.54 84.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.37 -43.44 92.86 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.31 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.74 -27.42 69.19 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.138 0.575 . . . . 0.0 111.78 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -93.63 29.19 2.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.303 0.573 . . . . 0.0 110.632 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -106.19 99.76 9.33 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.3 mt 65.47 27.76 11.66 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.873 0.869 . . . . 0.0 110.386 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -46.45 71.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.893 1.277 . . . . 0.0 111.299 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -145.41 -26.01 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.723 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 89.8 m-70 -80.19 66.7 5.77 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-O 122.031 0.919 . . . . 0.0 112.062 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -163.9 16.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.523 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -98.75 -75.31 0.56 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -92.41 -36.66 13.01 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.569 ' O ' ' HA ' ' A' ' 115' ' ' HIS . 5.6 t60 . . . . . 0 N--CA 1.422 -1.87 0 N-CA-C 100.993 -3.706 . . . . 0.0 100.993 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -87.75 160.14 18.19 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.947 0.403 . . . . 0.0 110.406 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.28 114.95 11.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.15 131.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.185 0.517 . . . . 0.0 109.778 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.1 mt -97.49 130.24 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -94.57 149.02 35.89 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 88.2 Cg_exo -50.96 -27.37 20.89 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.657 2.905 . . . . 0.0 114.94 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -64.25 -24.53 67.7 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 120.975 0.417 . . . . 0.0 112.061 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 6.52 43.2 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.643 0.377 . . . . 0.0 111.688 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 15.1 m-30 -68.76 154.33 42.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -34.47 3.48 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.016 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -98.95 11.87 37.64 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.004 0.907 . . . . 0.0 109.662 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.71 -36.37 74.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.296 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.741 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.17 -59.2 2.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.578 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.6 pt -57.18 -45.59 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.3 tp -66.97 -42.6 84.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.331 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.89 -33.16 34.28 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.593 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 m -77.27 -45.89 24.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.883 0.373 . . . . 0.0 111.507 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 111' ' ' SER . 43.7 t-20 -93.9 -58.41 2.26 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.254 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 57.69 -146.32 0.55 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.0 -14.02 0.25 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -117.77 157.48 26.47 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -90.63 102.67 15.42 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -75.06 120.38 20.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.843 0.83 . . . . 0.0 110.545 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.31 133.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.653 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.39 153.6 28.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.564 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 24.7 p -90.75 170.55 10.03 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -67.96 -38.64 83.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.943 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -73.04 -29.74 63.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.31 -56.18 25.0 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.578 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.9 m -60.82 -38.39 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.735 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 44.3 t -64.45 -40.33 95.51 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.811 0.339 . . . . 0.0 110.627 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.88 -38.92 87.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.91 86.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.379 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.2 mm -55.3 -56.81 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.6 0.562 . . . . 0.0 111.337 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 33' ' ' SER . 14.4 pttm -66.49 -30.27 70.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -87.41 -0.73 57.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.545 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.58 95.49 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.1 mt -92.07 147.8 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 123.566 0.746 . . . . 0.0 109.18 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.2 89.25 0.64 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.153 0.502 . . . . 0.0 110.922 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -102.84 -32.65 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -60.56 -39.29 87.43 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -30.62 71.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.274 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.95 -48.6 23.6 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.57 -41.93 95.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.249 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.68 -21.73 64.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.609 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -92.9 -7.95 44.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.94 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 5.82 6.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 115.248 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.63 129.72 36.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.149 0.974 . . . . 0.0 108.848 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.1 pt -104.88 152.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.18 124.35 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -122.41 124.76 44.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.18 146.27 24.11 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.82 108.35 5.07 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.4 m -80.21 9.75 5.3 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.52 -173.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -126.02 157.9 36.72 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -61.02 113.5 7.98 Favored Pre-proline 0 C--O 1.25 1.105 0 O-C-N 123.783 0.677 . . . . 0.0 111.285 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.15 125.07 12.49 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.892 2.395 . . . . 0.0 112.002 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.24 171.95 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.251 1.968 . . . . 0.0 110.064 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -96.13 147.42 23.75 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.476 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.12 118.06 50.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.77 -12.92 65.7 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.985 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.587 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 3.0 p-10 -94.34 -33.04 13.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.626 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.587 ' HG ' ' ND2' ' A' ' 64' ' ' ASN . 96.2 mt -108.49 153.22 42.22 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 116.871 -0.149 . . . . 0.0 111.195 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.84 153.66 76.84 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.981 1.788 . . . . 0.0 109.601 173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.85 -32.92 74.84 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -60.36 -40.46 90.86 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.58 -40.99 69.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -63.66 -37.88 89.03 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.325 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.564 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.7 tt0 -61.75 -40.83 96.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.06 89.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.511 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.19 -44.32 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.505 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 12.6 mmt -64.51 -40.05 94.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.67 -38.03 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.088 0.47 . . . . 0.0 110.067 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.18 -32.52 74.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -73.67 -35.96 65.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.313 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.95 -46.71 67.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.672 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.87 -17.77 39.75 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.03 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.54 69.19 0.7 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.21 176.18 7.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.721 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -85.86 134.49 33.9 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -101.97 122.62 44.4 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.459 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.36 113.47 36.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.22 159.54 42.49 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.95 -24.54 11.58 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.65 135.71 33.3 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.594 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -59.49 -38.52 81.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.078 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.38 -34.11 67.71 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.95 -53.08 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.625 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.3 -43.13 85.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.098 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -70.73 -41.65 71.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 40.3 tptt -65.87 -39.78 91.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.094 0.473 . . . . 0.0 110.311 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.47 98.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.08 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -71.74 -20.44 61.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.516 ' OE1' ' HD2' ' A' ' 93' ' ' LYS . 42.3 mt-10 -72.93 -31.8 64.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.27 -14.53 57.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.535 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.26 44.82 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.954 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.97 133.81 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -79.85 93.47 5.64 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.45 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.61 130.14 41.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.578 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.21 139.2 34.16 Favored Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.479 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 25.6 Cg_exo -61.28 159.98 28.8 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.321 2.014 . . . . 0.0 110.453 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 45.6 mt -56.09 -40.54 64.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -30.07 70.99 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -75.89 -33.57 59.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.782 0.325 . . . . 0.0 110.486 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.51 -43.39 80.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 85.7 mt -63.43 -42.59 98.7 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.01 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.0 110.877 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -65.81 -47.04 76.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.467 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.451 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 68.7 m -154.65 99.25 2.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.911 0.386 . . . . 0.0 111.228 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pp -97.31 -27.66 14.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.644 0.735 . . . . 0.0 110.655 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.54 -30.51 9.0 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.18 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 72.85 -43.23 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.95 1.3 . . . . 0.0 110.023 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -147.31 121.57 9.57 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.73 -21.8 65.27 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 72.77 -57.6 0.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.901 1.28 . . . . 0.0 112.498 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -158.26 -55.77 0.07 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 122.967 0.507 . . . . 0.0 110.465 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 CA--C 1.511 -0.555 0 C-N-CA 126.781 2.033 . . . . 0.0 108.029 177.49 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -86.77 146.04 26.4 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -130.91 113.55 14.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.74 134.57 30.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -95.97 128.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 85' ' ' ALA . 1.4 t -82.47 144.4 49.46 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.355 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 Cg_exo -58.07 -26.76 76.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.91 2.407 . . . . 0.0 112.452 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.411 ' HG ' ' CD ' ' A' ' 69' ' ' GLU . 49.0 m -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.151 0.5 . . . . 0.0 110.547 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.82 -0.1 49.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.615 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.475 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 16.3 m-30 -63.2 153.01 35.89 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.426 0.631 . . . . 0.0 112.362 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.59 -35.38 3.5 Favored Glycine 0 C--N 1.31 -0.915 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.166 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -99.05 3.67 46.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.76 1.267 . . . . 0.0 108.397 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.4 -34.92 78.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.038 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -61.66 -34.35 75.57 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.232 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.82 -62.66 1.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.822 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.446 ' CG2' HG21 ' A' ' 104' ' ' ILE . 29.9 pt -53.43 -40.37 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.5 -54.88 33.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.152 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.77 -30.47 13.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.175 -1.012 . . . . 0.0 114.134 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -78.54 -29.62 46.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 122.429 -0.454 . . . . 0.0 110.911 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -114.81 -55.04 2.52 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.913 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 51.6 tttp 58.01 -140.19 0.79 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.483 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 66.4 t30 69.93 -13.36 0.42 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 124.793 1.237 . . . . 0.0 113.949 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.54 161.22 18.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.695 -0.628 . . . . 0.0 109.737 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.95 102.35 14.71 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.49 124.04 26.48 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.359 0.6 . . . . 0.0 111.446 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.86 134.61 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.025 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.3 tp -121.14 149.47 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 24.1 p -85.86 168.63 14.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.584 0.707 . . . . 0.0 112.506 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.76 95.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.291 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.93 -30.52 58.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.93 -54.65 35.77 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.947 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.2 m -60.56 -42.42 91.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.475 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 m -63.16 -41.79 99.32 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.859 0.362 . . . . 0.0 111.378 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.02 -43.43 98.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.307 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.199 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 32' ' ' VAL . 31.8 mm -59.25 -52.53 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.805 0.442 . . . . 0.0 111.088 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -12.89 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -98.48 -16.01 19.37 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.19 41.36 13.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.192 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.4 mt -100.41 157.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.86 83.74 0.11 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.905 0.482 . . . . 0.0 111.364 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.3 tp -107.13 -31.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -71.09 -37.44 72.42 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.882 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.9 m -65.29 -28.92 69.67 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.934 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.99 -50.08 13.97 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.75 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 80.5 mt -57.88 -40.74 80.98 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.806 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.89 -49.61 65.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.883 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.4 mtt180 -82.09 -0.62 45.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.04 0.68 8.17 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 118.609 -1.757 . . . . 0.0 115.026 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.2 t -72.48 126.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 pt -104.53 148.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -96.03 137.98 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' NE ' HD22 ' A' ' 79' ' ' LEU . 37.8 ttt85 -147.91 136.11 21.34 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.266 0.555 . . . . 0.0 111.499 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.26 153.76 34.51 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.88 158.89 21.46 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 17.8 m -58.77 -56.96 15.42 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.118 0.261 . . . . 0.0 110.393 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' SER . 13.9 t-80 172.72 104.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.314 0.384 . . . . 0.0 110.199 175.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 58' ' ' LYS . 42.9 mtpt -134.74 153.29 78.75 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 172.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.27 123.85 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.098 1.199 . . . . 0.0 109.258 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HA ' ' SD ' ' A' ' 74' ' ' MET . 16.8 Cg_exo -70.48 128.96 16.07 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.123 1.215 . . . . 0.0 109.305 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -116.44 109.43 17.3 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 m -150.25 161.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.07 43.91 1.2 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.122 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -178.44 -43.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.062 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.37 149.17 81.41 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.53 161.25 46.69 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.396 2.064 . . . . 0.0 111.042 174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -56.46 -40.18 74.41 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.746 0.818 . . . . 0.0 112.623 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -62.68 -36.59 83.39 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' CD ' ' HG ' ' A' ' 8' ' ' SER . 73.9 mm-40 -75.4 -37.62 60.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -59.93 -44.8 94.14 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.463 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.3 tt0 -61.94 -37.88 86.38 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.88 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.87 97.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.32 -44.1 83.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.385 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 60' ' ' PRO . 23.2 mmt -60.92 -42.5 98.24 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.55 -40.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.134 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.02 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.295 0.569 . . . . 0.0 110.136 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.66 -44.07 74.88 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.439 1.096 . . . . 0.0 110.62 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -74.19 -27.22 60.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.072 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 HD22 ' NE ' ' A' ' 53' ' ' ARG . 93.1 mt -88.75 -19.13 26.44 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.06 48.86 6.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.98 176.92 5.93 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.819 -1.537 . . . . 0.0 112.243 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.94 128.03 36.14 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.2 tp -103.57 119.06 38.15 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.483 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.9 mt -94.58 110.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -126.11 173.45 9.2 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.0 -60.33 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.44 136.19 57.44 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.34 0.59 . . . . 0.0 111.232 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -58.34 -35.37 71.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.151 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.25 -31.07 54.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.111 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.39 -43.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.43 -49.52 82.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.739 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.16 -52.72 64.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.62 -33.23 75.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 -46.78 77.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.436 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.43 -20.94 61.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.82 -39.1 93.42 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.696 0.76 . . . . 0.0 109.176 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.57 -3.57 57.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.265 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.14 10.81 59.3 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.916 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.23 126.1 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.39 95.3 3.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.176 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.44 143.93 29.13 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.027 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -141.0 152.27 64.69 Favored Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 123.728 0.643 . . . . 0.0 110.445 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.94 159.45 53.23 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.54 1.493 . . . . 0.0 109.848 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.446 HG21 ' CG2' ' A' ' 16' ' ' ILE . 75.4 mt -54.89 -43.65 69.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.51 -32.38 54.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 120.954 0.406 . . . . 0.0 110.186 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.52 -37.9 71.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.2 -35.64 81.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 -9.22 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.249 0.547 . . . . 0.0 111.094 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -95.0 4.24 54.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.444 0.64 . . . . 0.0 109.735 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.6 t -87.14 165.29 15.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.6 mt 63.32 28.46 15.65 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -39.37 78.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -80.6 -3.94 52.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.615 0.721 . . . . 0.0 110.293 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.264 72.4 m80 52.37 -96.4 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 126.313 1.845 . . . . 0.0 115.896 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -120.53 128.69 53.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.734 0.302 . . . . 0.0 110.33 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -146.74 110.9 5.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -70.4 112.56 6.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.183 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.08 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.244 0.767 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -87.42 155.67 19.92 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.79 109.15 9.45 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' HD12 ' A' ' 83' ' ' LEU . 59.2 t -92.37 129.23 43.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.8 mt -96.96 133.99 36.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.573 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -91.7 147.13 34.46 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.521 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 45.5 Cg_exo -56.16 -21.45 35.48 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.219 2.613 . . . . 0.0 114.561 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -67.81 -25.67 65.69 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 122.094 -0.379 . . . . 0.0 111.729 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 19.57 8.83 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.025 0.53 . . . . 0.0 111.866 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.1 m-30 -72.33 168.09 19.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 -34.87 3.38 Favored Glycine 0 C--O 1.217 -0.943 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.357 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 16' ' ' ILE . 13.4 mmmm -100.12 21.22 13.17 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.414 0.626 . . . . 0.0 110.098 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 -27.32 68.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.711 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.52 -43.54 22.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -66.26 -46.24 77.73 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.457 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 12' ' ' LYS . 30.6 pt -64.88 -34.48 70.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.398 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 9.5 tp -66.65 -55.04 17.05 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.167 0.508 . . . . 0.0 109.671 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.4 -33.17 61.59 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.3 m -82.81 -48.1 11.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 117.358 0.579 . . . . 0.0 111.214 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 111' ' ' SER . 52.1 t30 -90.21 -59.07 2.29 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.668 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 75.1 tttt 59.7 -162.21 0.26 Allowed 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.448 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 43.1 m-80 73.86 -0.51 3.34 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 170.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -123.18 152.42 41.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.13 104.34 16.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -74.69 131.27 40.73 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.689 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 58.6 t -127.76 138.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.331 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.27 150.59 30.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -84.01 163.15 20.1 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.14 0.495 . . . . 0.0 111.415 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -62.56 -34.37 76.8 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.351 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.06 -32.64 63.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.03 67.51 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.108 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.9 m -61.35 -39.34 82.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.717 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -65.32 -37.54 87.41 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.693 0.282 . . . . 0.0 111.085 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.23 -42.23 88.96 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.446 0.641 . . . . 0.0 109.471 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.64 90.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.774 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' VAL . 40.8 mm -61.27 -50.58 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.572 0.349 . . . . 0.0 111.043 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -64.73 -35.78 82.18 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.3 t -80.45 -28.33 37.68 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.59 40.91 6.62 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.6 mt -95.77 149.04 4.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.14 91.72 0.23 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.725 0.774 . . . . 0.0 111.725 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.2 tp -109.59 -27.55 2.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.186 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.96 -48.21 77.35 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.332 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.593 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 3.1 m -72.77 -27.8 62.22 Favored 'General case' 0 C--O 1.204 -1.303 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -44.89 90.38 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.1 mt -60.1 -44.14 95.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.641 176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.94 -38.01 84.33 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.749 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 44' ' ' SER . 72.5 mtt85 -67.27 -19.8 65.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.71 4.11 6.88 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.85 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 61.9 t -75.98 119.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 pt -98.29 150.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 0.0 111.647 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.45 135.47 27.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -132.56 135.61 46.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.71 143.58 32.9 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.08 122.26 20.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 t -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.42 0.45 . . . . 0.0 110.679 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -100.82 -179.46 4.07 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -109.38 105.34 57.07 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.2 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.91 157.13 15.56 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 122.403 2.069 . . . . 0.0 111.193 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 130.75 32.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.865 1.71 . . . . 0.0 109.819 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -80.17 148.19 31.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 63' ' ' GLY . 21.1 t -76.57 130.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -77.53 161.45 50.05 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 174.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 t30 76.27 -40.12 0.38 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.91 0.884 . . . . 0.0 112.073 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.85 155.97 42.97 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 121.994 -0.441 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -66.43 145.15 76.23 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.245 1.963 . . . . 0.0 109.958 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.51 -38.94 89.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -33.49 75.74 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -73.98 -40.77 62.74 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.9 m -60.96 -40.41 93.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.646 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.67 -38.22 90.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.768 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.78 -46.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.662 0.601 . . . . 0.0 110.092 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.491 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 8.7 mmt -61.77 -49.55 75.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.77 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.57 -41.49 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -41.55 98.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.552 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -65.36 -46.31 80.68 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.696 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.75 -43.88 97.4 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.218 0.607 . . . . 0.0 109.517 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.0 -15.99 54.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.343 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.34 43.61 4.64 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.58 178.93 5.02 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.237 -1.801 . . . . 0.0 112.288 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.0 135.21 33.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 4' ' ' VAL . 45.0 tp -111.09 122.29 47.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.495 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mt -103.13 110.21 29.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.72 155.17 48.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -108.47 -25.4 10.97 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -75.76 129.55 37.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.755 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -50.85 -50.32 57.07 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 124.683 1.24 . . . . 0.0 112.611 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.47 -27.49 34.57 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.562 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.21 -47.77 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.06 -43.86 97.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.785 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 4.4 t30 -61.56 -47.77 84.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.873 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -66.41 -36.54 83.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.124 0.487 . . . . 0.0 111.1 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.31 84.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.498 0.666 . . . . 0.0 109.871 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -72.76 -26.26 61.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 51.6 mt-10 -63.8 -36.72 84.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.101 0.56 . . . . 0.0 110.23 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.49 -18.96 43.33 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.97 27.54 6.57 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.033 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -98.27 141.17 16.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -81.17 90.75 6.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.72 0.771 . . . . 0.0 109.5 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.0 131.04 54.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.124 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -143.09 157.16 61.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 123.782 0.677 . . . . 0.0 110.268 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.17 167.33 27.62 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.661 2.241 . . . . 0.0 111.981 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 79.4 mt -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.223 1.009 . . . . 0.0 113.274 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.44 -38.05 89.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 111.462 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.6 -31.19 64.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.476 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.44 -39.7 94.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 79.5 mt -68.26 -19.29 64.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.21 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.63 2.41 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -106.49 26.03 10.41 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.921 -0.487 . . . . 0.0 112.007 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.522 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 48.8 m -56.81 126.17 25.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -109.44 28.9 8.07 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.576 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.12 -57.54 11.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.935 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -135.22 -43.89 0.71 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 69.06 -38.59 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.887 1.675 . . . . 0.0 114.014 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -78.13 123.94 27.46 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.9 0.48 . . . . 0.0 111.152 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -78.06 -7.01 56.37 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.88 0.847 . . . . 0.0 111.078 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 175.44 -48.86 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 N--CA 1.416 -2.138 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 165.275 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.71 149.29 24.32 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.23 111.28 10.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 61.8 t -92.67 129.85 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mt -95.3 125.77 47.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.884 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -92.42 141.21 24.54 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -38.84 -32.2 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 125.074 3.849 . . . . 0.0 116.98 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.6 p -64.75 -22.97 67.1 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.754 0.706 . . . . 0.0 112.053 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.44 11.51 25.94 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.381 0.672 . . . . 0.0 111.411 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 12' ' ' LYS . 11.3 m-30 -76.28 159.63 30.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.359 0.6 . . . . 0.0 112.238 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.3 -34.97 2.2 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.403 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 10' ' ' PHE . 58.7 mtpt -96.3 13.12 28.66 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.939 0.876 . . . . 0.0 109.433 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -54.73 -39.21 68.03 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.216 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -73.13 -21.0 60.81 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.98 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -74.53 -58.39 3.32 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.34 -48.91 85.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 48' ' ' ARG . 57.6 tp -66.72 -45.96 77.01 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.941 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.16 48.75 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.292 -0.956 . . . . 0.0 114.061 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -84.79 -27.22 27.0 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.384 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -109.07 -59.1 1.94 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 119.629 -0.828 . . . . 0.0 112.089 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 59.06 -155.86 0.35 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 70.7 -15.32 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 124.847 1.259 . . . . 0.0 113.896 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -104.98 153.6 21.22 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -91.82 97.5 11.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -74.6 125.66 29.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.509 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 53.1 t -121.26 135.19 62.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.438 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.1 tt -123.45 154.38 29.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.521 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 20.4 p -89.86 167.93 12.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -45.57 92.45 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.719 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.67 -21.87 61.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -56.68 8.75 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.691 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.7 m -58.58 -38.33 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 117.323 0.561 . . . . 0.0 111.156 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -67.21 -35.05 78.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.91 -40.1 87.57 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.07 78.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.456 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 32' ' ' VAL . 42.7 mm -55.4 -51.15 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.999 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -12.35 61.44 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -106.78 -0.56 23.36 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.02 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.59 29.2 68.11 Favored Glycine 0 C--O 1.242 0.601 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.221 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.93 129.91 37.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.97 111.75 6.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.077 0.942 . . . . 0.0 111.049 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -116.77 -16.98 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.73 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 122.314 -0.241 . . . . 0.0 111.222 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -63.22 -32.18 73.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.14 58.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.39 -43.17 99.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.465 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.26 -43.18 74.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.695 1.198 . . . . 0.0 111.978 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.434 ' HB2' HD22 ' A' ' 17' ' ' LEU . 81.6 mtt180 -77.12 -13.59 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.26 13.38 3.56 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.265 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.2 t -81.3 133.13 29.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.2 pt -110.52 154.57 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.676 0.274 . . . . 0.0 110.593 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.2 p -107.92 136.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -127.34 133.18 50.11 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.01 130.86 41.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -90.15 137.68 32.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 49.5 m -85.9 -57.59 2.98 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -171.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 56' ' ' SER . 6.9 t60 176.81 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.731 0.696 . . . . 0.0 112.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -137.37 149.2 64.81 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 166.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -71.36 123.82 9.87 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.545 -1.367 . . . . 0.0 108.545 172.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.75 131.11 13.11 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.962 1.774 . . . . 0.0 111.419 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -89.63 109.17 20.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.76 162.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.21 -77.13 0.77 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.79 70.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.503 1.144 . . . . 0.0 111.107 175.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -108.09 148.7 38.0 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.164 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.93 140.29 37.95 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.465 2.11 . . . . 0.0 110.688 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -45.38 -45.39 12.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.804 1.241 . . . . 0.0 113.139 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -61.17 -34.57 75.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.83 -28.23 21.76 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -64.08 -38.69 91.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.929 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.521 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.5 tt0 -62.0 -40.82 96.96 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.7 80.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.917 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.99 -45.28 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.907 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.488 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 3.7 mmt -62.55 -44.48 96.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 -177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.72 -38.4 82.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.939 0.399 . . . . 0.0 110.746 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.43 80.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.589 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -69.84 -39.43 76.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.482 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 74' ' ' MET . 12.8 mm-40 -60.09 -49.89 75.87 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.485 0.659 . . . . 0.0 111.208 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.61 -16.83 46.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.343 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 60.73 56.09 3.08 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.05 177.76 4.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.031 -1.895 . . . . 0.0 111.649 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.38 134.69 34.4 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 34.5 tp -109.19 128.71 55.25 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.452 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.1 mt -106.89 113.09 42.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.56 146.57 32.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.63 -23.52 15.44 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.13 123.94 27.47 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.768 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.56 -38.12 80.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.805 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.57 -31.29 47.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.515 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.5 t -62.9 -46.53 96.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.26 -49.56 81.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.01 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -56.14 -48.74 75.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.258 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 2.2 tmtm? -65.55 -45.9 81.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.013 0.435 . . . . 0.0 110.351 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.06 82.84 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -57.82 -42.64 84.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.439 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.9 mt-10 -60.39 -35.57 76.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.76 0.824 . . . . 0.0 111.091 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 81.6 mt -77.54 -5.61 50.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.523 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.77 7.22 63.11 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.04 128.22 44.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -82.45 97.95 8.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.616 -1.233 . . . . 0.0 110.307 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.44 127.46 37.94 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.227 174.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 102' ' ' ILE . 2.6 pp -132.61 146.65 62.32 Favored Pre-proline 0 C--N 1.28 -2.449 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.293 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 40.3 Cg_endo -71.42 167.65 25.73 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.421 2.081 . . . . 0.0 111.065 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 63.2 mt -60.18 -40.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.11 -29.56 69.9 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.283 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.2 -32.59 63.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.968 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.39 -34.88 76.82 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 93.2 mt -65.9 -40.73 91.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.185 0.517 . . . . 0.0 109.948 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.57 -25.42 63.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.317 0.579 . . . . 0.0 110.811 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 t -67.5 -15.36 63.62 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.751 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -116.65 99.35 7.08 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 91.8 mt 55.32 89.24 0.04 OUTLIER 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.542 1.137 . . . . 0.0 113.961 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -75.41 -19.94 59.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.9 t60 82.64 86.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.878 2.071 . . . . 0.0 107.902 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.308 72.6 m-70 94.06 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 127.122 2.169 . . . . 0.0 112.914 -174.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -168.83 89.94 0.23 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 66.49 151.89 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.221 1.009 . . . . 0.0 110.314 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -150.3 154.4 37.79 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.813 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 . . . . . 0 C--N 1.305 -1.35 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.292 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -87.88 150.2 23.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.77 108.56 10.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -92.12 128.44 43.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 109.705 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.0 mt -93.94 124.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.716 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -87.2 149.01 46.28 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -59.05 -19.34 48.19 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.355 2.703 . . . . 0.0 114.4 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 p -69.1 -19.25 64.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.979 0.418 . . . . 0.0 110.941 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.49 13.52 33.06 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.282 0.633 . . . . 0.0 110.963 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.469 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.2 m-30 -71.44 153.87 41.94 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.18 -33.1 4.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.057 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.42 11.99 35.83 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.078 0.466 . . . . 0.0 111.653 -175.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.47 -32.01 69.85 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.773 0.796 . . . . 0.0 108.864 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.11 -39.68 87.06 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.319 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.46 -56.29 8.91 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.0 pt -58.62 -37.63 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.0 tp -72.94 -47.62 43.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.222 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -31.57 31.67 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.34 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -87.72 -22.51 24.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -114.84 -55.77 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.501 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' HZ3' ' HB3' ' A' ' 21' ' ' LYS . 8.6 mtpm? 60.78 -142.04 0.52 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -171.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 70.77 -13.86 0.46 Allowed 'General case' 0 N--CA 1.518 2.933 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.98 156.4 43.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -89.02 102.4 15.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -74.71 126.9 31.87 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.344 0.592 . . . . 0.0 110.027 -177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.3 t -115.69 126.66 73.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.263 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -113.89 145.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.246 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 p -84.79 160.44 20.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -44.22 97.43 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.968 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.78 -32.21 73.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.634 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.8 77.4 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.705 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.7 m -62.82 -41.56 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.599 0.699 . . . . 0.0 111.659 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -64.72 -36.4 84.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -67.75 -43.16 80.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.64 85.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 32' ' ' VAL . 44.2 mm -64.75 -52.67 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HZ2' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -67.64 -32.53 73.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -88.54 -11.77 44.72 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.09 18.02 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.86 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 66.3 mt -97.0 142.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -67.73 112.66 4.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.046 0.45 . . . . 0.0 110.705 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.62 -26.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.516 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.13 -35.62 78.4 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.659 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.7 p -65.28 -38.86 91.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.485 0.66 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -52.09 63.95 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.596 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.67 -39.78 85.6 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.466 0.65 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.5 -38.42 84.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.467 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.6 mtt180 -87.04 3.48 45.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.36 2.24 7.64 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 118.73 -1.7 . . . . 0.0 115.771 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' CG1' ' HB ' ' A' ' 27' ' ' ILE . 92.6 t -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -105.62 157.34 6.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.2 p -105.86 128.13 60.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.129 0.49 . . . . 0.0 110.768 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.89 137.4 52.83 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.24 126.3 51.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 31.4 t80 -80.83 104.25 11.22 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 p -75.16 -16.98 60.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.107 0.963 . . . . 0.0 113.158 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 49.2 t60 -90.68 159.21 16.5 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.89 119.44 77.19 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.893 176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -86.5 124.92 2.4 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.829 1.686 . . . . 0.0 111.086 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' HD2' ' SD ' ' A' ' 74' ' ' MET . 30.7 Cg_endo -66.78 134.11 33.84 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.746 1.631 . . . . 0.0 110.69 176.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -72.39 111.59 7.71 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.12 134.72 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.23 -61.87 3.81 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 123.622 0.576 . . . . 0.0 114.475 -174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -75.19 -37.47 61.2 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.156 0.503 . . . . 0.0 112.002 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.3 mt -86.7 132.98 40.76 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -169.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -60.05 169.1 5.13 Favored 'Trans proline' 0 C--O 1.256 1.385 0 C-N-CA 122.96 2.44 . . . . 0.0 112.238 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.21 -48.53 70.92 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.501 0.72 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -63.22 -31.21 72.3 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -75.71 -42.39 50.97 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -61.57 -39.98 93.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.123 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -54.03 -50.2 67.22 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.572 1.149 . . . . 0.0 109.234 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.01 -48.97 77.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.611 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.05 -45.56 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.934 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' A' ' 60' ' ' PRO . 29.8 mmt -65.09 -38.31 90.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.68 -43.37 96.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.41 77.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.67 -39.25 80.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.631 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.64 -48.83 36.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.289 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.09 -21.55 50.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.56 69.08 0.47 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.05 170.7 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.492 -172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -85.27 122.86 30.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 36.8 tp -99.59 125.75 45.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.18 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.54 113.86 43.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.85 145.54 36.35 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.896 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -95.77 -29.32 14.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -83.71 124.09 30.51 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.858 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.51 -36.53 6.81 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 125.892 1.677 . . . . 0.0 114.402 179.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 23.9 t70 -79.72 -33.82 40.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.363 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.93 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.66 -46.46 93.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.916 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.3 t30 -59.54 -51.6 69.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.1 mmmt -63.01 -41.68 99.64 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.03 88.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.464 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -68.53 -26.18 65.3 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.026 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.2 mt-10 -69.3 -28.74 66.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.189 0.519 . . . . 0.0 109.852 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.44 0.03 56.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.703 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.77 8.76 65.01 Favored Glycine 0 C--O 1.241 0.54 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.66 128.92 43.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.25 92.69 6.38 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.157 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.56 132.41 44.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.759 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.96 155.95 76.05 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.8 Cg_exo -70.76 160.65 48.73 Favored 'Trans proline' 0 C--O 1.256 1.409 0 C-N-CA 121.999 1.799 . . . . 0.0 110.868 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.456 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 39.8 mt -54.76 -42.9 64.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 123.651 0.78 . . . . 0.0 111.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -63.13 -36.72 84.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.13 -33.06 69.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.975 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.95 -47.95 75.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.8 mt -63.0 -33.33 75.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.056 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.64 59.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.526 ' HA ' ' OE1' ' A' ' 113' ' ' GLU . 50.2 m -109.29 20.98 17.67 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.328 0.585 . . . . 0.0 110.885 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -89.25 -17.63 28.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.87 -27.23 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -169.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' A' ' 110' ' ' SER . 1.1 mp0 -62.67 -41.46 99.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -172.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.1 m80 63.92 -166.88 0.22 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 59.8 -89.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.859 0.864 . . . . 0.0 111.294 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -114.11 113.87 25.31 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.49 0.662 . . . . 0.0 110.437 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -151.58 28.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 170.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -179.49 102.56 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 129.971 3.308 . . . . 0.0 105.89 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 C--N 1.287 -2.12 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.502 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 C--O 1.245 0.863 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.64 153.0 21.72 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.0 109.69 10.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.61 128.54 44.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.61 123.48 43.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 m -83.93 148.59 54.33 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.617 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 77.3 Cg_exo -53.32 -11.25 1.71 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 124.13 3.22 . . . . 0.0 114.679 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -64.25 -47.36 79.91 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.7 20.33 0.95 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.54 -171.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.617 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 4.3 m-30 -70.6 147.77 48.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.084 0.469 . . . . 0.0 111.175 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -34.32 3.53 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.58 -0.77 57.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.606 1.162 . . . . 0.0 109.605 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -47.52 -48.68 27.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.493 1.517 . . . . 0.0 111.999 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -75.12 -22.78 57.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.434 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -75.38 -52.37 10.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.417 ' CG2' HG23 ' A' ' 104' ' ' ILE . 23.7 pt -63.57 -41.45 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 48' ' ' ARG . 59.9 tp -65.38 -54.97 21.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.518 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.1 -33.6 56.78 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.225 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -79.35 -55.64 4.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.849 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 111' ' ' SER . 52.1 t30 -75.67 -59.06 2.92 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.017 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 60.09 -156.73 0.34 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 t30 73.11 -13.97 0.65 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.257 1.023 . . . . 0.0 113.38 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -116.35 155.16 28.94 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -90.85 101.92 14.68 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' HB2' HG21 ' A' ' 50' ' ' VAL . 87.1 m-85 -74.66 133.72 42.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.63 140.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.304 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -126.42 154.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.7 p -99.92 177.9 4.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -47.46 79.54 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 124.685 1.194 . . . . 0.0 112.133 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.61 -24.05 56.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.92 -56.42 22.67 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.044 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.2 m -61.42 -34.59 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 117.049 0.425 . . . . 0.0 111.379 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 m -67.93 -37.34 81.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.114 0.483 . . . . 0.0 110.665 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -69.24 -35.07 75.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.88 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.16 88.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.4 mm -58.81 -53.13 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HZ1' ' HB3' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -65.21 -29.48 70.29 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 -2.74 58.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.628 0.252 . . . . 0.0 111.558 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.3 41.23 53.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.667 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.66 137.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.43 88.63 3.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.259 1.028 . . . . 0.0 111.134 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -81.8 -22.72 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.333 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -32.38 72.74 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.143 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 m -65.42 -33.44 75.96 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.267 0.556 . . . . 0.0 110.875 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.58 -47.86 16.34 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.3 -42.83 82.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.38 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.52 -41.95 86.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.717 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.412 ' HB2' HD22 ' A' ' 17' ' ' LEU . 80.7 mtt85 -79.64 -2.6 43.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.64 24.08 4.48 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.923 -1.132 . . . . 0.0 114.771 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 25' ' ' PHE . 95.6 t -86.4 126.7 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 pt -100.47 151.02 5.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.378 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.1 t -99.52 123.25 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -121.3 125.59 47.42 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.1 149.08 22.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 28.7 t80 -85.22 113.02 21.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 m -69.68 -22.92 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.711 0.804 . . . . 0.0 112.712 -174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 61.4 t-80 -88.17 160.61 17.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.67 145.97 94.87 Favored Pre-proline 0 C--O 1.251 1.147 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.463 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.97 143.5 96.02 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 123.145 2.563 . . . . 0.0 112.726 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.51 171.61 16.54 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.538 2.158 . . . . 0.0 111.311 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -100.87 110.49 22.56 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.95 162.56 11.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.24 -68.5 0.56 Allowed Glycine 0 C--N 1.292 -1.903 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.147 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -79.39 -38.83 33.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.3 mt -73.97 141.31 78.15 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -64.68 148.38 90.24 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.398 2.066 . . . . 0.0 110.068 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -58.06 -42.22 85.03 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -61.77 -35.3 77.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -81.11 -27.26 35.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.221 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -70.51 -32.12 69.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.617 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.77 -46.81 86.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.14 73.95 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.7 0.625 . . . . 0.0 111.181 178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.03 -47.67 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.918 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.455 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 1.9 mmt -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.058 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.81 -39.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 120.731 0.301 . . . . 0.0 110.664 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.042 0.449 . . . . 0.0 110.532 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -71.21 -43.74 66.77 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.88 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -50.89 65.22 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 109.787 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.7 -20.34 56.7 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.89 68.47 0.57 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 179.74 4.02 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.629 -172.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.93 133.15 36.39 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 30.8 tp -108.91 127.76 54.34 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.391 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.8 mt -105.72 115.65 47.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.2 157.55 44.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.626 0.25 . . . . 0.0 110.424 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.92 -43.71 6.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.957 0.408 . . . . 0.0 110.074 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.47 126.84 31.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.474 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -62.49 -28.0 69.52 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.714 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 -39.48 58.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.18 -51.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.21 -49.9 73.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.664 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 96' ' ' GLU 0.264 0.2 OUTLIER -64.9 -42.99 94.3 Favored 'General case' 0 C--O 1.205 -1.255 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.221 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.0 mtpp -63.22 -41.54 99.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.72 99.87 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.26 0.552 . . . . 0.0 109.764 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -72.77 -26.13 61.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.698 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.8 mt-10 -64.62 -37.19 86.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.1 mt -80.82 -15.71 55.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.656 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.31 5.49 28.27 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.083 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.5 t -94.36 130.34 43.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.9 96.7 5.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.086 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.41 133.69 43.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.44 155.26 72.05 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.49 0.493 . . . . 0.0 111.171 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 23.6 Cg_exo -67.91 162.87 37.86 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.519 2.146 . . . . 0.0 112.066 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.417 HG23 ' CG2' ' A' ' 16' ' ' ILE . 84.3 mt -57.66 -46.4 86.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 123.859 0.864 . . . . 0.0 111.597 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.31 -37.71 78.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.85 -39.58 87.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.37 -46.8 81.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.81 -39.59 85.56 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.197 0.599 . . . . 0.0 110.646 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.57 -16.29 60.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.724 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 m -99.02 15.06 27.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.909 0.385 . . . . 0.0 110.274 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.569 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 23.3 t -71.4 108.76 5.0 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.82 83.73 2.09 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.385 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.05 -35.56 78.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 36.6 m80 73.22 169.8 0.31 Allowed 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.414 1.486 . . . . 0.0 112.847 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -65.82 -21.75 66.5 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.5 m80 66.51 -177.49 0.2 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.453 0.701 . . . . 0.0 111.546 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -131.91 107.82 8.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -102.12 144.07 31.14 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.6 t60 . . . . . 0 C--N 1.287 -2.144 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.24 0.581 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.86 154.49 20.49 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.5 108.99 9.95 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.7 t -93.54 134.41 31.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.9 mt -104.56 134.24 46.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -89.08 146.9 37.35 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 70.6 Cg_exo -52.65 -28.08 35.83 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.545 2.83 . . . . 0.0 114.328 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 p -61.75 -22.86 65.76 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.97 13.23 31.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.166 0.507 . . . . 0.0 111.445 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 3.6 m-30 -69.88 160.52 31.65 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -34.33 3.65 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.687 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HB2' HD12 ' A' ' 104' ' ' ILE . 28.6 mtpp -102.18 13.85 33.56 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.781 0.801 . . . . 0.0 110.382 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.4 mt -56.93 -40.74 76.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.572 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -65.92 -26.2 67.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.024 -1.443 . . . . 0.0 111.33 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.53 -49.15 9.52 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.74 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' CG2' HG23 ' A' ' 104' ' ' ILE . 19.0 pt -63.38 -46.55 95.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 111.368 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.97 -43.18 79.59 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.853 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.36 -33.19 64.52 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.196 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.1 m -83.79 -45.32 13.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 61.4 t30 -96.63 -53.67 3.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 23' ' ' TYR . 11.4 mptt 58.68 -114.28 0.74 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -164.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 55.94 -15.31 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 21' ' ' LYS . 96.1 m-85 -132.17 166.25 22.24 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.4 -0.813 . . . . 0.0 109.233 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -98.28 105.51 17.67 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.26 139.69 42.71 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.8 t -131.05 140.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.373 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 tp -130.0 156.96 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.7 p -91.64 169.03 11.07 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.171 0.51 . . . . 0.0 111.779 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -41.68 95.16 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.279 1.032 . . . . 0.0 110.176 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.216 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 -52.06 19.57 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.404 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 36' ' ' ILE . 32.1 m -58.58 -38.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.434 0.617 . . . . 0.0 112.001 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 47.3 p -75.78 -22.46 56.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.046 0.451 . . . . 0.0 111.34 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -69.1 -40.88 78.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 42' ' ' ILE . . . -66.45 -43.11 86.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.0 mm -57.72 -52.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.736 0.648 . . . . 0.0 111.391 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.8 ptpp? -65.51 -25.05 67.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -175.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -100.34 -28.39 12.98 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.334 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.68 41.57 3.1 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.91 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -100.45 147.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.44 97.89 0.45 Allowed 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.896 0.379 . . . . 0.0 111.511 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.6 tp -108.12 -34.29 2.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.622 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.23 -48.35 80.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.842 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 t -62.56 -37.25 85.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.839 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.5 69.72 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 87.4 mt -57.67 -45.86 85.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.68 -41.54 97.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.93 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -74.06 -8.03 54.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.27 23.18 1.78 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.151 -1.499 . . . . 0.0 115.154 175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 62.6 t -98.39 119.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -99.45 155.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 110.991 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.91 135.29 33.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -122.32 125.08 45.19 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.62 111.86 24.72 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.4 t80 -78.48 139.11 38.71 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 m -82.81 -57.24 3.39 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.67 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -173.49 101.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.638 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 6.6 tmtt? -135.8 117.22 11.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.64 124.16 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.7 1.6 . . . . 0.0 110.781 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -90.4 168.45 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.306 2.004 . . . . 0.0 112.77 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -113.72 108.15 16.72 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.35 160.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 124.012 0.925 . . . . 0.0 108.923 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.27 -59.04 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -93.35 -1.27 56.12 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.785 0.434 . . . . 0.0 111.197 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.5 mt -99.44 134.03 21.5 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 122.164 -0.335 . . . . 0.0 111.118 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 158.05 55.98 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 122.72 2.28 . . . . 0.0 111.582 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -66.07 -27.91 68.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.985 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.262 5.1 p90 -62.01 -37.09 83.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.737 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -71.29 -38.68 71.77 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 m -63.17 -40.9 98.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.699 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -65.97 -35.37 80.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.21 91.8 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.15 -45.09 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.615 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.483 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 26.6 mmt -61.67 -45.16 95.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.77 -40.66 87.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 120.876 0.37 . . . . 0.0 110.73 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.05 69.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -79.85 -27.61 40.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.323 0.582 . . . . 0.0 110.348 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.25 -48.79 21.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.09 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.69 -12.86 55.31 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.596 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 57.19 63.3 1.93 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.97 -179.92 3.8 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 113.455 -1.702 . . . . 0.0 112.308 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.34 130.83 36.39 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 4' ' ' VAL . 44.1 tp -107.55 130.25 54.89 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.301 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -111.03 115.83 50.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.84 146.18 33.9 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.42 -29.0 15.2 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.634 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.37 123.15 24.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -73.17 -17.55 61.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.699 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 34.0 t70 -81.01 -33.18 33.83 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.8 t -60.45 -41.48 87.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.748 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 82.5 mt -59.59 -50.34 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.87 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.699 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.6 p-10 -68.6 -41.47 79.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.2 mmmt -59.23 -43.98 92.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.432 . . . . 0.0 111.542 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.56 96.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.236 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 91' ' ' ILE 0.312 17.4 ptpt -74.55 -18.51 60.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.8 mt-10 -67.4 -29.79 69.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.48 -7.5 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.487 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.07 -7.19 47.97 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.235 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.21 127.21 39.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.27 95.41 3.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.523 . . . . 0.0 110.147 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.35 132.53 44.61 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.232 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.27 153.97 78.44 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 123.566 0.542 . . . . 0.0 110.392 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.7 Cg_endo -76.25 166.99 26.69 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 121.962 1.775 . . . . 0.0 111.637 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.418 HD12 ' HB2' ' A' ' 12' ' ' LYS . 41.7 mt -54.74 -44.72 72.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.014 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.54 -25.81 60.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.221 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.21 -44.67 68.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.26 -38.95 93.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.556 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -22.75 64.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.311 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.9 m -84.92 -10.27 57.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.26 0.552 . . . . 0.0 109.912 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 20' ' ' ASN . 10.1 t -89.73 94.15 9.73 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.94 8.33 8.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.392 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.23 -34.17 71.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.526 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -101.0 24.6 9.09 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -9.53 32.36 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.109 0.48 . . . . 0.0 112.267 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -115.23 74.47 0.88 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -81.84 79.78 8.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.194 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -161.98 151.55 16.23 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 . . . . . 0 C--N 1.29 -2.001 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.434 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -87.37 149.17 24.67 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -136.55 114.09 10.98 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.1 t -98.79 132.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -99.67 131.79 46.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.108 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -92.91 148.58 36.13 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 85.2 Cg_exo -53.8 -23.19 26.04 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.502 2.801 . . . . 0.0 114.505 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 p -65.21 -24.27 67.31 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.109 -0.369 . . . . 0.0 111.683 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.423 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . . . -91.44 7.74 39.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.108 0.48 . . . . 0.0 111.46 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 9.5 m-30 -66.81 157.55 32.67 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.81 -35.8 2.09 Favored Glycine 0 C--N 1.318 -0.449 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.208 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -93.59 12.29 25.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.344 1.068 . . . . 0.0 109.366 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.48 -38.66 81.43 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.834 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -58.74 -37.85 77.13 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.196 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -74.41 -59.45 2.72 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.722 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.477 ' CG2' HG22 ' A' ' 104' ' ' ILE . 24.9 pt -59.48 -43.84 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 48' ' ' ARG . 51.4 tp -68.73 -43.9 74.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.831 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.08 -33.15 15.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.492 -0.861 . . . . 0.0 114.893 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 m -81.31 -34.46 31.9 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 117.321 0.56 . . . . 0.0 111.436 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.0 -60.39 2.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 22' ' ' ASN . 4.2 tmmm? 59.83 141.88 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 CA-C-O 122.336 1.065 . . . . 0.0 112.537 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' N ' ' HD2' ' A' ' 21' ' ' LYS 0.31 14.4 t-20 81.58 63.84 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 125.509 1.523 . . . . 0.0 114.342 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -146.11 150.27 35.59 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 164.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -87.88 92.89 9.29 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.7 m-85 -74.33 126.43 30.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.131 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.87 133.17 67.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.974 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 tp -117.08 156.93 18.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.618 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.2 p -94.12 165.22 12.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -39.35 93.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.914 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.64 -33.28 66.51 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.48 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.5 -52.4 53.36 Favored Glycine 0 N--CA 1.446 -0.661 0 O-C-N 123.869 0.73 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.7 m -63.04 -39.97 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -65.34 -40.36 93.55 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.101 0.477 . . . . 0.0 110.271 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.52 -49.08 74.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.46 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.25 73.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.799 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.0 mm -59.71 -57.25 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.273 0.358 . . . . 0.0 110.934 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -26.31 63.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -81.37 -18.66 44.8 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.423 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.21 37.24 25.28 Favored Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.424 HG22 ' HB3' ' A' ' 10' ' ' PHE . 84.4 mt -101.35 140.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.7 98.54 0.07 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.574 0.75 . . . . 0.0 111.446 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.49 -30.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.14 -49.46 77.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 23.0 t -62.91 -34.39 77.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.709 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.9 63.02 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.4 mt -60.99 -39.89 91.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.955 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.24 -39.39 92.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.308 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 44' ' ' SER . 63.2 mtt180 -79.22 -7.22 58.08 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.35 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.06 12.09 4.06 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.995 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 90.2 t -82.58 131.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 pt -108.43 148.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 p -101.89 127.98 54.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 120.885 0.374 . . . . 0.0 111.257 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -118.52 154.24 32.87 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.322 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.32 116.63 30.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.73 98.05 11.55 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.4 t -70.49 -29.36 65.87 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.547 1.139 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -76.63 148.1 37.14 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB2' ' HZ3' ' A' ' 58' ' ' LYS . 2.6 ttmp? -92.41 121.4 66.46 Favored Pre-proline 0 C--N 1.294 -1.834 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.611 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.5 148.55 20.0 Favored 'Trans proline' 0 C--O 1.257 1.434 0 C-N-CA 124.062 3.175 . . . . 0.0 114.101 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 149.6 55.43 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.966 2.444 . . . . 0.0 110.246 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 3.3 mptp? -81.3 110.28 16.61 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.509 0.671 . . . . 0.0 111.539 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.75 106.83 19.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 66.26 0.85 Allowed Glycine 0 C--N 1.321 -0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.713 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -176.94 -44.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.058 0.943 . . . . 0.0 108.893 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt -93.52 138.78 22.82 Favored Pre-proline 0 C--O 1.243 0.757 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.512 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.06 150.28 60.04 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.246 1.964 . . . . 0.0 109.874 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.89 -28.91 62.49 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -64.64 -33.16 75.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.632 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.55 -44.62 50.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.6 m -59.7 -38.09 80.63 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.993 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.618 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 35.7 tt0 -63.74 -40.65 97.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.89 87.83 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.13 -46.05 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.181 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.463 ' HA ' ' HE1' ' A' ' 74' ' ' MET . 28.6 mmt -64.82 -37.59 88.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.15 -36.43 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.234 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.62 -33.35 73.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.237 0.541 . . . . 0.0 110.306 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.68 -35.93 70.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.605 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.48 -52.29 41.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.674 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.44 -15.12 53.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.811 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.78 62.85 1.8 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -170.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 177.82 4.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.813 -1.994 . . . . 0.0 111.368 -171.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.15 126.09 35.68 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.0 tp -103.02 125.74 49.9 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.499 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -107.25 118.98 56.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -147.76 159.17 44.11 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mt-10 -103.43 -25.93 13.07 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.152 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.39 126.61 31.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.076 -173.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.43 -42.09 63.82 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 124.423 1.077 . . . . 0.0 112.705 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.5 -35.27 58.45 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.586 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.77 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.99 -48.42 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 0.2 OUTLIER -68.64 -37.49 79.74 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 31.6 mmmt -67.19 -39.2 86.33 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.46 87.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -60.23 -42.39 95.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.341 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 52.9 mt-10 -55.82 -42.59 75.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.176 0.59 . . . . 0.0 111.097 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.72 -8.49 56.96 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.987 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.54 44.1 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.08 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.26 129.46 46.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.15 92.85 6.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.451 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.93 136.0 38.85 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.606 175.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.24 152.23 73.11 Favored Pre-proline 0 C--N 1.293 -1.885 0 O-C-N 123.376 0.423 . . . . 0.0 110.609 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 16.9 Cg_exo -68.73 160.27 50.24 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 121.968 1.779 . . . . 0.0 110.712 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.477 HG22 ' CG2' ' A' ' 16' ' ' ILE . 53.6 mt -54.78 -42.92 64.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 123.837 0.855 . . . . 0.0 111.728 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -63.07 -25.32 68.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.991 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.59 -34.84 46.51 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.828 0.346 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.88 -41.85 95.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.9 mt -64.14 -41.76 97.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.249 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.36 33.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.637 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 t -113.02 3.48 16.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 m -87.56 65.57 8.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 0.0 110.48 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' A' ' 114' ' ' HIS . 1.8 pt? -171.63 -172.4 1.04 Allowed 'General case' 0 C--O 1.247 0.944 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.885 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -15.07 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.093 0.246 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.458 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 69.6 t60 80.51 14.07 0.8 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.096 1.358 . . . . 0.0 110.127 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 57.37 -79.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.389 1.475 . . . . 0.0 113.178 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -133.4 119.91 20.26 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -78.42 -31.61 48.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -157.48 -44.22 0.07 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 126.625 1.97 . . . . 0.0 107.312 171.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 . . . . . 0 CA--C 1.491 -1.292 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.246 0.881 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -87.8 152.93 21.74 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.91 108.28 7.81 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG22 ' HB ' ' A' ' 26' ' ' VAL . 46.6 t -92.85 131.65 39.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -175.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -97.72 132.39 42.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.41 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -92.84 149.39 37.7 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 Cg_exo -57.07 -15.17 16.76 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 123.441 2.761 . . . . 0.0 114.961 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -75.14 -22.03 58.4 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.769 -0.582 . . . . 0.0 111.099 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.21 10.11 25.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.484 0.659 . . . . 0.0 110.995 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.9 m-30 -72.08 156.3 39.35 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.498 0.666 . . . . 0.0 111.749 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -33.7 4.88 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.741 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 57.8 mtpt -106.46 18.54 21.8 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 122.405 1.098 . . . . 0.0 109.539 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.94 -39.5 94.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.696 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -68.6 -35.21 77.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.15 -175.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 -54.57 19.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.676 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.413 ' CG2' HG22 ' A' ' 104' ' ' ILE . 24.5 pt -57.77 -39.81 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' CD2' ' HA ' ' A' ' 45' ' ' ALA . 4.1 mp -59.33 -55.05 39.64 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.764 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.93 -33.42 41.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.955 -1.117 . . . . 0.0 113.718 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -77.53 -15.49 59.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.526 ' OD1' ' HG ' ' A' ' 112' ' ' LEU . 54.1 t30 -122.42 -60.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.687 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 60.23 -171.45 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.308 0.643 . . . . 0.0 111.609 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.2 -14.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.677 1.991 . . . . 0.0 115.013 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -93.05 149.32 21.31 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -90.73 99.67 12.66 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.4 m-85 -74.71 131.42 40.84 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.636 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 4' ' ' VAL . 39.5 t -122.16 136.39 59.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.593 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.65 153.32 27.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.606 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 25.6 p -92.47 166.91 12.3 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.088 0.471 . . . . 0.0 112.007 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -41.09 99.03 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.443 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.45 -31.72 69.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -56.43 24.17 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.107 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -59.99 -40.74 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -63.77 -38.32 90.68 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.72 -39.6 76.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.671 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.06 -42.14 94.48 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.4 mm -56.34 -52.63 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 123.759 0.662 . . . . 0.0 110.951 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -21.79 61.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 m -88.74 -23.58 22.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.44 41.55 6.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.886 -1.15 . . . . 0.0 111.575 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.7 mt -103.22 153.53 5.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.85 83.25 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.118 0.485 . . . . 0.0 110.561 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -93.13 -27.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 -38.47 89.14 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.44 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.2 m -72.88 -24.45 60.85 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.421 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -76.77 -52.63 9.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.185 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.19 -40.35 81.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.689 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.48 -44.82 72.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.636 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HB2' HD22 ' A' ' 17' ' ' LEU . 53.5 mtt85 -81.65 -5.71 58.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.44 5.2 6.67 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 118.898 -1.62 . . . . 0.0 115.146 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.95 124.82 28.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.57 0.685 . . . . 0.0 109.167 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.79 149.82 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.931 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.03 120.39 45.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -113.14 126.51 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.54 125.32 40.93 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 74' ' ' MET . 13.4 t80 -73.68 100.42 3.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -66.05 -30.76 71.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.106 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -77.12 145.7 37.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.72 126.62 92.84 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.46 124.34 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 113.236 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.3 142.62 98.61 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.422 2.081 . . . . 0.0 110.003 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.59 110.37 19.2 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.076 0.465 . . . . 0.0 111.598 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.2 97.18 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.86 69.19 1.55 Allowed Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.161 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.417 HD21 ' HG ' ' A' ' 65' ' ' LEU . 7.4 t30 -176.36 -40.14 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.095 0.958 . . . . 0.0 109.57 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HG ' HD21 ' A' ' 64' ' ' ASN . 84.8 mt -107.56 154.73 40.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -59.03 148.11 86.92 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.738 2.292 . . . . 0.0 111.229 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.81 -44.37 77.8 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.204 1.002 . . . . 0.0 111.307 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -63.93 -34.69 78.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 73' ' ' ILE . 26.6 mm-40 -70.36 -39.92 74.34 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -63.15 -41.04 99.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.184 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.606 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -60.31 -39.6 87.56 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.33 83.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.48 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 69' ' ' GLU . 61.5 mt -58.18 -43.64 86.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.401 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 74' ' ' MET . 19.8 mmt -67.43 -38.68 84.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.093 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.2 -39.62 84.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.358 0.599 . . . . 0.0 110.209 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.66 71.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.118 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.69 -47.03 64.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.184 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.13 -39.07 79.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 111.328 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.19 -11.43 57.87 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.332 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.46 59.26 3.38 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.76 177.11 4.89 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.148 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.42 141.47 28.71 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.2 tp -105.72 124.66 49.93 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.815 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.08 110.77 25.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -138.96 147.48 42.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.06 -28.43 12.35 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 91' ' ' ILE . 19.6 t70 -76.06 122.47 24.29 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.02 -29.54 69.77 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.621 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 23.0 t70 -79.73 -39.27 31.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.5 -44.3 88.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.067 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 87' ' ' ASP . 96.7 mt -57.62 -49.91 79.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.621 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.4 p-10 -69.57 -42.94 73.83 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.223 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 32.2 mmmt -60.52 -41.99 95.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.425 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.54 92.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 5.2 ptmm? -71.33 -25.5 62.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.035 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 44.0 mt-10 -74.02 -30.34 62.39 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 174.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 95.2 mt -79.89 -12.45 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.248 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 12.78 16.43 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.601 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 44.6 t -108.48 132.14 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.98 97.47 6.07 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 118.904 -1.118 . . . . 0.0 109.727 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.3 129.3 41.02 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.781 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.14 143.49 49.35 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.034 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 33.2 Cg_exo -61.28 158.36 35.79 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.363 2.042 . . . . 0.0 110.947 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 9.5 mt -54.06 -40.47 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.39 -20.43 65.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -76.68 -31.8 57.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.886 0.85 . . . . 0.0 109.125 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.48 -32.72 66.44 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.018 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.3 mt -79.64 -48.55 13.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.172 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.08 63.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.846 0.355 . . . . 0.0 111.788 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m -97.14 35.91 1.52 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.796 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.0 p -62.23 96.19 0.07 Allowed 'General case' 0 C--O 1.255 1.383 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' HG ' ' OD1' ' A' ' 20' ' ' ASN . 85.9 mt 71.06 108.8 0.06 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 125.057 1.343 . . . . 0.0 113.766 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -41.78 39.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.787 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.475 ' CE1' HD13 ' A' ' 112' ' ' LEU . 13.0 m170 63.94 173.58 0.18 Allowed 'General case' 0 C--O 1.246 0.879 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 66.77 172.72 0.25 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.99 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -140.8 144.16 35.25 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 119.596 -0.842 . . . . 0.0 108.87 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -44.33 121.91 2.78 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.529 1.143 . . . . 0.0 113.916 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -68.43 -34.75 76.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.233 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.149 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.502 -0.899 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.39 153.65 21.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.65 107.69 9.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' HD13 ' A' ' 83' ' ' LEU . 46.9 t -92.38 131.73 38.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.7 mt -97.26 128.77 48.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.328 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 m -88.51 149.58 44.66 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 49.1 Cg_exo -58.03 -21.75 51.9 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.105 2.537 . . . . 0.0 113.404 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 p -68.84 -19.35 64.26 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.93 16.44 19.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.264 0.554 . . . . 0.0 111.521 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.5 m-30 -75.5 156.45 35.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.95 -34.32 5.0 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.565 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HB2' HD11 ' A' ' 104' ' ' ILE . 1.2 mmmp? -98.38 15.54 24.4 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.75 -38.83 86.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.129 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.62 -36.41 80.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.805 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.85 -56.08 5.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.329 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.5 pt -58.24 -41.22 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 45' ' ' ALA . 36.7 tp -72.25 -52.86 14.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.234 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.63 -31.15 58.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.84 -0.695 . . . . 0.0 114.3 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.8 m -83.3 -39.31 20.98 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 117.652 0.726 . . . . 0.0 112.231 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -91.26 -59.55 2.12 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.225 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 23' ' ' TYR . 97.5 mttt 55.8 -152.53 0.37 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -173.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 t30 70.05 -14.28 0.39 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 125.013 1.325 . . . . 0.0 112.845 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' H ' ' C ' ' A' ' 21' ' ' LYS . 80.8 m-85 -115.5 160.17 20.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 123.135 0.574 . . . . 0.0 109.63 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.6 102.07 13.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.437 ' CB ' HG23 ' A' ' 50' ' ' VAL . 57.0 m-85 -75.41 136.66 40.73 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.71 139.62 51.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.442 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 10.2 tp -127.58 158.86 38.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -96.71 168.53 10.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 122.138 -0.351 . . . . 0.0 110.404 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.8 p -68.69 -39.06 80.72 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.09 -31.8 72.53 Favored 'General case' 0 C--O 1.214 -0.807 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.92 -54.06 36.15 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.496 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.6 m -62.93 -35.12 69.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.046 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -68.4 -38.75 81.58 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -63.06 -40.52 97.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.68 96.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.376 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.7 mm -60.07 -53.91 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.439 ' HB3' ' HZ3' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -93.25 -9.87 37.57 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.502 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.82 37.81 60.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.655 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.91 140.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' CG ' ' HG ' ' A' ' 44' ' ' SER . 6.8 t70 -64.06 108.94 1.66 Allowed 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.819 0.699 . . . . 0.0 112.367 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.3 tp -113.73 -9.38 12.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.494 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.21 -49.01 66.14 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.113 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.436 ' HG ' ' CG ' ' A' ' 41' ' ' ASP . 5.6 m -62.21 -26.5 68.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.703 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -69.58 -57.08 5.64 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.552 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.47 -39.74 80.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.906 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.97 -47.17 81.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.979 1.312 . . . . 0.0 112.804 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' HB2' HD21 ' A' ' 17' ' ' LEU . 72.5 mtt85 -91.25 4.05 53.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 6.06 6.59 Favored Glycine 0 CA--C 1.505 -0.534 0 C-N-CA 118.67 -1.729 . . . . 0.0 115.813 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 25' ' ' PHE . 57.8 t -81.03 120.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.653 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.4 p -98.02 128.28 49.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.186 0.517 . . . . 0.0 111.444 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -150.5 126.89 10.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.7 158.68 39.96 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.324 0.39 . . . . 0.0 110.617 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -85.03 138.0 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 123.844 0.715 . . . . 0.0 110.254 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.2 t -92.75 -31.7 14.96 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.27 100.38 5.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.739 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -137.15 147.98 60.69 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 165.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.26 123.2 10.02 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -88.76 128.87 2.06 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 120.503 0.802 . . . . 0.0 113.091 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -116.01 109.51 17.64 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 172.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 65' ' ' LEU . 29.8 m -135.43 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 120.937 0.399 . . . . 0.0 110.65 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.65 -71.03 0.28 Allowed Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -14.68 22.4 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.606 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 97.1 mt -107.01 148.24 36.61 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.409 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.62 169.82 19.18 Favored 'Trans proline' 0 C--O 1.265 1.839 0 C-N-CA 123.05 2.5 . . . . 0.0 109.489 170.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -60.03 -42.74 95.06 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -55.26 -38.98 69.25 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.9 -40.92 71.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 0.0 109.685 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 m -73.79 -24.31 59.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.699 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.67 -45.11 95.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.71 87.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.752 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.4 -44.41 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.155 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.464 ' HE3' ' HA ' ' A' ' 74' ' ' MET . 3.4 mmt -60.71 -48.61 81.02 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.145 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.7 -38.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.907 0.384 . . . . 0.0 110.612 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.9 84.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.398 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -71.13 -40.73 71.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.23 0.538 . . . . 0.0 109.885 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -63.92 -45.1 90.79 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.982 0.913 . . . . 0.0 111.363 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.18 -15.13 44.73 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.044 -0.41 . . . . 0.0 111.695 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 57.8 60.16 2.89 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.913 1.34 . . . . 0.0 107.661 -169.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.46 175.43 5.47 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.272 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.46 135.28 33.69 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 4' ' ' VAL . 41.5 tp -110.83 125.19 53.34 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.713 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -98.1 110.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.25 146.55 35.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.307 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -108.78 -20.53 13.03 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.103 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.432 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 10.5 t70 -79.2 132.79 36.63 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -63.04 -35.43 80.22 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.28 -28.41 34.69 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.658 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 87' ' ' ASP . 91.4 t -63.64 -49.89 80.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.0 mt -57.58 -47.21 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.982 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.0 t30 -63.12 -54.74 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.57 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 84.5 tttt -55.79 -51.26 68.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.52 1.128 . . . . 0.0 111.367 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.4 93.72 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.603 0.565 . . . . 0.0 111.258 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 21.2 ttmm -65.27 -38.77 91.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.112 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.1 mt-10 -62.7 -38.72 91.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.221 0.534 . . . . 0.0 109.762 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 81.8 mt -72.68 -13.2 61.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.437 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.14 5.39 37.81 Favored Glycine 0 CA--C 1.501 -0.803 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.358 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.3 t -92.83 137.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.59 96.34 10.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.092 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.81 127.02 42.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.83 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.24 152.83 78.92 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 26.3 Cg_exo -66.53 163.44 32.59 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.353 2.035 . . . . 0.0 112.181 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.474 HG23 ' CG2' ' A' ' 16' ' ' ILE . 72.3 mt -52.74 -43.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.543 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -65.64 -27.96 68.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.12 -32.13 56.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.135 0.493 . . . . 0.0 110.411 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.88 -40.81 75.45 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.98 -43.28 96.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.059 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.64 94.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.394 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -63.92 -10.24 19.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.7 t -76.3 -22.22 55.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.3 mt -109.05 95.52 5.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -81.59 -58.28 3.09 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -165.61 167.22 17.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -77.84 114.16 16.43 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.969 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -85.57 169.58 13.4 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.347 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -66.68 139.05 57.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 123.411 0.445 . . . . 0.0 110.298 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -59.9 119.56 7.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.217 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.409 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -86.98 150.21 24.22 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -131.35 107.65 9.09 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 40.8 t -93.24 130.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.74 125.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.601 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -87.04 147.54 43.04 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.497 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 59.4 Cg_exo -53.17 -28.22 40.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.071 2.514 . . . . 0.0 113.971 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.3 m -60.53 -22.23 63.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.89 13.52 32.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.97 0.414 . . . . 0.0 111.382 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.8 m-30 -70.12 162.85 27.5 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.798 0.809 . . . . 0.0 112.604 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -33.88 3.63 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.153 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -95.98 14.24 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.671 0.789 . . . . 0.0 110.215 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -38.74 75.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.569 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -74.49 -26.98 60.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.141 0.496 . . . . 0.0 110.918 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.0 -46.67 20.38 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.728 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.6 pt -66.21 -39.65 84.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.301 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 45' ' ' ALA . 5.4 mp -65.24 -54.62 26.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.805 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.91 -31.3 75.21 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.635 -0.711 . . . . 0.0 114.147 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -88.63 -29.96 19.56 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -106.38 -59.24 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 118.34 -1.344 . . . . 0.0 113.64 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 56.07 -152.96 0.36 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -167.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 69.3 -15.0 0.29 Allowed 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 124.791 1.236 . . . . 0.0 113.566 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.73 149.09 32.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.85 98.08 11.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -75.0 129.6 37.92 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.065 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 52.0 t -125.01 138.0 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.172 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -130.87 142.38 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.489 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 23.2 p -82.7 165.12 20.23 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -38.24 78.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.8 -29.61 66.95 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.81 -54.09 33.44 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.399 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.0 m -60.82 -35.72 66.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.0 m -65.73 -42.24 91.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.74 -37.37 86.32 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.67 76.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.479 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.2 mm -59.33 -49.93 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.821 0.448 . . . . 0.0 111.201 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -98.12 -14.56 20.36 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 120.809 0.338 . . . . 0.0 111.607 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.55 35.31 20.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.155 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -92.32 146.54 6.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.74 88.3 5.21 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.889 1.328 . . . . 0.0 111.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 tp -88.72 -19.22 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.724 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.34 -49.36 76.4 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 125.908 1.683 . . . . 0.0 109.437 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -59.78 -30.92 69.22 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 111.226 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -75.21 -52.75 10.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.016 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.44 -39.33 79.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.95 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.01 -40.31 76.37 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.321 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 17' ' ' LEU . 45.5 mtt85 -82.98 -10.02 58.99 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.86 15.63 3.15 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.322 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.28 123.92 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -96.83 143.78 11.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.024 0.44 . . . . 0.0 110.871 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.9 t -87.9 136.81 22.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.69 126.59 43.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.809 176.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.73 114.82 26.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.58 141.8 51.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 m -68.69 -58.43 4.24 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 175.28 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -136.29 142.59 40.3 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 124.079 0.952 . . . . 0.0 109.144 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.34 142.1 84.3 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.805 1.67 . . . . 0.0 108.622 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.53 130.61 36.3 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.549 2.166 . . . . 0.0 113.394 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -110.82 109.82 20.18 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.12 162.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.647 -169.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.76 -67.13 1.18 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -127.68 -4.64 5.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.285 1.04 . . . . 0.0 109.697 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' ' OD2' ' A' ' 89' ' ' ASP . 59.4 mt -58.73 144.31 80.71 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.716 -176.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.71 166.12 28.95 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.389 2.059 . . . . 0.0 110.376 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -56.64 -36.03 69.02 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -62.83 -38.33 90.32 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' OE2' ' HB2' ' A' ' 7' ' ' PRO . 69.9 mm-40 -71.03 -36.16 72.27 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -62.04 -41.96 98.67 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.77 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -62.55 -36.85 83.94 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.16 78.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.109 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.78 -44.71 98.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.064 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 74' ' ' MET . 18.7 mmt -59.12 -45.96 89.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.19 -39.08 83.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-O 121.153 0.502 . . . . 0.0 110.131 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.03 66.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -75.2 -36.75 61.37 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.091 0.556 . . . . 0.0 110.477 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.58 -44.44 74.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.319 0.581 . . . . 0.0 111.536 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.84 -19.03 31.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.733 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.44 67.74 0.94 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -171.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.7 3.99 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.87 -170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 2.3 tm? -90.51 126.77 36.03 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -108.33 120.72 43.2 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.821 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.0 mt -94.21 112.14 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -145.02 139.71 27.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.878 0.37 . . . . 0.0 111.581 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.73 -22.69 16.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.606 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -87.67 132.95 33.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -51.17 -48.25 61.94 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 124.184 0.927 . . . . 0.0 113.07 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.62 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.4 t70 -69.4 -27.7 65.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 123.549 0.531 . . . . 0.0 111.374 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.5 t -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.03 -50.01 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.866 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.62 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.0 p-10 -70.57 -36.64 73.72 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -66.43 -40.97 89.83 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.468 -179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -67.89 -36.49 80.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.062 0.458 . . . . 0.0 109.827 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.78 -40.88 89.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.838 0.855 . . . . 0.0 109.233 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 62.6 mt-10 -63.18 -35.92 81.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.804 0.812 . . . . 0.0 110.787 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.12 -5.87 59.32 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.045 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.52 21.11 41.79 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.645 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.412 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 64.5 t -106.03 137.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -84.69 95.34 8.89 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.429 0.633 . . . . 0.0 110.966 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.68 131.23 45.01 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.882 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.95 155.45 76.3 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 122.686 0.394 . . . . 0.0 110.683 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.5 Cg_exo -71.7 162.03 43.37 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.151 1.901 . . . . 0.0 110.656 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.4 mt -54.21 -38.16 38.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 123.652 0.781 . . . . 0.0 112.71 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.23 -34.1 76.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.594 0.235 . . . . 0.0 110.945 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.85 -30.45 62.67 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.276 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.88 -38.79 89.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.76 -43.51 83.9 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.971 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.56 65.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -76.03 -12.22 60.09 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 121.637 0.732 . . . . 0.0 110.593 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 m -87.38 152.74 22.0 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . 0.275 2.2 pt? -83.57 86.66 7.07 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.542 -1.663 . . . . 0.0 110.636 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.32 -47.9 77.65 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 18.6 p-80 -94.05 121.76 35.87 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.97 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -95.07 -16.06 22.96 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 114' ' ' HIS . 37.2 m80 -142.15 -175.34 4.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -76.83 105.5 7.93 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.325 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -82.72 115.36 21.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.084 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.295 -0.859 . . . . 0.0 109.805 179.025 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.245 0.831 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -87.68 146.8 25.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.03 13.93 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.85 126.2 44.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt -93.12 125.7 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.885 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -89.48 152.22 47.08 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 82.6 Cg_exo -50.65 -27.95 21.06 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.461 2.774 . . . . 0.0 111.681 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -51.78 -36.42 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.864 1.266 . . . . 0.0 111.651 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 6.61 41.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.366 0.603 . . . . 0.0 111.625 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 10.0 m-85 -79.38 134.49 36.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.274 0.559 . . . . 0.0 111.323 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.14 -36.28 3.79 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 27.5 mtpp -110.36 15.74 22.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.92 -39.14 62.55 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.938 1.695 . . . . 0.0 110.877 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.94 -35.95 82.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.801 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.95 -53.39 21.07 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.648 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG2' HG21 ' A' ' 104' ' ' ILE . 25.9 pt -60.87 -41.13 87.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 48' ' ' ARG . 55.2 tp -69.35 -55.08 11.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.598 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.45 -34.12 12.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.743 -1.218 . . . . 0.0 114.694 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 m -84.4 -25.84 28.76 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 117.683 0.741 . . . . 0.0 112.015 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.568 ' OD1' ' HB2' ' A' ' 111' ' ' SER . 35.3 t30 -97.55 -59.63 1.74 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.852 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 58.31 -140.82 0.74 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.07 -14.79 0.29 Allowed 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -135.5 162.23 33.24 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -93.47 108.42 20.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -79.06 125.97 30.1 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.852 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.63 134.64 60.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.114 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.5 tp -121.19 153.58 24.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.517 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 47.2 p -97.19 176.77 5.8 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.996 0.427 . . . . 0.0 111.929 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -42.57 85.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 123.686 0.794 . . . . 0.0 112.11 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.61 -24.47 56.52 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.59 -49.52 59.64 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.376 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.9 m -66.89 -32.07 56.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 m -65.96 -40.52 91.38 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.59 -44.54 93.34 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.732 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 32' ' ' VAL . 48.3 mm -64.14 -48.32 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.296 0.372 . . . . 0.0 111.039 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.65 -30.12 65.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.3 t -84.41 -28.2 27.08 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.976 0.417 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.43 34.64 6.93 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.154 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 57.4 mt -97.27 149.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.09 87.77 0.78 Allowed 'General case' 0 C--O 1.241 0.63 0 O-C-N 123.315 0.384 . . . . 0.0 111.406 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -86.11 -27.13 6.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.31 -45.32 93.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -66.37 -29.8 70.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.796 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -67.88 -51.29 49.85 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.51 -40.12 81.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.085 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.9 -38.83 89.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.17 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HB2' HD22 ' A' ' 17' ' ' LEU . 74.5 mtt180 -87.85 2.9 50.27 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.89 -2.5 7.96 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.43 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 73.1 t -72.61 132.79 32.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 117.79 0.795 . . . . 0.0 109.645 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.7 pt -111.39 142.91 22.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.267 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.46 116.41 41.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-O 121.332 0.587 . . . . 0.0 110.689 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -118.64 126.27 51.57 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.4 150.76 21.12 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 57' ' ' HIS . 45.1 t80 -81.48 109.29 15.81 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -74.09 9.72 1.49 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.292 1.037 . . . . 0.0 113.181 -173.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 55' ' ' PHE . 64.2 m-70 -122.86 176.12 6.17 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.58 116.31 39.08 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.69 124.15 12.38 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 121.561 1.507 . . . . 0.0 110.943 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.39 163.89 12.81 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.272 1.981 . . . . 0.0 112.369 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.454 ' HE2' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -111.71 121.93 46.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.7 123.6 37.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.7 66.62 1.36 Allowed Glycine 0 C--O 1.238 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.733 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.9 t30 175.69 -39.8 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 125.815 1.646 . . . . 0.0 108.697 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -107.72 149.38 38.88 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.332 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.5 145.75 92.33 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.077 1.851 . . . . 0.0 110.647 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.454 ' NE2' ' HE2' ' A' ' 61' ' ' LYS . 58.0 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.718 0.407 . . . . 0.0 111.602 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -64.4 -33.31 75.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.878 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.35 -37.19 63.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.2 m -64.46 -39.92 94.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.535 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.517 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.4 tt0 -63.42 -40.5 97.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.46 94.62 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.4 mt -59.58 -45.45 94.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.207 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.461 ' HE1' ' HA ' ' A' ' 74' ' ' MET . 4.3 mmt -60.79 -47.35 86.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.61 -37.97 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.031 0.443 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.44 -29.59 69.1 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.43 -34.06 36.38 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.13 0.572 . . . . 0.0 110.583 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -46.21 68.05 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.467 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.24 -20.81 43.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.794 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 56.93 64.39 1.66 Allowed 'General case' 0 C--O 1.247 0.924 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.61 -176.81 3.07 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.805 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.29 126.76 35.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -107.73 127.5 53.74 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.534 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mt -106.39 114.95 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -148.13 155.17 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.84 -35.5 9.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.78 118.88 12.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.545 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -74.57 -17.56 60.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.182 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.63 -39.18 24.84 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.3 t -59.78 -51.68 70.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.588 171.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.9 mt -54.1 -44.93 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.437 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.549 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.3 t30 -54.29 -52.21 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.752 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.79 -43.71 95.5 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.555 0.535 . . . . 0.0 110.752 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.55 97.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.035 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -70.71 -28.43 64.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.2 mt-10 -68.45 -28.98 67.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.14 0.495 . . . . 0.0 109.811 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.86 -11.83 58.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.655 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.85 14.17 35.05 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.51 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -86.83 90.89 8.47 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.91 132.85 49.77 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.362 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.74 157.82 64.03 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 123.972 0.795 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.3 Cg_exo -70.45 164.7 34.26 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' A' ' 16' ' ' ILE . 33.9 mt -58.35 -46.93 89.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.327 53.7 mt-10 -76.03 -16.0 60.03 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.87 -35.03 38.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.83 -43.01 98.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.895 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.87 -34.66 78.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.164 0.507 . . . . 0.0 110.523 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.8 -4.42 43.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.363 0.602 . . . . 0.0 111.067 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.3 m -85.17 -4.03 59.02 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.568 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 36.1 t -113.21 107.48 15.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -143.45 -16.58 0.64 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.345 0.593 . . . . 0.0 111.98 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.515 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -80.9 84.88 6.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -134.4 -64.52 0.68 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -119.26 17.71 13.07 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -129.5 136.1 49.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -118.7 -52.58 2.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.836 0.35 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 . . . . . 0 C--N 1.296 -1.747 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.821 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.248 0.977 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.43 147.04 25.6 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.56 110.93 11.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.1 t -94.6 133.11 36.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.06 129.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -85.91 144.39 39.19 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 84.6 Cg_exo -52.52 -18.03 7.69 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.786 2.991 . . . . 0.0 113.879 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 p -73.99 -20.13 60.43 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.04 0.448 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.96 12.04 33.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.524 . . . . 0.0 111.224 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-85 -73.11 153.97 40.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.36 -34.22 3.31 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -92.66 1.6 57.18 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 124.577 1.151 . . . . 0.0 109.713 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -51.4 -39.97 58.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.038 1.335 . . . . 0.0 111.949 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.88 -33.59 76.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.861 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.41 -49.13 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.997 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.5 pt -68.26 -43.44 84.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.891 0.377 . . . . 0.0 111.935 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 tp -70.31 -48.56 56.05 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.83 -33.16 74.8 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.181 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 m -90.43 -15.1 31.55 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.439 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -114.64 -59.17 2.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 55.57 -155.21 0.28 Allowed 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 70.7 -13.97 0.45 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.99 148.33 34.03 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -85.87 96.47 9.79 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.2 m-85 -74.38 129.8 38.46 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.064 -176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.0 t -127.4 138.65 54.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.87 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 8.4 tp -123.7 160.21 27.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.566 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.8 p -99.62 165.48 11.59 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 120.835 0.35 . . . . 0.0 111.647 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.44 -36.66 84.89 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.919 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.96 -18.46 60.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.062 0.458 . . . . 0.0 110.014 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.24 -44.68 17.02 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 36' ' ' ILE . 20.2 m -66.64 -36.44 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.8 p -72.41 -31.96 65.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.535 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.63 -42.34 92.51 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.68 76.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.57 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.0 mm -59.15 -45.85 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.581 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.23 -26.53 62.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -103.46 4.08 35.65 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.52 37.92 85.88 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.354 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.09 155.92 4.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.41 129.6 35.12 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.69 -40.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.802 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.76 -31.52 72.21 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 122.159 -0.338 . . . . 0.0 111.01 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 m -57.72 -40.64 80.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 123.774 0.671 . . . . 0.0 109.922 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.15 60.08 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.808 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.6 mt -57.72 -45.11 86.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.058 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.37 -39.83 92.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.564 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.23 -3.79 41.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.85 7.43 5.59 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.017 -1.563 . . . . 0.0 115.862 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 63.6 t -86.78 138.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 pt -113.1 167.41 6.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 14.4 p -120.16 144.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.456 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -132.86 157.45 45.02 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.146 0.578 . . . . 0.0 110.241 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.01 133.02 35.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.666 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.1 144.05 31.16 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.9 m -97.62 -50.53 4.45 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.602 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.94 99.0 3.27 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.644 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -137.32 106.51 8.58 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.19 121.86 2.79 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 CA-C-N 119.94 1.014 . . . . 0.0 111.359 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -91.62 139.82 2.36 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.164 2.576 . . . . 0.0 110.354 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -85.83 108.22 18.02 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 117.97 -1.492 . . . . 0.0 109.076 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 m -153.3 162.06 2.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 125.255 1.422 . . . . 0.0 107.312 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.3 11.68 5.0 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.382 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -148.05 -36.72 0.2 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.563 ' HB3' ' OE2' ' A' ' 69' ' ' GLU . 80.7 mt -61.82 132.96 93.56 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 122.614 0.365 . . . . 0.0 111.937 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.24 144.86 13.35 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.509 2.806 . . . . 0.0 113.588 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -46.91 -35.22 6.21 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.138 1.375 . . . . 0.0 114.106 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -58.62 -43.2 89.55 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.563 ' OE2' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -85.45 -26.66 26.21 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.973 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 m -63.45 -34.9 78.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.685 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.566 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.6 tt0 -64.47 -40.89 96.56 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.46 -45.0 95.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.38 -45.76 97.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.751 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.483 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 17.4 mmt -65.82 -39.42 90.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -66.46 -36.28 76.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-O 121.196 0.522 . . . . 0.0 109.848 176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.74 72.2 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.52 -44.61 82.03 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.384 1.074 . . . . 0.0 110.219 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.83 -57.06 14.41 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.103 0.961 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.84 -13.6 57.42 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.087 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.47 64.74 1.4 Allowed 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -170.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.77 177.15 4.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.91 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.23 127.21 36.58 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 48.1 tp -108.23 122.83 47.75 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.635 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.8 115.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.08 144.0 32.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.648 0.261 . . . . 0.0 110.668 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -93.37 -25.58 17.63 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.81 123.82 29.71 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -73.33 -18.9 61.14 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -81.59 -33.25 31.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG22 ' OE1' ' A' ' 69' ' ' GLU . 95.8 t -61.18 -48.47 88.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 88.0 mt -56.65 -48.58 80.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.96 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 23.6 t30 -51.43 -58.85 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.622 1.169 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -65.87 -40.08 91.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.45 89.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 14.2 tppt? -57.77 -42.08 83.35 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.698 0.799 . . . . 0.0 109.655 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 41.0 mt-10 -67.3 -34.62 77.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.728 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -79.38 2.67 20.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.252 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.84 18.7 46.53 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.988 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 61.9 t -106.35 142.87 18.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -97.84 94.47 6.93 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.149 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -94.04 132.53 38.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.929 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.51 152.33 77.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 123.488 0.492 . . . . 0.0 110.691 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.0 Cg_exo -71.97 160.13 48.45 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.034 1.823 . . . . 0.0 110.27 175.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.2 mt -57.24 -36.88 53.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.02 -25.73 66.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.07 -30.8 62.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.464 0.649 . . . . 0.0 109.947 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.68 -42.39 67.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.16 -33.64 76.25 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.675 0.75 . . . . 0.0 110.786 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.33 69.34 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.831 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -103.63 13.03 34.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.2 p -110.33 178.53 4.36 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.028 -0.42 . . . . 0.0 111.268 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . 0.274 0.6 OUTLIER -112.79 102.05 10.1 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.17 -49.09 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -158.72 86.82 0.86 Allowed 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.833 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -157.7 83.96 0.89 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.684 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -132.19 164.26 26.75 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.27 125.44 46.46 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -84.72 -42.39 15.3 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 167.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.101 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.15 152.28 22.47 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.12 107.2 8.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.5 t -92.35 132.68 36.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.1 mt -98.32 131.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.573 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.18 149.82 42.1 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -54.45 -26.29 44.03 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.268 2.646 . . . . 0.0 113.483 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.5 m -63.31 -14.97 55.66 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -98.08 5.49 48.61 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 0.0 111.535 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 6.5 m-30 -68.09 149.91 49.05 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.17 5.2 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HE2' HG21 ' A' ' 104' ' ' ILE . 60.2 mtpt -105.66 19.93 19.74 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.915 0.864 . . . . 0.0 109.603 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.71 -30.41 69.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.796 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.92 -41.28 68.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.845 0.831 . . . . 0.0 109.035 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 12' ' ' LYS . 17.8 mp0 -58.62 -57.27 13.72 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.824 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 104' ' ' ILE . 15.7 pt -63.04 -43.74 99.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.99 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.8 mp -61.46 -54.31 45.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.637 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.14 -29.65 64.23 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 123.522 0.514 . . . . 0.0 114.14 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -81.79 -61.25 1.97 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.175 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -77.84 -53.39 7.54 Favored 'General case' 0 C--O 1.253 1.268 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.424 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 8.1 mtmp? 59.65 -162.17 0.25 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 66.91 -15.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -97.79 163.8 12.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.432 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -97.82 95.78 7.77 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 172.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.8 m-85 -74.8 135.32 41.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.3 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.09 138.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.616 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.68 159.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.609 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 p -100.03 171.46 7.82 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -45.51 84.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.283 1.033 . . . . 0.0 110.995 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.12 -26.55 61.27 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.75 -57.2 17.12 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.176 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.0 m -60.38 -34.96 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.988 0.394 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.7 m -65.6 -33.52 76.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.056 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -65.79 -40.2 91.72 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -67.28 -42.55 83.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.1 mm -62.62 -47.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.256 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -39.48 87.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -81.69 -28.5 33.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.888 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.54 41.04 4.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.207 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.42 HG21 ' HB3' ' A' ' 10' ' ' PHE . 62.8 mt -101.64 151.64 5.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.84 92.95 5.54 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.442 1.115 . . . . 0.0 111.489 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -89.57 -17.68 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.317 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.59 -33.72 76.57 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 m -61.72 -30.12 70.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.233 0.54 . . . . 0.0 110.955 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.96 -50.17 13.81 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.68 -38.38 84.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.915 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.44 -39.17 75.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.712 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB2' HD23 ' A' ' 17' ' ' LEU . 94.9 mtt180 -89.42 -14.81 34.64 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.208 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.77 16.64 3.3 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.735 -1.221 . . . . 0.0 115.106 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 25' ' ' PHE . 60.7 t -73.03 123.41 27.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 pt -93.99 150.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.75 118.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -116.09 126.47 53.78 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.357 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.391 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.581 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -79.36 161.67 25.57 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.759 2.306 . . . . 0.0 111.853 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 13.2 mm100 -53.32 -40.65 64.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -63.35 -38.4 91.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.56 -38.26 62.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 32.2 t -58.12 -48.04 81.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.075 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.609 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.8 tt0 -60.92 -38.13 84.69 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.563 0.345 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.62 74.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.946 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.61 -45.22 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.451 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 mmt -60.96 -45.16 95.84 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.39 -35.94 76.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 120.827 0.346 . . . . 0.0 110.972 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.51 -33.61 74.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.898 0.38 . . . . 0.0 110.539 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -69.52 -46.57 66.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -49.2 -56.8 8.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.08 1.352 . . . . 0.0 111.431 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.51 -16.64 36.33 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.392 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.65 68.44 0.75 Allowed 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.74 179.26 4.02 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.674 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.11 129.96 36.33 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 4' ' ' VAL . 42.5 tp -108.34 123.78 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.267 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.13 110.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.57 139.29 38.58 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.01 -29.3 14.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.206 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 130.16 39.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.93 0.395 . . . . 0.0 110.674 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -55.18 -42.51 73.31 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.94 1.296 . . . . 0.0 112.644 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.48 -34.12 31.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.156 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.39 -45.71 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.24 -51.64 70.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.897 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -71.07 -31.86 68.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 49.2 tptt -71.94 -42.87 66.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.388 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.66 74.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.998 0.427 . . . . 0.0 110.209 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.79 -38.35 90.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.554 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 50.3 mt-10 -57.39 -43.22 83.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.84 -11.35 60.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.017 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.3 15.92 31.28 Favored Glycine 0 CA--C 1.5 -0.868 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.268 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.1 131.43 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -80.82 89.98 5.85 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.503 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.3 128.1 38.02 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.325 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.68 157.05 78.09 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 123.578 0.549 . . . . 0.0 111.083 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.81 156.39 52.91 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.611 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 40.7 mt -55.8 -44.46 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.64 -24.29 65.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.93 -28.77 35.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.21 -35.22 79.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 86.0 mt -72.93 -31.66 64.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.046 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -26.94 62.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.877 0.37 . . . . 0.0 110.866 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.317 -0.848 0 CA-C-O 121.382 0.61 . . . . 0.0 110.611 179.017 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.2 156.38 19.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -133.73 110.31 9.74 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 26' ' ' VAL . 49.4 t -95.08 129.83 44.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.109 0.48 . . . . 0.0 110.068 -175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.98 129.76 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.127 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.7 m -90.39 152.63 45.73 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.0 Cg_exo -57.58 -24.79 64.01 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 123.204 2.603 . . . . 0.0 114.068 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -70.16 -17.67 63.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.12 0.486 . . . . 0.0 111.505 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -95.95 9.08 41.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.5 m-30 -66.7 144.34 56.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.884 0.373 . . . . 0.0 111.709 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.8 -36.08 2.49 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.929 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -87.91 -12.63 44.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.511 HD12 ' HG3' ' A' ' 14' ' ' LYS . 2.9 pp -62.34 -24.3 67.26 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.109 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' HD12 ' A' ' 13' ' ' LEU . 48.7 mtmt -75.02 -25.8 59.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.284 0.564 . . . . 0.0 110.029 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -76.08 -45.64 33.01 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.658 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 104' ' ' ILE . 12.7 pt -64.27 -37.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.205 0.526 . . . . 0.0 110.391 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 48' ' ' ARG . 47.9 tp -65.69 -55.16 18.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.252 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.53 -19.22 78.32 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.004 0.762 . . . . 0.0 115.004 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -105.42 -3.5 22.51 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.717 -0.872 . . . . 0.0 113.05 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -125.94 -59.36 1.34 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.009 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 61.92 178.72 0.12 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.634 1.174 . . . . 0.0 114.088 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 m120 74.34 -15.01 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.945 1.698 . . . . 0.0 114.814 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -80.43 152.9 28.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tpmt? -93.0 96.83 10.33 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HB2' HG22 ' A' ' 50' ' ' VAL . 93.0 m-85 -74.83 127.85 34.16 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.722 -176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 4' ' ' VAL . 72.3 t -120.42 130.43 74.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.562 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -116.98 144.77 23.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 22.8 p -81.85 169.68 16.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 p -72.27 -39.92 68.01 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.1 mt -70.09 -28.76 65.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.075 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.11 -53.01 36.05 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.806 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.0 m -61.25 -41.65 90.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.097 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 m -63.58 -37.59 87.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -66.53 -39.33 88.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.55 77.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.487 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.9 mm -57.46 -51.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.07 0.548 . . . . 0.0 111.4 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.8 -23.4 63.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -90.72 -23.03 20.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.046 0.451 . . . . 0.0 111.217 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 31.48 11.7 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.761 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 77.8 mt -92.14 138.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.55 88.25 0.93 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.743 1.258 . . . . 0.0 111.883 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.5 tp -86.96 -19.76 7.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.907 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.9 -41.29 91.3 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.945 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -57.71 -35.57 70.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.656 0.782 . . . . 0.0 110.952 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -50.2 13.57 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.332 0.586 . . . . 0.0 109.765 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.9 mt -58.51 -41.71 86.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.865 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -48.53 81.28 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.705 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.4 mtt180 -74.57 -8.56 56.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.61 13.27 3.85 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 118.776 -1.678 . . . . 0.0 114.676 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 25' ' ' PHE . 72.7 t -82.95 122.44 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -101.55 154.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.454 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 t -100.35 128.63 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -133.33 141.86 48.15 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.935 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.975 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 78.1 mt . . . . . 0 N--CA 1.427 -1.598 0 CA-C-O 120.63 0.252 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 31.7 Cg_exo -64.93 155.59 67.07 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 122.664 2.243 . . . . 0.0 110.037 172.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -62.4 -33.0 73.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.256 6.3 p90 -62.35 -39.27 92.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.99 -42.4 73.11 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.0 m -67.08 -29.86 69.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.522 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.1 tt0 -66.55 -40.37 89.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.39 84.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' HA ' HD22 ' A' ' 83' ' ' LEU . 67.2 mt -54.75 -50.64 58.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.646 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.8 mmt -71.66 -31.65 67.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.33 -35.02 69.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.62 72.95 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.508 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -70.25 -48.22 57.84 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.33 -44.15 92.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.23 -17.9 35.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.203 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 61.1 66.89 0.84 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 123.028 1.394 . . . . 0.0 107.4 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.56 178.16 4.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 113.156 -1.838 . . . . 0.0 111.229 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -89.53 121.13 31.45 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 101' ' ' ALA . 51.0 tp -97.11 127.09 42.74 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.177 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.3 mt -111.91 117.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.896 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.7 153.48 43.41 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.413 ' OE1' ' HB ' ' A' ' 104' ' ' ILE . 6.7 mm-40 -101.04 -17.63 16.63 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.17 127.91 40.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -69.43 -24.61 63.84 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.09 -35.27 31.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.03 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.54 -49.95 81.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.9 -47.82 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.689 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -62.22 -50.43 71.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.577 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tmtt? -60.26 -43.84 95.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.333 0.587 . . . . 0.0 109.443 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.58 98.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.021 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 35.7 ttmt -69.98 -31.2 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.602 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt-10 -63.54 -34.58 78.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 109.52 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 86.5 mt -80.35 -11.14 59.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.179 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.34 12.48 26.92 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.887 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 40.4 t -98.54 127.75 50.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.17 91.03 4.91 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.663 0.744 . . . . 0.0 109.545 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 83' ' ' LEU . . . -100.32 137.42 38.77 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.574 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.99 153.58 67.43 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.182 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 27.5 Cg_exo -63.59 155.45 62.85 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.443 2.095 . . . . 0.0 111.112 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 16' ' ' ILE . 7.4 mt -55.7 -43.52 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.93 -19.33 61.28 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.87 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.44 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 12.6 mm-40 -77.34 -33.48 55.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.4 -41.79 88.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.3 -46.5 88.39 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.3 -22.39 66.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.546 0.738 . . . . 0.0 112.68 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 121.526 0.679 . . . . 0.0 110.756 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.245 0.837 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -87.75 147.56 25.13 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.39 110.2 10.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 83' ' ' LEU . 47.0 t -92.57 132.65 36.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 13' ' ' LEU . 40.9 mm -95.41 130.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.329 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.6 m -90.22 152.5 45.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -57.04 -12.39 9.57 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 123.528 2.819 . . . . 0.0 113.977 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -81.97 -9.39 59.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.924 0.49 . . . . 0.0 111.172 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.4 13.66 33.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 111.801 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 40' ' ' ILE . 23.2 m-30 -76.67 152.43 35.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.489 0.661 . . . . 0.0 111.071 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 -36.01 3.55 Favored Glycine 0 C--N 1.313 -0.709 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.36 -1.57 47.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.723 0.773 . . . . 0.0 109.295 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 5' ' ' ILE . 43.4 tp -53.62 -38.64 64.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.669 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.36 -41.43 63.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.135 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.42 -50.87 61.94 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.278 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.18 -40.51 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 121.156 0.503 . . . . 0.0 111.434 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.5 tp -66.25 -48.42 70.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.297 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 -33.17 25.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 114.251 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 t -76.38 -46.33 27.85 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 116.925 0.362 . . . . 0.0 110.972 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -92.0 -47.58 7.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.909 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 58.55 -142.46 0.66 Allowed 'General case' 0 C--N 1.362 1.137 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.3 t30 68.68 -14.2 0.29 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 166.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -123.9 157.55 34.0 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 110.49 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -92.93 98.4 11.34 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.0 m-85 -75.37 130.61 39.29 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.568 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.6 t -123.77 134.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.106 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -117.9 152.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.3 p -91.28 170.58 9.87 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.959 0.409 . . . . 0.0 111.779 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -37.99 87.57 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.886 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.15 -20.39 55.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.158 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.93 -51.41 19.1 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.8 m -63.14 -39.28 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 p -70.4 -34.94 73.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.446 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -65.01 -38.19 90.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.67 75.24 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.548 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' VAL . 37.1 mm -58.31 -49.93 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.89 0.476 . . . . 0.0 111.808 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -27.06 65.66 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -91.78 -5.9 52.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.95 57.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.304 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 10' ' ' PHE . 69.3 mt -100.88 146.83 8.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.96 85.69 0.99 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.036 0.446 . . . . 0.0 111.288 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.1 tp -90.38 -24.42 5.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.83 -41.19 97.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.131 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 8.4 t -72.52 -26.41 61.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.207 0.527 . . . . 0.0 109.74 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.77 -47.63 29.9 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 84.7 mt -57.77 -44.05 85.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.044 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.76 -47.77 70.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.031 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.678 ' HB2' HD21 ' A' ' 17' ' ' LEU . 68.4 mtt180 -84.53 1.62 44.92 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.96 7.37 6.04 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 118.786 -1.673 . . . . 0.0 116.324 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.4 t -81.44 127.73 39.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 118.148 0.974 . . . . 0.0 108.722 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -102.48 159.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.4 p -114.88 137.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -141.05 139.82 34.16 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.247 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.15 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.05 170.24 12.09 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 123.098 2.532 . . . . 0.0 111.762 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -66.08 -24.76 66.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.269 42.1 p90 -72.75 -43.77 62.47 Favored 'General case' 0 C--O 1.255 1.391 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.33 -33.07 55.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.607 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.3 m -66.38 -28.2 68.45 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.299 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.4 tt0 -66.13 -40.02 90.32 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.23 87.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.901 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.2 -46.09 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.783 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mmt -63.46 -42.75 98.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 28' ' ' THR . 96.7 t -69.41 -35.06 65.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.477 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.85 88.46 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -66.22 -42.02 89.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.23 0.612 . . . . 0.0 109.899 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.91 -42.53 94.66 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.977 0.911 . . . . 0.0 111.251 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.35 -10.65 51.61 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.599 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.95 39.63 19.93 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -175.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.17 178.65 5.93 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.574 -1.648 . . . . 0.0 112.689 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.99 125.62 35.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 47.0 tp -102.49 123.25 45.9 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.046 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.49 113.69 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.07 160.07 40.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.754 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.52 -29.48 7.16 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.5 138.78 37.65 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.775 -0.77 . . . . 0.0 113.021 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -46.19 -55.49 7.03 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 126.833 2.053 . . . . 0.0 110.931 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.92 -37.58 64.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.964 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.81 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.47 0.481 . . . . 0.0 110.399 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -45.31 96.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.124 0.488 . . . . 0.0 109.857 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -64.56 -40.24 95.2 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.797 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 2.5 tmtm? -68.68 -39.28 80.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.322 0.582 . . . . 0.0 109.684 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.64 85.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.69 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -66.4 -35.07 79.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.405 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.6 mt-10 -58.13 -40.91 82.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.463 0.705 . . . . 0.0 110.187 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.06 -11.05 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.639 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.79 47.47 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.468 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.11 139.15 18.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.5 90.3 6.23 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.632 0.73 . . . . 0.0 110.694 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -103.6 131.17 50.98 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.498 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.6 154.95 79.9 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 123.458 0.474 . . . . 0.0 111.309 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.9 Cg_exo -70.07 160.5 49.41 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.664 2.243 . . . . 0.0 111.373 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 44.8 mt -58.9 -43.69 89.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.7 -24.95 67.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -45.4 62.29 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -43.53 95.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.301 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 95.1 mt -61.46 -40.22 93.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.899 0.48 . . . . 0.0 111.205 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 -21.73 63.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.783 -178.034 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 C--O 1.239 0.506 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.57 154.46 20.6 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 120.891 0.377 . . . . 0.0 110.755 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -135.69 111.2 9.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 26' ' ' VAL . 48.9 t -92.57 130.27 41.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.29 127.73 47.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.104 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -93.7 153.44 41.14 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.87 -20.78 13.82 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 123.521 2.814 . . . . 0.0 114.571 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -64.0 -29.86 70.98 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 120.621 0.248 . . . . 0.0 110.684 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.87 11.28 16.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB3' HD13 ' A' ' 40' ' ' ILE . 18.0 m-30 -74.26 148.68 41.28 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.169 0.509 . . . . 0.0 111.128 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 -35.65 3.29 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -90.0 -7.43 54.0 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.1 tp -45.15 -39.4 6.07 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 128.281 2.632 . . . . 0.0 112.36 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.82 -28.98 60.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -71.7 -48.82 44.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.565 0.221 . . . . 0.0 110.914 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' CG2' HG23 ' A' ' 104' ' ' ILE . 21.5 pt -64.32 -38.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.498 0.666 . . . . 0.0 111.133 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 48' ' ' ARG . 41.7 tp -73.7 -49.68 24.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.209 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.71 -33.05 28.53 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 114.596 0.599 . . . . 0.0 114.596 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -86.12 -30.65 22.37 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.791 0.796 . . . . 0.0 112.256 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.472 HD22 HD13 ' A' ' 107' ' ' LEU . 45.5 t-20 -103.83 -57.73 1.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.193 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 5.0 mmpt? 56.95 -137.1 1.04 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.5 t30 70.19 -14.95 0.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.906 0.882 . . . . 0.0 112.991 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -129.84 159.8 35.46 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -96.01 102.98 14.84 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 92.4 m-85 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.571 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HB ' HG22 ' A' ' 4' ' ' VAL . 45.4 t -123.67 139.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.514 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -128.4 153.8 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.506 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 22.8 p -100.07 175.71 5.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.41 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.84 -39.24 87.56 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.32 -20.5 60.78 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.373 0.606 . . . . 0.0 110.064 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.46 -54.9 5.83 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.842 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -60.54 -38.81 79.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -66.51 -36.49 82.85 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.446 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -69.27 -39.85 78.13 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.29 83.15 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.88 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.3 mm -65.5 -52.86 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.884 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.06 -27.85 67.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -90.45 -0.36 57.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.44 95.95 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.443 -0.408 . . . . 0.0 112.837 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 10' ' ' PHE . 62.7 mt -94.52 148.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.93 83.1 0.66 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.738 0.78 . . . . 0.0 111.076 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -23.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.561 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -66.67 -37.86 85.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 t -65.85 -33.83 76.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.45 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.34 -51.42 44.72 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 91.8 mt -54.88 -46.93 74.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.855 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.38 -43.43 96.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.702 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 17' ' ' LEU . 98.7 mtt180 -78.89 0.51 27.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.82 3.19 7.74 Favored Glycine 0 N--CA 1.458 0.144 0 C-N-CA 119.24 -1.457 . . . . 0.0 115.665 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 60.2 t -82.22 127.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 117.827 0.814 . . . . 0.0 109.438 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.4 pt -104.49 144.76 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 6.3 p -97.42 120.98 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -122.92 126.36 47.11 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.768 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.355 -179.378 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 120.146 0.022 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.74 161.39 24.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.409 2.739 . . . . 0.0 114.578 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -58.43 -33.04 69.24 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.432 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.273 6.7 p90 -61.52 -32.48 72.53 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -36.65 39.07 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.505 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 74' ' ' MET . 14.6 m -54.72 -51.73 64.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.722 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.506 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.7 tt0 -61.38 -43.53 98.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.185 0.303 . . . . 0.0 110.595 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.83 -51.4 69.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.338 0.59 . . . . 0.0 110.286 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HD2' ' A' ' 93' ' ' LYS . 71.5 mt -63.55 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.417 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 70' ' ' SER . 6.5 mmt -68.25 -38.44 81.81 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.868 -0.52 . . . . 0.0 111.196 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.33 -38.06 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.614 0.721 . . . . 0.0 109.71 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.76 73.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.115 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -71.87 -43.46 65.43 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.703 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.94 -30.53 67.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.652 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.91 -15.01 26.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 t30 55.2 61.97 2.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.99 -177.57 3.4 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.662 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.3 mt -90.0 147.82 23.45 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.62 133.73 55.67 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.359 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.1 mt -111.21 117.87 56.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.89 154.51 40.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.912 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.94 -37.26 12.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.328 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.16 130.67 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.196 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -62.59 -35.42 79.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.826 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -76.6 -36.6 57.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.124 0.42 . . . . 0.0 109.969 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.36 -44.85 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.96 -45.1 95.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.111 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.6 t30 -57.73 -52.88 63.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.346 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HD2' ' CD1' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -56.76 -43.08 80.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.696 0.799 . . . . 0.0 110.756 -178.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.3 -47.53 76.3 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.114 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -69.81 -27.61 65.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.513 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.1 mt-10 -70.6 -23.27 62.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 110.472 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.59 -18.39 33.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.523 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.2 11.99 18.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.104 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.79 131.32 46.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -78.17 95.91 5.06 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.288 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.78 130.01 42.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.892 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.45 153.55 80.47 Favored Pre-proline 0 C--N 1.29 -2.0 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.76 164.27 29.97 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.21 1.94 . . . . 0.0 111.711 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.498 HG23 ' CG2' ' A' ' 16' ' ' ILE . 64.1 mt -65.75 -43.93 93.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.65 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -66.49 -25.29 66.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.841 0.353 . . . . 0.0 111.448 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -41.78 66.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.254 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 20' ' ' ASN . 3.4 tm? -64.21 -39.22 93.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 92.7 mt -65.23 -45.25 85.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.512 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.12 71.37 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.686 0.794 . . . . 0.0 112.547 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.327 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 C--O 1.248 0.993 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -89.51 154.72 19.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 120.901 0.381 . . . . 0.0 110.003 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.55 110.43 9.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.5 t -91.92 129.33 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 13' ' ' LEU . 65.0 mt -93.1 128.01 44.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -93.15 138.5 23.16 Favored Pre-proline 0 N--CA 1.419 -2.023 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 22.7 Cg_exo -39.03 -31.7 0.28 Allowed 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 125.047 3.832 . . . . 0.0 117.003 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 p -65.96 -22.49 66.48 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.606 0.639 . . . . 0.0 112.238 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -88.79 10.27 21.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.517 0.727 . . . . 0.0 112.069 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-30 -68.44 152.67 45.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.397 0.618 . . . . 0.0 112.605 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.17 -34.11 4.07 Favored Glycine 0 N--CA 1.46 0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.783 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.21 7.07 44.75 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.015 0.912 . . . . 0.0 109.322 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.429 ' CD2' HG21 ' A' ' 5' ' ' ILE . 76.1 mt -51.51 -49.44 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 110.636 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.07 -20.47 63.22 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.654 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.19 -55.65 6.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG2' HG23 ' A' ' 104' ' ' ILE . 17.5 pt -60.53 -42.39 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 48' ' ' ARG . 3.4 mp -54.82 -51.92 64.31 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.577 0.751 . . . . 0.0 111.702 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.36 -33.13 29.32 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.057 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 m -71.89 -38.24 70.0 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.709 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -102.65 -59.35 1.72 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.623 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.46 -168.13 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 71.36 -13.39 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -107.14 143.95 34.57 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -88.83 103.91 16.43 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.438 ' CB ' HG22 ' A' ' 50' ' ' VAL . 94.5 m-85 -74.94 138.55 42.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.706 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.84 135.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.04 153.9 32.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 75' ' ' VAL . 48.3 p -94.98 172.02 8.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 120.934 0.397 . . . . 0.0 111.466 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -65.81 -44.22 86.3 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.38 -25.24 63.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.62 -52.6 28.99 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.9 m -61.5 -36.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.977 0.389 . . . . 0.0 110.835 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -67.37 -38.87 85.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -64.99 -38.5 91.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.952 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.43 -51.1 68.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.181 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 32' ' ' VAL . 50.3 mm -55.82 -50.5 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.607 0.567 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -71.2 -21.51 62.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -95.05 -4.44 46.43 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.365 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.21 54.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.109 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -103.24 133.15 47.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -76.01 108.25 8.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.23 1.014 . . . . 0.0 111.58 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.9 tp -98.8 -22.47 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.47 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.75 -27.44 66.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.391 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.2 t -70.38 -31.79 69.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -47.7 38.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 81.9 mt -54.7 -43.55 72.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.315 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.43 -33.94 74.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.443 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 44' ' ' SER . 33.7 mtt180 -85.49 -4.16 59.08 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.864 -0.735 . . . . 0.0 112.201 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.81 17.74 2.77 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.437 -1.364 . . . . 0.0 114.447 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 25' ' ' PHE . 59.3 t -89.24 124.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.3 pt -99.11 161.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.4 127.19 61.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -132.44 125.31 30.43 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.883 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.634 175.491 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -82.54 151.35 15.11 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.086 1.858 . . . . 0.0 111.505 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.98 -30.09 71.32 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -63.12 -32.71 74.15 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.495 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.3 mt-10 -89.6 -24.96 21.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.736 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 t -62.3 -40.05 95.01 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -57.23 -47.46 81.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.136 0.974 . . . . 0.0 108.598 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.12 87.13 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.219 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 69' ' ' GLU . 65.5 mt -59.98 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.95 -40.55 96.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.051 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 28' ' ' THR . 77.8 t -67.56 -40.59 84.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.68 70.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -77.22 -42.36 37.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.729 0.811 . . . . 0.0 110.212 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.48 -49.04 79.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.423 1.089 . . . . 0.0 110.102 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.73 -18.96 28.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.917 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 59.08 68.96 0.76 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.85 -177.21 3.35 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.468 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.01 137.75 33.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.66 116.12 31.38 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.136 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.43 110.29 23.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -137.49 146.83 44.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.223 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.1 -22.79 16.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.08 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.52 124.71 31.7 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 12.7 mptt -74.36 -16.45 60.9 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -81.19 -35.42 31.4 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.447 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.79 -44.34 97.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.709 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.79 -51.83 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.459 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 10.0 t30 -59.29 -46.13 89.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.35 -49.67 76.39 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 124.393 1.077 . . . . 0.0 110.202 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.16 79.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.051 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 38.0 ttmt -64.95 -34.98 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.9 mt-10 -61.61 -34.31 75.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.502 0.668 . . . . 0.0 109.811 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.8 -1.53 52.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.554 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.84 58.25 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.45 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 65.2 t -96.96 141.95 14.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -89.16 97.93 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.293 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.9 131.27 46.86 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.78 151.27 65.48 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 123.567 0.542 . . . . 0.0 111.013 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 6.8 Cg_exo -71.86 166.04 30.73 Favored 'Trans proline' 0 C--O 1.253 1.274 0 C-N-CA 122.226 1.951 . . . . 0.0 111.095 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.444 HD11 ' HB1' ' A' ' 9' ' ' ALA . 45.5 mt -58.46 -40.52 78.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -63.55 -23.04 67.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.871 0.367 . . . . 0.0 111.785 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 34.2 mm-40 -78.1 -35.15 49.61 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.18 -37.22 75.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.1 mt -64.52 -40.56 95.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 109.8 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.89 -18.45 62.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.395 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.554 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.82 144.72 26.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.752 0.31 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -129.73 109.88 11.32 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 41.0 t -92.61 133.88 32.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.85 121.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.78 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -82.63 149.3 60.29 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 52.0 Cg_exo -56.47 -15.75 16.33 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.604 2.869 . . . . 0.0 114.861 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 p -71.92 -20.78 61.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.0 111.261 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.67 11.82 31.98 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.637 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 8.7 m-30 -65.94 147.61 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.86 -34.69 3.83 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.973 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.0 mmmt -90.07 -1.09 57.9 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.583 0.353 . . . . 0.0 111.29 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 10' ' ' PHE . 7.9 mp -54.25 -35.77 62.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.429 0.633 . . . . 0.0 111.401 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -38.52 88.4 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.836 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.33 -38.95 33.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.4 pt -67.02 -35.26 74.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 13' ' ' LEU . 5.0 mp -57.23 -55.52 33.73 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.747 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.38 -33.35 53.42 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -76.98 -40.28 47.38 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.089 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.87 -52.67 3.25 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.545 -1.262 . . . . 0.0 111.803 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 59.51 -178.97 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 73.01 -14.64 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.59 1.556 . . . . 0.0 112.869 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -89.42 148.35 23.52 Favored 'General case' 0 CA--C 1.492 -1.281 0 O-C-N 121.75 -0.594 . . . . 0.0 109.398 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -91.94 98.29 11.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.6 m-85 -74.81 125.35 28.61 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.897 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.6 t -118.94 136.28 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -129.07 144.04 39.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.439 ' H ' HD13 ' A' ' 27' ' ' ILE . 39.8 p -81.62 169.58 16.86 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.395 0.617 . . . . 0.0 112.565 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 p -67.62 -36.47 80.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.79 -31.0 70.57 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.54 -50.55 42.62 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.247 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.3 m -61.74 -40.53 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 117.369 0.585 . . . . 0.0 112.007 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -69.89 -39.26 76.36 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.51 0.195 . . . . 0.0 110.617 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.05 -42.3 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.04 61.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.7 mm -53.85 -51.37 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.968 0.507 . . . . 0.0 112.085 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -67.86 -22.15 65.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -95.89 -3.9 44.52 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.84 34.97 55.34 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.877 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.17 137.18 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.08 94.07 1.87 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.2 tp -101.86 -20.34 5.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.82 -41.83 97.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.268 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.5 m -71.02 -24.91 62.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.999 0.428 . . . . 0.0 111.058 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.98 -47.36 59.34 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 85.3 mt -56.32 -40.27 74.14 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.234 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.58 -39.42 87.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.803 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 44' ' ' SER . 95.8 mtt180 -83.34 -1.9 54.44 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.96 2.54 7.19 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 114.714 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 65.5 t -76.05 120.33 25.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -97.95 140.42 18.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.233 0.54 . . . . 0.0 110.55 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -91.44 119.23 38.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -148.08 138.8 23.06 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.99 0.424 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.108 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 89' ' ' ASP . 90.0 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 15.3 Cg_exo -70.99 159.03 53.77 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.71 2.273 . . . . 0.0 109.888 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -62.7 -40.14 96.2 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -58.68 -37.62 76.43 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -71.03 -40.17 71.88 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 74' ' ' MET . 19.2 m -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.61 -37.81 87.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.37 89.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.555 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.27 -45.43 89.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.8 mmt -60.83 -45.54 94.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.699 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.39 -39.65 84.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 110.27 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.47 71.55 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.93 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -75.42 -27.07 58.85 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.596 0.758 . . . . 0.0 110.537 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' MET . 31.9 mm-40 -77.04 -42.85 36.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.479 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.26 -9.23 42.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.23 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t30 55.73 57.25 5.38 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.12 175.01 6.25 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.747 -170.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.06 121.63 30.69 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 tp -101.9 121.11 41.5 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.072 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.84 110.25 28.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.5 147.66 34.84 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.252 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -95.97 -26.24 15.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.254 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.89 131.22 37.4 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.069 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.54 -33.75 74.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HB3' HD21 ' A' ' 65' ' ' LEU . 13.2 t70 -76.39 -30.75 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.11 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.301 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.69 -47.14 86.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.13 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -58.07 -54.75 43.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.251 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -61.24 -44.93 96.46 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.593 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.7 98.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 37.9 ttmt -68.94 -28.09 66.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.9 mt-10 -64.4 -33.52 76.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.39 -3.86 57.94 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.092 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.36 59.92 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.537 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.6 t -81.64 135.08 25.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.03 96.17 8.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.672 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 133.7 51.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.502 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.74 156.48 62.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.333 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.4 Cg_exo -72.93 162.4 41.12 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.322 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 12' ' ' LYS . 69.3 mt -55.98 -44.68 79.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -72.0 -16.53 62.07 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.83 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.28 -27.63 27.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.743 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.86 -38.2 79.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.5 -14.57 60.84 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.517 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.79 -35.44 14.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.444 -0.765 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.587 -178.533 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 92.2 m-85 -87.89 155.58 19.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.275 0.56 . . . . 0.0 110.816 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -138.1 110.4 7.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -92.84 128.95 44.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.92 126.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 t -91.74 145.7 31.64 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.618 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 84.5 Cg_exo -50.85 -28.22 22.86 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 123.954 3.102 . . . . 0.0 115.103 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 p -60.56 -34.45 74.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.23 12.15 7.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.508 0.723 . . . . 0.0 112.825 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.618 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 10.5 m-30 -67.99 165.83 17.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.726 0.774 . . . . 0.0 112.754 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.73 -35.3 3.07 Favored Glycine 0 C--O 1.215 -1.081 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.214 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -113.13 14.78 19.55 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.659 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.29 -35.17 79.45 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.314 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -67.05 -40.68 87.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.7 -51.5 64.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.633 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.3 pt -60.31 -39.48 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.9 0.381 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -65.71 -48.32 72.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.065 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.19 -33.75 43.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -86.21 -36.23 19.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.488 0.644 . . . . 0.0 111.627 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.5 -53.96 4.68 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.945 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 59.16 -174.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.364 0.602 . . . . 0.0 111.364 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 -13.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.809 1.244 . . . . 0.0 114.011 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.8 154.57 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.3 tpmt? -91.66 97.97 11.35 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 50' ' ' VAL . 96.3 m-85 -74.81 129.36 37.55 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.49 138.06 51.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.973 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -126.46 152.47 34.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 41.9 p -90.88 169.32 11.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.108 -0.37 . . . . 0.0 111.246 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 54' ' ' ALA . 19.3 p -67.83 -41.84 82.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.482 0.658 . . . . 0.0 109.687 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.61 -34.43 78.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.139 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.7 -57.66 16.65 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.998 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 36' ' ' ILE . 29.3 m -59.73 -39.34 79.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 27.0 m -66.11 -36.22 82.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.76 0.314 . . . . 0.0 111.118 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -69.21 -40.13 78.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.65 84.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.773 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.2 mm -57.37 -57.68 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.223 0.327 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.7 ptpp? -65.07 -24.37 67.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 t -93.96 -8.2 40.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.371 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.84 34.34 43.33 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.665 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.2 mt -91.54 143.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.76 95.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 111.195 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.05 -28.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.32 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.07 -39.82 94.91 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 5.5 m -67.67 -30.88 70.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.292 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.1 -51.05 42.59 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -38.11 85.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 44' ' ' SER . 10.6 t70 -52.77 -45.51 67.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.631 1.172 . . . . 0.0 112.051 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -82.78 -9.81 59.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.416 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.11 19.09 4.42 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.257 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 25' ' ' PHE . 93.9 t -73.13 132.18 33.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.66 145.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.639 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.0 t -96.11 132.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . 23.3 ttm180 -153.25 138.65 17.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 29' ' ' THR . . . . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.07 147.25 91.63 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 122.527 2.152 . . . . 0.0 110.174 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.59 -34.7 77.53 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.296 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.252 10.4 p90 -64.08 -35.85 82.08 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.705 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' ILE . 72.0 mm-40 -71.97 -40.3 68.71 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' MET . 35.8 m -61.5 -38.19 86.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.922 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -58.78 -44.39 90.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.82 97.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.459 HD11 HG13 ' A' ' 90' ' ' VAL . 64.2 mt -59.63 -46.21 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.03 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.4 mmt -62.86 -45.17 93.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.625 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.42 -40.44 89.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 120.848 0.356 . . . . 0.0 110.606 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.69 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.203 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.52 -38.45 68.06 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.628 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -49.77 46.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.827 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.08 -14.11 58.09 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.021 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.6 m120 60.44 65.83 1.01 Allowed 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.871 1.32 . . . . 0.0 108.48 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -119.56 171.43 8.37 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 113.206 -1.815 . . . . 0.0 110.04 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -84.54 133.33 34.45 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -101.94 116.38 32.57 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.015 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.4 mt -96.34 110.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -134.49 154.99 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.59 -31.0 11.05 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.04 122.34 25.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.148 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 10.8 mptt -69.42 -25.96 64.39 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.63 -29.82 33.05 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.6 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.459 HG13 HD11 ' A' ' 73' ' ' ILE . 74.8 t -63.24 -49.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.77 -44.32 81.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.208 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -55.33 -56.0 25.05 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.354 1.462 . . . . 0.0 111.412 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.96 86.33 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 18.0 ptpt -76.54 -18.61 58.6 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.154 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.97 -28.24 68.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.58 -18.48 33.22 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.93 13.64 15.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.969 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.74 127.97 46.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.41 89.89 3.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.726 0.774 . . . . 0.0 109.484 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.99 129.31 43.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.174 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 pp -135.22 148.74 67.67 Favored Pre-proline 0 C--N 1.291 -1.96 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.14 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.3 Cg_exo -68.84 167.76 22.25 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.72 2.28 . . . . 0.0 111.68 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.64 -50.05 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.097 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.76 -36.58 72.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 56.6 mm-40 -69.51 -37.82 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.524 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.92 -44.54 84.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.37 -43.44 92.86 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.31 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.74 -27.42 69.19 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.138 0.575 . . . . 0.0 111.78 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 121.303 0.573 . . . . 0.0 110.632 -178.454 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -87.75 160.14 18.19 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.947 0.403 . . . . 0.0 110.406 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.28 114.95 11.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.15 131.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.185 0.517 . . . . 0.0 109.778 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.1 mt -97.49 130.24 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -94.57 149.02 35.89 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 88.2 Cg_exo -50.96 -27.37 20.89 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.657 2.905 . . . . 0.0 114.94 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -64.25 -24.53 67.7 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 120.975 0.417 . . . . 0.0 112.061 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 6.52 43.2 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.643 0.377 . . . . 0.0 111.688 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 15.1 m-30 -68.76 154.33 42.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -34.47 3.48 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.016 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 104' ' ' ILE . 59.2 mtpt -98.95 11.87 37.64 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.004 0.907 . . . . 0.0 109.662 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.71 -36.37 74.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.296 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.741 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.17 -59.2 2.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.578 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 104' ' ' ILE . 29.6 pt -57.18 -45.59 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 61.3 tp -66.97 -42.6 84.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.331 -177.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.89 -33.16 34.28 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.593 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 m -77.27 -45.89 24.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.883 0.373 . . . . 0.0 111.507 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -93.9 -58.41 2.26 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.254 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 57.69 -146.32 0.55 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.0 -14.02 0.25 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -117.77 157.48 26.47 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.8 tpmt? -90.63 102.67 15.42 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -75.06 120.38 20.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.843 0.83 . . . . 0.0 110.545 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.31 133.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.653 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.39 153.6 28.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 24.7 p -90.75 170.55 10.03 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -67.96 -38.64 83.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.943 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -73.04 -29.74 63.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.31 -56.18 25.0 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.578 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.9 m -60.82 -38.39 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.735 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 44.3 t -64.45 -40.33 95.51 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.811 0.339 . . . . 0.0 110.627 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.88 -38.92 87.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.91 86.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.379 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.2 mm -55.3 -56.81 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.6 0.562 . . . . 0.0 111.337 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 33' ' ' SER . 14.4 pttm -66.49 -30.27 70.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -87.41 -0.73 57.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.545 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.58 95.49 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 10' ' ' PHE . 81.1 mt -92.07 147.8 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 123.566 0.746 . . . . 0.0 109.18 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.2 89.25 0.64 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.153 0.502 . . . . 0.0 110.922 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -102.84 -32.65 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -60.56 -39.29 87.43 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -30.62 71.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.274 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.95 -48.6 23.6 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.57 -41.93 95.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.249 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.68 -21.73 64.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.609 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.8 mtt180 -92.9 -7.95 44.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.94 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 5.82 6.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 115.248 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.63 129.72 36.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.149 0.974 . . . . 0.0 108.848 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.1 pt -104.88 152.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.18 124.35 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -122.41 124.76 44.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 171.345 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 90' ' ' VAL . 96.2 mt . . . . . 0 CA--C 1.512 -0.498 0 CA-C-O 119.84 -0.124 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.84 153.66 76.84 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.981 1.788 . . . . 0.0 109.601 173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.85 -32.92 74.84 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -60.36 -40.46 90.86 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.58 -40.99 69.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -63.66 -37.88 89.03 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.325 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.571 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.7 tt0 -61.75 -40.83 96.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.06 89.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.511 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.19 -44.32 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.6 mmt -64.51 -40.05 94.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.67 -38.03 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.088 0.47 . . . . 0.0 110.067 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.18 -32.52 74.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -73.67 -35.96 65.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.313 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.95 -46.71 67.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.672 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.87 -17.77 39.75 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.03 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.54 69.19 0.7 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.21 176.18 7.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.721 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -85.86 134.49 33.9 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -101.97 122.62 44.4 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.459 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.36 113.47 36.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.22 159.54 42.49 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.95 -24.54 11.58 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.65 135.71 33.3 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.594 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.7 mppt? -59.49 -38.52 81.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.078 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.38 -34.11 67.71 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 65' ' ' LEU . 51.5 t -67.95 -53.08 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.625 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.3 -43.13 85.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.098 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -70.73 -41.65 71.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.505 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 40.3 tptt -65.87 -39.78 91.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.094 0.473 . . . . 0.0 110.311 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.47 98.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.08 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -71.74 -20.44 61.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.505 ' OE1' ' HD2' ' A' ' 93' ' ' LYS . 42.3 mt-10 -72.93 -31.8 64.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.27 -14.53 57.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.535 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.26 44.82 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.954 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.97 133.81 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -79.85 93.47 5.64 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.45 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.61 130.14 41.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.578 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.5 pp -132.21 139.2 34.16 Favored Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.479 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 25.6 Cg_exo -61.28 159.98 28.8 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.321 2.014 . . . . 0.0 110.453 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 12' ' ' LYS . 45.6 mt -56.09 -40.54 64.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -30.07 70.99 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 26.9 mm-40 -75.89 -33.57 59.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.782 0.325 . . . . 0.0 110.486 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.51 -43.39 80.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 85.7 mt -63.43 -42.59 98.7 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.01 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.0 110.877 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.443 -0.779 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.467 178.513 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -86.77 146.04 26.4 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -130.91 113.55 14.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.74 134.57 30.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -95.97 128.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 85' ' ' ALA . 1.4 t -82.47 144.4 49.46 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.355 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 Cg_exo -58.07 -26.76 76.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.91 2.407 . . . . 0.0 112.452 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.0 m -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.151 0.5 . . . . 0.0 110.547 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 104' ' ' ILE . . . -83.82 -0.1 49.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.615 -174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 16.3 m-30 -63.2 153.01 35.89 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.426 0.631 . . . . 0.0 112.362 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.59 -35.38 3.5 Favored Glycine 0 C--N 1.31 -0.915 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.166 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -99.05 3.67 46.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.76 1.267 . . . . 0.0 108.397 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.4 -34.92 78.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.038 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -61.66 -34.35 75.57 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.232 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.82 -62.66 1.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.822 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.463 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.9 pt -53.43 -40.37 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 48' ' ' ARG . 49.2 tp -62.5 -54.88 33.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.152 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.77 -30.47 13.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.175 -1.012 . . . . 0.0 114.134 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -78.54 -29.62 46.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 122.429 -0.454 . . . . 0.0 110.911 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -114.81 -55.04 2.52 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.913 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 51.6 tttp 58.01 -140.19 0.79 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.513 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 66.4 t30 69.93 -13.36 0.42 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 124.793 1.237 . . . . 0.0 113.949 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.54 161.22 18.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.695 -0.628 . . . . 0.0 109.737 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.95 102.35 14.71 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.49 124.04 26.48 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.359 0.6 . . . . 0.0 111.446 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.86 134.61 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.025 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.3 tp -121.14 149.47 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 24.1 p -85.86 168.63 14.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.584 0.707 . . . . 0.0 112.506 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.76 95.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.291 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.93 -30.52 58.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.93 -54.65 35.77 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.947 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.2 m -60.56 -42.42 91.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.475 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 m -63.16 -41.79 99.32 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.859 0.362 . . . . 0.0 111.378 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.02 -43.43 98.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.307 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.199 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 32' ' ' VAL . 31.8 mm -59.25 -52.53 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.805 0.442 . . . . 0.0 111.088 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -12.89 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -98.48 -16.01 19.37 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.19 41.36 13.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.192 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.4 mt -100.41 157.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.86 83.74 0.11 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.905 0.482 . . . . 0.0 111.364 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.3 tp -107.13 -31.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -71.09 -37.44 72.42 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.882 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.9 m -65.29 -28.92 69.67 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.934 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 50' ' ' VAL . . . -76.99 -50.08 13.97 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.75 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 80.5 mt -57.88 -40.74 80.98 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.806 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.89 -49.61 65.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.883 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.436 ' HB2' HD21 ' A' ' 17' ' ' LEU . 66.4 mtt180 -82.09 -0.62 45.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.04 0.68 8.17 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 118.609 -1.757 . . . . 0.0 115.026 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 45' ' ' ALA . 97.2 t -72.48 126.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 pt -104.53 148.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -96.03 137.98 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' NE ' HD21 ' A' ' 79' ' ' LEU . 37.8 ttt85 -147.91 136.11 21.34 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.266 0.555 . . . . 0.0 111.499 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -1.982 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.525 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 97.6 mt . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 17.0 Cg_exo -70.53 161.25 46.69 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.396 2.064 . . . . 0.0 111.042 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -56.46 -40.18 74.41 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.746 0.818 . . . . 0.0 112.623 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -62.68 -36.59 83.39 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -75.4 -37.62 60.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -59.93 -44.8 94.14 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.3 tt0 -61.94 -37.88 86.38 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.88 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -42.87 97.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.32 -44.1 83.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.385 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.2 mmt -60.92 -42.5 98.24 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.55 -40.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.134 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.02 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.295 0.569 . . . . 0.0 110.136 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.66 -44.07 74.88 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.439 1.096 . . . . 0.0 110.62 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -74.19 -27.22 60.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.072 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD21 ' NE ' ' A' ' 53' ' ' ARG . 93.1 mt -88.75 -19.13 26.44 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.06 48.86 6.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.98 176.92 5.93 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.819 -1.537 . . . . 0.0 112.243 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.94 128.03 36.14 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.2 tp -103.57 119.06 38.15 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.483 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.9 mt -94.58 110.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -126.11 173.45 9.2 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.0 -60.33 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.44 136.19 57.44 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.34 0.59 . . . . 0.0 111.232 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 45.9 mtmt -58.34 -35.37 71.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.151 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.25 -31.07 54.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.111 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 65' ' ' LEU . 46.5 t -63.39 -43.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.43 -49.52 82.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.739 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.16 -52.72 64.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.62 -33.23 75.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 -46.78 77.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.436 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.43 -20.94 61.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.82 -39.1 93.42 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.696 0.76 . . . . 0.0 109.176 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.57 -3.57 57.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.265 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.14 10.81 59.3 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.916 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.23 126.1 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -75.39 95.3 3.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.176 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.44 143.93 29.13 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.027 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -141.0 152.27 64.69 Favored Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 123.728 0.643 . . . . 0.0 110.445 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.6 Cg_endo -69.94 159.45 53.23 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.54 1.493 . . . . 0.0 109.848 172.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.463 HG23 ' CG2' ' A' ' 16' ' ' ILE . 75.4 mt -54.89 -43.65 69.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.51 -32.38 54.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 120.954 0.406 . . . . 0.0 110.186 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.52 -37.9 71.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.2 -35.64 81.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 -9.22 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.249 0.547 . . . . 0.0 111.094 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.443 -0.82 0 CA-C-O 121.444 0.64 . . . . 0.0 109.735 176.623 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.244 0.767 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -87.42 155.67 19.92 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.79 109.15 9.45 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' HD12 ' A' ' 83' ' ' LEU . 59.2 t -92.37 129.23 43.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.8 mt -96.96 133.99 36.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.573 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -91.7 147.13 34.46 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 45.5 Cg_exo -56.16 -21.45 35.48 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.219 2.613 . . . . 0.0 114.561 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -67.81 -25.67 65.69 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 122.094 -0.379 . . . . 0.0 111.729 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 19.57 8.83 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.025 0.53 . . . . 0.0 111.866 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.523 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.1 m-30 -72.33 168.09 19.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 -34.87 3.38 Favored Glycine 0 C--O 1.217 -0.943 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.357 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' ILE . 13.4 mmmm -100.12 21.22 13.17 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.414 0.626 . . . . 0.0 110.098 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 -27.32 68.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.711 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -79.52 -43.54 22.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.082 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -66.26 -46.24 77.73 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.457 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 12' ' ' LYS . 30.6 pt -64.88 -34.48 70.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.398 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 9.5 tp -66.65 -55.04 17.05 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.167 0.508 . . . . 0.0 109.671 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.4 -33.17 61.59 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.3 m -82.81 -48.1 11.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 117.358 0.579 . . . . 0.0 111.214 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.21 -59.07 2.29 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.668 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 75.1 tttt 59.7 -162.21 0.26 Allowed 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 43.1 m-80 73.86 -0.51 3.34 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 170.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -123.18 152.42 41.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.13 104.34 16.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.6 m-85 -74.69 131.27 40.73 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.689 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 58.6 t -127.76 138.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.331 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.27 150.59 30.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -84.01 163.15 20.1 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.14 0.495 . . . . 0.0 111.415 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -62.56 -34.37 76.8 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.351 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.06 -32.64 63.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.03 67.51 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.108 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.9 m -61.35 -39.34 82.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.717 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -65.32 -37.54 87.41 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.693 0.282 . . . . 0.0 111.085 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.23 -42.23 88.96 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.446 0.641 . . . . 0.0 109.471 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.64 90.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.774 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 32' ' ' VAL . 40.8 mm -61.27 -50.58 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.572 0.349 . . . . 0.0 111.043 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -64.73 -35.78 82.18 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.3 t -80.45 -28.33 37.68 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.59 40.91 6.62 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 ' HB3' ' A' ' 10' ' ' PHE . 79.6 mt -95.77 149.04 4.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.14 91.72 0.23 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.725 0.774 . . . . 0.0 111.725 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.2 tp -109.59 -27.55 2.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.186 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.96 -48.21 77.35 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.332 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.592 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 3.1 m -72.77 -27.8 62.22 Favored 'General case' 0 C--O 1.204 -1.303 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -44.89 90.38 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.1 mt -60.1 -44.14 95.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.641 176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.94 -38.01 84.33 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.749 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 44' ' ' SER . 72.5 mtt85 -67.27 -19.8 65.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.71 4.11 6.88 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.85 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 61.9 t -75.98 119.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 pt -98.29 150.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 0.0 111.647 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.45 135.47 27.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -132.56 135.61 46.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.535 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -66.43 145.15 76.23 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.245 1.963 . . . . 0.0 109.958 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.51 -38.94 89.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -33.49 75.74 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -73.98 -40.77 62.74 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.9 m -60.96 -40.41 93.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.646 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.67 -38.22 90.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.768 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.78 -46.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.662 0.601 . . . . 0.0 110.092 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.7 mmt -61.77 -49.55 75.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.77 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.57 -41.49 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -41.55 98.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.552 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -65.36 -46.31 80.68 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.696 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.75 -43.88 97.4 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.218 0.607 . . . . 0.0 109.517 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.0 -15.99 54.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.343 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.34 43.61 4.64 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.58 178.93 5.02 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.237 -1.801 . . . . 0.0 112.288 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD11 HD11 ' A' ' 102' ' ' ILE . 1.9 tm? -87.0 135.21 33.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 4' ' ' VAL . 45.0 tp -111.09 122.29 47.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.495 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mt -103.13 110.21 29.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.72 155.17 48.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -108.47 -25.4 10.97 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -75.76 129.55 37.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.755 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -50.85 -50.32 57.07 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 124.683 1.24 . . . . 0.0 112.611 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.47 -27.49 34.57 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.562 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.21 -47.77 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.06 -43.86 97.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.785 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 4.4 t30 -61.56 -47.77 84.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.873 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -66.41 -36.54 83.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.124 0.487 . . . . 0.0 111.1 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.31 84.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.498 0.666 . . . . 0.0 109.871 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -72.76 -26.26 61.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 51.6 mt-10 -63.8 -36.72 84.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.101 0.56 . . . . 0.0 110.23 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.49 -18.96 43.33 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.97 27.54 6.57 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.033 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -98.27 141.17 16.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -81.17 90.75 6.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.72 0.771 . . . . 0.0 109.5 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.0 131.04 54.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.124 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 82' ' ' LEU . 2.3 pp -143.09 157.16 61.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 123.782 0.677 . . . . 0.0 110.268 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.17 167.33 27.62 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.661 2.241 . . . . 0.0 111.981 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 79.4 mt -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.223 1.009 . . . . 0.0 113.274 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.44 -38.05 89.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 111.462 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.6 -31.19 64.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.476 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.44 -39.7 94.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 79.5 mt -68.26 -19.29 64.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.21 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.63 2.41 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.317 -0.838 0 O-C-N 121.921 -0.487 . . . . 0.0 112.007 -178.815 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.71 149.29 24.32 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.23 111.28 10.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 61.8 t -92.67 129.85 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mt -95.3 125.77 47.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.884 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -92.42 141.21 24.54 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -38.84 -32.2 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 125.074 3.849 . . . . 0.0 116.98 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.6 p -64.75 -22.97 67.1 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.754 0.706 . . . . 0.0 112.053 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.44 11.51 25.94 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.381 0.672 . . . . 0.0 111.411 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -76.28 159.63 30.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.359 0.6 . . . . 0.0 112.238 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.3 -34.97 2.2 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.403 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HE2' HG21 ' A' ' 104' ' ' ILE . 58.7 mtpt -96.3 13.12 28.66 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.939 0.876 . . . . 0.0 109.433 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -54.73 -39.21 68.03 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.216 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -73.13 -21.0 60.81 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.98 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -74.53 -58.39 3.32 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 104' ' ' ILE . 23.1 pt -59.34 -48.91 85.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 48' ' ' ARG . 57.6 tp -66.72 -45.96 77.01 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.941 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.16 48.75 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.292 -0.956 . . . . 0.0 114.061 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -84.79 -27.22 27.0 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.384 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -109.07 -59.1 1.94 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 119.629 -0.828 . . . . 0.0 112.089 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 59.06 -155.86 0.35 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 70.7 -15.32 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 124.847 1.259 . . . . 0.0 113.896 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -104.98 153.6 21.22 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -91.82 97.5 11.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 50' ' ' VAL . 90.2 m-85 -74.6 125.66 29.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.509 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 53.1 t -121.26 135.19 62.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.438 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.1 tt -123.45 154.38 29.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.528 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 20.4 p -89.86 167.93 12.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -45.57 92.45 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.719 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.67 -21.87 61.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -56.68 8.75 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.691 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.7 m -58.58 -38.33 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 117.323 0.561 . . . . 0.0 111.156 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -67.21 -35.05 78.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.91 -40.1 87.57 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.07 78.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.456 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 32' ' ' VAL . 42.7 mm -55.4 -51.15 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.999 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -12.35 61.44 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -106.78 -0.56 23.36 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.02 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.59 29.2 68.11 Favored Glycine 0 C--O 1.242 0.601 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.221 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.93 129.91 37.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.97 111.75 6.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.077 0.942 . . . . 0.0 111.049 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -116.77 -16.98 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.73 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 122.314 -0.241 . . . . 0.0 111.222 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -63.22 -32.18 73.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.14 58.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.39 -43.17 99.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.465 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.26 -43.18 74.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.695 1.198 . . . . 0.0 111.978 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.524 ' HB2' HD21 ' A' ' 17' ' ' LEU . 81.6 mtt180 -77.12 -13.59 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.26 13.38 3.56 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.265 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 25' ' ' PHE . 84.2 t -81.3 133.13 29.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.2 pt -110.52 154.57 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.676 0.274 . . . . 0.0 110.593 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.2 p -107.92 136.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -127.34 133.18 50.11 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 -178.405 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 120.304 0.097 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.93 140.29 37.95 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.465 2.11 . . . . 0.0 110.688 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -45.38 -45.39 12.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.804 1.241 . . . . 0.0 113.139 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -61.17 -34.57 75.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.83 -28.23 21.76 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -64.08 -38.69 91.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.929 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.528 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.5 tt0 -62.0 -40.82 96.96 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -59.44 -48.7 80.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.917 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 90' ' ' VAL . 61.9 mt -59.99 -45.28 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.907 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 3.7 mmt -62.55 -44.48 96.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 -177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.72 -38.4 82.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.939 0.399 . . . . 0.0 110.746 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.43 80.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.589 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -69.84 -39.43 76.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.482 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 74' ' ' MET . 12.8 mm-40 -60.09 -49.89 75.87 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.485 0.659 . . . . 0.0 111.208 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.61 -16.83 46.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.343 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 t30 60.73 56.09 3.08 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.05 177.76 4.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.031 -1.895 . . . . 0.0 111.649 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.38 134.69 34.4 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 34.5 tp -109.19 128.71 55.25 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.452 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.1 mt -106.89 113.09 42.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.56 146.57 32.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.63 -23.52 15.44 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.13 123.94 27.47 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.768 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.56 -38.12 80.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.805 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.57 -31.29 47.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.515 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 73' ' ' ILE . 81.5 t -62.9 -46.53 96.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.26 -49.56 81.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.01 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -56.14 -48.74 75.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.258 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 2.2 tmtm? -65.55 -45.9 81.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.013 0.435 . . . . 0.0 110.351 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.06 82.84 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -57.82 -42.64 84.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.439 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.9 mt-10 -60.39 -35.57 76.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.76 0.824 . . . . 0.0 111.091 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 81.6 mt -77.54 -5.61 50.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.523 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.77 7.22 63.11 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.04 128.22 44.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -82.45 97.95 8.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.616 -1.233 . . . . 0.0 110.307 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.44 127.46 37.94 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.227 174.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.61 146.65 62.32 Favored Pre-proline 0 C--N 1.28 -2.449 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.293 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 40.3 Cg_endo -71.42 167.65 25.73 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.421 2.081 . . . . 0.0 111.065 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 16' ' ' ILE . 63.2 mt -60.18 -40.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.11 -29.56 69.9 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.283 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.2 -32.59 63.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.968 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.39 -34.88 76.82 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 93.2 mt -65.9 -40.73 91.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.185 0.517 . . . . 0.0 109.948 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.57 -25.42 63.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.317 0.579 . . . . 0.0 110.811 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.751 178.679 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -87.88 150.2 23.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -127.77 108.56 10.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -92.12 128.44 43.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 109.705 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.0 mt -93.94 124.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.716 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -87.2 149.01 46.28 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -59.05 -19.34 48.19 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.355 2.703 . . . . 0.0 114.4 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 p -69.1 -19.25 64.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.979 0.418 . . . . 0.0 110.941 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -99.49 13.52 33.06 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.282 0.633 . . . . 0.0 110.963 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 12.2 m-30 -71.44 153.87 41.94 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.18 -33.1 4.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.057 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.42 11.99 35.83 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.078 0.466 . . . . 0.0 111.653 -175.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.8 mp -59.47 -32.01 69.85 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.773 0.796 . . . . 0.0 108.864 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.11 -39.68 87.06 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.319 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.46 -56.29 8.91 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 104' ' ' ILE . 22.0 pt -58.62 -37.63 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.0 tp -72.94 -47.62 43.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.222 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -31.57 31.67 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.34 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -87.72 -22.51 24.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -114.84 -55.77 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.501 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.78 -142.04 0.52 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -171.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 70.77 -13.86 0.46 Allowed 'General case' 0 N--CA 1.518 2.933 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.98 156.4 43.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.9 tpmt? -89.02 102.4 15.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.477 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.9 m-85 -74.71 126.9 31.87 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.344 0.592 . . . . 0.0 110.027 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.3 t -115.69 126.66 73.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.263 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -113.89 145.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.246 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 ' H ' HD13 ' A' ' 27' ' ' ILE . 26.9 p -84.79 160.44 20.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -44.22 97.43 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.968 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.78 -32.21 73.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.634 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.8 77.4 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.705 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.7 m -62.82 -41.56 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.599 0.699 . . . . 0.0 111.659 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -64.72 -36.4 84.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.422 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 76.8 t80 -67.75 -43.16 80.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.64 85.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 44.2 mm -64.75 -52.67 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -67.64 -32.53 73.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -88.54 -11.77 44.72 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.09 18.02 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.86 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.4 HG21 ' HB3' ' A' ' 10' ' ' PHE . 66.3 mt -97.0 142.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -67.73 112.66 4.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.046 0.45 . . . . 0.0 110.705 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.62 -26.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.516 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.13 -35.62 78.4 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.659 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.7 p -65.28 -38.86 91.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.485 0.66 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -52.09 63.95 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.596 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.67 -39.78 85.6 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.466 0.65 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.5 -38.42 84.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.467 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.6 mtt180 -87.04 3.48 45.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.36 2.24 7.64 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 118.73 -1.7 . . . . 0.0 115.771 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.6 t -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -105.62 157.34 6.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.2 p -105.86 128.13 60.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.129 0.49 . . . . 0.0 110.768 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.89 137.4 52.83 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.407 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.83 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 mt . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 45.1 Cg_exo -60.05 169.1 5.13 Favored 'Trans proline' 0 C--O 1.256 1.385 0 C-N-CA 122.96 2.44 . . . . 0.0 112.238 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -54.21 -48.53 70.92 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.501 0.72 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 3.5 p90 -63.22 -31.21 72.3 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -75.71 -42.39 50.97 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -61.57 -39.98 93.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.123 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -54.03 -50.2 67.22 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.572 1.149 . . . . 0.0 109.234 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.01 -48.97 77.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.611 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.05 -45.56 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.934 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.09 -38.31 90.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.68 -43.37 96.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.41 77.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.67 -39.25 80.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.631 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.64 -48.83 36.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.289 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.09 -21.55 50.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.6 t30 65.56 69.08 0.47 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.05 170.7 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.492 -172.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.7 tm? -85.27 122.86 30.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 36.8 tp -99.59 125.75 45.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.18 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.54 113.86 43.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.85 145.54 36.35 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.896 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -95.77 -29.32 14.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' A' ' 90' ' ' VAL . 14.1 t70 -83.71 124.09 30.51 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.858 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.51 -36.53 6.81 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 125.892 1.677 . . . . 0.0 114.402 179.07 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 23.9 t70 -79.72 -33.82 40.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.363 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 87' ' ' ASP . 59.2 t -62.93 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.66 -46.46 93.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.916 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 27.3 t-20 -59.54 -51.6 69.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.1 mmmt -63.01 -41.68 99.64 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.03 88.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.464 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 19.5 ptpt -68.53 -26.18 65.3 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.026 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.2 mt-10 -69.3 -28.74 66.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.189 0.519 . . . . 0.0 109.852 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.44 0.03 56.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.703 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.77 8.76 65.01 Favored Glycine 0 C--O 1.241 0.54 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.4 t -92.66 128.92 43.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.25 92.69 6.38 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.157 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.56 132.41 44.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.759 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.96 155.95 76.05 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.8 Cg_exo -70.76 160.65 48.73 Favored 'Trans proline' 0 C--O 1.256 1.409 0 C-N-CA 121.999 1.799 . . . . 0.0 110.868 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 16' ' ' ILE . 39.8 mt -54.76 -42.9 64.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 123.651 0.78 . . . . 0.0 111.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -63.13 -36.72 84.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.13 -33.06 69.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.975 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.95 -47.95 75.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.8 mt -63.0 -33.33 75.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.056 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.64 59.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.244 0.766 0 CA-C-O 121.328 0.585 . . . . 0.0 110.885 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 C--O 1.245 0.863 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.64 153.0 21.72 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.0 109.69 10.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.61 128.54 44.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.61 123.48 43.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 m -83.93 148.59 54.33 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 77.3 Cg_exo -53.32 -11.25 1.71 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 124.13 3.22 . . . . 0.0 114.679 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.438 ' HB2' ' H ' ' A' ' 86' ' ' GLU . 1.2 m -64.25 -47.36 79.91 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.7 20.33 0.95 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.54 -171.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 4.3 m-30 -70.6 147.77 48.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.084 0.469 . . . . 0.0 111.175 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -34.32 3.53 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.58 -0.77 57.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.606 1.162 . . . . 0.0 109.605 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -47.52 -48.68 27.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.493 1.517 . . . . 0.0 111.999 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -75.12 -22.78 57.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.434 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -75.38 -52.37 10.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 104' ' ' ILE . 23.7 pt -63.57 -41.45 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 48' ' ' ARG . 59.9 tp -65.38 -54.97 21.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.518 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.1 -33.6 56.78 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.225 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -79.35 -55.64 4.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.849 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -75.67 -59.06 2.92 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.017 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 60.09 -156.73 0.34 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 t30 73.11 -13.97 0.65 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.257 1.023 . . . . 0.0 113.38 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -116.35 155.16 28.94 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -90.85 101.92 14.68 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' HB2' HG22 ' A' ' 50' ' ' VAL . 87.1 m-85 -74.66 133.72 42.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.63 140.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.304 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -126.42 154.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 72' ' ' ALA . 81.7 p -99.92 177.9 4.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -47.46 79.54 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 124.685 1.194 . . . . 0.0 112.133 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.61 -24.05 56.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.92 -56.42 22.67 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.044 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.2 m -61.42 -34.59 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 117.049 0.425 . . . . 0.0 111.379 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 m -67.93 -37.34 81.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.114 0.483 . . . . 0.0 110.665 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -69.24 -35.07 75.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.88 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.16 88.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.4 mm -58.81 -53.13 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -29.48 70.29 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 -2.74 58.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.628 0.252 . . . . 0.0 111.558 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.3 41.23 53.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.667 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.66 137.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.43 88.63 3.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.259 1.028 . . . . 0.0 111.134 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -81.8 -22.72 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.333 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -32.38 72.74 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.143 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 m -65.42 -33.44 75.96 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.267 0.556 . . . . 0.0 110.875 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.58 -47.86 16.34 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.3 -42.83 82.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.38 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.52 -41.95 86.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.717 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.7 mtt85 -79.64 -2.6 43.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.64 24.08 4.48 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.923 -1.132 . . . . 0.0 114.771 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 25' ' ' PHE . 95.6 t -86.4 126.7 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 pt -100.47 151.02 5.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.378 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.1 t -99.52 123.25 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -121.3 125.59 47.42 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.204 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.136 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 83.3 mt . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 29.3 Cg_exo -64.68 148.38 90.24 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.398 2.066 . . . . 0.0 110.068 174.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -58.06 -42.22 85.03 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -61.77 -35.3 77.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 48.4 mt-10 -81.11 -27.26 35.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.221 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -70.51 -32.12 69.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.617 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.77 -46.81 86.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -55.08 -48.14 73.95 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.7 0.625 . . . . 0.0 111.181 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.03 -47.67 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.918 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 1.9 mmt -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.058 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.81 -39.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 120.731 0.301 . . . . 0.0 110.664 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.042 0.449 . . . . 0.0 110.532 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -71.21 -43.74 66.77 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.88 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -50.89 65.22 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 109.787 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.7 -20.34 56.7 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 63.89 68.47 0.57 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 179.74 4.02 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.629 -172.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.93 133.15 36.39 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 30.8 tp -108.91 127.76 54.34 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.391 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.8 mt -105.72 115.65 47.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.2 157.55 44.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.626 0.25 . . . . 0.0 110.424 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' H ' ' HB2' ' A' ' 8' ' ' SER . 49.0 mt-10 -97.92 -43.71 6.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.957 0.408 . . . . 0.0 110.074 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.47 126.84 31.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.474 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -62.49 -28.0 69.52 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.714 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 92' ' ' ASN . 15.8 t70 -75.54 -39.48 58.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.18 -51.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.21 -49.9 73.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.664 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.603 ' O ' ' HG3' ' A' ' 96' ' ' GLU 0.264 17.0 p30 -64.9 -42.99 94.3 Favored 'General case' 0 C--O 1.205 -1.255 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.0 mtpp -63.22 -41.54 99.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.72 99.87 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.26 0.552 . . . . 0.0 109.764 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -72.77 -26.13 61.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.698 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.8 mt-10 -64.62 -37.19 86.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.1 mt -80.82 -15.71 55.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.656 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.31 5.49 28.27 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.083 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.5 t -94.36 130.34 43.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.9 96.7 5.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.086 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.41 133.69 43.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.44 155.26 72.05 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.49 0.493 . . . . 0.0 111.171 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 23.6 Cg_exo -67.91 162.87 37.86 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.519 2.146 . . . . 0.0 112.066 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.431 HG23 ' CG2' ' A' ' 16' ' ' ILE . 84.3 mt -57.66 -46.4 86.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 123.859 0.864 . . . . 0.0 111.597 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.31 -37.71 78.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.85 -39.58 87.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.37 -46.8 81.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.81 -39.59 85.56 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.197 0.599 . . . . 0.0 110.646 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.57 -16.29 60.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.724 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.318 -0.778 0 CA-C-O 120.909 0.385 . . . . 0.0 110.274 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.24 0.581 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.86 154.49 20.49 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.5 108.99 9.95 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.7 t -93.54 134.41 31.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 13' ' ' LEU . 37.9 mt -104.56 134.24 46.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -89.08 146.9 37.35 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.58 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 70.6 Cg_exo -52.65 -28.08 35.83 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.545 2.83 . . . . 0.0 114.328 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 p -61.75 -22.86 65.76 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.97 13.23 31.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.166 0.507 . . . . 0.0 111.445 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 3.6 m-30 -69.88 160.52 31.65 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -34.33 3.65 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.687 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.527 ' HB2' HD13 ' A' ' 104' ' ' ILE . 28.6 mtpp -102.18 13.85 33.56 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.781 0.801 . . . . 0.0 110.382 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' CD2' HG21 ' A' ' 5' ' ' ILE . 61.4 mt -56.93 -40.74 76.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.572 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -65.92 -26.2 67.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.024 -1.443 . . . . 0.0 111.33 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.53 -49.15 9.52 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.74 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' HG23 ' A' ' 104' ' ' ILE . 19.0 pt -63.38 -46.55 95.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 111.368 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.7 tp -67.97 -43.18 79.59 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.853 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.36 -33.19 64.52 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.196 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.1 m -83.79 -45.32 13.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.63 -53.67 3.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 58.68 -114.28 0.74 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -164.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.1 t30 55.94 -15.31 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -132.17 166.25 22.24 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.4 -0.813 . . . . 0.0 109.233 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -98.28 105.51 17.67 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.417 ' HB2' HG22 ' A' ' 50' ' ' VAL . 57.9 m-85 -75.26 139.69 42.71 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.8 t -131.05 140.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.373 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 tp -130.0 156.96 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 75' ' ' VAL . 25.7 p -91.64 169.03 11.07 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.171 0.51 . . . . 0.0 111.779 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -41.68 95.16 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.279 1.032 . . . . 0.0 110.176 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.216 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 -52.06 19.57 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.404 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 36' ' ' ILE . 32.1 m -58.58 -38.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.434 0.617 . . . . 0.0 112.001 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 p -75.78 -22.46 56.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.046 0.451 . . . . 0.0 111.34 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -69.1 -40.88 78.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' ILE . . . -66.45 -43.11 86.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.0 mm -57.72 -52.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.736 0.648 . . . . 0.0 111.391 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -65.51 -25.05 67.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -100.34 -28.39 12.98 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.334 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.68 41.57 3.1 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.91 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -100.45 147.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.44 97.89 0.45 Allowed 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.896 0.379 . . . . 0.0 111.511 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.6 tp -108.12 -34.29 2.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.622 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.23 -48.35 80.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.842 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 t -62.56 -37.25 85.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.839 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.5 69.72 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 87.4 mt -57.67 -45.86 85.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.68 -41.54 97.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.93 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HB2' HD21 ' A' ' 17' ' ' LEU . 61.7 mtt180 -74.06 -8.03 54.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.27 23.18 1.78 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.151 -1.499 . . . . 0.0 115.154 175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 62.6 t -98.39 119.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -99.45 155.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 110.991 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.91 135.29 33.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' HG2' HG13 ' A' ' 75' ' ' VAL . 2.9 tpm_? -122.32 125.08 45.19 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.82 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 120.355 0.121 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 158.05 55.98 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 122.72 2.28 . . . . 0.0 111.582 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -66.07 -27.91 68.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.985 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.262 5.1 p90 -62.01 -37.09 83.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.737 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -71.29 -38.68 71.77 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 74' ' ' MET . 18.8 m -63.17 -40.9 98.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.699 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -65.97 -35.37 80.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.21 91.8 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.15 -45.09 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.615 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' SER . 26.6 mmt -61.67 -45.16 95.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 53' ' ' ARG . 46.4 t -61.77 -40.66 87.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 120.876 0.37 . . . . 0.0 110.73 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.05 69.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -79.85 -27.61 40.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.323 0.582 . . . . 0.0 110.348 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.25 -48.79 21.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.09 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.69 -12.86 55.31 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.596 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 57.19 63.3 1.93 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.97 -179.92 3.8 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 113.455 -1.702 . . . . 0.0 112.308 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.34 130.83 36.39 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.1 tp -107.55 130.25 54.89 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.301 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -111.03 115.83 50.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.84 146.18 33.9 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.42 -29.0 15.2 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.634 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.37 123.15 24.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -73.17 -17.55 61.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.674 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 34.0 t70 -81.01 -33.18 33.83 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.8 t -60.45 -41.48 87.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.748 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 82.5 mt -59.59 -50.34 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.87 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.674 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.6 p-10 -68.6 -41.47 79.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.2 mmmt -59.23 -43.98 92.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.432 . . . . 0.0 111.542 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.56 96.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.236 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' ILE 0.312 17.4 ptpt -74.55 -18.51 60.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.8 mt-10 -67.4 -29.79 69.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.48 -7.5 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.487 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.07 -7.19 47.97 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.235 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.21 127.21 39.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.27 95.41 3.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.523 . . . . 0.0 110.147 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.35 132.53 44.61 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.232 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.27 153.97 78.44 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 123.566 0.542 . . . . 0.0 110.392 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.7 Cg_endo -76.25 166.99 26.69 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 121.962 1.775 . . . . 0.0 111.637 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 12' ' ' LYS . 41.7 mt -54.74 -44.72 72.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.014 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.54 -25.81 60.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.221 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.21 -44.67 68.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.26 -38.95 93.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.556 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -22.75 64.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.311 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.26 0.552 . . . . 0.0 109.912 177.803 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -87.37 149.17 24.67 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -136.55 114.09 10.98 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.1 t -98.79 132.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -99.67 131.79 46.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.108 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -92.91 148.58 36.13 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 85.2 Cg_exo -53.8 -23.19 26.04 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.502 2.801 . . . . 0.0 114.505 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 p -65.21 -24.27 67.31 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.109 -0.369 . . . . 0.0 111.683 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . . . -91.44 7.74 39.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.108 0.48 . . . . 0.0 111.46 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HB3' HG21 ' A' ' 40' ' ' ILE . 9.5 m-30 -66.81 157.55 32.67 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.81 -35.8 2.09 Favored Glycine 0 C--N 1.318 -0.449 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.208 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -93.59 12.29 25.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.344 1.068 . . . . 0.0 109.366 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.48 -38.66 81.43 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.834 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -58.74 -37.85 77.13 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.196 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -74.41 -59.45 2.72 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.722 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.9 pt -59.48 -43.84 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.4 tp -68.73 -43.9 74.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.831 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.08 -33.15 15.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.492 -0.861 . . . . 0.0 114.893 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 m -81.31 -34.46 31.9 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 117.321 0.56 . . . . 0.0 111.436 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.0 -60.39 2.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 22' ' ' ASN . 4.2 tmmm? 59.83 141.88 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 CA-C-O 122.336 1.065 . . . . 0.0 112.537 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 21' ' ' LYS 0.31 14.4 t-20 81.58 63.84 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 125.509 1.523 . . . . 0.0 114.342 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -146.11 150.27 35.59 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 164.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -87.88 92.89 9.29 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.7 m-85 -74.33 126.43 30.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.131 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.87 133.17 67.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.974 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 tp -117.08 156.93 18.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.626 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.2 p -94.12 165.22 12.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -39.35 93.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.914 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.64 -33.28 66.51 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.48 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.5 -52.4 53.36 Favored Glycine 0 N--CA 1.446 -0.661 0 O-C-N 123.869 0.73 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.7 m -63.04 -39.97 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -65.34 -40.36 93.55 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.101 0.477 . . . . 0.0 110.271 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.52 -49.08 74.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.46 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.25 73.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.799 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.0 mm -59.71 -57.25 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.273 0.358 . . . . 0.0 110.934 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -26.31 63.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -81.37 -18.66 44.8 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.423 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.21 37.24 25.28 Favored Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.525 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.4 mt -101.35 140.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.7 98.54 0.07 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.574 0.75 . . . . 0.0 111.446 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.49 -30.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.14 -49.46 77.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 23.0 t -62.91 -34.39 77.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.709 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.9 63.02 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.4 mt -60.99 -39.89 91.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.955 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.24 -39.39 92.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.308 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.544 ' HB2' HD21 ' A' ' 17' ' ' LEU . 63.2 mtt180 -79.22 -7.22 58.08 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.35 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.06 12.09 4.06 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.995 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 90.2 t -82.58 131.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 pt -108.43 148.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 p -101.89 127.98 54.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 120.885 0.374 . . . . 0.0 111.257 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -118.52 154.24 32.87 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.322 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -174.499 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 76.7 mt . . . . . 0 C--O 1.243 0.757 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 8.3 Cg_exo -71.06 150.28 60.04 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.246 1.964 . . . . 0.0 109.874 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.89 -28.91 62.49 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -64.64 -33.16 75.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.632 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.55 -44.62 50.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.6 m -59.7 -38.09 80.63 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.993 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.626 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 35.7 tt0 -63.74 -40.65 97.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.89 87.83 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.13 -46.05 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.181 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.82 -37.59 88.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.15 -36.43 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.234 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.62 -33.35 73.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.237 0.541 . . . . 0.0 110.306 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.68 -35.93 70.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.605 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.48 -52.29 41.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.674 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.44 -15.12 53.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.811 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.78 62.85 1.8 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -170.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 177.82 4.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.813 -1.994 . . . . 0.0 111.368 -171.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.15 126.09 35.68 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.0 tp -103.02 125.74 49.9 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.499 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -107.25 118.98 56.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -147.76 159.17 44.11 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mt-10 -103.43 -25.93 13.07 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.152 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.39 126.61 31.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.076 -173.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.43 -42.09 63.82 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 124.423 1.077 . . . . 0.0 112.705 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.428 ' HA ' ' ND2' ' A' ' 92' ' ' ASN . 21.0 t70 -76.5 -35.27 58.45 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.586 -174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.77 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.99 -48.42 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 89' ' ' ASP . 23.3 p30 -68.64 -37.49 79.74 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 31.6 mmmt -67.19 -39.2 86.33 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.46 87.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -60.23 -42.39 95.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.341 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 52.9 mt-10 -55.82 -42.59 75.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.176 0.59 . . . . 0.0 111.097 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.72 -8.49 56.96 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.987 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.54 44.1 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.08 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.26 129.46 46.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.15 92.85 6.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.451 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -97.93 136.0 38.85 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.606 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.24 152.23 73.11 Favored Pre-proline 0 C--N 1.293 -1.885 0 O-C-N 123.376 0.423 . . . . 0.0 110.609 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 16.9 Cg_exo -68.73 160.27 50.24 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 121.968 1.779 . . . . 0.0 110.712 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG23 ' CG2' ' A' ' 16' ' ' ILE . 53.6 mt -54.78 -42.92 64.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 123.837 0.855 . . . . 0.0 111.728 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -63.07 -25.32 68.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.991 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.59 -34.84 46.51 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.828 0.346 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.88 -41.85 95.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.9 mt -64.14 -41.76 97.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.249 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.36 33.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.637 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.057 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.246 0.881 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.412 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 95.5 m-85 -87.8 152.93 21.74 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.91 108.28 7.81 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 26' ' ' VAL . 46.6 t -92.85 131.65 39.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -97.72 132.39 42.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.41 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -92.84 149.39 37.7 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 Cg_exo -57.07 -15.17 16.76 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 123.441 2.761 . . . . 0.0 114.961 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -75.14 -22.03 58.4 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.769 -0.582 . . . . 0.0 111.099 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.21 10.11 25.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.484 0.659 . . . . 0.0 110.995 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.459 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.9 m-30 -72.08 156.3 39.35 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.498 0.666 . . . . 0.0 111.749 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -33.7 4.88 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.741 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 57.8 mtpt -106.46 18.54 21.8 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 122.405 1.098 . . . . 0.0 109.539 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.94 -39.5 94.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.696 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -68.6 -35.21 77.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.15 -175.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 -54.57 19.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.676 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.5 pt -57.77 -39.81 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp -59.33 -55.05 39.64 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.764 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.93 -33.42 41.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.955 -1.117 . . . . 0.0 113.718 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -77.53 -15.49 59.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -122.42 -60.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.687 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 60.23 -171.45 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.308 0.643 . . . . 0.0 111.609 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 66.6 t30 65.2 -14.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.677 1.991 . . . . 0.0 115.013 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -93.05 149.32 21.31 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -90.73 99.67 12.66 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.4 m-85 -74.71 131.42 40.84 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.636 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 4' ' ' VAL . 39.5 t -122.16 136.39 59.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.593 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.65 153.32 27.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.614 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 25.6 p -92.47 166.91 12.3 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.088 0.471 . . . . 0.0 112.007 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -41.09 99.03 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.443 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.45 -31.72 69.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -56.43 24.17 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.107 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -59.99 -40.74 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -63.77 -38.32 90.68 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.72 -39.6 76.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.671 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.06 -42.14 94.48 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.4 mm -56.34 -52.63 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 123.759 0.662 . . . . 0.0 110.951 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -21.79 61.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 m -88.74 -23.58 22.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.44 41.55 6.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.886 -1.15 . . . . 0.0 111.575 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.7 mt -103.22 153.53 5.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.85 83.25 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.118 0.485 . . . . 0.0 110.561 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -93.13 -27.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 -38.47 89.14 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.44 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.2 m -72.88 -24.45 60.85 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.421 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.77 -52.63 9.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.185 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.19 -40.35 81.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.689 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.48 -44.82 72.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.636 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 17' ' ' LEU . 53.5 mtt85 -81.65 -5.71 58.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.44 5.2 6.67 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 118.898 -1.62 . . . . 0.0 115.146 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.95 124.82 28.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.57 0.685 . . . . 0.0 109.167 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.79 149.82 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.931 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.03 120.39 45.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HG2' HG13 ' A' ' 75' ' ' VAL . 31.8 tpt180 -113.14 126.51 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.025 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.062 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 93' ' ' LYS . 84.8 mt . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -59.03 148.11 86.92 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.738 2.292 . . . . 0.0 111.229 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.81 -44.37 77.8 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.204 1.002 . . . . 0.0 111.307 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -63.93 -34.69 78.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 73' ' ' ILE . 26.6 mm-40 -70.36 -39.92 74.34 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -63.15 -41.04 99.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.184 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.614 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -60.31 -39.6 87.56 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.33 83.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.48 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 69' ' ' GLU . 61.5 mt -58.18 -43.64 86.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.401 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -67.43 -38.68 84.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.093 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 53' ' ' ARG . 55.8 t -66.2 -39.62 84.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.358 0.599 . . . . 0.0 110.209 176.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.66 71.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.118 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.69 -47.03 64.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.184 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.13 -39.07 79.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 111.328 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.19 -11.43 57.87 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.332 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.4 t30 57.46 59.26 3.38 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -117.76 177.11 4.89 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.148 -171.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.42 141.47 28.71 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.2 tp -105.72 124.66 49.93 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.815 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.08 110.77 25.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -138.96 147.48 42.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.06 -28.43 12.35 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 91' ' ' ILE . 19.6 t70 -76.06 122.47 24.29 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.02 -29.54 69.77 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.621 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 23.0 t70 -79.73 -39.27 31.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.5 -44.3 88.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.067 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 87' ' ' ASP . 96.7 mt -57.62 -49.91 79.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.621 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.4 p-10 -69.57 -42.94 73.83 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.223 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 65' ' ' LEU . 32.2 mmmt -60.52 -41.99 95.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.425 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.54 92.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 5.2 ptmm? -71.33 -25.5 62.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.035 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 44.0 mt-10 -74.02 -30.34 62.39 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 174.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 95.2 mt -79.89 -12.45 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.248 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 12.78 16.43 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.601 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 44.6 t -108.48 132.14 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.98 97.47 6.07 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 118.904 -1.118 . . . . 0.0 109.727 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.3 129.3 41.02 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.781 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 106' ' ' GLU . 2.6 pp -130.14 143.49 49.35 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.034 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 33.2 Cg_exo -61.28 158.36 35.79 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.363 2.042 . . . . 0.0 110.947 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 9.5 mt -54.06 -40.47 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.39 -20.43 65.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 102' ' ' ILE . 53.0 mm-40 -76.68 -31.8 57.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.886 0.85 . . . . 0.0 109.125 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.48 -32.72 66.44 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.018 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.3 mt -79.64 -48.55 13.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.172 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.08 63.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.846 0.355 . . . . 0.0 111.788 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.796 -178.22 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.502 -0.899 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.39 153.65 21.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.65 107.69 9.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 83' ' ' LEU . 46.9 t -92.38 131.73 38.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.7 mt -97.26 128.77 48.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.328 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 m -88.51 149.58 44.66 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 49.1 Cg_exo -58.03 -21.75 51.9 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.105 2.537 . . . . 0.0 113.404 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 p -68.84 -19.35 64.26 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.93 16.44 19.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.264 0.554 . . . . 0.0 111.521 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.5 m-30 -75.5 156.45 35.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.95 -34.32 5.0 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.565 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.2 mmmp? -98.38 15.54 24.4 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.75 -38.83 86.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.129 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.62 -36.41 80.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.805 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.85 -56.08 5.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.329 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.482 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.5 pt -58.24 -41.22 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 48' ' ' ARG . 36.7 tp -72.25 -52.86 14.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.234 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.63 -31.15 58.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.84 -0.695 . . . . 0.0 114.3 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.8 m -83.3 -39.31 20.98 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 117.652 0.726 . . . . 0.0 112.231 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -91.26 -59.55 2.12 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.225 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.8 -152.53 0.37 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 t30 70.05 -14.28 0.39 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 125.013 1.325 . . . . 0.0 112.845 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -115.5 160.17 20.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 123.135 0.574 . . . . 0.0 109.63 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.6 102.07 13.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CB ' HG22 ' A' ' 50' ' ' VAL . 57.0 m-85 -75.41 136.66 40.73 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG22 ' A' ' 4' ' ' VAL . 54.9 t -128.71 139.62 51.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.442 -177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 10.2 tp -127.58 158.86 38.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -96.71 168.53 10.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 122.138 -0.351 . . . . 0.0 110.404 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.8 p -68.69 -39.06 80.72 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.09 -31.8 72.53 Favored 'General case' 0 C--O 1.214 -0.807 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.92 -54.06 36.15 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.496 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.562 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.6 m -62.93 -35.12 69.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.046 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -68.4 -38.75 81.58 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -63.06 -40.52 97.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.68 96.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.376 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.7 mm -60.07 -53.91 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -93.25 -9.87 37.57 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.502 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.82 37.81 60.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.655 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.91 140.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.06 108.94 1.66 Allowed 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.819 0.699 . . . . 0.0 112.367 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.3 tp -113.73 -9.38 12.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.494 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.21 -49.01 66.14 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.113 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -62.21 -26.5 68.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.703 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -69.58 -57.08 5.64 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.552 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.47 -39.74 80.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.906 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.97 -47.17 81.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.979 1.312 . . . . 0.0 112.804 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 17' ' ' LEU . 72.5 mtt85 -91.25 4.05 53.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 6.06 6.59 Favored Glycine 0 CA--C 1.505 -0.534 0 C-N-CA 118.67 -1.729 . . . . 0.0 115.813 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' CB ' ' A' ' 25' ' ' PHE . 57.8 t -81.03 120.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.653 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.4 p -98.02 128.28 49.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.186 0.517 . . . . 0.0 111.444 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -150.5 126.89 10.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.442 0 O-C-N 123.324 0.39 . . . . 0.0 110.617 -178.847 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 97.1 mt . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 3.0 Cg_exo -78.62 169.82 19.18 Favored 'Trans proline' 0 C--O 1.265 1.839 0 C-N-CA 123.05 2.5 . . . . 0.0 109.489 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -60.03 -42.74 95.06 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -55.26 -38.98 69.25 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.9 -40.92 71.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 0.0 109.685 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 m -73.79 -24.31 59.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.699 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.67 -45.11 95.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.71 87.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.752 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.4 -44.41 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.155 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 3.4 mmt -60.71 -48.61 81.02 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.145 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.7 -38.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.907 0.384 . . . . 0.0 110.612 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.9 84.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.398 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -71.13 -40.73 71.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.23 0.538 . . . . 0.0 109.885 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -63.92 -45.1 90.79 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.982 0.913 . . . . 0.0 111.363 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.18 -15.13 44.73 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.044 -0.41 . . . . 0.0 111.695 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 57.8 60.16 2.89 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.913 1.34 . . . . 0.0 107.661 -169.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.46 175.43 5.47 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.272 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.46 135.28 33.69 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 4' ' ' VAL . 41.5 tp -110.83 125.19 53.34 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.713 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -98.1 110.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.25 146.55 35.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.307 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -108.78 -20.53 13.03 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.103 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 10.5 t70 -79.2 132.79 36.63 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -63.04 -35.43 80.22 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.28 -28.41 34.69 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.658 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 87' ' ' ASP . 91.4 t -63.64 -49.89 80.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.0 mt -57.58 -47.21 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.982 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.0 t30 -63.12 -54.74 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 84.5 tttt -55.79 -51.26 68.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.52 1.128 . . . . 0.0 111.367 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.4 93.72 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.603 0.565 . . . . 0.0 111.258 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 21.2 ttmm -65.27 -38.77 91.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.112 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.1 mt-10 -62.7 -38.72 91.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.221 0.534 . . . . 0.0 109.762 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 81.8 mt -72.68 -13.2 61.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.437 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.14 5.39 37.81 Favored Glycine 0 CA--C 1.501 -0.803 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.358 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.3 t -92.83 137.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.59 96.34 10.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.092 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.81 127.02 42.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.83 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.24 152.83 78.92 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 26.3 Cg_exo -66.53 163.44 32.59 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.353 2.035 . . . . 0.0 112.181 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 12' ' ' LYS . 72.3 mt -52.74 -43.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.543 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -65.64 -27.96 68.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.12 -32.13 56.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.135 0.493 . . . . 0.0 110.411 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.88 -40.81 75.45 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.98 -43.28 96.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.059 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.64 94.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.394 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.186 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -86.98 150.21 24.22 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -131.35 107.65 9.09 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 40.8 t -93.24 130.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.74 125.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.601 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -87.04 147.54 43.04 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 59.4 Cg_exo -53.17 -28.22 40.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.071 2.514 . . . . 0.0 113.971 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.3 m -60.53 -22.23 63.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.89 13.52 32.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.97 0.414 . . . . 0.0 111.382 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.8 m-30 -70.12 162.85 27.5 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.798 0.809 . . . . 0.0 112.604 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -33.88 3.63 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.153 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -95.98 14.24 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.671 0.789 . . . . 0.0 110.215 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -38.74 75.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.569 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -74.49 -26.98 60.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.141 0.496 . . . . 0.0 110.918 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.0 -46.67 20.38 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.728 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.6 pt -66.21 -39.65 84.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.301 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 48' ' ' ARG . 5.4 mp -65.24 -54.62 26.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.805 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.91 -31.3 75.21 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.635 -0.711 . . . . 0.0 114.147 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -88.63 -29.96 19.56 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -106.38 -59.24 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 118.34 -1.344 . . . . 0.0 113.64 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 56.07 -152.96 0.36 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -167.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 69.3 -15.0 0.29 Allowed 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 124.791 1.236 . . . . 0.0 113.566 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.73 149.09 32.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -86.85 98.08 11.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.019 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -75.0 129.6 37.92 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.065 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 52.0 t -125.01 138.0 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.172 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -130.87 142.38 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.498 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 23.2 p -82.7 165.12 20.23 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -38.24 78.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.8 -29.61 66.95 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.81 -54.09 33.44 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.399 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.0 m -60.82 -35.72 66.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.0 m -65.73 -42.24 91.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.74 -37.37 86.32 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.67 76.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.479 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.2 mm -59.33 -49.93 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.821 0.448 . . . . 0.0 111.201 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -98.12 -14.56 20.36 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 120.809 0.338 . . . . 0.0 111.607 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.55 35.31 20.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.155 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -92.32 146.54 6.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.74 88.3 5.21 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.889 1.328 . . . . 0.0 111.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 tp -88.72 -19.22 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.724 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.34 -49.36 76.4 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 125.908 1.683 . . . . 0.0 109.437 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -59.78 -30.92 69.22 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 111.226 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -75.21 -52.75 10.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.016 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.44 -39.33 79.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.95 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.01 -40.31 76.37 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.321 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.594 ' HB2' HD23 ' A' ' 17' ' ' LEU . 45.5 mtt85 -82.98 -10.02 58.99 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.86 15.63 3.15 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.322 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.28 123.92 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -96.83 143.78 11.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.024 0.44 . . . . 0.0 110.871 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.9 t -87.9 136.81 22.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.69 126.59 43.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.809 176.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.534 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.555 ' HG ' ' OD2' ' A' ' 89' ' ' ASP . 59.4 mt . . . . . 0 C--O 1.235 0.338 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.71 166.12 28.95 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.389 2.059 . . . . 0.0 110.376 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -56.64 -36.03 69.02 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -62.83 -38.33 90.32 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' OE2' ' HB2' ' A' ' 7' ' ' PRO . 69.9 mm-40 -71.03 -36.16 72.27 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -62.04 -41.96 98.67 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.77 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.498 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -62.55 -36.85 83.94 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.16 78.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.109 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.78 -44.71 98.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.064 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.7 mmt -59.12 -45.96 89.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.19 -39.08 83.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-O 121.153 0.502 . . . . 0.0 110.131 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.03 66.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -75.2 -36.75 61.37 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.091 0.556 . . . . 0.0 110.477 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.58 -44.44 74.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.319 0.581 . . . . 0.0 111.536 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.84 -19.03 31.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.733 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.44 67.74 0.94 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -171.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.7 3.99 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.87 -170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 2.3 tm? -90.51 126.77 36.03 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -108.33 120.72 43.2 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.821 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.0 mt -94.21 112.14 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -145.02 139.71 27.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.878 0.37 . . . . 0.0 111.581 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.73 -22.69 16.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.606 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' HG23 ' A' ' 90' ' ' VAL . 12.6 t70 -87.67 132.95 33.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -51.17 -48.25 61.94 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 124.184 0.927 . . . . 0.0 113.07 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.607 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.4 t70 -69.4 -27.7 65.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 123.549 0.531 . . . . 0.0 111.374 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 87' ' ' ASP . 40.5 t -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.03 -50.01 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.866 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.0 p-10 -70.57 -36.64 73.72 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 43.6 tptt -66.43 -40.97 89.83 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.468 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -67.89 -36.49 80.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.062 0.458 . . . . 0.0 109.827 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.78 -40.88 89.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.838 0.855 . . . . 0.0 109.233 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 62.6 mt-10 -63.18 -35.92 81.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.804 0.812 . . . . 0.0 110.787 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.12 -5.87 59.32 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.045 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.52 21.11 41.79 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.645 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 64.5 t -106.03 137.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -84.69 95.34 8.89 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.429 0.633 . . . . 0.0 110.966 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.68 131.23 45.01 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.882 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.95 155.45 76.3 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 122.686 0.394 . . . . 0.0 110.683 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.5 Cg_exo -71.7 162.03 43.37 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.151 1.901 . . . . 0.0 110.656 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.4 mt -54.21 -38.16 38.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 123.652 0.781 . . . . 0.0 112.71 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.23 -34.1 76.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.594 0.235 . . . . 0.0 110.945 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.85 -30.45 62.67 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.276 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.88 -38.79 89.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.76 -43.51 83.9 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.971 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.56 65.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.245 0.866 0 CA-C-O 121.637 0.732 . . . . 0.0 110.593 178.465 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.245 0.831 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -87.68 146.8 25.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.03 13.93 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 83' ' ' LEU . 55.2 t -91.85 126.2 44.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt -93.12 125.7 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.885 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -89.48 152.22 47.08 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 82.6 Cg_exo -50.65 -27.95 21.06 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.461 2.774 . . . . 0.0 111.681 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -51.78 -36.42 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.864 1.266 . . . . 0.0 111.651 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 6.61 41.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.366 0.603 . . . . 0.0 111.625 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 10.0 m-85 -79.38 134.49 36.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.274 0.559 . . . . 0.0 111.323 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.14 -36.28 3.79 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HB2' HD13 ' A' ' 104' ' ' ILE . 27.5 mtpp -110.36 15.74 22.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.92 -39.14 62.55 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.938 1.695 . . . . 0.0 110.877 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.94 -35.95 82.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.801 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.95 -53.39 21.07 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.648 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CG2' HG23 ' A' ' 104' ' ' ILE . 25.9 pt -60.87 -41.13 87.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.2 tp -69.35 -55.08 11.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.598 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.45 -34.12 12.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.743 -1.218 . . . . 0.0 114.694 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 m -84.4 -25.84 28.76 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 117.683 0.741 . . . . 0.0 112.015 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -59.63 1.74 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.852 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 58.31 -140.82 0.74 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.9 m120 69.07 -14.79 0.29 Allowed 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -135.5 162.23 33.24 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -93.47 108.42 20.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' HG22 ' A' ' 50' ' ' VAL . 99.2 m-85 -79.06 125.97 30.1 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.852 -176.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.63 134.64 60.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.114 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.5 tp -121.19 153.58 24.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 47.2 p -97.19 176.77 5.8 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.996 0.427 . . . . 0.0 111.929 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -42.57 85.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 123.686 0.794 . . . . 0.0 112.11 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.61 -24.47 56.52 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.59 -49.52 59.64 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.376 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.9 m -66.89 -32.07 56.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 m -65.96 -40.52 91.38 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.59 -44.54 93.34 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.732 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' VAL . 48.3 mm -64.14 -48.32 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.296 0.372 . . . . 0.0 111.039 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.65 -30.12 65.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.3 t -84.41 -28.2 27.08 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.976 0.417 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.43 34.64 6.93 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.154 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.4 mt -97.27 149.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.09 87.77 0.78 Allowed 'General case' 0 C--O 1.241 0.63 0 O-C-N 123.315 0.384 . . . . 0.0 111.406 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -86.11 -27.13 6.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.31 -45.32 93.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -66.37 -29.8 70.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.796 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -67.88 -51.29 49.85 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.51 -40.12 81.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.085 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.9 -38.83 89.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.17 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.5 mtt180 -87.85 2.9 50.27 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.89 -2.5 7.96 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.43 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 25' ' ' PHE . 73.1 t -72.61 132.79 32.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 117.79 0.795 . . . . 0.0 109.645 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.7 pt -111.39 142.91 22.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.267 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.46 116.41 41.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-O 121.332 0.587 . . . . 0.0 110.689 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -118.64 126.27 51.57 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.196 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 -176.191 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.5 145.75 92.33 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.077 1.851 . . . . 0.0 110.647 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.718 0.407 . . . . 0.0 111.602 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -64.4 -33.31 75.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.878 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.35 -37.19 63.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.2 m -64.46 -39.92 94.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.535 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.4 tt0 -63.42 -40.5 97.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -61.1 -45.46 94.62 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 90' ' ' VAL . 73.4 mt -59.58 -45.45 94.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.207 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.413 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmt -60.79 -47.35 86.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.61 -37.97 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.031 0.443 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.44 -29.59 69.1 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.43 -34.06 36.38 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.13 0.572 . . . . 0.0 110.583 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -46.21 68.05 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.467 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.24 -20.81 43.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.794 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 56.93 64.39 1.66 Allowed 'General case' 0 C--O 1.247 0.924 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.61 -176.81 3.07 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.805 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.29 126.76 35.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 4' ' ' VAL . 43.5 tp -107.73 127.5 53.74 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.534 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mt -106.39 114.95 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -148.13 155.17 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.84 -35.5 9.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.78 118.88 12.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.545 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -74.57 -17.56 60.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.182 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.63 -39.18 24.84 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 73' ' ' ILE . 79.3 t -59.78 -51.68 70.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.588 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.9 mt -54.1 -44.93 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.437 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.3 t30 -54.29 -52.21 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.752 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.79 -43.71 95.5 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.555 0.535 . . . . 0.0 110.752 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.55 97.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.035 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -70.71 -28.43 64.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.2 mt-10 -68.45 -28.98 67.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.14 0.495 . . . . 0.0 109.811 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.86 -11.83 58.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.655 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.85 14.17 35.05 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.51 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -86.83 90.89 8.47 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.91 132.85 49.77 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.362 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.74 157.82 64.03 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 123.972 0.795 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.3 Cg_exo -70.45 164.7 34.26 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.505 HG23 ' CG2' ' A' ' 16' ' ' ILE . 33.9 mt -58.35 -46.93 89.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.327 53.7 mt-10 -76.03 -16.0 60.03 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.87 -35.03 38.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 16' ' ' ILE . 3.3 tm? -60.83 -43.01 98.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.895 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.87 -34.66 78.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.164 0.507 . . . . 0.0 110.523 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.8 -4.42 43.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.363 0.602 . . . . 0.0 111.067 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.435 -1.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 177.404 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.248 0.977 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.43 147.04 25.6 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.56 110.93 11.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.1 t -94.6 133.11 36.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.06 129.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -85.91 144.39 39.19 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 84.6 Cg_exo -52.52 -18.03 7.69 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.786 2.991 . . . . 0.0 113.879 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 p -73.99 -20.13 60.43 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.04 0.448 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.96 12.04 33.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.524 . . . . 0.0 111.224 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-85 -73.11 153.97 40.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.36 -34.22 3.31 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -92.66 1.6 57.18 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 124.577 1.151 . . . . 0.0 109.713 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -51.4 -39.97 58.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.038 1.335 . . . . 0.0 111.949 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.88 -33.59 76.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.861 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.41 -49.13 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.997 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.405 ' CG2' HG23 ' A' ' 104' ' ' ILE . 26.5 pt -68.26 -43.44 84.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.891 0.377 . . . . 0.0 111.935 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 52.6 tp -70.31 -48.56 56.05 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.83 -33.16 74.8 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.181 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 m -90.43 -15.1 31.55 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.439 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -114.64 -59.17 2.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 55.57 -155.21 0.28 Allowed 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 70.7 -13.97 0.45 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.99 148.33 34.03 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -85.87 96.47 9.79 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.2 m-85 -74.38 129.8 38.46 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.064 -176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.0 t -127.4 138.65 54.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.87 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 8.4 tp -123.7 160.21 27.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.575 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.8 p -99.62 165.48 11.59 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 120.835 0.35 . . . . 0.0 111.647 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.44 -36.66 84.89 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.919 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.96 -18.46 60.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.062 0.458 . . . . 0.0 110.014 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.24 -44.68 17.02 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 36' ' ' ILE . 20.2 m -66.64 -36.44 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.8 p -72.41 -31.96 65.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.535 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.63 -42.34 92.51 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -65.05 -47.68 76.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.57 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.0 mm -59.15 -45.85 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.581 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.23 -26.53 62.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -103.46 4.08 35.65 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.52 37.92 85.88 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.354 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.09 155.92 4.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.41 129.6 35.12 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.69 -40.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.802 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.76 -31.52 72.21 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 122.159 -0.338 . . . . 0.0 111.01 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 m -57.72 -40.64 80.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 123.774 0.671 . . . . 0.0 109.922 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.15 60.08 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.808 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.6 mt -57.72 -45.11 86.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.058 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.37 -39.83 92.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.564 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 78.6 mtt180 -77.23 -3.79 41.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.85 7.43 5.59 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.017 -1.563 . . . . 0.0 115.862 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 63.6 t -86.78 138.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 pt -113.1 167.41 6.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 14.4 p -120.16 144.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.456 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' THR . 49.4 mtt180 -132.86 157.45 45.02 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.146 0.578 . . . . 0.0 110.241 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.162 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.666 -177.343 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' ' OE2' ' A' ' 69' ' ' GLU . 80.7 mt . . . . . 0 C--O 1.241 0.615 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.24 144.86 13.35 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.509 2.806 . . . . 0.0 113.588 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -46.91 -35.22 6.21 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.138 1.375 . . . . 0.0 114.106 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -58.62 -43.2 89.55 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' OE2' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -85.45 -26.66 26.21 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.973 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 m -63.45 -34.9 78.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.685 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.575 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.6 tt0 -64.47 -40.89 96.56 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -45.0 95.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.38 -45.76 97.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.751 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.4 mmt -65.82 -39.42 90.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 28' ' ' THR . 70.7 t -66.46 -36.28 76.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-O 121.196 0.522 . . . . 0.0 109.848 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.74 72.2 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.52 -44.61 82.03 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.384 1.074 . . . . 0.0 110.219 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.83 -57.06 14.41 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.103 0.961 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.84 -13.6 57.42 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.087 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 58.47 64.74 1.4 Allowed 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.77 177.15 4.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.91 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.23 127.21 36.58 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 48.1 tp -108.23 122.83 47.75 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.635 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.8 115.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.08 144.0 32.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.648 0.261 . . . . 0.0 110.668 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -93.37 -25.58 17.63 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.81 123.82 29.71 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -73.33 -18.9 61.14 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -81.59 -33.25 31.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OE1' ' A' ' 69' ' ' GLU . 95.8 t -61.18 -48.47 88.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 88.0 mt -56.65 -48.58 80.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.96 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 23.6 t30 -51.43 -58.85 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.622 1.169 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 mmmp? -65.87 -40.08 91.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.45 89.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 14.2 tppt? -57.77 -42.08 83.35 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.698 0.799 . . . . 0.0 109.655 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 41.0 mt-10 -67.3 -34.62 77.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.728 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.4 mt -79.38 2.67 20.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.252 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.84 18.7 46.53 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.988 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 61.9 t -106.35 142.87 18.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -97.84 94.47 6.93 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.149 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -94.04 132.53 38.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.929 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.51 152.33 77.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 123.488 0.492 . . . . 0.0 110.691 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.0 Cg_exo -71.97 160.13 48.45 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.034 1.823 . . . . 0.0 110.27 175.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG23 ' CG2' ' A' ' 16' ' ' ILE . 43.2 mt -57.24 -36.88 53.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.02 -25.73 66.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.07 -30.8 62.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.464 0.649 . . . . 0.0 109.947 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.68 -42.39 67.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.16 -33.64 76.25 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.675 0.75 . . . . 0.0 110.786 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.33 69.34 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.831 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.028 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.15 152.28 22.47 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.12 107.2 8.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.5 t -92.35 132.68 36.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.1 mt -98.32 131.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.573 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.18 149.82 42.1 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -54.45 -26.29 44.03 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.268 2.646 . . . . 0.0 113.483 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.5 m -63.31 -14.97 55.66 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -98.08 5.49 48.61 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 0.0 111.535 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 6.5 m-30 -68.09 149.91 49.05 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.17 5.2 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HE2' HG21 ' A' ' 104' ' ' ILE . 60.2 mtpt -105.66 19.93 19.74 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.915 0.864 . . . . 0.0 109.603 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.71 -30.41 69.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.796 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.92 -41.28 68.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.845 0.831 . . . . 0.0 109.035 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 12' ' ' LYS . 17.8 mp0 -58.62 -57.27 13.72 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.824 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 104' ' ' ILE . 15.7 pt -63.04 -43.74 99.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.99 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.8 mp -61.46 -54.31 45.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.637 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.14 -29.65 64.23 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 123.522 0.514 . . . . 0.0 114.14 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -81.79 -61.25 1.97 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.175 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -77.84 -53.39 7.54 Favored 'General case' 0 C--O 1.253 1.268 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.424 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 8.1 mtmp? 59.65 -162.17 0.25 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 66.91 -15.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -97.79 163.8 12.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.432 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -97.82 95.78 7.77 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 172.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.8 m-85 -74.8 135.32 41.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.3 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.09 138.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.616 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.68 159.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.609 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 p -100.03 171.46 7.82 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -45.51 84.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.283 1.033 . . . . 0.0 110.995 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.12 -26.55 61.27 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.75 -57.2 17.12 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.176 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.0 m -60.38 -34.96 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.988 0.394 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.7 m -65.6 -33.52 76.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.056 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -65.79 -40.2 91.72 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -67.28 -42.55 83.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.1 mm -62.62 -47.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.256 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -39.48 87.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -81.69 -28.5 33.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.888 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.54 41.04 4.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.207 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.42 HG21 ' HB3' ' A' ' 10' ' ' PHE . 62.8 mt -101.64 151.64 5.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.84 92.95 5.54 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.442 1.115 . . . . 0.0 111.489 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -89.57 -17.68 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.317 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.59 -33.72 76.57 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 m -61.72 -30.12 70.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.233 0.54 . . . . 0.0 110.955 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.96 -50.17 13.81 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.68 -38.38 84.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.915 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.44 -39.17 75.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.712 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB2' HD23 ' A' ' 17' ' ' LEU . 94.9 mtt180 -89.42 -14.81 34.64 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.208 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.77 16.64 3.3 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.735 -1.221 . . . . 0.0 115.106 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 25' ' ' PHE . 60.7 t -73.03 123.41 27.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 pt -93.99 150.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.75 118.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -116.09 126.47 53.78 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.357 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.83 132.61 56.12 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -87.56 158.9 18.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -69.33 -56.32 7.84 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -167.47 120.48 0.93 Allowed 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.949 1.3 . . . . 0.0 110.053 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -133.83 130.67 20.72 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 23.9 Cg_exo -65.95 121.94 9.4 Favored 'Trans proline' 0 C--O 1.241 0.65 0 CA-C-N 120.252 1.126 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 59' ' ' PRO . 6.1 Cg_endo -91.07 132.73 1.54 Allowed 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.869 2.379 . . . . 0.0 111.52 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -114.09 107.97 16.37 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.554 -0.859 . . . . 0.0 108.694 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 m -156.13 144.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.82 -37.16 1.3 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.924 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.28 -34.9 12.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.53 0.681 . . . . 0.0 111.1 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -84.24 143.29 41.95 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.932 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -79.36 161.67 25.57 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.759 2.306 . . . . 0.0 111.853 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 13.2 mm100 -53.32 -40.65 64.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -63.35 -38.4 91.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.56 -38.26 62.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 32.2 t -58.12 -48.04 81.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.075 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.609 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.8 tt0 -60.92 -38.13 84.69 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.563 0.345 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.62 74.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.946 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.61 -45.22 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.451 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 mmt -60.96 -45.16 95.84 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.39 -35.94 76.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 120.827 0.346 . . . . 0.0 110.972 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.51 -33.61 74.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.898 0.38 . . . . 0.0 110.539 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -69.52 -46.57 66.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -49.2 -56.8 8.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.08 1.352 . . . . 0.0 111.431 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.51 -16.64 36.33 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.392 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.65 68.44 0.75 Allowed 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.74 179.26 4.02 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.674 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.11 129.96 36.33 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 4' ' ' VAL . 42.5 tp -108.34 123.78 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.267 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.13 110.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.57 139.29 38.58 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.01 -29.3 14.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.206 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 130.16 39.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.93 0.395 . . . . 0.0 110.674 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -55.18 -42.51 73.31 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.94 1.296 . . . . 0.0 112.644 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.48 -34.12 31.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.156 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.39 -45.71 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.24 -51.64 70.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.897 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -71.07 -31.86 68.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 49.2 tptt -71.94 -42.87 66.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.388 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.66 74.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.998 0.427 . . . . 0.0 110.209 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.79 -38.35 90.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.554 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 50.3 mt-10 -57.39 -43.22 83.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.84 -11.35 60.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.017 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.3 15.92 31.28 Favored Glycine 0 CA--C 1.5 -0.868 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.268 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.1 131.43 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -80.82 89.98 5.85 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.503 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.3 128.1 38.02 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.325 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.68 157.05 78.09 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 123.578 0.549 . . . . 0.0 111.083 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.81 156.39 52.91 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.611 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 40.7 mt -55.8 -44.46 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.64 -24.29 65.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.93 -28.77 35.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.21 -35.22 79.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 86.0 mt -72.93 -31.66 64.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.046 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -26.94 62.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.877 0.37 . . . . 0.0 110.866 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.9 p -100.43 25.56 7.56 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.382 0.61 . . . . 0.0 110.611 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.5 t -74.38 1.48 11.59 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.018 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt 65.32 32.6 9.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.048 0.939 . . . . 0.0 111.303 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.68 -26.02 28.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.038 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 64.01 75.53 0.38 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.228 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -100.45 131.42 46.38 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.644 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -68.19 143.77 55.22 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -57.7 110.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -118.37 159.55 23.22 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.8 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.8 m80 . . . . . 0 C--N 1.296 -1.725 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.193 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.2 156.38 19.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -133.73 110.31 9.74 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 26' ' ' VAL . 49.4 t -95.08 129.83 44.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.109 0.48 . . . . 0.0 110.068 -175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.98 129.76 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.127 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.7 m -90.39 152.63 45.73 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.0 Cg_exo -57.58 -24.79 64.01 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 123.204 2.603 . . . . 0.0 114.068 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -70.16 -17.67 63.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.12 0.486 . . . . 0.0 111.505 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -95.95 9.08 41.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.5 m-30 -66.7 144.34 56.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.884 0.373 . . . . 0.0 111.709 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.8 -36.08 2.49 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.929 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -87.91 -12.63 44.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.511 HD12 ' HG3' ' A' ' 14' ' ' LYS . 2.9 pp -62.34 -24.3 67.26 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.109 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' HD12 ' A' ' 13' ' ' LEU . 48.7 mtmt -75.02 -25.8 59.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.284 0.564 . . . . 0.0 110.029 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -76.08 -45.64 33.01 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.658 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 104' ' ' ILE . 12.7 pt -64.27 -37.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.205 0.526 . . . . 0.0 110.391 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 48' ' ' ARG . 47.9 tp -65.69 -55.16 18.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.252 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.53 -19.22 78.32 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.004 0.762 . . . . 0.0 115.004 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -105.42 -3.5 22.51 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.717 -0.872 . . . . 0.0 113.05 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.94 -59.36 1.34 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.009 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 61.92 178.72 0.12 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.634 1.174 . . . . 0.0 114.088 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 m120 74.34 -15.01 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.945 1.698 . . . . 0.0 114.814 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -80.43 152.9 28.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tpmt? -93.0 96.83 10.33 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HB2' HG22 ' A' ' 50' ' ' VAL . 93.0 m-85 -74.83 127.85 34.16 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.722 -176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 4' ' ' VAL . 72.3 t -120.42 130.43 74.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.562 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -116.98 144.77 23.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 22.8 p -81.85 169.68 16.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 p -72.27 -39.92 68.01 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.1 mt -70.09 -28.76 65.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.075 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.11 -53.01 36.05 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.806 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.0 m -61.25 -41.65 90.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.097 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 m -63.58 -37.59 87.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -66.53 -39.33 88.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.55 77.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.487 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.9 mm -57.46 -51.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.07 0.548 . . . . 0.0 111.4 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.8 -23.4 63.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -90.72 -23.03 20.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.046 0.451 . . . . 0.0 111.217 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 31.48 11.7 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.761 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 77.8 mt -92.14 138.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.55 88.25 0.93 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.743 1.258 . . . . 0.0 111.883 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.5 tp -86.96 -19.76 7.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.907 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.9 -41.29 91.3 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.945 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -57.71 -35.57 70.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.656 0.782 . . . . 0.0 110.952 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -50.2 13.57 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.332 0.586 . . . . 0.0 109.765 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.9 mt -58.51 -41.71 86.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.865 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -48.53 81.28 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.705 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.4 mtt180 -74.57 -8.56 56.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.61 13.27 3.85 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 118.776 -1.678 . . . . 0.0 114.676 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 25' ' ' PHE . 72.7 t -82.95 122.44 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -101.55 154.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.454 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 t -100.35 128.63 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -133.33 141.86 48.15 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.935 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.79 157.03 17.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 29.2 t80 -80.63 117.1 21.04 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -93.51 -23.41 18.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.316 0.579 . . . . 0.0 112.061 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 20.4 t60 -80.37 169.29 17.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -80.98 130.91 61.38 Favored Pre-proline 0 C--N 1.318 -0.761 0 O-C-N 122.025 -0.422 . . . . 0.0 110.872 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 73.3 Cg_endo -76.33 124.22 7.64 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.828 2.352 . . . . 0.0 114.392 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 59' ' ' PRO . 16.6 Cg_exo -75.24 172.57 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.606 2.87 . . . . 0.0 111.702 172.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.09 136.66 33.46 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.837 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.88 145.06 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.1 -52.37 0.29 Allowed Glycine 0 C--N 1.304 -1.222 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.609 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.52 -45.52 93.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.868 0.867 . . . . 0.0 111.919 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 78.1 mt -95.14 142.5 24.69 Favored Pre-proline 0 N--CA 1.427 -1.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.658 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 31.7 Cg_exo -64.93 155.59 67.07 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 122.664 2.243 . . . . 0.0 110.037 172.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -62.4 -33.0 73.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.256 6.3 p90 -62.35 -39.27 92.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.99 -42.4 73.11 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.0 m -67.08 -29.86 69.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.522 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.1 tt0 -66.55 -40.37 89.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.39 84.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' HA ' HD22 ' A' ' 83' ' ' LEU . 67.2 mt -54.75 -50.64 58.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.646 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.583 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 11.8 mmt -71.66 -31.65 67.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.33 -35.02 69.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.62 72.95 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.508 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -70.25 -48.22 57.84 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.33 -44.15 92.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.23 -17.9 35.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.203 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 61.1 66.89 0.84 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 123.028 1.394 . . . . 0.0 107.4 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.56 178.16 4.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 113.156 -1.838 . . . . 0.0 111.229 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -89.53 121.13 31.45 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 101' ' ' ALA . 51.0 tp -97.11 127.09 42.74 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.177 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.3 mt -111.91 117.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.896 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.7 153.48 43.41 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.413 ' OE1' ' HB ' ' A' ' 104' ' ' ILE . 6.7 mm-40 -101.04 -17.63 16.63 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.17 127.91 40.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -69.43 -24.61 63.84 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.09 -35.27 31.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.03 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.54 -49.95 81.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.9 -47.82 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.689 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -62.22 -50.43 71.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.577 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tmtt? -60.26 -43.84 95.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.333 0.587 . . . . 0.0 109.443 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.58 98.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.021 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 35.7 ttmt -69.98 -31.2 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.602 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt-10 -63.54 -34.58 78.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 109.52 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 86.5 mt -80.35 -11.14 59.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.179 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.34 12.48 26.92 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.887 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 40.4 t -98.54 127.75 50.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.17 91.03 4.91 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.663 0.744 . . . . 0.0 109.545 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 83' ' ' LEU . . . -100.32 137.42 38.77 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.574 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.99 153.58 67.43 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.182 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 27.5 Cg_exo -63.59 155.45 62.85 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.443 2.095 . . . . 0.0 111.112 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 16' ' ' ILE . 7.4 mt -55.7 -43.52 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.93 -19.33 61.28 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.87 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.44 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 12.6 mm-40 -77.34 -33.48 55.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.4 -41.79 88.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.3 -46.5 88.39 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.663 ' HA ' ' O ' ' A' ' 112' ' ' LEU . . . -62.3 -22.39 66.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.546 0.738 . . . . 0.0 112.68 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.2 m -74.71 -7.77 54.34 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.526 0.679 . . . . 0.0 110.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.3 t -122.62 -35.99 2.99 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 31.5 mt -128.21 94.09 3.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.784 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -75.48 -32.75 60.68 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.219 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -99.59 122.34 42.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 167.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -70.38 79.18 0.55 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.628 0.771 . . . . 0.0 112.247 -171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -77.45 -42.51 35.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.854 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.42 ' H ' HD13 ' A' ' 112' ' ' LEU . 51.7 m80 -75.94 119.02 19.33 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -103.63 128.57 50.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.04 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.245 0.837 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -87.75 147.56 25.13 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.39 110.2 10.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 83' ' ' LEU . 47.0 t -92.57 132.65 36.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 13' ' ' LEU . 40.9 mm -95.41 130.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.329 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.6 m -90.22 152.5 45.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -57.04 -12.39 9.57 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 123.528 2.819 . . . . 0.0 113.977 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -81.97 -9.39 59.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.924 0.49 . . . . 0.0 111.172 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.4 13.66 33.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 111.801 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 40' ' ' ILE . 23.2 m-30 -76.67 152.43 35.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.489 0.661 . . . . 0.0 111.071 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 -36.01 3.55 Favored Glycine 0 C--N 1.313 -0.709 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.36 -1.57 47.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.723 0.773 . . . . 0.0 109.295 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 5' ' ' ILE . 43.4 tp -53.62 -38.64 64.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.669 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.36 -41.43 63.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.135 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.42 -50.87 61.94 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.278 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.18 -40.51 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 121.156 0.503 . . . . 0.0 111.434 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.5 tp -66.25 -48.42 70.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.297 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 -33.17 25.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 114.251 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 t -76.38 -46.33 27.85 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 116.925 0.362 . . . . 0.0 110.972 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -92.0 -47.58 7.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.909 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 58.55 -142.46 0.66 Allowed 'General case' 0 C--N 1.362 1.137 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.3 t30 68.68 -14.2 0.29 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 166.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -123.9 157.55 34.0 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 110.49 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -92.93 98.4 11.34 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.0 m-85 -75.37 130.61 39.29 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.568 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.6 t -123.77 134.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.106 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -117.9 152.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.3 p -91.28 170.58 9.87 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.959 0.409 . . . . 0.0 111.779 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -37.99 87.57 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.886 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.15 -20.39 55.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.158 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.93 -51.41 19.1 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.8 m -63.14 -39.28 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 p -70.4 -34.94 73.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.446 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -65.01 -38.19 90.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.67 75.24 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.548 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' VAL . 37.1 mm -58.31 -49.93 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.89 0.476 . . . . 0.0 111.808 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -27.06 65.66 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -91.78 -5.9 52.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.95 57.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.304 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 10' ' ' PHE . 69.3 mt -100.88 146.83 8.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.96 85.69 0.99 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.036 0.446 . . . . 0.0 111.288 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.1 tp -90.38 -24.42 5.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.83 -41.19 97.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.131 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 8.4 t -72.52 -26.41 61.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.207 0.527 . . . . 0.0 109.74 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.77 -47.63 29.9 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 84.7 mt -57.77 -44.05 85.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.044 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.76 -47.77 70.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.031 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.678 ' HB2' HD21 ' A' ' 17' ' ' LEU . 68.4 mtt180 -84.53 1.62 44.92 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.96 7.37 6.04 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 118.786 -1.673 . . . . 0.0 116.324 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.4 t -81.44 127.73 39.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 118.148 0.974 . . . . 0.0 108.722 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -102.48 159.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.4 p -114.88 137.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -141.05 139.82 34.16 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.31 152.15 21.7 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 57' ' ' HIS . 22.7 t80 -84.52 108.6 17.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -60.25 -34.85 74.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.353 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 m-70 -79.76 154.26 28.64 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 11.3 mptt -95.65 111.14 54.64 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.75 157.39 24.54 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.798 2.332 . . . . 0.0 112.459 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -82.52 171.72 12.0 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.936 1.757 . . . . 0.0 110.97 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -83.65 122.64 28.88 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.39 125.16 39.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.515 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.76 62.76 4.35 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.6 t30 178.81 -55.34 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.766 1.226 . . . . 0.0 108.542 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -107.59 141.14 22.38 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.494 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.05 170.24 12.09 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 123.098 2.532 . . . . 0.0 111.762 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.439 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.08 -24.76 66.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.269 42.1 p90 -72.75 -43.77 62.47 Favored 'General case' 0 C--O 1.255 1.391 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.33 -33.07 55.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.607 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.3 m -66.38 -28.2 68.45 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.299 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.4 tt0 -66.13 -40.02 90.32 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.23 87.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.901 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.2 -46.09 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.783 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mmt -63.46 -42.75 98.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 28' ' ' THR . 96.7 t -69.41 -35.06 65.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.477 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.85 88.46 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -66.22 -42.02 89.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.23 0.612 . . . . 0.0 109.899 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.91 -42.53 94.66 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.977 0.911 . . . . 0.0 111.251 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.35 -10.65 51.61 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.599 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.95 39.63 19.93 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -175.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.17 178.65 5.93 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.574 -1.648 . . . . 0.0 112.689 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.99 125.62 35.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 47.0 tp -102.49 123.25 45.9 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.046 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.49 113.69 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.07 160.07 40.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.754 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.52 -29.48 7.16 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.5 138.78 37.65 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.775 -0.77 . . . . 0.0 113.021 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -46.19 -55.49 7.03 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 126.833 2.053 . . . . 0.0 110.931 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.92 -37.58 64.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.964 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.81 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.47 0.481 . . . . 0.0 110.399 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -45.31 96.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.124 0.488 . . . . 0.0 109.857 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -64.56 -40.24 95.2 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.797 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 2.5 tmtm? -68.68 -39.28 80.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.322 0.582 . . . . 0.0 109.684 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.64 85.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.69 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -66.4 -35.07 79.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.405 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.6 mt-10 -58.13 -40.91 82.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.463 0.705 . . . . 0.0 110.187 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.06 -11.05 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.639 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.79 47.47 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.468 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.11 139.15 18.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.5 90.3 6.23 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.632 0.73 . . . . 0.0 110.694 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -103.6 131.17 50.98 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.498 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.6 154.95 79.9 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 123.458 0.474 . . . . 0.0 111.309 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.9 Cg_exo -70.07 160.5 49.41 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.664 2.243 . . . . 0.0 111.373 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 44.8 mt -58.9 -43.69 89.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.7 -24.95 67.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -45.4 62.29 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -43.53 95.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.301 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 95.1 mt -61.46 -40.22 93.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.899 0.48 . . . . 0.0 111.205 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 -21.73 63.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.3 m -92.16 12.17 23.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.783 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -80.06 91.1 5.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pp -158.04 162.18 38.1 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.256 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HB2' ' CD2' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -89.14 -20.19 24.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 75.1 t60 74.36 12.21 4.01 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.457 1.103 . . . . 0.0 113.315 172.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 113' ' ' GLU . 21.1 p80 -117.0 -37.39 3.59 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.824 -1.172 . . . . 0.0 113.289 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 66.5 m80 69.38 -67.28 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.965 1.306 . . . . 0.0 109.962 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -152.56 135.44 15.51 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -88.34 -32.81 18.22 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 . . . . . 0 N--CA 1.421 -1.893 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.129 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 C--O 1.239 0.506 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.57 154.46 20.6 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 120.891 0.377 . . . . 0.0 110.755 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -135.69 111.2 9.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 26' ' ' VAL . 48.9 t -92.57 130.27 41.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.29 127.73 47.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.104 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -93.7 153.44 41.14 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.87 -20.78 13.82 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 123.521 2.814 . . . . 0.0 114.571 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -64.0 -29.86 70.98 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 120.621 0.248 . . . . 0.0 110.684 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.87 11.28 16.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB3' HD13 ' A' ' 40' ' ' ILE . 18.0 m-30 -74.26 148.68 41.28 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.169 0.509 . . . . 0.0 111.128 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 -35.65 3.29 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -90.0 -7.43 54.0 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.1 tp -45.15 -39.4 6.07 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 128.281 2.632 . . . . 0.0 112.36 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.82 -28.98 60.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -71.7 -48.82 44.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.565 0.221 . . . . 0.0 110.914 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' CG2' HG23 ' A' ' 104' ' ' ILE . 21.5 pt -64.32 -38.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.498 0.666 . . . . 0.0 111.133 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 48' ' ' ARG . 41.7 tp -73.7 -49.68 24.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.209 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 118' ' ' HIS . . . -81.71 -33.05 28.53 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 114.596 0.599 . . . . 0.0 114.596 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -86.12 -30.65 22.37 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.791 0.796 . . . . 0.0 112.256 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.472 HD22 HD13 ' A' ' 107' ' ' LEU . 45.5 t-20 -103.83 -57.73 1.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.193 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 5.0 mmpt? 56.95 -137.1 1.04 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.5 t30 70.19 -14.95 0.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.906 0.882 . . . . 0.0 112.991 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -129.84 159.8 35.46 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -96.01 102.98 14.84 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 92.4 m-85 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.571 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HB ' HG22 ' A' ' 4' ' ' VAL . 45.4 t -123.67 139.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.514 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -128.4 153.8 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.506 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 22.8 p -100.07 175.71 5.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.41 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.84 -39.24 87.56 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.32 -20.5 60.78 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.373 0.606 . . . . 0.0 110.064 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.46 -54.9 5.83 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.842 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -60.54 -38.81 79.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -66.51 -36.49 82.85 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.446 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -69.27 -39.85 78.13 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.29 83.15 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.88 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.3 mm -65.5 -52.86 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.884 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.06 -27.85 67.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -90.45 -0.36 57.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.44 95.95 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.443 -0.408 . . . . 0.0 112.837 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 10' ' ' PHE . 62.7 mt -94.52 148.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.93 83.1 0.66 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.738 0.78 . . . . 0.0 111.076 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -23.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.561 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -66.67 -37.86 85.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 t -65.85 -33.83 76.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.45 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.34 -51.42 44.72 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 91.8 mt -54.88 -46.93 74.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.855 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.38 -43.43 96.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.702 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 17' ' ' LEU . 98.7 mtt180 -78.89 0.51 27.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.82 3.19 7.74 Favored Glycine 0 N--CA 1.458 0.144 0 C-N-CA 119.24 -1.457 . . . . 0.0 115.665 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 60.2 t -82.22 127.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 117.827 0.814 . . . . 0.0 109.438 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.4 pt -104.49 144.76 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 6.3 p -97.42 120.98 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -122.92 126.36 47.11 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.6 141.72 48.05 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.355 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.31 147.75 37.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -73.71 -40.93 63.23 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -158.03 100.63 1.73 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.346 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -136.46 101.59 9.92 Favored Pre-proline 0 C--N 1.292 -1.904 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.4 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.24 125.69 18.16 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 121.7 1.6 . . . . 0.0 108.938 172.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.64 137.17 67.17 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.067 2.511 . . . . 0.0 113.356 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -95.35 109.11 21.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.43 159.97 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.507 0.67 . . . . 0.0 112.139 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.16 88.99 0.08 OUTLIER Glycine 0 C--N 1.29 -2.01 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.5 t30 80.05 -21.27 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.815 1.246 . . . . 0.0 111.183 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.0 mt -103.38 146.94 33.41 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.011 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.74 161.39 24.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.409 2.739 . . . . 0.0 114.578 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -58.43 -33.04 69.24 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.432 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.273 6.7 p90 -61.52 -32.48 72.53 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -79.35 -36.65 39.07 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.505 176.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 74' ' ' MET . 14.6 m -54.72 -51.73 64.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.722 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.506 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.7 tt0 -61.38 -43.53 98.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.185 0.303 . . . . 0.0 110.595 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.83 -51.4 69.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.338 0.59 . . . . 0.0 110.286 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HD2' ' A' ' 93' ' ' LYS . 71.5 mt -63.55 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.417 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 70' ' ' SER . 6.5 mmt -68.25 -38.44 81.81 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.868 -0.52 . . . . 0.0 111.196 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.33 -38.06 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.614 0.721 . . . . 0.0 109.71 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.76 73.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.115 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -71.87 -43.46 65.43 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.703 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.94 -30.53 67.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.652 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.91 -15.01 26.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 t30 55.2 61.97 2.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.99 -177.57 3.4 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.662 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.3 mt -90.0 147.82 23.45 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.62 133.73 55.67 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.359 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.1 mt -111.21 117.87 56.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.89 154.51 40.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.912 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.94 -37.26 12.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.328 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.16 130.67 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.196 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -62.59 -35.42 79.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.826 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -76.6 -36.6 57.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.124 0.42 . . . . 0.0 109.969 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.36 -44.85 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.96 -45.1 95.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.111 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.6 t30 -57.73 -52.88 63.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.346 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -56.76 -43.08 80.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.696 0.799 . . . . 0.0 110.756 -178.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.3 -47.53 76.3 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.114 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -69.81 -27.61 65.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.513 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.1 mt-10 -70.6 -23.27 62.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 110.472 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.59 -18.39 33.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.523 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.2 11.99 18.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.104 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.79 131.32 46.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -78.17 95.91 5.06 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.288 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.78 130.01 42.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.892 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.45 153.55 80.47 Favored Pre-proline 0 C--N 1.29 -2.0 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.76 164.27 29.97 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.21 1.94 . . . . 0.0 111.711 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.498 HG23 ' CG2' ' A' ' 16' ' ' ILE . 64.1 mt -65.75 -43.93 93.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.65 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -66.49 -25.29 66.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.841 0.353 . . . . 0.0 111.448 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -41.78 66.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.254 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 20' ' ' ASN . 3.4 tm? -64.21 -39.22 93.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 92.7 mt -65.23 -45.25 85.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.512 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.12 71.37 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.686 0.794 . . . . 0.0 112.547 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 m -62.85 -26.85 68.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 9.1 m -103.25 99.15 8.99 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.629 0.728 . . . . 0.0 111.165 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.1 pt? -126.78 -41.0 1.86 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -28.93 68.19 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.493 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 111' ' ' SER . 35.0 m80 -81.72 74.12 8.73 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -105.98 151.62 24.39 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.5 t60 63.89 50.1 2.67 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.56 -75.75 0.48 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.878 -172.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 12.6 t-80 -85.92 -28.59 24.21 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 . . . . . 0 CA--C 1.479 -1.766 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 170.603 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 C--O 1.248 0.993 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -89.51 154.72 19.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 120.901 0.381 . . . . 0.0 110.003 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.55 110.43 9.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.5 t -91.92 129.33 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 13' ' ' LEU . 65.0 mt -93.1 128.01 44.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -93.15 138.5 23.16 Favored Pre-proline 0 N--CA 1.419 -2.023 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 22.7 Cg_exo -39.03 -31.7 0.28 Allowed 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 125.047 3.832 . . . . 0.0 117.003 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 p -65.96 -22.49 66.48 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.606 0.639 . . . . 0.0 112.238 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -88.79 10.27 21.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.517 0.727 . . . . 0.0 112.069 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-30 -68.44 152.67 45.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.397 0.618 . . . . 0.0 112.605 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.17 -34.11 4.07 Favored Glycine 0 N--CA 1.46 0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.783 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.21 7.07 44.75 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.015 0.912 . . . . 0.0 109.322 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.429 ' CD2' HG21 ' A' ' 5' ' ' ILE . 76.1 mt -51.51 -49.44 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 110.636 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.07 -20.47 63.22 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.654 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.19 -55.65 6.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG2' HG23 ' A' ' 104' ' ' ILE . 17.5 pt -60.53 -42.39 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 48' ' ' ARG . 3.4 mp -54.82 -51.92 64.31 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.577 0.751 . . . . 0.0 111.702 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.36 -33.13 29.32 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.057 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 m -71.89 -38.24 70.0 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.709 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' CG ' ' HA ' ' A' ' 111' ' ' SER . 27.1 t-20 -102.65 -59.35 1.72 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.623 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.46 -168.13 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 71.36 -13.39 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -107.14 143.95 34.57 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -88.83 103.91 16.43 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.438 ' CB ' HG22 ' A' ' 50' ' ' VAL . 94.5 m-85 -74.94 138.55 42.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.706 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.84 135.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.04 153.9 32.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 75' ' ' VAL . 48.3 p -94.98 172.02 8.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 120.934 0.397 . . . . 0.0 111.466 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -65.81 -44.22 86.3 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.38 -25.24 63.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.62 -52.6 28.99 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.9 m -61.5 -36.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.977 0.389 . . . . 0.0 110.835 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -67.37 -38.87 85.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -64.99 -38.5 91.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.952 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.43 -51.1 68.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.181 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 32' ' ' VAL . 50.3 mm -55.82 -50.5 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.607 0.567 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -71.2 -21.51 62.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -95.05 -4.44 46.43 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.365 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.21 54.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.109 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -103.24 133.15 47.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -76.01 108.25 8.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.23 1.014 . . . . 0.0 111.58 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.9 tp -98.8 -22.47 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.47 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.75 -27.44 66.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.391 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.2 t -70.38 -31.79 69.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -47.7 38.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 81.9 mt -54.7 -43.55 72.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.315 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.43 -33.94 74.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.443 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 44' ' ' SER . 33.7 mtt180 -85.49 -4.16 59.08 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.864 -0.735 . . . . 0.0 112.201 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.81 17.74 2.77 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.437 -1.364 . . . . 0.0 114.447 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 25' ' ' PHE . 59.3 t -89.24 124.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.3 pt -99.11 161.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.4 127.19 61.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -132.44 125.31 30.43 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.98 141.72 29.06 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.634 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 57' ' ' HIS . 40.0 t80 -79.26 108.73 12.98 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 m -65.56 -25.0 67.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 111.588 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . 59.6 m80 -80.21 166.09 21.76 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -93.24 118.35 67.68 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.63 141.46 31.07 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.966 2.444 . . . . 0.0 112.229 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.56 153.7 60.14 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.165 1.91 . . . . 0.0 110.768 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -85.74 119.42 26.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 65' ' ' LEU . 17.0 m -89.79 159.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.554 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.82 -69.44 1.39 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.949 -0.644 . . . . 0.0 114.236 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.06 -32.37 26.86 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 62' ' ' VAL . 72.2 mt -79.89 153.24 75.17 Favored Pre-proline 0 C--N 1.308 -1.211 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -82.54 151.35 15.11 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.086 1.858 . . . . 0.0 111.505 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.98 -30.09 71.32 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -63.12 -32.71 74.15 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.495 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.3 mt-10 -89.6 -24.96 21.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.736 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 t -62.3 -40.05 95.01 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -57.23 -47.46 81.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.136 0.974 . . . . 0.0 108.598 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.12 87.13 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.219 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 69' ' ' GLU . 65.5 mt -59.98 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.95 -40.55 96.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.051 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 28' ' ' THR . 77.8 t -67.56 -40.59 84.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.68 70.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -77.22 -42.36 37.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.729 0.811 . . . . 0.0 110.212 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.48 -49.04 79.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.423 1.089 . . . . 0.0 110.102 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.73 -18.96 28.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.917 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 59.08 68.96 0.76 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.85 -177.21 3.35 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.468 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.01 137.75 33.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.66 116.12 31.38 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.136 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.43 110.29 23.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -137.49 146.83 44.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.223 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.1 -22.79 16.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.08 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.52 124.71 31.7 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 12.7 mptt -74.36 -16.45 60.9 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -81.19 -35.42 31.4 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.447 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.79 -44.34 97.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.709 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.79 -51.83 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.459 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 10.0 t30 -59.29 -46.13 89.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.35 -49.67 76.39 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 124.393 1.077 . . . . 0.0 110.202 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.16 79.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.051 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 38.0 ttmt -64.95 -34.98 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.9 mt-10 -61.61 -34.31 75.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.502 0.668 . . . . 0.0 109.811 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.8 -1.53 52.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.554 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.84 58.25 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.45 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 65.2 t -96.96 141.95 14.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -89.16 97.93 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.293 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.9 131.27 46.86 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.78 151.27 65.48 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 123.567 0.542 . . . . 0.0 111.013 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 6.8 Cg_exo -71.86 166.04 30.73 Favored 'Trans proline' 0 C--O 1.253 1.274 0 C-N-CA 122.226 1.951 . . . . 0.0 111.095 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.444 HD11 ' HB1' ' A' ' 9' ' ' ALA . 45.5 mt -58.46 -40.52 78.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -63.55 -23.04 67.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.871 0.367 . . . . 0.0 111.785 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 34.2 mm-40 -78.1 -35.15 49.61 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.18 -37.22 75.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.1 mt -64.52 -40.56 95.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 109.8 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.89 -18.45 62.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.395 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 m -105.82 16.31 25.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.554 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.508 ' HA ' ' CG ' ' A' ' 20' ' ' ASN . 69.7 m -67.39 149.86 49.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.548 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt 75.99 66.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.754 1.221 . . . . 0.0 109.801 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.9 -28.34 36.0 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.87 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 73.64 96.04 0.07 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.037 0.935 . . . . 0.0 111.459 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -135.06 112.15 10.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.745 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -83.49 80.27 9.16 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.114 0.959 . . . . 0.0 108.54 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -128.14 142.92 51.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -65.62 -32.11 73.5 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.653 0.661 . . . . 0.0 112.014 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 174.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.82 144.72 26.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.752 0.31 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -129.73 109.88 11.32 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 41.0 t -92.61 133.88 32.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.85 121.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.78 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -82.63 149.3 60.29 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 52.0 Cg_exo -56.47 -15.75 16.33 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.604 2.869 . . . . 0.0 114.861 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 p -71.92 -20.78 61.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.0 111.261 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.67 11.82 31.98 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.637 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 8.7 m-30 -65.94 147.61 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.86 -34.69 3.83 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.973 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.0 mmmt -90.07 -1.09 57.9 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.583 0.353 . . . . 0.0 111.29 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 10' ' ' PHE . 7.9 mp -54.25 -35.77 62.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.429 0.633 . . . . 0.0 111.401 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -38.52 88.4 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.836 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.33 -38.95 33.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.4 pt -67.02 -35.26 74.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 13' ' ' LEU . 5.0 mp -57.23 -55.52 33.73 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.747 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.38 -33.35 53.42 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -76.98 -40.28 47.38 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.089 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.87 -52.67 3.25 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.545 -1.262 . . . . 0.0 111.803 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 59.51 -178.97 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 73.01 -14.64 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.59 1.556 . . . . 0.0 112.869 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -89.42 148.35 23.52 Favored 'General case' 0 CA--C 1.492 -1.281 0 O-C-N 121.75 -0.594 . . . . 0.0 109.398 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -91.94 98.29 11.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.6 m-85 -74.81 125.35 28.61 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.897 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.6 t -118.94 136.28 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -129.07 144.04 39.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.439 ' H ' HD13 ' A' ' 27' ' ' ILE . 39.8 p -81.62 169.58 16.86 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.395 0.617 . . . . 0.0 112.565 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 p -67.62 -36.47 80.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.79 -31.0 70.57 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.54 -50.55 42.62 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.247 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.3 m -61.74 -40.53 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 117.369 0.585 . . . . 0.0 112.007 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -69.89 -39.26 76.36 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.51 0.195 . . . . 0.0 110.617 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.05 -42.3 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.04 61.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.7 mm -53.85 -51.37 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.968 0.507 . . . . 0.0 112.085 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -67.86 -22.15 65.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -95.89 -3.9 44.52 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.84 34.97 55.34 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.877 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.17 137.18 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.08 94.07 1.87 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.2 tp -101.86 -20.34 5.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.82 -41.83 97.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.268 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.5 m -71.02 -24.91 62.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.999 0.428 . . . . 0.0 111.058 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.98 -47.36 59.34 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 85.3 mt -56.32 -40.27 74.14 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.234 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.58 -39.42 87.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.803 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 44' ' ' SER . 95.8 mtt180 -83.34 -1.9 54.44 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.96 2.54 7.19 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 114.714 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 65.5 t -76.05 120.33 25.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -97.95 140.42 18.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.233 0.54 . . . . 0.0 110.55 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -91.44 119.23 38.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -148.08 138.8 23.06 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.99 0.424 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.57 151.37 51.95 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.54 162.31 24.38 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 14.8 m -53.83 -56.81 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 56' ' ' SER . 7.8 t-80 156.75 136.49 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.979 1.312 . . . . 0.0 110.697 164.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.21 145.17 54.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.09 124.0 11.27 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 111.048 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.82 130.32 7.54 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.822 1.682 . . . . 0.0 112.469 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 61.7 tttp -96.66 109.47 22.1 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 m -150.87 162.79 3.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 123.888 0.875 . . . . 0.0 108.875 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -123.31 -54.71 0.2 Allowed Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.92 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -97.61 1.35 48.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.653 0.74 . . . . 0.0 110.82 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 89' ' ' ASP . 90.0 mt -104.99 140.56 21.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 15.3 Cg_exo -70.99 159.03 53.77 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.71 2.273 . . . . 0.0 109.888 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -62.7 -40.14 96.2 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -58.68 -37.62 76.43 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -71.03 -40.17 71.88 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 74' ' ' MET . 19.2 m -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.61 -37.81 87.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.37 89.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.555 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.27 -45.43 89.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.8 mmt -60.83 -45.54 94.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.699 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.39 -39.65 84.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 110.27 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.47 71.55 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.93 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -75.42 -27.07 58.85 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.596 0.758 . . . . 0.0 110.537 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' MET . 31.9 mm-40 -77.04 -42.85 36.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.479 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.26 -9.23 42.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.23 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t30 55.73 57.25 5.38 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.12 175.01 6.25 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.747 -170.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.06 121.63 30.69 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 tp -101.9 121.11 41.5 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.072 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.84 110.25 28.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.5 147.66 34.84 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.252 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -95.97 -26.24 15.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.254 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.89 131.22 37.4 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.069 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.54 -33.75 74.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HB3' HD21 ' A' ' 65' ' ' LEU . 13.2 t70 -76.39 -30.75 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.11 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.301 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.69 -47.14 86.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.13 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -58.07 -54.75 43.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.251 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 61' ' ' LYS . 1.3 tmtm? -61.24 -44.93 96.46 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.593 -173.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.7 98.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 37.9 ttmt -68.94 -28.09 66.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.9 mt-10 -64.4 -33.52 76.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.39 -3.86 57.94 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.092 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.36 59.92 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.537 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.6 t -81.64 135.08 25.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.03 96.17 8.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.672 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 133.7 51.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.502 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.74 156.48 62.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.333 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.4 Cg_exo -72.93 162.4 41.12 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.322 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 12' ' ' LYS . 69.3 mt -55.98 -44.68 79.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -72.0 -16.53 62.07 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.83 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.28 -27.63 27.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.743 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.86 -38.2 79.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.5 -14.57 60.84 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.517 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.79 -35.44 14.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.7 m -91.45 11.47 23.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.587 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.8 p -80.98 -25.01 37.62 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 116' ' ' HIS . 86.4 mt 60.37 83.1 0.14 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.859 -1.519 . . . . 0.0 113.608 174.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -26.97 50.92 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.02 0.914 . . . . 0.0 109.153 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -92.87 106.94 18.83 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -58.04 103.83 0.16 Allowed 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.637 0.585 . . . . 0.0 110.669 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.409 ' HA ' HD13 ' A' ' 112' ' ' LEU . 9.3 m170 66.64 118.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.537 1.135 . . . . 0.0 111.7 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -65.59 -35.92 82.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 70.77 -46.55 0.63 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.53 1.532 . . . . 0.0 113.537 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.198 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 92.2 m-85 -87.89 155.58 19.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.275 0.56 . . . . 0.0 110.816 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -138.1 110.4 7.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -92.84 128.95 44.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.92 126.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 t -91.74 145.7 31.64 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.618 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 84.5 Cg_exo -50.85 -28.22 22.86 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 123.954 3.102 . . . . 0.0 115.103 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 p -60.56 -34.45 74.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.23 12.15 7.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.508 0.723 . . . . 0.0 112.825 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.618 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 10.5 m-30 -67.99 165.83 17.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.726 0.774 . . . . 0.0 112.754 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.73 -35.3 3.07 Favored Glycine 0 C--O 1.215 -1.081 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.214 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -113.13 14.78 19.55 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.659 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.29 -35.17 79.45 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.314 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -67.05 -40.68 87.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.7 -51.5 64.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.633 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.3 pt -60.31 -39.48 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.9 0.381 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -65.71 -48.32 72.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.065 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.19 -33.75 43.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -86.21 -36.23 19.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.488 0.644 . . . . 0.0 111.627 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.5 -53.96 4.68 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.945 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 59.16 -174.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.364 0.602 . . . . 0.0 111.364 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 -13.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.809 1.244 . . . . 0.0 114.011 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.8 154.57 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.3 tpmt? -91.66 97.97 11.35 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 50' ' ' VAL . 96.3 m-85 -74.81 129.36 37.55 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.49 138.06 51.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.973 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -126.46 152.47 34.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 41.9 p -90.88 169.32 11.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.108 -0.37 . . . . 0.0 111.246 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 54' ' ' ALA . 19.3 p -67.83 -41.84 82.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.482 0.658 . . . . 0.0 109.687 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.61 -34.43 78.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.139 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.7 -57.66 16.65 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.998 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 36' ' ' ILE . 29.3 m -59.73 -39.34 79.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 27.0 m -66.11 -36.22 82.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.76 0.314 . . . . 0.0 111.118 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -69.21 -40.13 78.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.65 84.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.773 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.2 mm -57.37 -57.68 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.223 0.327 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.7 ptpp? -65.07 -24.37 67.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 t -93.96 -8.2 40.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.371 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.84 34.34 43.33 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.665 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.2 mt -91.54 143.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.76 95.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 111.195 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.05 -28.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.32 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.07 -39.82 94.91 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 5.5 m -67.67 -30.88 70.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.292 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.1 -51.05 42.59 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -38.11 85.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 44' ' ' SER . 10.6 t70 -52.77 -45.51 67.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.631 1.172 . . . . 0.0 112.051 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -82.78 -9.81 59.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.416 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.11 19.09 4.42 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.257 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 25' ' ' PHE . 93.9 t -73.13 132.18 33.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.66 145.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.639 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.0 t -96.11 132.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . 23.3 ttm180 -153.25 138.65 17.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 29' ' ' THR . . . -152.93 157.87 41.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 11.4 m-85 -71.84 147.07 47.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -74.15 -39.08 63.52 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -165.86 100.12 0.66 Allowed 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.605 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.567 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 5.7 tmtm? -137.43 110.71 8.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.47 121.76 2.67 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 CA-C-N 119.978 1.028 . . . . 0.0 111.463 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -91.6 132.12 1.35 Allowed 'Trans proline' 0 N--CA 1.438 -1.735 0 C-N-CA 122.998 2.465 . . . . 0.0 110.337 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.97 107.16 16.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.097 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.79 148.32 17.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.055 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.77 38.5 0.86 Allowed Glycine 0 C--N 1.283 -2.392 0 N-CA-C 106.658 -2.577 . . . . 0.0 106.658 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -158.0 -56.07 0.07 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.838 -1.181 . . . . 0.0 110.027 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt -83.72 141.85 41.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.163 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.07 147.25 91.63 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 122.527 2.152 . . . . 0.0 110.174 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.59 -34.7 77.53 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.296 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.252 10.4 p90 -64.08 -35.85 82.08 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.705 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' ILE . 72.0 mm-40 -71.97 -40.3 68.71 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' MET . 35.8 m -61.5 -38.19 86.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.922 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -58.78 -44.39 90.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.82 97.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.459 HD11 HG13 ' A' ' 90' ' ' VAL . 64.2 mt -59.63 -46.21 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.03 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 13.4 mmt -62.86 -45.17 93.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.625 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.42 -40.44 89.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 120.848 0.356 . . . . 0.0 110.606 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.69 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.203 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.52 -38.45 68.06 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.628 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -49.77 46.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.827 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.08 -14.11 58.09 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.021 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.6 m120 60.44 65.83 1.01 Allowed 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.871 1.32 . . . . 0.0 108.48 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -119.56 171.43 8.37 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 113.206 -1.815 . . . . 0.0 110.04 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -84.54 133.33 34.45 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -101.94 116.38 32.57 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.015 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.4 mt -96.34 110.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -134.49 154.99 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.59 -31.0 11.05 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.04 122.34 25.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.148 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 10.8 mptt -69.42 -25.96 64.39 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.63 -29.82 33.05 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.6 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.459 HG13 HD11 ' A' ' 73' ' ' ILE . 74.8 t -63.24 -49.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.77 -44.32 81.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.208 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -55.33 -56.0 25.05 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.354 1.462 . . . . 0.0 111.412 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.96 86.33 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 18.0 ptpt -76.54 -18.61 58.6 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.154 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.97 -28.24 68.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.58 -18.48 33.22 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.93 13.64 15.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.969 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.74 127.97 46.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -76.41 89.89 3.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.726 0.774 . . . . 0.0 109.484 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.99 129.31 43.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.174 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 pp -135.22 148.74 67.67 Favored Pre-proline 0 C--N 1.291 -1.96 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.14 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.3 Cg_exo -68.84 167.76 22.25 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.72 2.28 . . . . 0.0 111.68 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.64 -50.05 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.097 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.76 -36.58 72.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 56.6 mm-40 -69.51 -37.82 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.524 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.92 -44.54 84.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.37 -43.44 92.86 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.31 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.74 -27.42 69.19 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.138 0.575 . . . . 0.0 111.78 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -93.63 29.19 2.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.303 0.573 . . . . 0.0 110.632 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -106.19 99.76 9.33 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.3 mt 65.47 27.76 11.66 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.873 0.869 . . . . 0.0 110.386 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -46.45 71.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.893 1.277 . . . . 0.0 111.299 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -145.41 -26.01 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.723 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 89.8 m-70 -80.19 66.7 5.77 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-O 122.031 0.919 . . . . 0.0 112.062 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -163.9 16.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.523 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -98.75 -75.31 0.56 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -92.41 -36.66 13.01 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 115' ' ' HIS . 5.6 t60 . . . . . 0 N--CA 1.422 -1.87 0 N-CA-C 100.993 -3.706 . . . . 0.0 100.993 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -87.75 160.14 18.19 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.947 0.403 . . . . 0.0 110.406 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.28 114.95 11.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.15 131.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.185 0.517 . . . . 0.0 109.778 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.1 mt -97.49 130.24 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -94.57 149.02 35.89 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 88.2 Cg_exo -50.96 -27.37 20.89 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.657 2.905 . . . . 0.0 114.94 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -64.25 -24.53 67.7 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 120.975 0.417 . . . . 0.0 112.061 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 6.52 43.2 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.643 0.377 . . . . 0.0 111.688 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 15.1 m-30 -68.76 154.33 42.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -34.47 3.48 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.016 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 104' ' ' ILE . 59.2 mtpt -98.95 11.87 37.64 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.004 0.907 . . . . 0.0 109.662 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.71 -36.37 74.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.296 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.741 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.17 -59.2 2.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.578 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 104' ' ' ILE . 29.6 pt -57.18 -45.59 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 61.3 tp -66.97 -42.6 84.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.331 -177.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.89 -33.16 34.28 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.593 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 m -77.27 -45.89 24.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.883 0.373 . . . . 0.0 111.507 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 111' ' ' SER . 43.7 t-20 -93.9 -58.41 2.26 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.254 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 57.69 -146.32 0.55 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.0 -14.02 0.25 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -117.77 157.48 26.47 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.8 tpmt? -90.63 102.67 15.42 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -75.06 120.38 20.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.843 0.83 . . . . 0.0 110.545 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.31 133.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.653 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.39 153.6 28.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 24.7 p -90.75 170.55 10.03 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -67.96 -38.64 83.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.943 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -73.04 -29.74 63.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.31 -56.18 25.0 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.578 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.9 m -60.82 -38.39 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.735 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 44.3 t -64.45 -40.33 95.51 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.811 0.339 . . . . 0.0 110.627 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.88 -38.92 87.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.91 86.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.379 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.2 mm -55.3 -56.81 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.6 0.562 . . . . 0.0 111.337 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 33' ' ' SER . 14.4 pttm -66.49 -30.27 70.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -87.41 -0.73 57.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.545 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.58 95.49 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 10' ' ' PHE . 81.1 mt -92.07 147.8 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 123.566 0.746 . . . . 0.0 109.18 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.2 89.25 0.64 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.153 0.502 . . . . 0.0 110.922 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -102.84 -32.65 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -60.56 -39.29 87.43 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -30.62 71.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.274 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.95 -48.6 23.6 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.57 -41.93 95.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.249 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.68 -21.73 64.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.609 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.8 mtt180 -92.9 -7.95 44.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.94 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 5.82 6.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 115.248 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.63 129.72 36.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.149 0.974 . . . . 0.0 108.848 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.1 pt -104.88 152.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.18 124.35 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -122.41 124.76 44.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.18 146.27 24.11 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.82 108.35 5.07 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.4 m -80.21 9.75 5.3 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.52 -173.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -126.02 157.9 36.72 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -61.02 113.5 7.98 Favored Pre-proline 0 C--O 1.25 1.105 0 O-C-N 123.783 0.677 . . . . 0.0 111.285 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.15 125.07 12.49 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.892 2.395 . . . . 0.0 112.002 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.24 171.95 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.251 1.968 . . . . 0.0 110.064 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -96.13 147.42 23.75 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.476 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 65' ' ' LEU . 57.3 t -126.12 118.06 50.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.77 -12.92 65.7 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.985 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 3.0 p-10 -94.34 -33.04 13.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.626 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' HG ' ' ND2' ' A' ' 64' ' ' ASN . 96.2 mt -108.49 153.22 42.22 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 116.871 -0.149 . . . . 0.0 111.195 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.84 153.66 76.84 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.981 1.788 . . . . 0.0 109.601 173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -64.85 -32.92 74.84 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -60.36 -40.46 90.86 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.58 -40.99 69.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -63.66 -37.88 89.03 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.325 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.7 tt0 -61.75 -40.83 96.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.06 89.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.511 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.19 -44.32 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.6 mmt -64.51 -40.05 94.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.67 -38.03 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.088 0.47 . . . . 0.0 110.067 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.18 -32.52 74.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -73.67 -35.96 65.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.313 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.95 -46.71 67.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.672 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.87 -17.77 39.75 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.03 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.54 69.19 0.7 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.21 176.18 7.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.721 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -85.86 134.49 33.9 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -101.97 122.62 44.4 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.459 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.36 113.47 36.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.22 159.54 42.49 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.95 -24.54 11.58 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.65 135.71 33.3 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.594 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 2.7 mppt? -59.49 -38.52 81.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.078 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.38 -34.11 67.71 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 65' ' ' LEU . 51.5 t -67.95 -53.08 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.625 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.3 -43.13 85.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.098 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -70.73 -41.65 71.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.505 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 40.3 tptt -65.87 -39.78 91.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.094 0.473 . . . . 0.0 110.311 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.47 98.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.08 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -71.74 -20.44 61.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' OE1' ' HD2' ' A' ' 93' ' ' LYS . 42.3 mt-10 -72.93 -31.8 64.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.27 -14.53 57.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.535 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.26 44.82 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.954 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.97 133.81 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -79.85 93.47 5.64 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.45 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.61 130.14 41.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.578 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.5 pp -132.21 139.2 34.16 Favored Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.479 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 25.6 Cg_exo -61.28 159.98 28.8 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.321 2.014 . . . . 0.0 110.453 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 12' ' ' LYS . 45.6 mt -56.09 -40.54 64.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -30.07 70.99 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 26.9 mm-40 -75.89 -33.57 59.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.782 0.325 . . . . 0.0 110.486 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.51 -43.39 80.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 85.7 mt -63.43 -42.59 98.7 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.01 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.0 110.877 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -65.81 -47.04 76.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.467 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.457 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 68.7 m -154.65 99.25 2.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.911 0.386 . . . . 0.0 111.228 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pp -97.31 -27.66 14.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.644 0.735 . . . . 0.0 110.655 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.54 -30.51 9.0 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.18 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 72.85 -43.23 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.95 1.3 . . . . 0.0 110.023 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -147.31 121.57 9.57 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.73 -21.8 65.27 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 72.77 -57.6 0.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.901 1.28 . . . . 0.0 112.498 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -158.26 -55.77 0.07 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 122.967 0.507 . . . . 0.0 110.465 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 CA--C 1.511 -0.555 0 C-N-CA 126.781 2.033 . . . . 0.0 108.029 177.49 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -86.77 146.04 26.4 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -130.91 113.55 14.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.74 134.57 30.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -95.97 128.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 85' ' ' ALA . 1.4 t -82.47 144.4 49.46 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.355 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 Cg_exo -58.07 -26.76 76.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.91 2.407 . . . . 0.0 112.452 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.0 m -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.151 0.5 . . . . 0.0 110.547 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 104' ' ' ILE . . . -83.82 -0.1 49.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.615 -174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 16.3 m-30 -63.2 153.01 35.89 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.426 0.631 . . . . 0.0 112.362 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.59 -35.38 3.5 Favored Glycine 0 C--N 1.31 -0.915 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.166 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -99.05 3.67 46.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.76 1.267 . . . . 0.0 108.397 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.4 -34.92 78.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.038 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -61.66 -34.35 75.57 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.232 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.82 -62.66 1.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.822 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.463 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.9 pt -53.43 -40.37 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 48' ' ' ARG . 49.2 tp -62.5 -54.88 33.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.152 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.77 -30.47 13.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.175 -1.012 . . . . 0.0 114.134 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -78.54 -29.62 46.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 122.429 -0.454 . . . . 0.0 110.911 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -114.81 -55.04 2.52 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.913 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 51.6 tttp 58.01 -140.19 0.79 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.513 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 66.4 t30 69.93 -13.36 0.42 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 124.793 1.237 . . . . 0.0 113.949 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.54 161.22 18.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.695 -0.628 . . . . 0.0 109.737 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.95 102.35 14.71 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.49 124.04 26.48 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.359 0.6 . . . . 0.0 111.446 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.86 134.61 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.025 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.3 tp -121.14 149.47 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 24.1 p -85.86 168.63 14.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.584 0.707 . . . . 0.0 112.506 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.76 95.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.291 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.93 -30.52 58.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.93 -54.65 35.77 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.947 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.2 m -60.56 -42.42 91.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.475 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 m -63.16 -41.79 99.32 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.859 0.362 . . . . 0.0 111.378 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.02 -43.43 98.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.307 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.199 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 32' ' ' VAL . 31.8 mm -59.25 -52.53 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.805 0.442 . . . . 0.0 111.088 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -12.89 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -98.48 -16.01 19.37 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.19 41.36 13.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.192 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.4 mt -100.41 157.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.86 83.74 0.11 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.905 0.482 . . . . 0.0 111.364 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.3 tp -107.13 -31.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -71.09 -37.44 72.42 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.882 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.9 m -65.29 -28.92 69.67 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.934 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 50' ' ' VAL . . . -76.99 -50.08 13.97 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.75 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 80.5 mt -57.88 -40.74 80.98 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.806 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.89 -49.61 65.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.883 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.436 ' HB2' HD21 ' A' ' 17' ' ' LEU . 66.4 mtt180 -82.09 -0.62 45.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.04 0.68 8.17 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 118.609 -1.757 . . . . 0.0 115.026 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 45' ' ' ALA . 97.2 t -72.48 126.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 pt -104.53 148.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -96.03 137.98 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' NE ' HD21 ' A' ' 79' ' ' LEU . 37.8 ttt85 -147.91 136.11 21.34 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.266 0.555 . . . . 0.0 111.499 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.26 153.76 34.51 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.88 158.89 21.46 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 17.8 m -58.77 -56.96 15.42 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.118 0.261 . . . . 0.0 110.393 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' SER . 13.9 t-80 172.72 104.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.314 0.384 . . . . 0.0 110.199 175.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -134.74 153.29 78.75 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.27 123.85 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.098 1.199 . . . . 0.0 109.258 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HA ' ' SD ' ' A' ' 74' ' ' MET . 16.8 Cg_exo -70.48 128.96 16.07 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.123 1.215 . . . . 0.0 109.305 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -116.44 109.43 17.3 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 m -150.25 161.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.07 43.91 1.2 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.122 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -178.44 -43.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.062 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 97.6 mt -76.37 149.17 81.41 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 17.0 Cg_exo -70.53 161.25 46.69 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.396 2.064 . . . . 0.0 111.042 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -56.46 -40.18 74.41 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.746 0.818 . . . . 0.0 112.623 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -62.68 -36.59 83.39 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -75.4 -37.62 60.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -59.93 -44.8 94.14 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.3 tt0 -61.94 -37.88 86.38 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.88 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -42.87 97.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.32 -44.1 83.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.385 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 60' ' ' PRO . 23.2 mmt -60.92 -42.5 98.24 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.55 -40.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.134 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.02 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.295 0.569 . . . . 0.0 110.136 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.66 -44.07 74.88 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.439 1.096 . . . . 0.0 110.62 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -74.19 -27.22 60.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.072 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD21 ' NE ' ' A' ' 53' ' ' ARG . 93.1 mt -88.75 -19.13 26.44 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.06 48.86 6.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.98 176.92 5.93 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.819 -1.537 . . . . 0.0 112.243 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.94 128.03 36.14 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.2 tp -103.57 119.06 38.15 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.483 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.9 mt -94.58 110.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -126.11 173.45 9.2 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.0 -60.33 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.44 136.19 57.44 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.34 0.59 . . . . 0.0 111.232 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 45.9 mtmt -58.34 -35.37 71.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.151 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.25 -31.07 54.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.111 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 65' ' ' LEU . 46.5 t -63.39 -43.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.43 -49.52 82.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.739 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.16 -52.72 64.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.62 -33.23 75.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 -46.78 77.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.436 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.43 -20.94 61.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.82 -39.1 93.42 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.696 0.76 . . . . 0.0 109.176 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.57 -3.57 57.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.265 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.14 10.81 59.3 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.916 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.23 126.1 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -75.39 95.3 3.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.176 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.44 143.93 29.13 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.027 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -141.0 152.27 64.69 Favored Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 123.728 0.643 . . . . 0.0 110.445 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.6 Cg_endo -69.94 159.45 53.23 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.54 1.493 . . . . 0.0 109.848 172.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.463 HG23 ' CG2' ' A' ' 16' ' ' ILE . 75.4 mt -54.89 -43.65 69.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.51 -32.38 54.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 120.954 0.406 . . . . 0.0 110.186 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.52 -37.9 71.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.2 -35.64 81.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 -9.22 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.249 0.547 . . . . 0.0 111.094 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -95.0 4.24 54.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.444 0.64 . . . . 0.0 109.735 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.6 t -87.14 165.29 15.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.6 mt 63.32 28.46 15.65 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -39.37 78.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -80.6 -3.94 52.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.615 0.721 . . . . 0.0 110.293 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.264 72.4 m80 52.37 -96.4 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 126.313 1.845 . . . . 0.0 115.896 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -120.53 128.69 53.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.734 0.302 . . . . 0.0 110.33 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -146.74 110.9 5.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -70.4 112.56 6.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.183 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.08 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.244 0.767 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -87.42 155.67 19.92 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.79 109.15 9.45 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' HD12 ' A' ' 83' ' ' LEU . 59.2 t -92.37 129.23 43.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.8 mt -96.96 133.99 36.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.573 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -91.7 147.13 34.46 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 45.5 Cg_exo -56.16 -21.45 35.48 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.219 2.613 . . . . 0.0 114.561 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -67.81 -25.67 65.69 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 122.094 -0.379 . . . . 0.0 111.729 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 19.57 8.83 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.025 0.53 . . . . 0.0 111.866 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.523 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.1 m-30 -72.33 168.09 19.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 -34.87 3.38 Favored Glycine 0 C--O 1.217 -0.943 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.357 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' ILE . 13.4 mmmm -100.12 21.22 13.17 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.414 0.626 . . . . 0.0 110.098 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 -27.32 68.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.711 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -79.52 -43.54 22.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -66.26 -46.24 77.73 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.457 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 12' ' ' LYS . 30.6 pt -64.88 -34.48 70.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.398 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 9.5 tp -66.65 -55.04 17.05 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.167 0.508 . . . . 0.0 109.671 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.4 -33.17 61.59 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.3 m -82.81 -48.1 11.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 117.358 0.579 . . . . 0.0 111.214 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 111' ' ' SER . 52.1 t30 -90.21 -59.07 2.29 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.668 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 75.1 tttt 59.7 -162.21 0.26 Allowed 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 43.1 m-80 73.86 -0.51 3.34 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 170.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -123.18 152.42 41.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.13 104.34 16.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.6 m-85 -74.69 131.27 40.73 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.689 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 58.6 t -127.76 138.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.331 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.27 150.59 30.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -84.01 163.15 20.1 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.14 0.495 . . . . 0.0 111.415 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -62.56 -34.37 76.8 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.351 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.06 -32.64 63.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.03 67.51 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.108 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.9 m -61.35 -39.34 82.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.717 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -65.32 -37.54 87.41 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.693 0.282 . . . . 0.0 111.085 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.23 -42.23 88.96 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.446 0.641 . . . . 0.0 109.471 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.64 90.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.774 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 32' ' ' VAL . 40.8 mm -61.27 -50.58 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.572 0.349 . . . . 0.0 111.043 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -64.73 -35.78 82.18 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.3 t -80.45 -28.33 37.68 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.59 40.91 6.62 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 ' HB3' ' A' ' 10' ' ' PHE . 79.6 mt -95.77 149.04 4.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.14 91.72 0.23 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.725 0.774 . . . . 0.0 111.725 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.2 tp -109.59 -27.55 2.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.186 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.96 -48.21 77.35 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.332 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.592 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 3.1 m -72.77 -27.8 62.22 Favored 'General case' 0 C--O 1.204 -1.303 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -44.89 90.38 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.1 mt -60.1 -44.14 95.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.641 176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.94 -38.01 84.33 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.749 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 44' ' ' SER . 72.5 mtt85 -67.27 -19.8 65.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.71 4.11 6.88 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.85 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 61.9 t -75.98 119.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 pt -98.29 150.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 0.0 111.647 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.45 135.47 27.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -132.56 135.61 46.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.71 143.58 32.9 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.08 122.26 20.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 t -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.42 0.45 . . . . 0.0 110.679 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -100.82 -179.46 4.07 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -109.38 105.34 57.07 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.2 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.91 157.13 15.56 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 122.403 2.069 . . . . 0.0 111.193 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 130.75 32.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.865 1.71 . . . . 0.0 109.819 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -80.17 148.19 31.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 63' ' ' GLY . 21.1 t -76.57 130.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' HG12 ' A' ' 62' ' ' VAL . . . -77.53 161.45 50.05 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 174.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 t30 76.27 -40.12 0.38 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.91 0.884 . . . . 0.0 112.073 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.85 155.97 42.97 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 121.994 -0.441 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -66.43 145.15 76.23 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.245 1.963 . . . . 0.0 109.958 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.51 -38.94 89.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -33.49 75.74 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -73.98 -40.77 62.74 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.9 m -60.96 -40.41 93.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.646 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.67 -38.22 90.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.768 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.78 -46.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.662 0.601 . . . . 0.0 110.092 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.7 mmt -61.77 -49.55 75.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.77 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.57 -41.49 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -41.55 98.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.552 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -65.36 -46.31 80.68 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.696 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.75 -43.88 97.4 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.218 0.607 . . . . 0.0 109.517 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.0 -15.99 54.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.343 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.34 43.61 4.64 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.58 178.93 5.02 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.237 -1.801 . . . . 0.0 112.288 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD11 HD11 ' A' ' 102' ' ' ILE . 1.9 tm? -87.0 135.21 33.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 4' ' ' VAL . 45.0 tp -111.09 122.29 47.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.495 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mt -103.13 110.21 29.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.72 155.17 48.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -108.47 -25.4 10.97 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -75.76 129.55 37.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.755 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -50.85 -50.32 57.07 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 124.683 1.24 . . . . 0.0 112.611 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.47 -27.49 34.57 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.562 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.21 -47.77 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.06 -43.86 97.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.785 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 4.4 t30 -61.56 -47.77 84.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.873 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HG2' HG11 ' A' ' 62' ' ' VAL . 50.4 tptt -66.41 -36.54 83.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.124 0.487 . . . . 0.0 111.1 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.31 84.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.498 0.666 . . . . 0.0 109.871 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -72.76 -26.26 61.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 51.6 mt-10 -63.8 -36.72 84.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.101 0.56 . . . . 0.0 110.23 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.49 -18.96 43.33 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.97 27.54 6.57 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.033 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -98.27 141.17 16.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -81.17 90.75 6.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.72 0.771 . . . . 0.0 109.5 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.0 131.04 54.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.124 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 82' ' ' LEU . 2.3 pp -143.09 157.16 61.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 123.782 0.677 . . . . 0.0 110.268 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.17 167.33 27.62 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.661 2.241 . . . . 0.0 111.981 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 79.4 mt -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.223 1.009 . . . . 0.0 113.274 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.44 -38.05 89.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 111.462 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.6 -31.19 64.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.476 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.44 -39.7 94.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 79.5 mt -68.26 -19.29 64.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.21 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.63 2.41 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -106.49 26.03 10.41 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.921 -0.487 . . . . 0.0 112.007 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.502 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 48.8 m -56.81 126.17 25.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.4 pt? -109.44 28.9 8.07 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.576 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.12 -57.54 11.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.935 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -135.22 -43.89 0.71 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 69.06 -38.59 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.887 1.675 . . . . 0.0 114.014 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -78.13 123.94 27.46 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.9 0.48 . . . . 0.0 111.152 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -78.06 -7.01 56.37 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.88 0.847 . . . . 0.0 111.078 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 175.44 -48.86 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 N--CA 1.416 -2.138 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 165.275 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.71 149.29 24.32 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.23 111.28 10.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 61.8 t -92.67 129.85 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mt -95.3 125.77 47.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.884 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -92.42 141.21 24.54 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -38.84 -32.2 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 125.074 3.849 . . . . 0.0 116.98 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.6 p -64.75 -22.97 67.1 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.754 0.706 . . . . 0.0 112.053 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.44 11.51 25.94 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.381 0.672 . . . . 0.0 111.411 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -76.28 159.63 30.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.359 0.6 . . . . 0.0 112.238 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.3 -34.97 2.2 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.403 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HE2' HG21 ' A' ' 104' ' ' ILE . 58.7 mtpt -96.3 13.12 28.66 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.939 0.876 . . . . 0.0 109.433 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -54.73 -39.21 68.03 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.216 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -73.13 -21.0 60.81 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.98 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -74.53 -58.39 3.32 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 104' ' ' ILE . 23.1 pt -59.34 -48.91 85.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 48' ' ' ARG . 57.6 tp -66.72 -45.96 77.01 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.941 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.16 48.75 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.292 -0.956 . . . . 0.0 114.061 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -84.79 -27.22 27.0 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.384 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.405 ' CG ' ' HB2' ' A' ' 111' ' ' SER . 43.1 t-20 -109.07 -59.1 1.94 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 119.629 -0.828 . . . . 0.0 112.089 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 59.06 -155.86 0.35 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 70.7 -15.32 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 124.847 1.259 . . . . 0.0 113.896 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -104.98 153.6 21.22 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -91.82 97.5 11.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 50' ' ' VAL . 90.2 m-85 -74.6 125.66 29.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.509 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 53.1 t -121.26 135.19 62.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.438 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.1 tt -123.45 154.38 29.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.528 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 20.4 p -89.86 167.93 12.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -45.57 92.45 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.719 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.67 -21.87 61.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -56.68 8.75 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.691 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.7 m -58.58 -38.33 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 117.323 0.561 . . . . 0.0 111.156 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -67.21 -35.05 78.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.91 -40.1 87.57 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.07 78.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.456 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 32' ' ' VAL . 42.7 mm -55.4 -51.15 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.999 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -12.35 61.44 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -106.78 -0.56 23.36 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.02 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.59 29.2 68.11 Favored Glycine 0 C--O 1.242 0.601 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.221 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.93 129.91 37.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.97 111.75 6.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.077 0.942 . . . . 0.0 111.049 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -116.77 -16.98 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.73 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 122.314 -0.241 . . . . 0.0 111.222 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -63.22 -32.18 73.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.14 58.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.39 -43.17 99.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.465 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.26 -43.18 74.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.695 1.198 . . . . 0.0 111.978 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.524 ' HB2' HD21 ' A' ' 17' ' ' LEU . 81.6 mtt180 -77.12 -13.59 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.26 13.38 3.56 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.265 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 25' ' ' PHE . 84.2 t -81.3 133.13 29.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.2 pt -110.52 154.57 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.676 0.274 . . . . 0.0 110.593 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.2 p -107.92 136.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -127.34 133.18 50.11 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.01 130.86 41.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -90.15 137.68 32.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 49.5 m -85.9 -57.59 2.98 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -171.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' SER . 6.9 t60 176.81 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.731 0.696 . . . . 0.0 112.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -137.37 149.2 64.81 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 166.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 16.1 Cg_exo -71.36 123.82 9.87 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.545 -1.367 . . . . 0.0 108.545 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 59' ' ' PRO . 5.6 Cg_exo -75.75 131.11 13.11 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.962 1.774 . . . . 0.0 111.419 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 63.0 mttm -89.63 109.17 20.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.76 162.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.21 -77.13 0.77 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.79 70.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.503 1.144 . . . . 0.0 111.107 175.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -108.09 148.7 38.0 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.164 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.93 140.29 37.95 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.465 2.11 . . . . 0.0 110.688 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -45.38 -45.39 12.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.804 1.241 . . . . 0.0 113.139 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -61.17 -34.57 75.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.83 -28.23 21.76 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -64.08 -38.69 91.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.929 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.528 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.5 tt0 -62.0 -40.82 96.96 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -59.44 -48.7 80.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.917 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 90' ' ' VAL . 61.9 mt -59.99 -45.28 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.907 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 3.7 mmt -62.55 -44.48 96.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 -177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.72 -38.4 82.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.939 0.399 . . . . 0.0 110.746 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.43 80.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.589 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -69.84 -39.43 76.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.482 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 74' ' ' MET . 12.8 mm-40 -60.09 -49.89 75.87 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.485 0.659 . . . . 0.0 111.208 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.61 -16.83 46.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.343 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.5 t30 60.73 56.09 3.08 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.05 177.76 4.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.031 -1.895 . . . . 0.0 111.649 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.38 134.69 34.4 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 34.5 tp -109.19 128.71 55.25 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.452 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.1 mt -106.89 113.09 42.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.56 146.57 32.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.63 -23.52 15.44 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.13 123.94 27.47 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.768 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.56 -38.12 80.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.805 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.57 -31.29 47.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.515 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 73' ' ' ILE . 81.5 t -62.9 -46.53 96.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.26 -49.56 81.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.01 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -56.14 -48.74 75.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.258 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 2.2 tmtm? -65.55 -45.9 81.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.013 0.435 . . . . 0.0 110.351 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.06 82.84 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -57.82 -42.64 84.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.439 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.9 mt-10 -60.39 -35.57 76.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.76 0.824 . . . . 0.0 111.091 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 81.6 mt -77.54 -5.61 50.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.523 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.77 7.22 63.11 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.04 128.22 44.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -82.45 97.95 8.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.616 -1.233 . . . . 0.0 110.307 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.44 127.46 37.94 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.227 174.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.61 146.65 62.32 Favored Pre-proline 0 C--N 1.28 -2.449 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.293 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 40.3 Cg_endo -71.42 167.65 25.73 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.421 2.081 . . . . 0.0 111.065 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 16' ' ' ILE . 63.2 mt -60.18 -40.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.11 -29.56 69.9 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.283 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.2 -32.59 63.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.968 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.39 -34.88 76.82 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 93.2 mt -65.9 -40.73 91.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.185 0.517 . . . . 0.0 109.948 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.57 -25.42 63.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.317 0.579 . . . . 0.0 110.811 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 t -67.5 -15.36 63.62 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.751 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 31.1 t -116.65 99.35 7.08 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 91.8 mt 55.32 89.24 0.04 OUTLIER 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.542 1.137 . . . . 0.0 113.961 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -75.41 -19.94 59.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.9 t60 82.64 86.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.878 2.071 . . . . 0.0 107.902 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.308 72.6 m-70 94.06 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 127.122 2.169 . . . . 0.0 112.914 -174.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -168.83 89.94 0.23 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 66.49 151.89 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.221 1.009 . . . . 0.0 110.314 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -150.3 154.4 37.79 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.813 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 . . . . . 0 C--N 1.305 -1.35 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.292 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -87.88 150.2 23.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -127.77 108.56 10.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -92.12 128.44 43.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 109.705 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.0 mt -93.94 124.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.716 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -87.2 149.01 46.28 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -59.05 -19.34 48.19 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.355 2.703 . . . . 0.0 114.4 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 p -69.1 -19.25 64.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.979 0.418 . . . . 0.0 110.941 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -99.49 13.52 33.06 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.282 0.633 . . . . 0.0 110.963 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 12.2 m-30 -71.44 153.87 41.94 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.18 -33.1 4.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.057 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.42 11.99 35.83 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.078 0.466 . . . . 0.0 111.653 -175.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.8 mp -59.47 -32.01 69.85 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.773 0.796 . . . . 0.0 108.864 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.11 -39.68 87.06 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.319 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.46 -56.29 8.91 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 104' ' ' ILE . 22.0 pt -58.62 -37.63 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.0 tp -72.94 -47.62 43.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.222 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -31.57 31.67 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.34 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -87.72 -22.51 24.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -114.84 -55.77 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.501 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.78 -142.04 0.52 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -171.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 70.77 -13.86 0.46 Allowed 'General case' 0 N--CA 1.518 2.933 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.98 156.4 43.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.9 tpmt? -89.02 102.4 15.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.477 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.9 m-85 -74.71 126.9 31.87 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.344 0.592 . . . . 0.0 110.027 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.3 t -115.69 126.66 73.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.263 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -113.89 145.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.246 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 ' H ' HD13 ' A' ' 27' ' ' ILE . 26.9 p -84.79 160.44 20.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -44.22 97.43 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.968 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.78 -32.21 73.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.634 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.8 77.4 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.705 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.7 m -62.82 -41.56 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.599 0.699 . . . . 0.0 111.659 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -64.72 -36.4 84.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 76.8 t80 -67.75 -43.16 80.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.64 85.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 44.2 mm -64.75 -52.67 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -67.64 -32.53 73.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -88.54 -11.77 44.72 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.09 18.02 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.86 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.4 HG21 ' HB3' ' A' ' 10' ' ' PHE . 66.3 mt -97.0 142.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -67.73 112.66 4.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.046 0.45 . . . . 0.0 110.705 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.62 -26.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.516 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.13 -35.62 78.4 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.659 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.7 p -65.28 -38.86 91.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.485 0.66 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -52.09 63.95 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.596 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.67 -39.78 85.6 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.466 0.65 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.5 -38.42 84.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.467 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.6 mtt180 -87.04 3.48 45.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.36 2.24 7.64 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 118.73 -1.7 . . . . 0.0 115.771 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.6 t -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -105.62 157.34 6.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.2 p -105.86 128.13 60.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.129 0.49 . . . . 0.0 110.768 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.89 137.4 52.83 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.24 126.3 51.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 31.4 t80 -80.83 104.25 11.22 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 p -75.16 -16.98 60.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.107 0.963 . . . . 0.0 113.158 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 49.2 t60 -90.68 159.21 16.5 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 58' ' ' LYS . 53.4 mtpt -75.89 119.44 77.19 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.893 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -86.5 124.92 2.4 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.829 1.686 . . . . 0.0 111.086 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HD2' ' SD ' ' A' ' 74' ' ' MET . 30.7 Cg_endo -66.78 134.11 33.84 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.746 1.631 . . . . 0.0 110.69 176.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -72.39 111.59 7.71 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 65' ' ' LEU . 61.3 t -69.12 134.72 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.23 -61.87 3.81 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 123.622 0.576 . . . . 0.0 114.475 -174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -75.19 -37.47 61.2 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.156 0.503 . . . . 0.0 112.002 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 mt -86.7 132.98 40.76 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -169.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 45.1 Cg_exo -60.05 169.1 5.13 Favored 'Trans proline' 0 C--O 1.256 1.385 0 C-N-CA 122.96 2.44 . . . . 0.0 112.238 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -54.21 -48.53 70.92 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.501 0.72 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.447 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 3.5 p90 -63.22 -31.21 72.3 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -75.71 -42.39 50.97 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -61.57 -39.98 93.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.123 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -54.03 -50.2 67.22 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.572 1.149 . . . . 0.0 109.234 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.01 -48.97 77.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.611 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.05 -45.56 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.934 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.492 ' SD ' ' HD2' ' A' ' 60' ' ' PRO . 29.8 mmt -65.09 -38.31 90.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.68 -43.37 96.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.41 77.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.67 -39.25 80.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.631 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.64 -48.83 36.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.289 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.09 -21.55 50.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.6 t30 65.56 69.08 0.47 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.05 170.7 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.492 -172.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.7 tm? -85.27 122.86 30.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 36.8 tp -99.59 125.75 45.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.18 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.54 113.86 43.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.85 145.54 36.35 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.896 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -95.77 -29.32 14.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' A' ' 90' ' ' VAL . 14.1 t70 -83.71 124.09 30.51 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.858 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.51 -36.53 6.81 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 125.892 1.677 . . . . 0.0 114.402 179.07 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 23.9 t70 -79.72 -33.82 40.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.363 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 87' ' ' ASP . 59.2 t -62.93 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.66 -46.46 93.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.916 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 27.3 t-20 -59.54 -51.6 69.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.1 mmmt -63.01 -41.68 99.64 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.03 88.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.464 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 19.5 ptpt -68.53 -26.18 65.3 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.026 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.2 mt-10 -69.3 -28.74 66.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.189 0.519 . . . . 0.0 109.852 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.44 0.03 56.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.703 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.77 8.76 65.01 Favored Glycine 0 C--O 1.241 0.54 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.4 t -92.66 128.92 43.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.25 92.69 6.38 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.157 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.56 132.41 44.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.759 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.96 155.95 76.05 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.8 Cg_exo -70.76 160.65 48.73 Favored 'Trans proline' 0 C--O 1.256 1.409 0 C-N-CA 121.999 1.799 . . . . 0.0 110.868 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 16' ' ' ILE . 39.8 mt -54.76 -42.9 64.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 123.651 0.78 . . . . 0.0 111.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -63.13 -36.72 84.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.13 -33.06 69.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.975 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.95 -47.95 75.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.8 mt -63.0 -33.33 75.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.056 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.64 59.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.538 ' HA ' ' OE1' ' A' ' 113' ' ' GLU . 50.2 m -109.29 20.98 17.67 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.328 0.585 . . . . 0.0 110.885 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -89.25 -17.63 28.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.87 -27.23 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -169.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 110' ' ' SER . 1.1 mp0 -62.67 -41.46 99.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -172.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.1 m80 63.92 -166.88 0.22 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 59.8 -89.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.859 0.864 . . . . 0.0 111.294 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -114.11 113.87 25.31 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.49 0.662 . . . . 0.0 110.437 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -151.58 28.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 170.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -179.49 102.56 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 129.971 3.308 . . . . 0.0 105.89 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 C--N 1.287 -2.12 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.502 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 C--O 1.245 0.863 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.64 153.0 21.72 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.0 109.69 10.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.61 128.54 44.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.61 123.48 43.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 m -83.93 148.59 54.33 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 77.3 Cg_exo -53.32 -11.25 1.71 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 124.13 3.22 . . . . 0.0 114.679 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.438 ' HB2' ' H ' ' A' ' 86' ' ' GLU . 1.2 m -64.25 -47.36 79.91 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.7 20.33 0.95 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.54 -171.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 4.3 m-30 -70.6 147.77 48.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.084 0.469 . . . . 0.0 111.175 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -34.32 3.53 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.58 -0.77 57.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.606 1.162 . . . . 0.0 109.605 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -47.52 -48.68 27.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.493 1.517 . . . . 0.0 111.999 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -75.12 -22.78 57.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.434 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -75.38 -52.37 10.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 104' ' ' ILE . 23.7 pt -63.57 -41.45 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 48' ' ' ARG . 59.9 tp -65.38 -54.97 21.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.518 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.1 -33.6 56.78 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.225 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -79.35 -55.64 4.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.849 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.593 ' OD1' ' HA ' ' A' ' 111' ' ' SER . 52.1 t30 -75.67 -59.06 2.92 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.017 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 60.09 -156.73 0.34 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 t30 73.11 -13.97 0.65 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.257 1.023 . . . . 0.0 113.38 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -116.35 155.16 28.94 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -90.85 101.92 14.68 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' HB2' HG22 ' A' ' 50' ' ' VAL . 87.1 m-85 -74.66 133.72 42.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.63 140.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.304 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -126.42 154.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 72' ' ' ALA . 81.7 p -99.92 177.9 4.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -47.46 79.54 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 124.685 1.194 . . . . 0.0 112.133 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.61 -24.05 56.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.92 -56.42 22.67 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.044 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.2 m -61.42 -34.59 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 117.049 0.425 . . . . 0.0 111.379 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 m -67.93 -37.34 81.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.114 0.483 . . . . 0.0 110.665 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -69.24 -35.07 75.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.88 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.16 88.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.4 mm -58.81 -53.13 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -29.48 70.29 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 -2.74 58.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.628 0.252 . . . . 0.0 111.558 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.3 41.23 53.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.667 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.66 137.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.43 88.63 3.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.259 1.028 . . . . 0.0 111.134 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -81.8 -22.72 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.333 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -32.38 72.74 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.143 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 m -65.42 -33.44 75.96 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.267 0.556 . . . . 0.0 110.875 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.58 -47.86 16.34 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.3 -42.83 82.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.38 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.52 -41.95 86.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.717 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.7 mtt85 -79.64 -2.6 43.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.64 24.08 4.48 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.923 -1.132 . . . . 0.0 114.771 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 25' ' ' PHE . 95.6 t -86.4 126.7 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 pt -100.47 151.02 5.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.378 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.1 t -99.52 123.25 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -121.3 125.59 47.42 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.1 149.08 22.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 28.7 t80 -85.22 113.02 21.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 m -69.68 -22.92 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.711 0.804 . . . . 0.0 112.712 -174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 61.4 t-80 -88.17 160.61 17.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.67 145.97 94.87 Favored Pre-proline 0 C--O 1.251 1.147 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.463 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.97 143.5 96.02 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 123.145 2.563 . . . . 0.0 112.726 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.51 171.61 16.54 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.538 2.158 . . . . 0.0 111.311 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -100.87 110.49 22.56 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.95 162.56 11.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.24 -68.5 0.56 Allowed Glycine 0 C--N 1.292 -1.903 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.147 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -79.39 -38.83 33.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 83.3 mt -73.97 141.31 78.15 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 29.3 Cg_exo -64.68 148.38 90.24 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.398 2.066 . . . . 0.0 110.068 174.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -58.06 -42.22 85.03 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -61.77 -35.3 77.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 48.4 mt-10 -81.11 -27.26 35.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.221 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -70.51 -32.12 69.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.617 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.77 -46.81 86.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -55.08 -48.14 73.95 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.7 0.625 . . . . 0.0 111.181 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.03 -47.67 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.918 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 1.9 mmt -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.058 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.81 -39.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 120.731 0.301 . . . . 0.0 110.664 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.042 0.449 . . . . 0.0 110.532 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -71.21 -43.74 66.77 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.88 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -50.89 65.22 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 109.787 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.7 -20.34 56.7 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 63.89 68.47 0.57 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 179.74 4.02 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.629 -172.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.93 133.15 36.39 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 30.8 tp -108.91 127.76 54.34 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.391 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.8 mt -105.72 115.65 47.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.2 157.55 44.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.626 0.25 . . . . 0.0 110.424 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' H ' ' HB2' ' A' ' 8' ' ' SER . 49.0 mt-10 -97.92 -43.71 6.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.957 0.408 . . . . 0.0 110.074 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.47 126.84 31.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.474 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -62.49 -28.0 69.52 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.714 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' HA ' ' ND2' ' A' ' 92' ' ' ASN . 15.8 t70 -75.54 -39.48 58.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.18 -51.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.21 -49.9 73.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.664 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.603 ' O ' ' HG3' ' A' ' 96' ' ' GLU 0.264 17.0 p30 -64.9 -42.99 94.3 Favored 'General case' 0 C--O 1.205 -1.255 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.485 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.0 mtpp -63.22 -41.54 99.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.72 99.87 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.26 0.552 . . . . 0.0 109.764 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -72.77 -26.13 61.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.698 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.8 mt-10 -64.62 -37.19 86.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.1 mt -80.82 -15.71 55.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.656 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.31 5.49 28.27 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.083 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.5 t -94.36 130.34 43.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.9 96.7 5.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.086 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.41 133.69 43.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.44 155.26 72.05 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.49 0.493 . . . . 0.0 111.171 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 23.6 Cg_exo -67.91 162.87 37.86 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.519 2.146 . . . . 0.0 112.066 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.431 HG23 ' CG2' ' A' ' 16' ' ' ILE . 84.3 mt -57.66 -46.4 86.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 123.859 0.864 . . . . 0.0 111.597 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.31 -37.71 78.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.85 -39.58 87.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.37 -46.8 81.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.81 -39.59 85.56 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.197 0.599 . . . . 0.0 110.646 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.57 -16.29 60.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.724 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 m -99.02 15.06 27.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.909 0.385 . . . . 0.0 110.274 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.593 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 23.3 t -71.4 108.76 5.0 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.82 83.73 2.09 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.385 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.05 -35.56 78.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 36.6 m80 73.22 169.8 0.31 Allowed 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.414 1.486 . . . . 0.0 112.847 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -65.82 -21.75 66.5 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.5 m80 66.51 -177.49 0.2 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.453 0.701 . . . . 0.0 111.546 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -131.91 107.82 8.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -102.12 144.07 31.14 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.6 t60 . . . . . 0 C--N 1.287 -2.144 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.24 0.581 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.86 154.49 20.49 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.5 108.99 9.95 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.7 t -93.54 134.41 31.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 13' ' ' LEU . 37.9 mt -104.56 134.24 46.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -89.08 146.9 37.35 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.58 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 70.6 Cg_exo -52.65 -28.08 35.83 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.545 2.83 . . . . 0.0 114.328 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 p -61.75 -22.86 65.76 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.97 13.23 31.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.166 0.507 . . . . 0.0 111.445 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 3.6 m-30 -69.88 160.52 31.65 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -34.33 3.65 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.687 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.527 ' HB2' HD13 ' A' ' 104' ' ' ILE . 28.6 mtpp -102.18 13.85 33.56 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.781 0.801 . . . . 0.0 110.382 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' CD2' HG21 ' A' ' 5' ' ' ILE . 61.4 mt -56.93 -40.74 76.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.572 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -65.92 -26.2 67.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.024 -1.443 . . . . 0.0 111.33 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.53 -49.15 9.52 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.74 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' HG23 ' A' ' 104' ' ' ILE . 19.0 pt -63.38 -46.55 95.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 111.368 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.7 tp -67.97 -43.18 79.59 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.853 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.36 -33.19 64.52 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.196 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.1 m -83.79 -45.32 13.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.411 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 61.4 t30 -96.63 -53.67 3.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 58.68 -114.28 0.74 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -164.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.1 t30 55.94 -15.31 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -132.17 166.25 22.24 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.4 -0.813 . . . . 0.0 109.233 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -98.28 105.51 17.67 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.417 ' HB2' HG22 ' A' ' 50' ' ' VAL . 57.9 m-85 -75.26 139.69 42.71 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.8 t -131.05 140.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.373 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 tp -130.0 156.96 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 75' ' ' VAL . 25.7 p -91.64 169.03 11.07 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.171 0.51 . . . . 0.0 111.779 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -41.68 95.16 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.279 1.032 . . . . 0.0 110.176 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.216 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 -52.06 19.57 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.404 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 36' ' ' ILE . 32.1 m -58.58 -38.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.434 0.617 . . . . 0.0 112.001 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 p -75.78 -22.46 56.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.046 0.451 . . . . 0.0 111.34 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -69.1 -40.88 78.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' ILE . . . -66.45 -43.11 86.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.0 mm -57.72 -52.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.736 0.648 . . . . 0.0 111.391 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -65.51 -25.05 67.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -100.34 -28.39 12.98 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.334 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.68 41.57 3.1 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.91 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -100.45 147.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.44 97.89 0.45 Allowed 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.896 0.379 . . . . 0.0 111.511 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.6 tp -108.12 -34.29 2.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.622 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.23 -48.35 80.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.842 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 t -62.56 -37.25 85.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.839 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.5 69.72 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 87.4 mt -57.67 -45.86 85.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.68 -41.54 97.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.93 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HB2' HD21 ' A' ' 17' ' ' LEU . 61.7 mtt180 -74.06 -8.03 54.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.27 23.18 1.78 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.151 -1.499 . . . . 0.0 115.154 175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 62.6 t -98.39 119.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -99.45 155.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 110.991 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.91 135.29 33.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' HG2' HG13 ' A' ' 75' ' ' VAL . 2.9 tpm_? -122.32 125.08 45.19 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.62 111.86 24.72 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.4 t80 -78.48 139.11 38.71 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 m -82.81 -57.24 3.39 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.67 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -173.49 101.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 6.6 tmtt? -135.8 117.22 11.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.64 124.16 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.7 1.6 . . . . 0.0 110.781 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -90.4 168.45 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.306 2.004 . . . . 0.0 112.77 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -113.72 108.15 16.72 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.35 160.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 124.012 0.925 . . . . 0.0 108.923 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.27 -59.04 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -93.35 -1.27 56.12 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.785 0.434 . . . . 0.0 111.197 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.5 mt -99.44 134.03 21.5 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 122.164 -0.335 . . . . 0.0 111.118 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 158.05 55.98 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 122.72 2.28 . . . . 0.0 111.582 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -66.07 -27.91 68.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.985 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.262 5.1 p90 -62.01 -37.09 83.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.737 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -71.29 -38.68 71.77 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 74' ' ' MET . 18.8 m -63.17 -40.9 98.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.699 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -65.97 -35.37 80.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.21 91.8 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.15 -45.09 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.615 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' SER . 26.6 mmt -61.67 -45.16 95.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 53' ' ' ARG . 46.4 t -61.77 -40.66 87.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 120.876 0.37 . . . . 0.0 110.73 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.05 69.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -79.85 -27.61 40.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.323 0.582 . . . . 0.0 110.348 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.25 -48.79 21.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.09 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.69 -12.86 55.31 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.596 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 57.19 63.3 1.93 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.97 -179.92 3.8 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 113.455 -1.702 . . . . 0.0 112.308 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.34 130.83 36.39 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.1 tp -107.55 130.25 54.89 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.301 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -111.03 115.83 50.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.84 146.18 33.9 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.42 -29.0 15.2 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.634 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.37 123.15 24.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -73.17 -17.55 61.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.674 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 34.0 t70 -81.01 -33.18 33.83 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.8 t -60.45 -41.48 87.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.748 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 82.5 mt -59.59 -50.34 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.87 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.674 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.6 p-10 -68.6 -41.47 79.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.2 mmmt -59.23 -43.98 92.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.432 . . . . 0.0 111.542 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.56 96.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.236 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' ILE 0.312 17.4 ptpt -74.55 -18.51 60.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.8 mt-10 -67.4 -29.79 69.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.48 -7.5 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.487 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.07 -7.19 47.97 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.235 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.21 127.21 39.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.27 95.41 3.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.523 . . . . 0.0 110.147 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.35 132.53 44.61 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.232 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.27 153.97 78.44 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 123.566 0.542 . . . . 0.0 110.392 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.7 Cg_endo -76.25 166.99 26.69 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 121.962 1.775 . . . . 0.0 111.637 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 12' ' ' LYS . 41.7 mt -54.74 -44.72 72.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.014 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.54 -25.81 60.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.221 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.21 -44.67 68.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.26 -38.95 93.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.556 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -22.75 64.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.311 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.9 m -84.92 -10.27 57.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.26 0.552 . . . . 0.0 109.912 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 20' ' ' ASN . 10.1 t -89.73 94.15 9.73 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.94 8.33 8.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.392 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.23 -34.17 71.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.526 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -101.0 24.6 9.09 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -9.53 32.36 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.109 0.48 . . . . 0.0 112.267 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -115.23 74.47 0.88 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -81.84 79.78 8.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.194 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -161.98 151.55 16.23 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 . . . . . 0 C--N 1.29 -2.001 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.434 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -87.37 149.17 24.67 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -136.55 114.09 10.98 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.1 t -98.79 132.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -99.67 131.79 46.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.108 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -92.91 148.58 36.13 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 85.2 Cg_exo -53.8 -23.19 26.04 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.502 2.801 . . . . 0.0 114.505 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 p -65.21 -24.27 67.31 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.109 -0.369 . . . . 0.0 111.683 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . . . -91.44 7.74 39.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.108 0.48 . . . . 0.0 111.46 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HB3' HG21 ' A' ' 40' ' ' ILE . 9.5 m-30 -66.81 157.55 32.67 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.81 -35.8 2.09 Favored Glycine 0 C--N 1.318 -0.449 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.208 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -93.59 12.29 25.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.344 1.068 . . . . 0.0 109.366 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.48 -38.66 81.43 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.834 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -58.74 -37.85 77.13 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.196 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -74.41 -59.45 2.72 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.722 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.9 pt -59.48 -43.84 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.4 tp -68.73 -43.9 74.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.831 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.08 -33.15 15.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.492 -0.861 . . . . 0.0 114.893 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 m -81.31 -34.46 31.9 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 117.321 0.56 . . . . 0.0 111.436 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.0 -60.39 2.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 22' ' ' ASN . 4.2 tmmm? 59.83 141.88 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 CA-C-O 122.336 1.065 . . . . 0.0 112.537 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 21' ' ' LYS 0.31 14.4 t-20 81.58 63.84 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 125.509 1.523 . . . . 0.0 114.342 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -146.11 150.27 35.59 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 164.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -87.88 92.89 9.29 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.7 m-85 -74.33 126.43 30.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.131 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.87 133.17 67.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.974 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 tp -117.08 156.93 18.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.626 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.2 p -94.12 165.22 12.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -39.35 93.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.914 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.64 -33.28 66.51 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.48 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.5 -52.4 53.36 Favored Glycine 0 N--CA 1.446 -0.661 0 O-C-N 123.869 0.73 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.7 m -63.04 -39.97 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -65.34 -40.36 93.55 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.101 0.477 . . . . 0.0 110.271 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.52 -49.08 74.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.46 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.25 73.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.799 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.0 mm -59.71 -57.25 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.273 0.358 . . . . 0.0 110.934 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -26.31 63.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -81.37 -18.66 44.8 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.423 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.21 37.24 25.28 Favored Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.525 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.4 mt -101.35 140.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.7 98.54 0.07 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.574 0.75 . . . . 0.0 111.446 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.49 -30.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.14 -49.46 77.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 23.0 t -62.91 -34.39 77.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.709 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.9 63.02 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.4 mt -60.99 -39.89 91.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.955 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.24 -39.39 92.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.308 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.544 ' HB2' HD21 ' A' ' 17' ' ' LEU . 63.2 mtt180 -79.22 -7.22 58.08 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.35 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.06 12.09 4.06 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.995 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 90.2 t -82.58 131.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 pt -108.43 148.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 p -101.89 127.98 54.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 120.885 0.374 . . . . 0.0 111.257 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -118.52 154.24 32.87 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.322 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.32 116.63 30.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.73 98.05 11.55 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.4 t -70.49 -29.36 65.87 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.547 1.139 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -76.63 148.1 37.14 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -92.41 121.4 66.46 Favored Pre-proline 0 C--N 1.294 -1.834 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.5 148.55 20.0 Favored 'Trans proline' 0 C--O 1.257 1.434 0 C-N-CA 124.062 3.175 . . . . 0.0 114.101 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 149.6 55.43 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.966 2.444 . . . . 0.0 110.246 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 3.3 mptp? -81.3 110.28 16.61 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.509 0.671 . . . . 0.0 111.539 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.75 106.83 19.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 66.26 0.85 Allowed Glycine 0 C--N 1.321 -0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.713 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -176.94 -44.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.058 0.943 . . . . 0.0 108.893 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 76.7 mt -93.52 138.78 22.82 Favored Pre-proline 0 C--O 1.243 0.757 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.512 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 8.3 Cg_exo -71.06 150.28 60.04 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.246 1.964 . . . . 0.0 109.874 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.89 -28.91 62.49 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -64.64 -33.16 75.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.632 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.55 -44.62 50.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.6 m -59.7 -38.09 80.63 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.993 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.626 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 35.7 tt0 -63.74 -40.65 97.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.89 87.83 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.13 -46.05 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.181 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.82 -37.59 88.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.15 -36.43 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.234 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.62 -33.35 73.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.237 0.541 . . . . 0.0 110.306 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.68 -35.93 70.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.605 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.48 -52.29 41.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.674 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.44 -15.12 53.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.811 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.78 62.85 1.8 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -170.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 177.82 4.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.813 -1.994 . . . . 0.0 111.368 -171.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.15 126.09 35.68 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.0 tp -103.02 125.74 49.9 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.499 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -107.25 118.98 56.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -147.76 159.17 44.11 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mt-10 -103.43 -25.93 13.07 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.152 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.39 126.61 31.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.076 -173.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.43 -42.09 63.82 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 124.423 1.077 . . . . 0.0 112.705 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.428 ' HA ' ' ND2' ' A' ' 92' ' ' ASN . 21.0 t70 -76.5 -35.27 58.45 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.586 -174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.77 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.99 -48.42 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 89' ' ' ASP . 23.3 p30 -68.64 -37.49 79.74 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HD2' ' OE2' ' A' ' 96' ' ' GLU . 31.6 mmmt -67.19 -39.2 86.33 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.46 87.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -60.23 -42.39 95.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.341 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 52.9 mt-10 -55.82 -42.59 75.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.176 0.59 . . . . 0.0 111.097 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.72 -8.49 56.96 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.987 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.54 44.1 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.08 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.26 129.46 46.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.15 92.85 6.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.451 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -97.93 136.0 38.85 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.606 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.24 152.23 73.11 Favored Pre-proline 0 C--N 1.293 -1.885 0 O-C-N 123.376 0.423 . . . . 0.0 110.609 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 16.9 Cg_exo -68.73 160.27 50.24 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 121.968 1.779 . . . . 0.0 110.712 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG23 ' CG2' ' A' ' 16' ' ' ILE . 53.6 mt -54.78 -42.92 64.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 123.837 0.855 . . . . 0.0 111.728 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -63.07 -25.32 68.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.991 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.59 -34.84 46.51 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.828 0.346 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.88 -41.85 95.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.9 mt -64.14 -41.76 97.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.249 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.36 33.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.637 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 t -113.02 3.48 16.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 m -87.56 65.57 8.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 0.0 110.48 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.584 ' HG ' ' H ' ' A' ' 114' ' ' HIS . 1.8 pt? -171.63 -172.4 1.04 Allowed 'General case' 0 C--O 1.247 0.944 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.885 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -15.07 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.093 0.246 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.584 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 69.6 t60 80.51 14.07 0.8 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.096 1.358 . . . . 0.0 110.127 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 57.37 -79.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.389 1.475 . . . . 0.0 113.178 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -133.4 119.91 20.26 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -78.42 -31.61 48.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -157.48 -44.22 0.07 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 126.625 1.97 . . . . 0.0 107.312 171.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 . . . . . 0 CA--C 1.491 -1.292 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.68 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.246 0.881 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.412 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 95.5 m-85 -87.8 152.93 21.74 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.91 108.28 7.81 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 26' ' ' VAL . 46.6 t -92.85 131.65 39.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -175.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -97.72 132.39 42.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.41 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -92.84 149.39 37.7 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 Cg_exo -57.07 -15.17 16.76 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 123.441 2.761 . . . . 0.0 114.961 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -75.14 -22.03 58.4 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.769 -0.582 . . . . 0.0 111.099 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.21 10.11 25.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.484 0.659 . . . . 0.0 110.995 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.459 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.9 m-30 -72.08 156.3 39.35 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.498 0.666 . . . . 0.0 111.749 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -33.7 4.88 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.741 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 57.8 mtpt -106.46 18.54 21.8 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 122.405 1.098 . . . . 0.0 109.539 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.94 -39.5 94.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.696 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -68.6 -35.21 77.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.15 -175.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 -54.57 19.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.676 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.5 pt -57.77 -39.81 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp -59.33 -55.05 39.64 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.764 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.93 -33.42 41.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.955 -1.117 . . . . 0.0 113.718 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -77.53 -15.49 59.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' OD1' ' HG ' ' A' ' 112' ' ' LEU . 54.1 t30 -122.42 -60.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.687 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 60.23 -171.45 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.308 0.643 . . . . 0.0 111.609 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.2 -14.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.677 1.991 . . . . 0.0 115.013 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -93.05 149.32 21.31 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -90.73 99.67 12.66 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.4 m-85 -74.71 131.42 40.84 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.636 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 4' ' ' VAL . 39.5 t -122.16 136.39 59.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.593 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.65 153.32 27.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.614 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 25.6 p -92.47 166.91 12.3 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.088 0.471 . . . . 0.0 112.007 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -41.09 99.03 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.443 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.45 -31.72 69.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -56.43 24.17 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.107 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -59.99 -40.74 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -63.77 -38.32 90.68 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.72 -39.6 76.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.671 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.06 -42.14 94.48 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.4 mm -56.34 -52.63 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 123.759 0.662 . . . . 0.0 110.951 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -21.79 61.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 m -88.74 -23.58 22.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.44 41.55 6.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.886 -1.15 . . . . 0.0 111.575 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.7 mt -103.22 153.53 5.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.85 83.25 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.118 0.485 . . . . 0.0 110.561 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -93.13 -27.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 -38.47 89.14 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.44 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.2 m -72.88 -24.45 60.85 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.421 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.77 -52.63 9.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.185 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.19 -40.35 81.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.689 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.48 -44.82 72.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.636 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 17' ' ' LEU . 53.5 mtt85 -81.65 -5.71 58.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.44 5.2 6.67 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 118.898 -1.62 . . . . 0.0 115.146 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.95 124.82 28.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.57 0.685 . . . . 0.0 109.167 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.79 149.82 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.931 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.03 120.39 45.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HG2' HG13 ' A' ' 75' ' ' VAL . 31.8 tpt180 -113.14 126.51 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.54 125.32 40.93 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 74' ' ' MET . 13.4 t80 -73.68 100.42 3.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -66.05 -30.76 71.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.106 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -77.12 145.7 37.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.72 126.62 92.84 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.46 124.34 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 113.236 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.3 142.62 98.61 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.422 2.081 . . . . 0.0 110.003 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.59 110.37 19.2 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.076 0.465 . . . . 0.0 111.598 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.2 97.18 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.86 69.19 1.55 Allowed Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.161 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -176.36 -40.14 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.095 0.958 . . . . 0.0 109.57 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 93' ' ' LYS . 84.8 mt -107.56 154.73 40.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -59.03 148.11 86.92 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.738 2.292 . . . . 0.0 111.229 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.81 -44.37 77.8 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.204 1.002 . . . . 0.0 111.307 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -63.93 -34.69 78.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 73' ' ' ILE . 26.6 mm-40 -70.36 -39.92 74.34 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -63.15 -41.04 99.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.184 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.614 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -60.31 -39.6 87.56 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.33 83.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.48 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 69' ' ' GLU . 61.5 mt -58.18 -43.64 86.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.401 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 19.8 mmt -67.43 -38.68 84.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.093 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 53' ' ' ARG . 55.8 t -66.2 -39.62 84.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.358 0.599 . . . . 0.0 110.209 176.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.66 71.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.118 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.69 -47.03 64.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.184 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.13 -39.07 79.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 111.328 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.19 -11.43 57.87 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.332 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.4 t30 57.46 59.26 3.38 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -117.76 177.11 4.89 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.148 -171.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.42 141.47 28.71 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.2 tp -105.72 124.66 49.93 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.815 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.08 110.77 25.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -138.96 147.48 42.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.06 -28.43 12.35 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 91' ' ' ILE . 19.6 t70 -76.06 122.47 24.29 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.02 -29.54 69.77 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.621 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 23.0 t70 -79.73 -39.27 31.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.5 -44.3 88.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.067 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 87' ' ' ASP . 96.7 mt -57.62 -49.91 79.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.621 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.4 p-10 -69.57 -42.94 73.83 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.223 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 65' ' ' LEU . 32.2 mmmt -60.52 -41.99 95.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.425 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.54 92.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 5.2 ptmm? -71.33 -25.5 62.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.035 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 44.0 mt-10 -74.02 -30.34 62.39 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 174.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 95.2 mt -79.89 -12.45 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.248 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 12.78 16.43 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.601 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 44.6 t -108.48 132.14 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.98 97.47 6.07 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 118.904 -1.118 . . . . 0.0 109.727 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.3 129.3 41.02 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.781 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 106' ' ' GLU . 2.6 pp -130.14 143.49 49.35 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.034 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 33.2 Cg_exo -61.28 158.36 35.79 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.363 2.042 . . . . 0.0 110.947 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 9.5 mt -54.06 -40.47 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.39 -20.43 65.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 102' ' ' ILE . 53.0 mm-40 -76.68 -31.8 57.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.886 0.85 . . . . 0.0 109.125 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.48 -32.72 66.44 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.018 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.3 mt -79.64 -48.55 13.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.172 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.08 63.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.846 0.355 . . . . 0.0 111.788 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m -97.14 35.91 1.52 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.796 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.0 p -62.23 96.19 0.07 Allowed 'General case' 0 C--O 1.255 1.383 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 20' ' ' ASN . 85.9 mt 71.06 108.8 0.06 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 125.057 1.343 . . . . 0.0 113.766 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -41.78 39.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.787 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.518 ' CE1' HD13 ' A' ' 112' ' ' LEU . 13.0 m170 63.94 173.58 0.18 Allowed 'General case' 0 C--O 1.246 0.879 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 66.77 172.72 0.25 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.99 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -140.8 144.16 35.25 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 119.596 -0.842 . . . . 0.0 108.87 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -44.33 121.91 2.78 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.529 1.143 . . . . 0.0 113.916 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -68.43 -34.75 76.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.233 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.149 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.502 -0.899 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.39 153.65 21.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.65 107.69 9.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 83' ' ' LEU . 46.9 t -92.38 131.73 38.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.7 mt -97.26 128.77 48.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.328 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 m -88.51 149.58 44.66 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 49.1 Cg_exo -58.03 -21.75 51.9 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.105 2.537 . . . . 0.0 113.404 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 p -68.84 -19.35 64.26 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.93 16.44 19.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.264 0.554 . . . . 0.0 111.521 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.5 m-30 -75.5 156.45 35.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.95 -34.32 5.0 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.565 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.2 mmmp? -98.38 15.54 24.4 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.75 -38.83 86.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.129 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.62 -36.41 80.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.805 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.85 -56.08 5.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.329 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.482 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.5 pt -58.24 -41.22 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 48' ' ' ARG . 36.7 tp -72.25 -52.86 14.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.234 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.63 -31.15 58.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.84 -0.695 . . . . 0.0 114.3 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.8 m -83.3 -39.31 20.98 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 117.652 0.726 . . . . 0.0 112.231 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -91.26 -59.55 2.12 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.225 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.8 -152.53 0.37 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 t30 70.05 -14.28 0.39 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 125.013 1.325 . . . . 0.0 112.845 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -115.5 160.17 20.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 123.135 0.574 . . . . 0.0 109.63 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.6 102.07 13.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CB ' HG22 ' A' ' 50' ' ' VAL . 57.0 m-85 -75.41 136.66 40.73 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG22 ' A' ' 4' ' ' VAL . 54.9 t -128.71 139.62 51.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.442 -177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 10.2 tp -127.58 158.86 38.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -96.71 168.53 10.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 122.138 -0.351 . . . . 0.0 110.404 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.8 p -68.69 -39.06 80.72 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.09 -31.8 72.53 Favored 'General case' 0 C--O 1.214 -0.807 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.92 -54.06 36.15 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.496 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.562 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.6 m -62.93 -35.12 69.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.046 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -68.4 -38.75 81.58 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -63.06 -40.52 97.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.68 96.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.376 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.7 mm -60.07 -53.91 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -93.25 -9.87 37.57 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.502 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.82 37.81 60.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.655 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.91 140.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.06 108.94 1.66 Allowed 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.819 0.699 . . . . 0.0 112.367 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.3 tp -113.73 -9.38 12.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.494 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.21 -49.01 66.14 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.113 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -62.21 -26.5 68.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.703 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -69.58 -57.08 5.64 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.552 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.47 -39.74 80.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.906 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.97 -47.17 81.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.979 1.312 . . . . 0.0 112.804 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 17' ' ' LEU . 72.5 mtt85 -91.25 4.05 53.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 6.06 6.59 Favored Glycine 0 CA--C 1.505 -0.534 0 C-N-CA 118.67 -1.729 . . . . 0.0 115.813 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' CB ' ' A' ' 25' ' ' PHE . 57.8 t -81.03 120.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.653 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.4 p -98.02 128.28 49.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.186 0.517 . . . . 0.0 111.444 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -150.5 126.89 10.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.7 158.68 39.96 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.324 0.39 . . . . 0.0 110.617 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -85.03 138.0 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 123.844 0.715 . . . . 0.0 110.254 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.2 t -92.75 -31.7 14.96 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.27 100.38 5.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.739 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -137.15 147.98 60.69 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 165.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.26 123.2 10.02 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -88.76 128.87 2.06 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 120.503 0.802 . . . . 0.0 113.091 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -116.01 109.51 17.64 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 172.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 65' ' ' LEU . 29.8 m -135.43 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 120.937 0.399 . . . . 0.0 110.65 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.65 -71.03 0.28 Allowed Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -14.68 22.4 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 97.1 mt -107.01 148.24 36.61 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.409 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 3.0 Cg_exo -78.62 169.82 19.18 Favored 'Trans proline' 0 C--O 1.265 1.839 0 C-N-CA 123.05 2.5 . . . . 0.0 109.489 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -60.03 -42.74 95.06 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -55.26 -38.98 69.25 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.9 -40.92 71.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 0.0 109.685 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 m -73.79 -24.31 59.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.699 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.67 -45.11 95.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.71 87.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.752 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.4 -44.41 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.155 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 3.4 mmt -60.71 -48.61 81.02 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.145 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.7 -38.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.907 0.384 . . . . 0.0 110.612 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.9 84.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.398 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -71.13 -40.73 71.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.23 0.538 . . . . 0.0 109.885 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -63.92 -45.1 90.79 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.982 0.913 . . . . 0.0 111.363 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.18 -15.13 44.73 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.044 -0.41 . . . . 0.0 111.695 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 57.8 60.16 2.89 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.913 1.34 . . . . 0.0 107.661 -169.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.46 175.43 5.47 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.272 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.46 135.28 33.69 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 4' ' ' VAL . 41.5 tp -110.83 125.19 53.34 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.713 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -98.1 110.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.25 146.55 35.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.307 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -108.78 -20.53 13.03 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.103 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 10.5 t70 -79.2 132.79 36.63 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -63.04 -35.43 80.22 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.28 -28.41 34.69 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.658 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 87' ' ' ASP . 91.4 t -63.64 -49.89 80.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.0 mt -57.58 -47.21 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.982 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.0 t30 -63.12 -54.74 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 84.5 tttt -55.79 -51.26 68.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.52 1.128 . . . . 0.0 111.367 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.4 93.72 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.603 0.565 . . . . 0.0 111.258 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 21.2 ttmm -65.27 -38.77 91.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.112 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.1 mt-10 -62.7 -38.72 91.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.221 0.534 . . . . 0.0 109.762 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 81.8 mt -72.68 -13.2 61.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.437 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.14 5.39 37.81 Favored Glycine 0 CA--C 1.501 -0.803 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.358 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.3 t -92.83 137.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.59 96.34 10.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.092 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.81 127.02 42.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.83 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.24 152.83 78.92 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 26.3 Cg_exo -66.53 163.44 32.59 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.353 2.035 . . . . 0.0 112.181 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 12' ' ' LYS . 72.3 mt -52.74 -43.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.543 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -65.64 -27.96 68.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.12 -32.13 56.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.135 0.493 . . . . 0.0 110.411 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.88 -40.81 75.45 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.98 -43.28 96.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.059 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.64 94.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.394 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -63.92 -10.24 19.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.7 t -76.3 -22.22 55.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.3 mt -109.05 95.52 5.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -81.59 -58.28 3.09 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -165.61 167.22 17.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -77.84 114.16 16.43 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.969 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -85.57 169.58 13.4 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.347 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -66.68 139.05 57.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 123.411 0.445 . . . . 0.0 110.298 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -59.9 119.56 7.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.217 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.409 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -86.98 150.21 24.22 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -131.35 107.65 9.09 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 40.8 t -93.24 130.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.74 125.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.601 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -87.04 147.54 43.04 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 59.4 Cg_exo -53.17 -28.22 40.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.071 2.514 . . . . 0.0 113.971 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.3 m -60.53 -22.23 63.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.89 13.52 32.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.97 0.414 . . . . 0.0 111.382 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.8 m-30 -70.12 162.85 27.5 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.798 0.809 . . . . 0.0 112.604 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -33.88 3.63 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.153 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -95.98 14.24 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.671 0.789 . . . . 0.0 110.215 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -38.74 75.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.569 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -74.49 -26.98 60.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.141 0.496 . . . . 0.0 110.918 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.0 -46.67 20.38 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.728 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.6 pt -66.21 -39.65 84.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.301 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 48' ' ' ARG . 5.4 mp -65.24 -54.62 26.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.805 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.91 -31.3 75.21 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.635 -0.711 . . . . 0.0 114.147 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -88.63 -29.96 19.56 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -106.38 -59.24 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 118.34 -1.344 . . . . 0.0 113.64 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 56.07 -152.96 0.36 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -167.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 69.3 -15.0 0.29 Allowed 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 124.791 1.236 . . . . 0.0 113.566 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.73 149.09 32.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -86.85 98.08 11.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.019 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -75.0 129.6 37.92 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.065 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 52.0 t -125.01 138.0 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.172 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -130.87 142.38 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.498 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 23.2 p -82.7 165.12 20.23 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -38.24 78.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.8 -29.61 66.95 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.81 -54.09 33.44 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.399 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.0 m -60.82 -35.72 66.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.0 m -65.73 -42.24 91.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.74 -37.37 86.32 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.67 76.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.479 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.2 mm -59.33 -49.93 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.821 0.448 . . . . 0.0 111.201 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -98.12 -14.56 20.36 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 120.809 0.338 . . . . 0.0 111.607 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.55 35.31 20.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.155 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -92.32 146.54 6.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.74 88.3 5.21 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.889 1.328 . . . . 0.0 111.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 tp -88.72 -19.22 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.724 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.34 -49.36 76.4 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 125.908 1.683 . . . . 0.0 109.437 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -59.78 -30.92 69.22 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 111.226 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -75.21 -52.75 10.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.016 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.44 -39.33 79.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.95 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.01 -40.31 76.37 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.321 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.594 ' HB2' HD23 ' A' ' 17' ' ' LEU . 45.5 mtt85 -82.98 -10.02 58.99 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.86 15.63 3.15 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.322 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.28 123.92 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -96.83 143.78 11.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.024 0.44 . . . . 0.0 110.871 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.9 t -87.9 136.81 22.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.69 126.59 43.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.809 176.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.73 114.82 26.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 44.0 t80 -70.58 141.8 51.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 m -68.69 -58.43 4.24 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 175.28 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -136.29 142.59 40.3 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 124.079 0.952 . . . . 0.0 109.144 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.34 142.1 84.3 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.805 1.67 . . . . 0.0 108.622 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.53 130.61 36.3 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.549 2.166 . . . . 0.0 113.394 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -110.82 109.82 20.18 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 65' ' ' LEU . 27.3 m -148.12 162.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.647 -169.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.76 -67.13 1.18 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -127.68 -4.64 5.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.285 1.04 . . . . 0.0 109.697 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.555 ' HG ' ' OD2' ' A' ' 89' ' ' ASP . 59.4 mt -58.73 144.31 80.71 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.716 -176.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.71 166.12 28.95 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.389 2.059 . . . . 0.0 110.376 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -56.64 -36.03 69.02 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -62.83 -38.33 90.32 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' OE2' ' HB2' ' A' ' 7' ' ' PRO . 69.9 mm-40 -71.03 -36.16 72.27 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -62.04 -41.96 98.67 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.77 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.498 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -62.55 -36.85 83.94 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.16 78.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.109 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.78 -44.71 98.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.064 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.401 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 18.7 mmt -59.12 -45.96 89.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.19 -39.08 83.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-O 121.153 0.502 . . . . 0.0 110.131 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.03 66.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -75.2 -36.75 61.37 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.091 0.556 . . . . 0.0 110.477 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.58 -44.44 74.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.319 0.581 . . . . 0.0 111.536 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.84 -19.03 31.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.733 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.44 67.74 0.94 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -171.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.7 3.99 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.87 -170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 2.3 tm? -90.51 126.77 36.03 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -108.33 120.72 43.2 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.821 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.0 mt -94.21 112.14 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -145.02 139.71 27.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.878 0.37 . . . . 0.0 111.581 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.73 -22.69 16.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.606 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' HG23 ' A' ' 90' ' ' VAL . 12.6 t70 -87.67 132.95 33.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -51.17 -48.25 61.94 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 124.184 0.927 . . . . 0.0 113.07 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.607 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.4 t70 -69.4 -27.7 65.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 123.549 0.531 . . . . 0.0 111.374 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 87' ' ' ASP . 40.5 t -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.03 -50.01 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.866 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.0 p-10 -70.57 -36.64 73.72 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 43.6 tptt -66.43 -40.97 89.83 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.468 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -67.89 -36.49 80.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.062 0.458 . . . . 0.0 109.827 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.78 -40.88 89.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.838 0.855 . . . . 0.0 109.233 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 62.6 mt-10 -63.18 -35.92 81.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.804 0.812 . . . . 0.0 110.787 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.12 -5.87 59.32 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.045 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.52 21.11 41.79 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.645 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 64.5 t -106.03 137.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -84.69 95.34 8.89 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.429 0.633 . . . . 0.0 110.966 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.68 131.23 45.01 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.882 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.95 155.45 76.3 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 122.686 0.394 . . . . 0.0 110.683 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.5 Cg_exo -71.7 162.03 43.37 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.151 1.901 . . . . 0.0 110.656 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.4 mt -54.21 -38.16 38.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 123.652 0.781 . . . . 0.0 112.71 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.23 -34.1 76.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.594 0.235 . . . . 0.0 110.945 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.85 -30.45 62.67 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.276 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.88 -38.79 89.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.76 -43.51 83.9 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.971 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.56 65.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -76.03 -12.22 60.09 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 121.637 0.732 . . . . 0.0 110.593 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 m -87.38 152.74 22.0 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 112' ' ' LEU 0.275 2.2 pt? -83.57 86.66 7.07 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.542 -1.663 . . . . 0.0 110.636 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.32 -47.9 77.65 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 18.6 p-80 -94.05 121.76 35.87 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.97 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -95.07 -16.06 22.96 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 114' ' ' HIS . 37.2 m80 -142.15 -175.34 4.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -76.83 105.5 7.93 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.325 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -82.72 115.36 21.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.084 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.295 -0.859 . . . . 0.0 109.805 179.025 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.245 0.831 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -87.68 146.8 25.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.03 13.93 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 83' ' ' LEU . 55.2 t -91.85 126.2 44.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt -93.12 125.7 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.885 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -89.48 152.22 47.08 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 82.6 Cg_exo -50.65 -27.95 21.06 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.461 2.774 . . . . 0.0 111.681 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -51.78 -36.42 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.864 1.266 . . . . 0.0 111.651 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 6.61 41.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.366 0.603 . . . . 0.0 111.625 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 10.0 m-85 -79.38 134.49 36.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.274 0.559 . . . . 0.0 111.323 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.14 -36.28 3.79 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HB2' HD13 ' A' ' 104' ' ' ILE . 27.5 mtpp -110.36 15.74 22.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.92 -39.14 62.55 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.938 1.695 . . . . 0.0 110.877 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.94 -35.95 82.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.801 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.95 -53.39 21.07 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.648 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CG2' HG23 ' A' ' 104' ' ' ILE . 25.9 pt -60.87 -41.13 87.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.2 tp -69.35 -55.08 11.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.598 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.45 -34.12 12.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.743 -1.218 . . . . 0.0 114.694 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 m -84.4 -25.84 28.76 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 117.683 0.741 . . . . 0.0 112.015 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.586 ' OD1' ' HB2' ' A' ' 111' ' ' SER . 35.3 t30 -97.55 -59.63 1.74 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.852 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 58.31 -140.82 0.74 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.07 -14.79 0.29 Allowed 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -135.5 162.23 33.24 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -93.47 108.42 20.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' HG22 ' A' ' 50' ' ' VAL . 99.2 m-85 -79.06 125.97 30.1 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.852 -176.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.63 134.64 60.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.114 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.5 tp -121.19 153.58 24.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 47.2 p -97.19 176.77 5.8 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.996 0.427 . . . . 0.0 111.929 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -42.57 85.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 123.686 0.794 . . . . 0.0 112.11 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.61 -24.47 56.52 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.59 -49.52 59.64 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.376 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.9 m -66.89 -32.07 56.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 m -65.96 -40.52 91.38 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.59 -44.54 93.34 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.732 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' VAL . 48.3 mm -64.14 -48.32 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.296 0.372 . . . . 0.0 111.039 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.65 -30.12 65.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.3 t -84.41 -28.2 27.08 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.976 0.417 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.43 34.64 6.93 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.154 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.4 mt -97.27 149.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.09 87.77 0.78 Allowed 'General case' 0 C--O 1.241 0.63 0 O-C-N 123.315 0.384 . . . . 0.0 111.406 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -86.11 -27.13 6.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.31 -45.32 93.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -66.37 -29.8 70.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.796 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -67.88 -51.29 49.85 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.51 -40.12 81.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.085 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.9 -38.83 89.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.17 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.5 mtt180 -87.85 2.9 50.27 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.89 -2.5 7.96 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.43 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 25' ' ' PHE . 73.1 t -72.61 132.79 32.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 117.79 0.795 . . . . 0.0 109.645 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.7 pt -111.39 142.91 22.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.267 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.46 116.41 41.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-O 121.332 0.587 . . . . 0.0 110.689 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -118.64 126.27 51.57 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.4 150.76 21.12 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 57' ' ' HIS . 45.1 t80 -81.48 109.29 15.81 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -74.09 9.72 1.49 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.292 1.037 . . . . 0.0 113.181 -173.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 55' ' ' PHE . 64.2 m-70 -122.86 176.12 6.17 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.58 116.31 39.08 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.69 124.15 12.38 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 121.561 1.507 . . . . 0.0 110.943 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.39 163.89 12.81 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.272 1.981 . . . . 0.0 112.369 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HE2' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -111.71 121.93 46.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.7 123.6 37.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.7 66.62 1.36 Allowed Glycine 0 C--O 1.238 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.733 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.9 t30 175.69 -39.8 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 125.815 1.646 . . . . 0.0 108.697 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -107.72 149.38 38.88 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.332 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.5 145.75 92.33 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.077 1.851 . . . . 0.0 110.647 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.467 ' NE2' ' HE2' ' A' ' 61' ' ' LYS . 58.0 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.718 0.407 . . . . 0.0 111.602 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -64.4 -33.31 75.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.878 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.35 -37.19 63.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.2 m -64.46 -39.92 94.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.535 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.4 tt0 -63.42 -40.5 97.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -61.1 -45.46 94.62 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 90' ' ' VAL . 73.4 mt -59.58 -45.45 94.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.207 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.413 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmt -60.79 -47.35 86.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.61 -37.97 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.031 0.443 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.44 -29.59 69.1 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.43 -34.06 36.38 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.13 0.572 . . . . 0.0 110.583 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -46.21 68.05 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.467 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.24 -20.81 43.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.794 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 56.93 64.39 1.66 Allowed 'General case' 0 C--O 1.247 0.924 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.61 -176.81 3.07 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.805 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.29 126.76 35.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 4' ' ' VAL . 43.5 tp -107.73 127.5 53.74 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.534 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mt -106.39 114.95 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -148.13 155.17 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.84 -35.5 9.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.78 118.88 12.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.545 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -74.57 -17.56 60.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.182 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.63 -39.18 24.84 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 73' ' ' ILE . 79.3 t -59.78 -51.68 70.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.588 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.9 mt -54.1 -44.93 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.437 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.3 t30 -54.29 -52.21 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.752 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.79 -43.71 95.5 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.555 0.535 . . . . 0.0 110.752 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.55 97.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.035 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -70.71 -28.43 64.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.2 mt-10 -68.45 -28.98 67.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.14 0.495 . . . . 0.0 109.811 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.86 -11.83 58.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.655 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.85 14.17 35.05 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.51 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -86.83 90.89 8.47 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.91 132.85 49.77 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.362 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.74 157.82 64.03 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 123.972 0.795 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.3 Cg_exo -70.45 164.7 34.26 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.505 HG23 ' CG2' ' A' ' 16' ' ' ILE . 33.9 mt -58.35 -46.93 89.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.327 53.7 mt-10 -76.03 -16.0 60.03 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.87 -35.03 38.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 16' ' ' ILE . 3.3 tm? -60.83 -43.01 98.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.895 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.87 -34.66 78.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.164 0.507 . . . . 0.0 110.523 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.8 -4.42 43.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.363 0.602 . . . . 0.0 111.067 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.3 m -85.17 -4.03 59.02 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.586 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 36.1 t -113.21 107.48 15.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -143.45 -16.58 0.64 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.345 0.593 . . . . 0.0 111.98 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.515 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -80.9 84.88 6.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -134.4 -64.52 0.68 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -119.26 17.71 13.07 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 113' ' ' GLU . 39.5 t60 -129.5 136.1 49.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -118.7 -52.58 2.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.836 0.35 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 . . . . . 0 C--N 1.296 -1.747 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.821 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.248 0.977 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.43 147.04 25.6 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.56 110.93 11.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.1 t -94.6 133.11 36.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.06 129.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -85.91 144.39 39.19 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 84.6 Cg_exo -52.52 -18.03 7.69 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.786 2.991 . . . . 0.0 113.879 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 p -73.99 -20.13 60.43 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.04 0.448 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.96 12.04 33.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.524 . . . . 0.0 111.224 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-85 -73.11 153.97 40.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.36 -34.22 3.31 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -92.66 1.6 57.18 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 124.577 1.151 . . . . 0.0 109.713 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -51.4 -39.97 58.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.038 1.335 . . . . 0.0 111.949 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.88 -33.59 76.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.861 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.41 -49.13 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.997 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.405 ' CG2' HG23 ' A' ' 104' ' ' ILE . 26.5 pt -68.26 -43.44 84.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.891 0.377 . . . . 0.0 111.935 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 52.6 tp -70.31 -48.56 56.05 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.83 -33.16 74.8 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.181 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 m -90.43 -15.1 31.55 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.439 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -114.64 -59.17 2.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 55.57 -155.21 0.28 Allowed 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 70.7 -13.97 0.45 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.99 148.33 34.03 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -85.87 96.47 9.79 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.2 m-85 -74.38 129.8 38.46 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.064 -176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.0 t -127.4 138.65 54.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.87 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 8.4 tp -123.7 160.21 27.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.575 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.8 p -99.62 165.48 11.59 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 120.835 0.35 . . . . 0.0 111.647 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.44 -36.66 84.89 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.919 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.96 -18.46 60.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.062 0.458 . . . . 0.0 110.014 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.24 -44.68 17.02 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 36' ' ' ILE . 20.2 m -66.64 -36.44 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.8 p -72.41 -31.96 65.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.535 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.63 -42.34 92.51 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -65.05 -47.68 76.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.57 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.0 mm -59.15 -45.85 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.581 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.23 -26.53 62.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -103.46 4.08 35.65 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.52 37.92 85.88 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.354 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.09 155.92 4.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.41 129.6 35.12 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.69 -40.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.802 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.76 -31.52 72.21 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 122.159 -0.338 . . . . 0.0 111.01 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 m -57.72 -40.64 80.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 123.774 0.671 . . . . 0.0 109.922 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.15 60.08 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.808 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.6 mt -57.72 -45.11 86.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.058 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.37 -39.83 92.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.564 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 78.6 mtt180 -77.23 -3.79 41.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.85 7.43 5.59 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.017 -1.563 . . . . 0.0 115.862 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 63.6 t -86.78 138.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 pt -113.1 167.41 6.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 14.4 p -120.16 144.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.456 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' THR . 49.4 mtt180 -132.86 157.45 45.02 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.146 0.578 . . . . 0.0 110.241 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.01 133.02 35.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.666 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.1 144.05 31.16 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.9 m -97.62 -50.53 4.45 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.602 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.94 99.0 3.27 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.644 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -137.32 106.51 8.58 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.19 121.86 2.79 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 CA-C-N 119.94 1.014 . . . . 0.0 111.359 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -91.62 139.82 2.36 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.164 2.576 . . . . 0.0 110.354 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -85.83 108.22 18.02 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 117.97 -1.492 . . . . 0.0 109.076 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 m -153.3 162.06 2.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 125.255 1.422 . . . . 0.0 107.312 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.3 11.68 5.0 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.382 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -148.05 -36.72 0.2 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' ' OE2' ' A' ' 69' ' ' GLU . 80.7 mt -61.82 132.96 93.56 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 122.614 0.365 . . . . 0.0 111.937 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.24 144.86 13.35 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.509 2.806 . . . . 0.0 113.588 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -46.91 -35.22 6.21 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.138 1.375 . . . . 0.0 114.106 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -58.62 -43.2 89.55 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' OE2' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -85.45 -26.66 26.21 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.973 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 m -63.45 -34.9 78.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.685 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.575 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.6 tt0 -64.47 -40.89 96.56 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -45.0 95.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.38 -45.76 97.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.751 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.4 mmt -65.82 -39.42 90.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 28' ' ' THR . 70.7 t -66.46 -36.28 76.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-O 121.196 0.522 . . . . 0.0 109.848 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.74 72.2 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.52 -44.61 82.03 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.384 1.074 . . . . 0.0 110.219 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.83 -57.06 14.41 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.103 0.961 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.84 -13.6 57.42 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.087 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 58.47 64.74 1.4 Allowed 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.77 177.15 4.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.91 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.23 127.21 36.58 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 48.1 tp -108.23 122.83 47.75 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.635 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.8 115.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.08 144.0 32.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.648 0.261 . . . . 0.0 110.668 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -93.37 -25.58 17.63 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.81 123.82 29.71 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -73.33 -18.9 61.14 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -81.59 -33.25 31.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OE1' ' A' ' 69' ' ' GLU . 95.8 t -61.18 -48.47 88.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 88.0 mt -56.65 -48.58 80.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.96 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 23.6 t30 -51.43 -58.85 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.622 1.169 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 mmmp? -65.87 -40.08 91.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.45 89.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 14.2 tppt? -57.77 -42.08 83.35 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.698 0.799 . . . . 0.0 109.655 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 41.0 mt-10 -67.3 -34.62 77.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.728 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.4 mt -79.38 2.67 20.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.252 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.84 18.7 46.53 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.988 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 61.9 t -106.35 142.87 18.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -97.84 94.47 6.93 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.149 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -94.04 132.53 38.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.929 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.51 152.33 77.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 123.488 0.492 . . . . 0.0 110.691 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.0 Cg_exo -71.97 160.13 48.45 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.034 1.823 . . . . 0.0 110.27 175.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG23 ' CG2' ' A' ' 16' ' ' ILE . 43.2 mt -57.24 -36.88 53.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.02 -25.73 66.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.07 -30.8 62.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.464 0.649 . . . . 0.0 109.947 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.68 -42.39 67.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.16 -33.64 76.25 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.675 0.75 . . . . 0.0 110.786 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.33 69.34 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.831 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -103.63 13.03 34.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.2 p -110.33 178.53 4.36 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.028 -0.42 . . . . 0.0 111.268 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . 0.274 0.6 OUTLIER -112.79 102.05 10.1 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.17 -49.09 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -158.72 86.82 0.86 Allowed 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.833 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -157.7 83.96 0.89 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.684 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -132.19 164.26 26.75 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.27 125.44 46.46 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -84.72 -42.39 15.3 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 167.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.101 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.15 152.28 22.47 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.12 107.2 8.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.5 t -92.35 132.68 36.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.1 mt -98.32 131.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.573 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.18 149.82 42.1 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -54.45 -26.29 44.03 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.268 2.646 . . . . 0.0 113.483 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.5 m -63.31 -14.97 55.66 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -98.08 5.49 48.61 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 0.0 111.535 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 6.5 m-30 -68.09 149.91 49.05 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.17 5.2 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HE2' HG21 ' A' ' 104' ' ' ILE . 60.2 mtpt -105.66 19.93 19.74 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.915 0.864 . . . . 0.0 109.603 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.71 -30.41 69.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.796 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.92 -41.28 68.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.845 0.831 . . . . 0.0 109.035 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 12' ' ' LYS . 17.8 mp0 -58.62 -57.27 13.72 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.824 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 104' ' ' ILE . 15.7 pt -63.04 -43.74 99.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.99 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.8 mp -61.46 -54.31 45.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.637 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.14 -29.65 64.23 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 123.522 0.514 . . . . 0.0 114.14 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -81.79 -61.25 1.97 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.175 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -77.84 -53.39 7.54 Favored 'General case' 0 C--O 1.253 1.268 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.424 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 8.1 mtmp? 59.65 -162.17 0.25 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 66.91 -15.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -97.79 163.8 12.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.432 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -97.82 95.78 7.77 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 172.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.8 m-85 -74.8 135.32 41.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.3 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.09 138.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.616 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.68 159.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.609 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 p -100.03 171.46 7.82 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -45.51 84.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.283 1.033 . . . . 0.0 110.995 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.12 -26.55 61.27 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.75 -57.2 17.12 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.176 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.0 m -60.38 -34.96 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.988 0.394 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.7 m -65.6 -33.52 76.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.056 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -65.79 -40.2 91.72 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -67.28 -42.55 83.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.1 mm -62.62 -47.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.256 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -39.48 87.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -81.69 -28.5 33.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.888 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.54 41.04 4.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.207 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.42 HG21 ' HB3' ' A' ' 10' ' ' PHE . 62.8 mt -101.64 151.64 5.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.84 92.95 5.54 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.442 1.115 . . . . 0.0 111.489 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -89.57 -17.68 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.317 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.59 -33.72 76.57 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 m -61.72 -30.12 70.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.233 0.54 . . . . 0.0 110.955 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.96 -50.17 13.81 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.68 -38.38 84.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.915 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.44 -39.17 75.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.712 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB2' HD23 ' A' ' 17' ' ' LEU . 94.9 mtt180 -89.42 -14.81 34.64 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.208 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.77 16.64 3.3 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.735 -1.221 . . . . 0.0 115.106 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 25' ' ' PHE . 60.7 t -73.03 123.41 27.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 pt -93.99 150.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.75 118.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -116.09 126.47 53.78 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.357 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.391 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.581 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -79.36 161.67 25.57 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.759 2.306 . . . . 0.0 111.853 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 13.2 mm100 -53.32 -40.65 64.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -63.35 -38.4 91.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.56 -38.26 62.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 32.2 t -58.12 -48.04 81.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.075 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.609 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.8 tt0 -60.92 -38.13 84.69 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.563 0.345 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.62 74.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.946 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.61 -45.22 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.451 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 mmt -60.96 -45.16 95.84 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.39 -35.94 76.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 120.827 0.346 . . . . 0.0 110.972 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.51 -33.61 74.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.898 0.38 . . . . 0.0 110.539 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -69.52 -46.57 66.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -49.2 -56.8 8.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.08 1.352 . . . . 0.0 111.431 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.51 -16.64 36.33 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.392 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.65 68.44 0.75 Allowed 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.74 179.26 4.02 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.674 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.11 129.96 36.33 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 4' ' ' VAL . 42.5 tp -108.34 123.78 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.267 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.13 110.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.57 139.29 38.58 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.01 -29.3 14.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.206 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 130.16 39.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.93 0.395 . . . . 0.0 110.674 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -55.18 -42.51 73.31 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.94 1.296 . . . . 0.0 112.644 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.48 -34.12 31.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.156 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.39 -45.71 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.24 -51.64 70.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.897 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -71.07 -31.86 68.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 92' ' ' ASN . 49.2 tptt -71.94 -42.87 66.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.388 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.66 74.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.998 0.427 . . . . 0.0 110.209 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.79 -38.35 90.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.554 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.447 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 50.3 mt-10 -57.39 -43.22 83.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.84 -11.35 60.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.017 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.3 15.92 31.28 Favored Glycine 0 CA--C 1.5 -0.868 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.268 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.1 131.43 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -80.82 89.98 5.85 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.503 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.3 128.1 38.02 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.325 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.68 157.05 78.09 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 123.578 0.549 . . . . 0.0 111.083 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.81 156.39 52.91 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.611 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 40.7 mt -55.8 -44.46 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.64 -24.29 65.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.93 -28.77 35.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.21 -35.22 79.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 86.0 mt -72.93 -31.66 64.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.046 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -26.94 62.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.877 0.37 . . . . 0.0 110.866 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.317 -0.848 0 CA-C-O 121.382 0.61 . . . . 0.0 110.611 179.017 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.2 156.38 19.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -133.73 110.31 9.74 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 26' ' ' VAL . 49.4 t -95.08 129.83 44.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.109 0.48 . . . . 0.0 110.068 -175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.98 129.76 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.127 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.7 m -90.39 152.63 45.73 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.0 Cg_exo -57.58 -24.79 64.01 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 123.204 2.603 . . . . 0.0 114.068 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -70.16 -17.67 63.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.12 0.486 . . . . 0.0 111.505 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -95.95 9.08 41.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.5 m-30 -66.7 144.34 56.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.884 0.373 . . . . 0.0 111.709 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.8 -36.08 2.49 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.929 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -87.91 -12.63 44.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.511 HD12 ' HG3' ' A' ' 14' ' ' LYS . 2.9 pp -62.34 -24.3 67.26 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.109 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' HD12 ' A' ' 13' ' ' LEU . 48.7 mtmt -75.02 -25.8 59.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.284 0.564 . . . . 0.0 110.029 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -76.08 -45.64 33.01 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.658 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 104' ' ' ILE . 12.7 pt -64.27 -37.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.205 0.526 . . . . 0.0 110.391 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 48' ' ' ARG . 47.9 tp -65.69 -55.16 18.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.252 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.53 -19.22 78.32 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.004 0.762 . . . . 0.0 115.004 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -105.42 -3.5 22.51 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.717 -0.872 . . . . 0.0 113.05 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -125.94 -59.36 1.34 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.009 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 61.92 178.72 0.12 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.634 1.174 . . . . 0.0 114.088 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 m120 74.34 -15.01 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.945 1.698 . . . . 0.0 114.814 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -80.43 152.9 28.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tpmt? -93.0 96.83 10.33 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HB2' HG22 ' A' ' 50' ' ' VAL . 93.0 m-85 -74.83 127.85 34.16 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.722 -176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 4' ' ' VAL . 72.3 t -120.42 130.43 74.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.562 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -116.98 144.77 23.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 22.8 p -81.85 169.68 16.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 p -72.27 -39.92 68.01 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.1 mt -70.09 -28.76 65.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.075 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.11 -53.01 36.05 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.806 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.0 m -61.25 -41.65 90.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.097 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 m -63.58 -37.59 87.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -66.53 -39.33 88.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.55 77.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.487 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.9 mm -57.46 -51.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.07 0.548 . . . . 0.0 111.4 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.8 -23.4 63.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -90.72 -23.03 20.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.046 0.451 . . . . 0.0 111.217 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 31.48 11.7 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.761 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 77.8 mt -92.14 138.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.55 88.25 0.93 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.743 1.258 . . . . 0.0 111.883 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.5 tp -86.96 -19.76 7.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.907 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.9 -41.29 91.3 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.945 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -57.71 -35.57 70.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.656 0.782 . . . . 0.0 110.952 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -50.2 13.57 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.332 0.586 . . . . 0.0 109.765 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.9 mt -58.51 -41.71 86.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.865 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -48.53 81.28 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.705 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.4 mtt180 -74.57 -8.56 56.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.61 13.27 3.85 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 118.776 -1.678 . . . . 0.0 114.676 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 25' ' ' PHE . 72.7 t -82.95 122.44 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -101.55 154.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.454 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 t -100.35 128.63 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -133.33 141.86 48.15 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.935 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 78.1 mt . . . . . 0 N--CA 1.427 -1.598 0 CA-C-O 120.63 0.252 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 31.7 Cg_exo -64.93 155.59 67.07 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 122.664 2.243 . . . . 0.0 110.037 172.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -62.4 -33.0 73.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.256 6.3 p90 -62.35 -39.27 92.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.99 -42.4 73.11 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.0 m -67.08 -29.86 69.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.522 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.1 tt0 -66.55 -40.37 89.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.39 84.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' HA ' HD22 ' A' ' 83' ' ' LEU . 67.2 mt -54.75 -50.64 58.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.646 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.8 mmt -71.66 -31.65 67.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.33 -35.02 69.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.62 72.95 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.508 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -70.25 -48.22 57.84 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.33 -44.15 92.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.23 -17.9 35.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.203 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 61.1 66.89 0.84 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 123.028 1.394 . . . . 0.0 107.4 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.56 178.16 4.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 113.156 -1.838 . . . . 0.0 111.229 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -89.53 121.13 31.45 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 101' ' ' ALA . 51.0 tp -97.11 127.09 42.74 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.177 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.3 mt -111.91 117.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.896 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.7 153.48 43.41 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.413 ' OE1' ' HB ' ' A' ' 104' ' ' ILE . 6.7 mm-40 -101.04 -17.63 16.63 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.17 127.91 40.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -69.43 -24.61 63.84 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.09 -35.27 31.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.03 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.54 -49.95 81.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.9 -47.82 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.689 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -62.22 -50.43 71.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.577 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tmtt? -60.26 -43.84 95.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.333 0.587 . . . . 0.0 109.443 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.58 98.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.021 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 35.7 ttmt -69.98 -31.2 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.602 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt-10 -63.54 -34.58 78.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 109.52 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 86.5 mt -80.35 -11.14 59.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.179 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.34 12.48 26.92 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.887 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 40.4 t -98.54 127.75 50.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.17 91.03 4.91 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.663 0.744 . . . . 0.0 109.545 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 83' ' ' LEU . . . -100.32 137.42 38.77 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.574 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.99 153.58 67.43 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.182 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 27.5 Cg_exo -63.59 155.45 62.85 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.443 2.095 . . . . 0.0 111.112 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 16' ' ' ILE . 7.4 mt -55.7 -43.52 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.93 -19.33 61.28 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.87 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.44 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 12.6 mm-40 -77.34 -33.48 55.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.4 -41.79 88.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.3 -46.5 88.39 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.3 -22.39 66.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.546 0.738 . . . . 0.0 112.68 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 121.526 0.679 . . . . 0.0 110.756 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.245 0.837 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -87.75 147.56 25.13 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.39 110.2 10.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 83' ' ' LEU . 47.0 t -92.57 132.65 36.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 13' ' ' LEU . 40.9 mm -95.41 130.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.329 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.6 m -90.22 152.5 45.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -57.04 -12.39 9.57 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 123.528 2.819 . . . . 0.0 113.977 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -81.97 -9.39 59.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.924 0.49 . . . . 0.0 111.172 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.4 13.66 33.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 111.801 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 40' ' ' ILE . 23.2 m-30 -76.67 152.43 35.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.489 0.661 . . . . 0.0 111.071 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 -36.01 3.55 Favored Glycine 0 C--N 1.313 -0.709 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.36 -1.57 47.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.723 0.773 . . . . 0.0 109.295 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 5' ' ' ILE . 43.4 tp -53.62 -38.64 64.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.669 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.36 -41.43 63.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.135 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.42 -50.87 61.94 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.278 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.18 -40.51 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 121.156 0.503 . . . . 0.0 111.434 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.5 tp -66.25 -48.42 70.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.297 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 -33.17 25.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 114.251 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 t -76.38 -46.33 27.85 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 116.925 0.362 . . . . 0.0 110.972 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -92.0 -47.58 7.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.909 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 58.55 -142.46 0.66 Allowed 'General case' 0 C--N 1.362 1.137 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.3 t30 68.68 -14.2 0.29 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 166.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -123.9 157.55 34.0 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 110.49 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -92.93 98.4 11.34 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.0 m-85 -75.37 130.61 39.29 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.568 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.6 t -123.77 134.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.106 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -117.9 152.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.486 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.3 p -91.28 170.58 9.87 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.959 0.409 . . . . 0.0 111.779 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -37.99 87.57 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.886 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.15 -20.39 55.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.158 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.93 -51.41 19.1 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.8 m -63.14 -39.28 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 p -70.4 -34.94 73.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.446 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -65.01 -38.19 90.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.67 75.24 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.548 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' VAL . 37.1 mm -58.31 -49.93 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.89 0.476 . . . . 0.0 111.808 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -27.06 65.66 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -91.78 -5.9 52.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.95 57.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.304 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 10' ' ' PHE . 69.3 mt -100.88 146.83 8.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.96 85.69 0.99 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.036 0.446 . . . . 0.0 111.288 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.1 tp -90.38 -24.42 5.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.83 -41.19 97.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.131 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 8.4 t -72.52 -26.41 61.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.207 0.527 . . . . 0.0 109.74 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.77 -47.63 29.9 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 84.7 mt -57.77 -44.05 85.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.044 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.76 -47.77 70.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.031 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.678 ' HB2' HD21 ' A' ' 17' ' ' LEU . 68.4 mtt180 -84.53 1.62 44.92 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.96 7.37 6.04 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 118.786 -1.673 . . . . 0.0 116.324 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.4 t -81.44 127.73 39.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 118.148 0.974 . . . . 0.0 108.722 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -102.48 159.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.4 p -114.88 137.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -141.05 139.82 34.16 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.247 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.15 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.05 170.24 12.09 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 123.098 2.532 . . . . 0.0 111.762 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.439 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.08 -24.76 66.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.269 42.1 p90 -72.75 -43.77 62.47 Favored 'General case' 0 C--O 1.255 1.391 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.33 -33.07 55.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.607 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.3 m -66.38 -28.2 68.45 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.299 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.4 tt0 -66.13 -40.02 90.32 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.23 87.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.901 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.2 -46.09 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.783 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mmt -63.46 -42.75 98.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 28' ' ' THR . 96.7 t -69.41 -35.06 65.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.477 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.85 88.46 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -66.22 -42.02 89.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.23 0.612 . . . . 0.0 109.899 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.91 -42.53 94.66 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.977 0.911 . . . . 0.0 111.251 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.35 -10.65 51.61 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.599 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.95 39.63 19.93 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -175.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.17 178.65 5.93 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.574 -1.648 . . . . 0.0 112.689 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.99 125.62 35.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 47.0 tp -102.49 123.25 45.9 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.046 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.49 113.69 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.07 160.07 40.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.754 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.52 -29.48 7.16 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.5 138.78 37.65 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.775 -0.77 . . . . 0.0 113.021 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -46.19 -55.49 7.03 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 126.833 2.053 . . . . 0.0 110.931 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.92 -37.58 64.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.964 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.81 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.47 0.481 . . . . 0.0 110.399 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -45.31 96.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.124 0.488 . . . . 0.0 109.857 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -64.56 -40.24 95.2 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.797 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 2.5 tmtm? -68.68 -39.28 80.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.322 0.582 . . . . 0.0 109.684 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.64 85.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.69 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -66.4 -35.07 79.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.405 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.6 mt-10 -58.13 -40.91 82.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.463 0.705 . . . . 0.0 110.187 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.06 -11.05 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.639 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.79 47.47 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.468 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.11 139.15 18.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.5 90.3 6.23 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.632 0.73 . . . . 0.0 110.694 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -103.6 131.17 50.98 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.498 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.6 154.95 79.9 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 123.458 0.474 . . . . 0.0 111.309 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.9 Cg_exo -70.07 160.5 49.41 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.664 2.243 . . . . 0.0 111.373 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 44.8 mt -58.9 -43.69 89.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.7 -24.95 67.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -45.4 62.29 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -43.53 95.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.301 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 95.1 mt -61.46 -40.22 93.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.899 0.48 . . . . 0.0 111.205 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 -21.73 63.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.3 m . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.783 -178.034 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 C--O 1.239 0.506 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.57 154.46 20.6 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 120.891 0.377 . . . . 0.0 110.755 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -135.69 111.2 9.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 26' ' ' VAL . 48.9 t -92.57 130.27 41.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.29 127.73 47.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.104 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -93.7 153.44 41.14 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.87 -20.78 13.82 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 123.521 2.814 . . . . 0.0 114.571 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -64.0 -29.86 70.98 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 120.621 0.248 . . . . 0.0 110.684 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.87 11.28 16.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB3' HD13 ' A' ' 40' ' ' ILE . 18.0 m-30 -74.26 148.68 41.28 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.169 0.509 . . . . 0.0 111.128 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 -35.65 3.29 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -90.0 -7.43 54.0 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.1 tp -45.15 -39.4 6.07 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 128.281 2.632 . . . . 0.0 112.36 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.82 -28.98 60.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -71.7 -48.82 44.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.565 0.221 . . . . 0.0 110.914 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.498 ' CG2' HG23 ' A' ' 104' ' ' ILE . 21.5 pt -64.32 -38.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.498 0.666 . . . . 0.0 111.133 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 48' ' ' ARG . 41.7 tp -73.7 -49.68 24.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.209 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.71 -33.05 28.53 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 114.596 0.599 . . . . 0.0 114.596 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -86.12 -30.65 22.37 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.791 0.796 . . . . 0.0 112.256 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.472 HD22 HD13 ' A' ' 107' ' ' LEU . 45.5 t-20 -103.83 -57.73 1.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.193 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 5.0 mmpt? 56.95 -137.1 1.04 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.5 t30 70.19 -14.95 0.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.906 0.882 . . . . 0.0 112.991 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -129.84 159.8 35.46 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -96.01 102.98 14.84 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 92.4 m-85 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.571 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HB ' HG22 ' A' ' 4' ' ' VAL . 45.4 t -123.67 139.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.514 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -128.4 153.8 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.506 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 22.8 p -100.07 175.71 5.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.41 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.84 -39.24 87.56 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.32 -20.5 60.78 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.373 0.606 . . . . 0.0 110.064 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.46 -54.9 5.83 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.842 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -60.54 -38.81 79.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -66.51 -36.49 82.85 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.446 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -69.27 -39.85 78.13 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.29 83.15 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.88 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.3 mm -65.5 -52.86 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.884 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.06 -27.85 67.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -90.45 -0.36 57.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.44 95.95 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.443 -0.408 . . . . 0.0 112.837 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 10' ' ' PHE . 62.7 mt -94.52 148.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.93 83.1 0.66 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.738 0.78 . . . . 0.0 111.076 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -23.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.561 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -66.67 -37.86 85.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 t -65.85 -33.83 76.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.45 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.34 -51.42 44.72 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 91.8 mt -54.88 -46.93 74.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.855 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.38 -43.43 96.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.702 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 17' ' ' LEU . 98.7 mtt180 -78.89 0.51 27.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.82 3.19 7.74 Favored Glycine 0 N--CA 1.458 0.144 0 C-N-CA 119.24 -1.457 . . . . 0.0 115.665 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 60.2 t -82.22 127.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 117.827 0.814 . . . . 0.0 109.438 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.4 pt -104.49 144.76 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 6.3 p -97.42 120.98 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -122.92 126.36 47.11 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.768 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.355 -179.378 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 120.146 0.022 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.74 161.39 24.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.409 2.739 . . . . 0.0 114.578 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.43 -33.04 69.24 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.432 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.273 6.7 p90 -61.52 -32.48 72.53 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.35 -36.65 39.07 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.505 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 74' ' ' MET . 14.6 m -54.72 -51.73 64.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.722 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.506 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.7 tt0 -61.38 -43.53 98.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.185 0.303 . . . . 0.0 110.595 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.83 -51.4 69.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.338 0.59 . . . . 0.0 110.286 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HD2' ' A' ' 93' ' ' LYS . 71.5 mt -63.55 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.417 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 70' ' ' SER . 6.5 mmt -68.25 -38.44 81.81 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.868 -0.52 . . . . 0.0 111.196 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.33 -38.06 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.614 0.721 . . . . 0.0 109.71 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.76 73.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.115 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -71.87 -43.46 65.43 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.703 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.94 -30.53 67.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.652 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.91 -15.01 26.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 t30 55.2 61.97 2.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.99 -177.57 3.4 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.662 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.3 mt -90.0 147.82 23.45 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.62 133.73 55.67 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.359 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.1 mt -111.21 117.87 56.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.89 154.51 40.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.912 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.94 -37.26 12.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.328 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.16 130.67 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.196 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -62.59 -35.42 79.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.826 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -76.6 -36.6 57.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.124 0.42 . . . . 0.0 109.969 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.36 -44.85 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.96 -45.1 95.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.111 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.6 t30 -57.73 -52.88 63.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.346 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HD2' ' CD1' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -56.76 -43.08 80.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.696 0.799 . . . . 0.0 110.756 -178.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.3 -47.53 76.3 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.114 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -69.81 -27.61 65.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.513 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.1 mt-10 -70.6 -23.27 62.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 110.472 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.59 -18.39 33.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.523 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.2 11.99 18.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.104 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.79 131.32 46.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -78.17 95.91 5.06 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.288 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.78 130.01 42.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.892 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.45 153.55 80.47 Favored Pre-proline 0 C--N 1.29 -2.0 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.76 164.27 29.97 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.21 1.94 . . . . 0.0 111.711 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.498 HG23 ' CG2' ' A' ' 16' ' ' ILE . 64.1 mt -65.75 -43.93 93.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.65 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -66.49 -25.29 66.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.841 0.353 . . . . 0.0 111.448 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -41.78 66.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.254 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 20' ' ' ASN . 3.4 tm? -64.21 -39.22 93.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 92.7 mt -65.23 -45.25 85.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.512 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.12 71.37 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.686 0.794 . . . . 0.0 112.547 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--N 1.32 -0.712 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.327 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 C--O 1.248 0.993 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -89.51 154.72 19.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 120.901 0.381 . . . . 0.0 110.003 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.55 110.43 9.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.5 t -91.92 129.33 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 13' ' ' LEU . 65.0 mt -93.1 128.01 44.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -93.15 138.5 23.16 Favored Pre-proline 0 N--CA 1.419 -2.023 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 22.7 Cg_exo -39.03 -31.7 0.28 Allowed 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 125.047 3.832 . . . . 0.0 117.003 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 p -65.96 -22.49 66.48 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.606 0.639 . . . . 0.0 112.238 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -88.79 10.27 21.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.517 0.727 . . . . 0.0 112.069 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-30 -68.44 152.67 45.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.397 0.618 . . . . 0.0 112.605 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.17 -34.11 4.07 Favored Glycine 0 N--CA 1.46 0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.783 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.21 7.07 44.75 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.015 0.912 . . . . 0.0 109.322 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.429 ' CD2' HG21 ' A' ' 5' ' ' ILE . 76.1 mt -51.51 -49.44 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 110.636 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.07 -20.47 63.22 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.654 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.19 -55.65 6.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG2' HG23 ' A' ' 104' ' ' ILE . 17.5 pt -60.53 -42.39 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 48' ' ' ARG . 3.4 mp -54.82 -51.92 64.31 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.577 0.751 . . . . 0.0 111.702 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.36 -33.13 29.32 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.057 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 m -71.89 -38.24 70.0 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.709 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -102.65 -59.35 1.72 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.623 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.46 -168.13 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 71.36 -13.39 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -107.14 143.95 34.57 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -88.83 103.91 16.43 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.438 ' CB ' HG22 ' A' ' 50' ' ' VAL . 94.5 m-85 -74.94 138.55 42.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.706 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.84 135.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.04 153.9 32.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 75' ' ' VAL . 48.3 p -94.98 172.02 8.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 120.934 0.397 . . . . 0.0 111.466 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -65.81 -44.22 86.3 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.38 -25.24 63.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.62 -52.6 28.99 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.9 m -61.5 -36.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.977 0.389 . . . . 0.0 110.835 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -67.37 -38.87 85.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -64.99 -38.5 91.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.952 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.43 -51.1 68.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.181 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 32' ' ' VAL . 50.3 mm -55.82 -50.5 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.607 0.567 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -71.2 -21.51 62.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -95.05 -4.44 46.43 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.365 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.21 54.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.109 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -103.24 133.15 47.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -76.01 108.25 8.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.23 1.014 . . . . 0.0 111.58 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.9 tp -98.8 -22.47 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.47 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.75 -27.44 66.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.391 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.2 t -70.38 -31.79 69.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -47.7 38.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 81.9 mt -54.7 -43.55 72.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.315 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.43 -33.94 74.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.443 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 44' ' ' SER . 33.7 mtt180 -85.49 -4.16 59.08 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.864 -0.735 . . . . 0.0 112.201 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.81 17.74 2.77 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.437 -1.364 . . . . 0.0 114.447 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 25' ' ' PHE . 59.3 t -89.24 124.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.3 pt -99.11 161.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.4 127.19 61.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -132.44 125.31 30.43 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.883 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.634 175.491 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -82.54 151.35 15.11 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.086 1.858 . . . . 0.0 111.505 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.98 -30.09 71.32 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -63.12 -32.71 74.15 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.495 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.3 mt-10 -89.6 -24.96 21.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.736 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 t -62.3 -40.05 95.01 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -57.23 -47.46 81.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.136 0.974 . . . . 0.0 108.598 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.12 87.13 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.219 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 69' ' ' GLU . 65.5 mt -59.98 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.95 -40.55 96.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.051 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 28' ' ' THR . 77.8 t -67.56 -40.59 84.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.68 70.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -77.22 -42.36 37.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.729 0.811 . . . . 0.0 110.212 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.48 -49.04 79.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.423 1.089 . . . . 0.0 110.102 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.73 -18.96 28.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.917 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 59.08 68.96 0.76 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.85 -177.21 3.35 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.468 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.01 137.75 33.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.66 116.12 31.38 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.136 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.43 110.29 23.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -137.49 146.83 44.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.223 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.1 -22.79 16.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.08 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.52 124.71 31.7 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 12.7 mptt -74.36 -16.45 60.9 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -81.19 -35.42 31.4 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.447 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.79 -44.34 97.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.709 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.79 -51.83 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.459 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 10.0 t30 -59.29 -46.13 89.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.35 -49.67 76.39 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 124.393 1.077 . . . . 0.0 110.202 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.16 79.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.051 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 38.0 ttmt -64.95 -34.98 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.9 mt-10 -61.61 -34.31 75.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.502 0.668 . . . . 0.0 109.811 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.8 -1.53 52.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.554 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.84 58.25 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.45 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 65.2 t -96.96 141.95 14.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -89.16 97.93 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.293 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.9 131.27 46.86 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.78 151.27 65.48 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 123.567 0.542 . . . . 0.0 111.013 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 6.8 Cg_exo -71.86 166.04 30.73 Favored 'Trans proline' 0 C--O 1.253 1.274 0 C-N-CA 122.226 1.951 . . . . 0.0 111.095 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.444 HD11 ' HB1' ' A' ' 9' ' ' ALA . 45.5 mt -58.46 -40.52 78.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -63.55 -23.04 67.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.871 0.367 . . . . 0.0 111.785 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 34.2 mm-40 -78.1 -35.15 49.61 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.18 -37.22 75.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.1 mt -64.52 -40.56 95.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 109.8 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.89 -18.45 62.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.395 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.554 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.82 144.72 26.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.752 0.31 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -129.73 109.88 11.32 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 41.0 t -92.61 133.88 32.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.85 121.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.78 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -82.63 149.3 60.29 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 52.0 Cg_exo -56.47 -15.75 16.33 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.604 2.869 . . . . 0.0 114.861 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 p -71.92 -20.78 61.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.0 111.261 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.67 11.82 31.98 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.637 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 8.7 m-30 -65.94 147.61 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.86 -34.69 3.83 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.973 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.0 mmmt -90.07 -1.09 57.9 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.583 0.353 . . . . 0.0 111.29 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 10' ' ' PHE . 7.9 mp -54.25 -35.77 62.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.429 0.633 . . . . 0.0 111.401 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -38.52 88.4 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.836 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.33 -38.95 33.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.4 pt -67.02 -35.26 74.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 13' ' ' LEU . 5.0 mp -57.23 -55.52 33.73 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.747 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.38 -33.35 53.42 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -76.98 -40.28 47.38 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.089 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.87 -52.67 3.25 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.545 -1.262 . . . . 0.0 111.803 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 59.51 -178.97 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 73.01 -14.64 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.59 1.556 . . . . 0.0 112.869 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -89.42 148.35 23.52 Favored 'General case' 0 CA--C 1.492 -1.281 0 O-C-N 121.75 -0.594 . . . . 0.0 109.398 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -91.94 98.29 11.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.6 m-85 -74.81 125.35 28.61 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.897 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.6 t -118.94 136.28 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -129.07 144.04 39.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.439 ' H ' HD13 ' A' ' 27' ' ' ILE . 39.8 p -81.62 169.58 16.86 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.395 0.617 . . . . 0.0 112.565 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 p -67.62 -36.47 80.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.79 -31.0 70.57 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.54 -50.55 42.62 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.247 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.3 m -61.74 -40.53 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 117.369 0.585 . . . . 0.0 112.007 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -69.89 -39.26 76.36 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.51 0.195 . . . . 0.0 110.617 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.05 -42.3 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.04 61.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.7 mm -53.85 -51.37 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.968 0.507 . . . . 0.0 112.085 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -67.86 -22.15 65.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -95.89 -3.9 44.52 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.84 34.97 55.34 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.877 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.17 137.18 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.08 94.07 1.87 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.2 tp -101.86 -20.34 5.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.82 -41.83 97.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.268 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.5 m -71.02 -24.91 62.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.999 0.428 . . . . 0.0 111.058 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.98 -47.36 59.34 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 85.3 mt -56.32 -40.27 74.14 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.234 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.58 -39.42 87.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.803 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 44' ' ' SER . 95.8 mtt180 -83.34 -1.9 54.44 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.96 2.54 7.19 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 114.714 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 65.5 t -76.05 120.33 25.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -97.95 140.42 18.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.233 0.54 . . . . 0.0 110.55 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -91.44 119.23 38.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -148.08 138.8 23.06 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.99 0.424 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.108 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 89' ' ' ASP . 90.0 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 15.3 Cg_exo -70.99 159.03 53.77 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.71 2.273 . . . . 0.0 109.888 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -62.7 -40.14 96.2 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -58.68 -37.62 76.43 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -71.03 -40.17 71.88 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 74' ' ' MET . 19.2 m -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.61 -37.81 87.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.37 89.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.555 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.27 -45.43 89.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.8 mmt -60.83 -45.54 94.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.699 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.39 -39.65 84.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 110.27 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.47 71.55 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.93 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -75.42 -27.07 58.85 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.596 0.758 . . . . 0.0 110.537 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' MET . 31.9 mm-40 -77.04 -42.85 36.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.479 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.26 -9.23 42.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.23 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t30 55.73 57.25 5.38 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.12 175.01 6.25 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.747 -170.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.06 121.63 30.69 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 tp -101.9 121.11 41.5 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.072 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.84 110.25 28.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.5 147.66 34.84 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.252 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -95.97 -26.24 15.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.254 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.89 131.22 37.4 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.069 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.54 -33.75 74.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HB3' HD21 ' A' ' 65' ' ' LEU . 13.2 t70 -76.39 -30.75 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.11 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.301 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.69 -47.14 86.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.13 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -58.07 -54.75 43.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.251 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -61.24 -44.93 96.46 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.593 -173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.7 98.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 37.9 ttmt -68.94 -28.09 66.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.9 mt-10 -64.4 -33.52 76.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.39 -3.86 57.94 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.092 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.36 59.92 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.537 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.6 t -81.64 135.08 25.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.03 96.17 8.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.672 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 133.7 51.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.502 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.74 156.48 62.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.333 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.4 Cg_exo -72.93 162.4 41.12 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.322 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 12' ' ' LYS . 69.3 mt -55.98 -44.68 79.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -72.0 -16.53 62.07 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.83 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.28 -27.63 27.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.743 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.86 -38.2 79.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.5 -14.57 60.84 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.517 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.79 -35.44 14.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.444 -0.765 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.587 -178.533 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 92.2 m-85 -87.89 155.58 19.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.275 0.56 . . . . 0.0 110.816 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -138.1 110.4 7.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -92.84 128.95 44.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.92 126.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 t -91.74 145.7 31.64 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.618 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 84.5 Cg_exo -50.85 -28.22 22.86 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 123.954 3.102 . . . . 0.0 115.103 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 p -60.56 -34.45 74.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.23 12.15 7.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.508 0.723 . . . . 0.0 112.825 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.618 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 10.5 m-30 -67.99 165.83 17.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.726 0.774 . . . . 0.0 112.754 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.73 -35.3 3.07 Favored Glycine 0 C--O 1.215 -1.081 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.214 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -113.13 14.78 19.55 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.659 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.29 -35.17 79.45 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.314 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -67.05 -40.68 87.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.7 -51.5 64.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.633 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.3 pt -60.31 -39.48 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.9 0.381 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -65.71 -48.32 72.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.065 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.19 -33.75 43.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -86.21 -36.23 19.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.488 0.644 . . . . 0.0 111.627 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.5 -53.96 4.68 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.945 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 59.16 -174.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.364 0.602 . . . . 0.0 111.364 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 -13.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.809 1.244 . . . . 0.0 114.011 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.8 154.57 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.3 tpmt? -91.66 97.97 11.35 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 50' ' ' VAL . 96.3 m-85 -74.81 129.36 37.55 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.49 138.06 51.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.973 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -126.46 152.47 34.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 41.9 p -90.88 169.32 11.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.108 -0.37 . . . . 0.0 111.246 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 54' ' ' ALA . 19.3 p -67.83 -41.84 82.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.482 0.658 . . . . 0.0 109.687 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.61 -34.43 78.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.139 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.7 -57.66 16.65 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.998 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 36' ' ' ILE . 29.3 m -59.73 -39.34 79.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 27.0 m -66.11 -36.22 82.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.76 0.314 . . . . 0.0 111.118 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -69.21 -40.13 78.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.65 84.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.773 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.2 mm -57.37 -57.68 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.223 0.327 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.7 ptpp? -65.07 -24.37 67.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 t -93.96 -8.2 40.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.371 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.84 34.34 43.33 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.665 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.2 mt -91.54 143.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.76 95.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 111.195 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.05 -28.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.32 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.07 -39.82 94.91 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 5.5 m -67.67 -30.88 70.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.292 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.1 -51.05 42.59 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -38.11 85.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 44' ' ' SER . 10.6 t70 -52.77 -45.51 67.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.631 1.172 . . . . 0.0 112.051 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -82.78 -9.81 59.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.416 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.11 19.09 4.42 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.257 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 25' ' ' PHE . 93.9 t -73.13 132.18 33.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.66 145.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.639 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.0 t -96.11 132.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . 23.3 ttm180 -153.25 138.65 17.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 29' ' ' THR . . . . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.07 147.25 91.63 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 122.527 2.152 . . . . 0.0 110.174 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.59 -34.7 77.53 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.296 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.252 10.4 p90 -64.08 -35.85 82.08 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.705 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' ILE . 72.0 mm-40 -71.97 -40.3 68.71 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' MET . 35.8 m -61.5 -38.19 86.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.922 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -58.78 -44.39 90.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.82 97.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.459 HD11 HG13 ' A' ' 90' ' ' VAL . 64.2 mt -59.63 -46.21 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.03 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.4 mmt -62.86 -45.17 93.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.625 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.42 -40.44 89.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 120.848 0.356 . . . . 0.0 110.606 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.69 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.203 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.52 -38.45 68.06 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.628 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -49.77 46.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.827 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.08 -14.11 58.09 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.021 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.6 m120 60.44 65.83 1.01 Allowed 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.871 1.32 . . . . 0.0 108.48 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -119.56 171.43 8.37 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 113.206 -1.815 . . . . 0.0 110.04 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -84.54 133.33 34.45 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -101.94 116.38 32.57 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.015 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.4 mt -96.34 110.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -134.49 154.99 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.59 -31.0 11.05 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.04 122.34 25.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.148 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 10.8 mptt -69.42 -25.96 64.39 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.63 -29.82 33.05 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.6 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.459 HG13 HD11 ' A' ' 73' ' ' ILE . 74.8 t -63.24 -49.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.77 -44.32 81.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.208 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -55.33 -56.0 25.05 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.354 1.462 . . . . 0.0 111.412 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.96 86.33 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 18.0 ptpt -76.54 -18.61 58.6 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.154 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.97 -28.24 68.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.58 -18.48 33.22 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.93 13.64 15.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.969 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.74 127.97 46.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -76.41 89.89 3.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.726 0.774 . . . . 0.0 109.484 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.99 129.31 43.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.174 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 pp -135.22 148.74 67.67 Favored Pre-proline 0 C--N 1.291 -1.96 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.14 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.3 Cg_exo -68.84 167.76 22.25 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.72 2.28 . . . . 0.0 111.68 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.64 -50.05 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.097 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.76 -36.58 72.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 56.6 mm-40 -69.51 -37.82 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.524 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.92 -44.54 84.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.37 -43.44 92.86 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.31 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.74 -27.42 69.19 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.138 0.575 . . . . 0.0 111.78 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 121.303 0.573 . . . . 0.0 110.632 -178.454 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -87.75 160.14 18.19 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.947 0.403 . . . . 0.0 110.406 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.28 114.95 11.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.15 131.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.185 0.517 . . . . 0.0 109.778 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.1 mt -97.49 130.24 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -94.57 149.02 35.89 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 88.2 Cg_exo -50.96 -27.37 20.89 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.657 2.905 . . . . 0.0 114.94 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -64.25 -24.53 67.7 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 120.975 0.417 . . . . 0.0 112.061 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 6.52 43.2 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.643 0.377 . . . . 0.0 111.688 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 15.1 m-30 -68.76 154.33 42.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -34.47 3.48 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.016 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 104' ' ' ILE . 59.2 mtpt -98.95 11.87 37.64 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.004 0.907 . . . . 0.0 109.662 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.71 -36.37 74.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.296 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.741 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.17 -59.2 2.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.578 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 104' ' ' ILE . 29.6 pt -57.18 -45.59 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 61.3 tp -66.97 -42.6 84.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.331 -177.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.89 -33.16 34.28 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.593 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 m -77.27 -45.89 24.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.883 0.373 . . . . 0.0 111.507 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -93.9 -58.41 2.26 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.254 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 57.69 -146.32 0.55 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.0 -14.02 0.25 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -117.77 157.48 26.47 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.8 tpmt? -90.63 102.67 15.42 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -75.06 120.38 20.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.843 0.83 . . . . 0.0 110.545 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.31 133.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.653 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.39 153.6 28.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 24.7 p -90.75 170.55 10.03 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -67.96 -38.64 83.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.943 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -73.04 -29.74 63.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.31 -56.18 25.0 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.578 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.9 m -60.82 -38.39 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.735 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 44.3 t -64.45 -40.33 95.51 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.811 0.339 . . . . 0.0 110.627 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.88 -38.92 87.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.91 86.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.379 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.2 mm -55.3 -56.81 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.6 0.562 . . . . 0.0 111.337 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 33' ' ' SER . 14.4 pttm -66.49 -30.27 70.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -87.41 -0.73 57.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.545 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.58 95.49 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 10' ' ' PHE . 81.1 mt -92.07 147.8 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 123.566 0.746 . . . . 0.0 109.18 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.2 89.25 0.64 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.153 0.502 . . . . 0.0 110.922 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -102.84 -32.65 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -60.56 -39.29 87.43 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -30.62 71.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.274 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.95 -48.6 23.6 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.57 -41.93 95.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.249 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.68 -21.73 64.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.609 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.8 mtt180 -92.9 -7.95 44.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.94 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 5.82 6.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 115.248 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.63 129.72 36.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.149 0.974 . . . . 0.0 108.848 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.1 pt -104.88 152.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.18 124.35 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -122.41 124.76 44.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 171.345 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 90' ' ' VAL . 96.2 mt . . . . . 0 CA--C 1.512 -0.498 0 CA-C-O 119.84 -0.124 . . . . 0.0 111.195 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.84 153.66 76.84 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.981 1.788 . . . . 0.0 109.601 173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.85 -32.92 74.84 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -60.36 -40.46 90.86 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.58 -40.99 69.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -63.66 -37.88 89.03 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.325 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.571 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.7 tt0 -61.75 -40.83 96.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.06 89.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.511 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.19 -44.32 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.6 mmt -64.51 -40.05 94.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.67 -38.03 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.088 0.47 . . . . 0.0 110.067 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.18 -32.52 74.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -73.67 -35.96 65.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.313 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.95 -46.71 67.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.672 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.87 -17.77 39.75 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.03 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.54 69.19 0.7 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.21 176.18 7.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.721 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -85.86 134.49 33.9 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -101.97 122.62 44.4 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.459 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.36 113.47 36.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.22 159.54 42.49 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.95 -24.54 11.58 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.65 135.71 33.3 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.594 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 88' ' ' LYS . 2.7 mppt? -59.49 -38.52 81.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.078 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.38 -34.11 67.71 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 65' ' ' LEU . 51.5 t -67.95 -53.08 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.625 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.3 -43.13 85.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.098 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -70.73 -41.65 71.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.505 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 40.3 tptt -65.87 -39.78 91.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.094 0.473 . . . . 0.0 110.311 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.47 98.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.08 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -71.74 -20.44 61.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.505 ' OE1' ' HD2' ' A' ' 93' ' ' LYS . 42.3 mt-10 -72.93 -31.8 64.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.27 -14.53 57.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.535 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.26 44.82 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.954 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.97 133.81 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -79.85 93.47 5.64 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.45 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.61 130.14 41.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.578 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.5 pp -132.21 139.2 34.16 Favored Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.479 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 25.6 Cg_exo -61.28 159.98 28.8 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.321 2.014 . . . . 0.0 110.453 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 12' ' ' LYS . 45.6 mt -56.09 -40.54 64.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -30.07 70.99 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 26.9 mm-40 -75.89 -33.57 59.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.782 0.325 . . . . 0.0 110.486 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.51 -43.39 80.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 85.7 mt -63.43 -42.59 98.7 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.01 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.0 110.877 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.443 -0.779 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.467 178.513 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -86.77 146.04 26.4 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -130.91 113.55 14.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.74 134.57 30.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -95.97 128.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 85' ' ' ALA . 1.4 t -82.47 144.4 49.46 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.355 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 Cg_exo -58.07 -26.76 76.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.91 2.407 . . . . 0.0 112.452 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.0 m -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.151 0.5 . . . . 0.0 110.547 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 104' ' ' ILE . . . -83.82 -0.1 49.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.615 -174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 16.3 m-30 -63.2 153.01 35.89 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.426 0.631 . . . . 0.0 112.362 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.59 -35.38 3.5 Favored Glycine 0 C--N 1.31 -0.915 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.166 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -99.05 3.67 46.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.76 1.267 . . . . 0.0 108.397 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.4 -34.92 78.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.038 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -61.66 -34.35 75.57 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.232 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.82 -62.66 1.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.822 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.463 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.9 pt -53.43 -40.37 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 48' ' ' ARG . 49.2 tp -62.5 -54.88 33.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.152 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.77 -30.47 13.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.175 -1.012 . . . . 0.0 114.134 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -78.54 -29.62 46.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 122.429 -0.454 . . . . 0.0 110.911 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -114.81 -55.04 2.52 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.913 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 51.6 tttp 58.01 -140.19 0.79 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.513 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 66.4 t30 69.93 -13.36 0.42 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 124.793 1.237 . . . . 0.0 113.949 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.54 161.22 18.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.695 -0.628 . . . . 0.0 109.737 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.95 102.35 14.71 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.49 124.04 26.48 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.359 0.6 . . . . 0.0 111.446 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.86 134.61 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.025 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.3 tp -121.14 149.47 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 24.1 p -85.86 168.63 14.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.584 0.707 . . . . 0.0 112.506 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.76 95.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.291 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.93 -30.52 58.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.93 -54.65 35.77 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.947 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.2 m -60.56 -42.42 91.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.475 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 m -63.16 -41.79 99.32 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.859 0.362 . . . . 0.0 111.378 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.02 -43.43 98.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.307 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.199 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 32' ' ' VAL . 31.8 mm -59.25 -52.53 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.805 0.442 . . . . 0.0 111.088 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -12.89 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -98.48 -16.01 19.37 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.19 41.36 13.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.192 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.4 mt -100.41 157.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.86 83.74 0.11 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.905 0.482 . . . . 0.0 111.364 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.3 tp -107.13 -31.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -71.09 -37.44 72.42 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.882 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.9 m -65.29 -28.92 69.67 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.934 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 50' ' ' VAL . . . -76.99 -50.08 13.97 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.75 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 80.5 mt -57.88 -40.74 80.98 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.806 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.89 -49.61 65.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.883 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.436 ' HB2' HD21 ' A' ' 17' ' ' LEU . 66.4 mtt180 -82.09 -0.62 45.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.04 0.68 8.17 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 118.609 -1.757 . . . . 0.0 115.026 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 45' ' ' ALA . 97.2 t -72.48 126.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 pt -104.53 148.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -96.03 137.98 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' NE ' HD21 ' A' ' 79' ' ' LEU . 37.8 ttt85 -147.91 136.11 21.34 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.266 0.555 . . . . 0.0 111.499 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -1.982 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.525 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 97.6 mt . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 17.0 Cg_exo -70.53 161.25 46.69 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.396 2.064 . . . . 0.0 111.042 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -56.46 -40.18 74.41 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.746 0.818 . . . . 0.0 112.623 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -62.68 -36.59 83.39 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -75.4 -37.62 60.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -59.93 -44.8 94.14 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.3 tt0 -61.94 -37.88 86.38 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.88 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -42.87 97.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.32 -44.1 83.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.385 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.2 mmt -60.92 -42.5 98.24 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.55 -40.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.134 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.02 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.295 0.569 . . . . 0.0 110.136 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.66 -44.07 74.88 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.439 1.096 . . . . 0.0 110.62 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -74.19 -27.22 60.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.072 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD21 ' NE ' ' A' ' 53' ' ' ARG . 93.1 mt -88.75 -19.13 26.44 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.06 48.86 6.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.98 176.92 5.93 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.819 -1.537 . . . . 0.0 112.243 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.94 128.03 36.14 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.2 tp -103.57 119.06 38.15 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.483 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.9 mt -94.58 110.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -126.11 173.45 9.2 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.0 -60.33 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.44 136.19 57.44 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.34 0.59 . . . . 0.0 111.232 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 45.9 mtmt -58.34 -35.37 71.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.151 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.25 -31.07 54.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.111 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 65' ' ' LEU . 46.5 t -63.39 -43.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.43 -49.52 82.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.739 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.16 -52.72 64.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.62 -33.23 75.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 -46.78 77.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.436 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.43 -20.94 61.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.82 -39.1 93.42 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.696 0.76 . . . . 0.0 109.176 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.57 -3.57 57.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.265 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.14 10.81 59.3 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.916 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.23 126.1 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.39 95.3 3.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.176 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.44 143.93 29.13 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.027 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -141.0 152.27 64.69 Favored Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 123.728 0.643 . . . . 0.0 110.445 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.6 Cg_endo -69.94 159.45 53.23 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.54 1.493 . . . . 0.0 109.848 172.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.463 HG23 ' CG2' ' A' ' 16' ' ' ILE . 75.4 mt -54.89 -43.65 69.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.51 -32.38 54.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 120.954 0.406 . . . . 0.0 110.186 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.52 -37.9 71.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.2 -35.64 81.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 -9.22 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.249 0.547 . . . . 0.0 111.094 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.443 -0.82 0 CA-C-O 121.444 0.64 . . . . 0.0 109.735 176.623 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.244 0.767 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -87.42 155.67 19.92 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.79 109.15 9.45 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' HD12 ' A' ' 83' ' ' LEU . 59.2 t -92.37 129.23 43.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.8 mt -96.96 133.99 36.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.573 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -91.7 147.13 34.46 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 45.5 Cg_exo -56.16 -21.45 35.48 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.219 2.613 . . . . 0.0 114.561 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -67.81 -25.67 65.69 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 122.094 -0.379 . . . . 0.0 111.729 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 19.57 8.83 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.025 0.53 . . . . 0.0 111.866 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.523 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.1 m-30 -72.33 168.09 19.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 -34.87 3.38 Favored Glycine 0 C--O 1.217 -0.943 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.357 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' ILE . 13.4 mmmm -100.12 21.22 13.17 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.414 0.626 . . . . 0.0 110.098 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 -27.32 68.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.711 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -79.52 -43.54 22.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -66.26 -46.24 77.73 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.457 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 12' ' ' LYS . 30.6 pt -64.88 -34.48 70.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.398 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 9.5 tp -66.65 -55.04 17.05 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.167 0.508 . . . . 0.0 109.671 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.4 -33.17 61.59 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.3 m -82.81 -48.1 11.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 117.358 0.579 . . . . 0.0 111.214 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.21 -59.07 2.29 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.668 -176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 75.1 tttt 59.7 -162.21 0.26 Allowed 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 43.1 m-80 73.86 -0.51 3.34 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 170.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -123.18 152.42 41.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.13 104.34 16.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.6 m-85 -74.69 131.27 40.73 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.689 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 58.6 t -127.76 138.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.331 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.27 150.59 30.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -84.01 163.15 20.1 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.14 0.495 . . . . 0.0 111.415 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -62.56 -34.37 76.8 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.351 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.06 -32.64 63.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.03 67.51 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.108 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.9 m -61.35 -39.34 82.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.717 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -65.32 -37.54 87.41 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.693 0.282 . . . . 0.0 111.085 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.23 -42.23 88.96 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.446 0.641 . . . . 0.0 109.471 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.64 90.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.774 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 32' ' ' VAL . 40.8 mm -61.27 -50.58 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.572 0.349 . . . . 0.0 111.043 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -64.73 -35.78 82.18 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.3 t -80.45 -28.33 37.68 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.59 40.91 6.62 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 ' HB3' ' A' ' 10' ' ' PHE . 79.6 mt -95.77 149.04 4.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.14 91.72 0.23 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.725 0.774 . . . . 0.0 111.725 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.2 tp -109.59 -27.55 2.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.186 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.96 -48.21 77.35 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.332 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.592 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 3.1 m -72.77 -27.8 62.22 Favored 'General case' 0 C--O 1.204 -1.303 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -44.89 90.38 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.1 mt -60.1 -44.14 95.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.641 176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.94 -38.01 84.33 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.749 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 44' ' ' SER . 72.5 mtt85 -67.27 -19.8 65.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.71 4.11 6.88 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.85 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 61.9 t -75.98 119.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 pt -98.29 150.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 0.0 111.647 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.45 135.47 27.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -132.56 135.61 46.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.689 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 110.665 -0.124 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -66.43 145.15 76.23 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.245 1.963 . . . . 0.0 109.958 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.51 -38.94 89.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -33.49 75.74 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -73.98 -40.77 62.74 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.9 m -60.96 -40.41 93.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.646 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.67 -38.22 90.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.768 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.78 -46.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.662 0.601 . . . . 0.0 110.092 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.7 mmt -61.77 -49.55 75.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.77 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.57 -41.49 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -41.55 98.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.552 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -65.36 -46.31 80.68 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.696 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.75 -43.88 97.4 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.218 0.607 . . . . 0.0 109.517 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.0 -15.99 54.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.343 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.34 43.61 4.64 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.58 178.93 5.02 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.237 -1.801 . . . . 0.0 112.288 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD11 HD11 ' A' ' 102' ' ' ILE . 1.9 tm? -87.0 135.21 33.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 4' ' ' VAL . 45.0 tp -111.09 122.29 47.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.495 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mt -103.13 110.21 29.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.72 155.17 48.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -108.47 -25.4 10.97 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -75.76 129.55 37.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.755 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -50.85 -50.32 57.07 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 124.683 1.24 . . . . 0.0 112.611 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.47 -27.49 34.57 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.562 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.21 -47.77 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.06 -43.86 97.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.785 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 4.4 t30 -61.56 -47.77 84.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.873 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -66.41 -36.54 83.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.124 0.487 . . . . 0.0 111.1 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.31 84.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.498 0.666 . . . . 0.0 109.871 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -72.76 -26.26 61.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 51.6 mt-10 -63.8 -36.72 84.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.101 0.56 . . . . 0.0 110.23 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.49 -18.96 43.33 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.97 27.54 6.57 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.033 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -98.27 141.17 16.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -81.17 90.75 6.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.72 0.771 . . . . 0.0 109.5 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.0 131.04 54.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.124 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 82' ' ' LEU . 2.3 pp -143.09 157.16 61.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 123.782 0.677 . . . . 0.0 110.268 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.17 167.33 27.62 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.661 2.241 . . . . 0.0 111.981 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 79.4 mt -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.223 1.009 . . . . 0.0 113.274 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.44 -38.05 89.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 111.462 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.6 -31.19 64.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.476 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.44 -39.7 94.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 79.5 mt -68.26 -19.29 64.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.21 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.63 2.41 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.317 -0.838 0 O-C-N 121.921 -0.487 . . . . 0.0 112.007 -178.815 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.71 149.29 24.32 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.23 111.28 10.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 61.8 t -92.67 129.85 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mt -95.3 125.77 47.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.884 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -92.42 141.21 24.54 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -38.84 -32.2 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 125.074 3.849 . . . . 0.0 116.98 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.6 p -64.75 -22.97 67.1 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.754 0.706 . . . . 0.0 112.053 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.44 11.51 25.94 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.381 0.672 . . . . 0.0 111.411 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -76.28 159.63 30.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.359 0.6 . . . . 0.0 112.238 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.3 -34.97 2.2 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.403 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HE2' HG21 ' A' ' 104' ' ' ILE . 58.7 mtpt -96.3 13.12 28.66 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.939 0.876 . . . . 0.0 109.433 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -54.73 -39.21 68.03 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.216 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -73.13 -21.0 60.81 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.98 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -74.53 -58.39 3.32 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 104' ' ' ILE . 23.1 pt -59.34 -48.91 85.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 48' ' ' ARG . 57.6 tp -66.72 -45.96 77.01 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.941 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.16 48.75 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.292 -0.956 . . . . 0.0 114.061 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -84.79 -27.22 27.0 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.384 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -109.07 -59.1 1.94 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 119.629 -0.828 . . . . 0.0 112.089 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 59.06 -155.86 0.35 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 70.7 -15.32 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 124.847 1.259 . . . . 0.0 113.896 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -104.98 153.6 21.22 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -91.82 97.5 11.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 50' ' ' VAL . 90.2 m-85 -74.6 125.66 29.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.509 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 53.1 t -121.26 135.19 62.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.438 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.1 tt -123.45 154.38 29.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.528 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 20.4 p -89.86 167.93 12.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -45.57 92.45 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.719 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.67 -21.87 61.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -56.68 8.75 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.691 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.7 m -58.58 -38.33 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 117.323 0.561 . . . . 0.0 111.156 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -67.21 -35.05 78.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.91 -40.1 87.57 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.07 78.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.456 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 32' ' ' VAL . 42.7 mm -55.4 -51.15 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.999 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -12.35 61.44 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -106.78 -0.56 23.36 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.02 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.59 29.2 68.11 Favored Glycine 0 C--O 1.242 0.601 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.221 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.93 129.91 37.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.97 111.75 6.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.077 0.942 . . . . 0.0 111.049 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -116.77 -16.98 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.73 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 122.314 -0.241 . . . . 0.0 111.222 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -63.22 -32.18 73.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.14 58.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.39 -43.17 99.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.465 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.26 -43.18 74.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.695 1.198 . . . . 0.0 111.978 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.524 ' HB2' HD21 ' A' ' 17' ' ' LEU . 81.6 mtt180 -77.12 -13.59 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.26 13.38 3.56 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.265 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 25' ' ' PHE . 84.2 t -81.3 133.13 29.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.2 pt -110.52 154.57 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.676 0.274 . . . . 0.0 110.593 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.2 p -107.92 136.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -127.34 133.18 50.11 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 -178.405 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.442 -0.867 0 CA-C-O 120.304 0.097 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.93 140.29 37.95 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.465 2.11 . . . . 0.0 110.688 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -45.38 -45.39 12.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.804 1.241 . . . . 0.0 113.139 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -61.17 -34.57 75.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.83 -28.23 21.76 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -64.08 -38.69 91.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.929 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.528 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.5 tt0 -62.0 -40.82 96.96 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -59.44 -48.7 80.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.917 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 90' ' ' VAL . 61.9 mt -59.99 -45.28 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.907 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 3.7 mmt -62.55 -44.48 96.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 -177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.72 -38.4 82.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.939 0.399 . . . . 0.0 110.746 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.43 80.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.589 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -69.84 -39.43 76.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.482 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 74' ' ' MET . 12.8 mm-40 -60.09 -49.89 75.87 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.485 0.659 . . . . 0.0 111.208 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.61 -16.83 46.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.343 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 60.73 56.09 3.08 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.05 177.76 4.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.031 -1.895 . . . . 0.0 111.649 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.38 134.69 34.4 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 34.5 tp -109.19 128.71 55.25 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.452 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.1 mt -106.89 113.09 42.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.56 146.57 32.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.63 -23.52 15.44 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.13 123.94 27.47 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.768 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.56 -38.12 80.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.805 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.57 -31.29 47.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.515 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 73' ' ' ILE . 81.5 t -62.9 -46.53 96.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.26 -49.56 81.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.01 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -56.14 -48.74 75.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.258 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 2.2 tmtm? -65.55 -45.9 81.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.013 0.435 . . . . 0.0 110.351 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.06 82.84 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -57.82 -42.64 84.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.439 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.9 mt-10 -60.39 -35.57 76.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.76 0.824 . . . . 0.0 111.091 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 81.6 mt -77.54 -5.61 50.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.523 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.77 7.22 63.11 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.04 128.22 44.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -82.45 97.95 8.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.616 -1.233 . . . . 0.0 110.307 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.44 127.46 37.94 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.227 174.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.61 146.65 62.32 Favored Pre-proline 0 C--N 1.28 -2.449 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.293 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 40.3 Cg_endo -71.42 167.65 25.73 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.421 2.081 . . . . 0.0 111.065 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 16' ' ' ILE . 63.2 mt -60.18 -40.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.11 -29.56 69.9 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.283 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.2 -32.59 63.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.968 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.39 -34.88 76.82 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 93.2 mt -65.9 -40.73 91.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.185 0.517 . . . . 0.0 109.948 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.57 -25.42 63.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.317 0.579 . . . . 0.0 110.811 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 t . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.751 178.679 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -87.88 150.2 23.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -127.77 108.56 10.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -92.12 128.44 43.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 109.705 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.0 mt -93.94 124.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.716 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -87.2 149.01 46.28 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -59.05 -19.34 48.19 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.355 2.703 . . . . 0.0 114.4 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 p -69.1 -19.25 64.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.979 0.418 . . . . 0.0 110.941 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -99.49 13.52 33.06 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.282 0.633 . . . . 0.0 110.963 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 12.2 m-30 -71.44 153.87 41.94 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.18 -33.1 4.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.057 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.42 11.99 35.83 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.078 0.466 . . . . 0.0 111.653 -175.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.8 mp -59.47 -32.01 69.85 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.773 0.796 . . . . 0.0 108.864 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.11 -39.68 87.06 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.319 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.46 -56.29 8.91 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 104' ' ' ILE . 22.0 pt -58.62 -37.63 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.0 tp -72.94 -47.62 43.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.222 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -31.57 31.67 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.34 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -87.72 -22.51 24.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -114.84 -55.77 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.501 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.78 -142.04 0.52 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -171.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 70.77 -13.86 0.46 Allowed 'General case' 0 N--CA 1.518 2.933 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.98 156.4 43.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.9 tpmt? -89.02 102.4 15.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.477 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.9 m-85 -74.71 126.9 31.87 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.344 0.592 . . . . 0.0 110.027 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.3 t -115.69 126.66 73.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.263 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -113.89 145.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 ' H ' HD13 ' A' ' 27' ' ' ILE . 26.9 p -84.79 160.44 20.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -44.22 97.43 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.968 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.78 -32.21 73.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.634 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.8 77.4 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.705 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.7 m -62.82 -41.56 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.599 0.699 . . . . 0.0 111.659 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -64.72 -36.4 84.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.422 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 76.8 t80 -67.75 -43.16 80.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.64 85.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 44.2 mm -64.75 -52.67 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -67.64 -32.53 73.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -88.54 -11.77 44.72 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.09 18.02 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.86 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.4 HG21 ' HB3' ' A' ' 10' ' ' PHE . 66.3 mt -97.0 142.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -67.73 112.66 4.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.046 0.45 . . . . 0.0 110.705 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.62 -26.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.516 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.13 -35.62 78.4 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.659 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.7 p -65.28 -38.86 91.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.485 0.66 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -52.09 63.95 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.596 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.67 -39.78 85.6 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.466 0.65 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.5 -38.42 84.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.467 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.6 mtt180 -87.04 3.48 45.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.36 2.24 7.64 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 118.73 -1.7 . . . . 0.0 115.771 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.6 t -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -105.62 157.34 6.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.2 p -105.86 128.13 60.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.129 0.49 . . . . 0.0 110.768 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.89 137.4 52.83 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.407 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.83 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 mt . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 45.1 Cg_exo -60.05 169.1 5.13 Favored 'Trans proline' 0 C--O 1.256 1.385 0 C-N-CA 122.96 2.44 . . . . 0.0 112.238 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.21 -48.53 70.92 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.501 0.72 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 3.5 p90 -63.22 -31.21 72.3 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -75.71 -42.39 50.97 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -61.57 -39.98 93.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.123 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -54.03 -50.2 67.22 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.572 1.149 . . . . 0.0 109.234 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.01 -48.97 77.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.611 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.05 -45.56 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.934 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.09 -38.31 90.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.68 -43.37 96.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.41 77.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.67 -39.25 80.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.631 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.64 -48.83 36.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.289 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.09 -21.55 50.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.56 69.08 0.47 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.05 170.7 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.492 -172.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.7 tm? -85.27 122.86 30.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 36.8 tp -99.59 125.75 45.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.18 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.54 113.86 43.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.85 145.54 36.35 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.896 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -95.77 -29.32 14.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' A' ' 90' ' ' VAL . 14.1 t70 -83.71 124.09 30.51 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.858 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.51 -36.53 6.81 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 125.892 1.677 . . . . 0.0 114.402 179.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 23.9 t70 -79.72 -33.82 40.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.363 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 87' ' ' ASP . 59.2 t -62.93 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.66 -46.46 93.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.916 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.3 t30 -59.54 -51.6 69.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.1 mmmt -63.01 -41.68 99.64 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.03 88.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.464 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 19.5 ptpt -68.53 -26.18 65.3 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.026 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.2 mt-10 -69.3 -28.74 66.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.189 0.519 . . . . 0.0 109.852 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.44 0.03 56.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.703 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.77 8.76 65.01 Favored Glycine 0 C--O 1.241 0.54 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.4 t -92.66 128.92 43.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.25 92.69 6.38 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.157 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.56 132.41 44.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.759 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.96 155.95 76.05 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.8 Cg_exo -70.76 160.65 48.73 Favored 'Trans proline' 0 C--O 1.256 1.409 0 C-N-CA 121.999 1.799 . . . . 0.0 110.868 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 16' ' ' ILE . 39.8 mt -54.76 -42.9 64.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 123.651 0.78 . . . . 0.0 111.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -63.13 -36.72 84.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.13 -33.06 69.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.975 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.95 -47.95 75.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.8 mt -63.0 -33.33 75.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.056 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.64 59.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.244 0.766 0 CA-C-O 121.328 0.585 . . . . 0.0 110.885 -179.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 C--O 1.245 0.863 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.64 153.0 21.72 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.0 109.69 10.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.61 128.54 44.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.61 123.48 43.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 m -83.93 148.59 54.33 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 77.3 Cg_exo -53.32 -11.25 1.71 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 124.13 3.22 . . . . 0.0 114.679 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.438 ' HB2' ' H ' ' A' ' 86' ' ' GLU . 1.2 m -64.25 -47.36 79.91 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.7 20.33 0.95 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.54 -171.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 4.3 m-30 -70.6 147.77 48.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.084 0.469 . . . . 0.0 111.175 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -34.32 3.53 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.58 -0.77 57.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.606 1.162 . . . . 0.0 109.605 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -47.52 -48.68 27.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.493 1.517 . . . . 0.0 111.999 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -75.12 -22.78 57.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.434 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -75.38 -52.37 10.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 104' ' ' ILE . 23.7 pt -63.57 -41.45 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 48' ' ' ARG . 59.9 tp -65.38 -54.97 21.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.518 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.1 -33.6 56.78 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.225 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -79.35 -55.64 4.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.849 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -75.67 -59.06 2.92 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.017 -173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 60.09 -156.73 0.34 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 t30 73.11 -13.97 0.65 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.257 1.023 . . . . 0.0 113.38 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -116.35 155.16 28.94 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -90.85 101.92 14.68 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' HB2' HG22 ' A' ' 50' ' ' VAL . 87.1 m-85 -74.66 133.72 42.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.63 140.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.304 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -126.42 154.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 72' ' ' ALA . 81.7 p -99.92 177.9 4.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -47.46 79.54 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 124.685 1.194 . . . . 0.0 112.133 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.61 -24.05 56.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.92 -56.42 22.67 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.044 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.2 m -61.42 -34.59 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 117.049 0.425 . . . . 0.0 111.379 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 m -67.93 -37.34 81.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.114 0.483 . . . . 0.0 110.665 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -69.24 -35.07 75.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.88 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.16 88.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.4 mm -58.81 -53.13 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -29.48 70.29 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 -2.74 58.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.628 0.252 . . . . 0.0 111.558 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.3 41.23 53.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.667 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.66 137.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.43 88.63 3.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.259 1.028 . . . . 0.0 111.134 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -81.8 -22.72 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.333 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -32.38 72.74 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.143 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 m -65.42 -33.44 75.96 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.267 0.556 . . . . 0.0 110.875 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.58 -47.86 16.34 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.3 -42.83 82.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.38 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.52 -41.95 86.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.717 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.7 mtt85 -79.64 -2.6 43.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.64 24.08 4.48 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.923 -1.132 . . . . 0.0 114.771 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 25' ' ' PHE . 95.6 t -86.4 126.7 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 pt -100.47 151.02 5.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.378 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.1 t -99.52 123.25 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -121.3 125.59 47.42 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.204 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.136 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 83.3 mt . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 29.3 Cg_exo -64.68 148.38 90.24 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.398 2.066 . . . . 0.0 110.068 174.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -58.06 -42.22 85.03 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -61.77 -35.3 77.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 48.4 mt-10 -81.11 -27.26 35.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.221 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -70.51 -32.12 69.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.617 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.77 -46.81 86.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -55.08 -48.14 73.95 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.7 0.625 . . . . 0.0 111.181 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.03 -47.67 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.918 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 1.9 mmt -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.058 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.81 -39.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 120.731 0.301 . . . . 0.0 110.664 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.042 0.449 . . . . 0.0 110.532 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -71.21 -43.74 66.77 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.88 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -50.89 65.22 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 109.787 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.7 -20.34 56.7 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.89 68.47 0.57 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 179.74 4.02 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.629 -172.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.93 133.15 36.39 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 30.8 tp -108.91 127.76 54.34 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.391 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.8 mt -105.72 115.65 47.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.2 157.55 44.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.626 0.25 . . . . 0.0 110.424 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' H ' ' HB2' ' A' ' 8' ' ' SER . 49.0 mt-10 -97.92 -43.71 6.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.957 0.408 . . . . 0.0 110.074 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.47 126.84 31.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.474 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -62.49 -28.0 69.52 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.714 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 -39.48 58.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.18 -51.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.21 -49.9 73.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.664 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.603 ' O ' ' HG3' ' A' ' 96' ' ' GLU 0.264 0.2 OUTLIER -64.9 -42.99 94.3 Favored 'General case' 0 C--O 1.205 -1.255 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.221 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.574 ' N ' HD22 ' A' ' 92' ' ' ASN . 10.0 mtpp -63.22 -41.54 99.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.72 99.87 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.26 0.552 . . . . 0.0 109.764 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -72.77 -26.13 61.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.698 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.8 mt-10 -64.62 -37.19 86.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.1 mt -80.82 -15.71 55.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.656 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.31 5.49 28.27 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.083 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.5 t -94.36 130.34 43.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.9 96.7 5.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.086 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.41 133.69 43.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.44 155.26 72.05 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.49 0.493 . . . . 0.0 111.171 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 23.6 Cg_exo -67.91 162.87 37.86 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.519 2.146 . . . . 0.0 112.066 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.431 HG23 ' CG2' ' A' ' 16' ' ' ILE . 84.3 mt -57.66 -46.4 86.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 123.859 0.864 . . . . 0.0 111.597 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.31 -37.71 78.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.85 -39.58 87.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.37 -46.8 81.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.81 -39.59 85.56 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.197 0.599 . . . . 0.0 110.646 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.57 -16.29 60.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.724 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.318 -0.778 0 CA-C-O 120.909 0.385 . . . . 0.0 110.274 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.24 0.581 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.86 154.49 20.49 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.5 108.99 9.95 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.7 t -93.54 134.41 31.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 13' ' ' LEU . 37.9 mt -104.56 134.24 46.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -89.08 146.9 37.35 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.58 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 70.6 Cg_exo -52.65 -28.08 35.83 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.545 2.83 . . . . 0.0 114.328 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 p -61.75 -22.86 65.76 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.97 13.23 31.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.166 0.507 . . . . 0.0 111.445 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 3.6 m-30 -69.88 160.52 31.65 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -34.33 3.65 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.687 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.527 ' HB2' HD13 ' A' ' 104' ' ' ILE . 28.6 mtpp -102.18 13.85 33.56 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.781 0.801 . . . . 0.0 110.382 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' CD2' HG21 ' A' ' 5' ' ' ILE . 61.4 mt -56.93 -40.74 76.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.572 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -65.92 -26.2 67.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.024 -1.443 . . . . 0.0 111.33 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.53 -49.15 9.52 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.74 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' HG23 ' A' ' 104' ' ' ILE . 19.0 pt -63.38 -46.55 95.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 111.368 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.7 tp -67.97 -43.18 79.59 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.853 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.36 -33.19 64.52 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.196 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.1 m -83.79 -45.32 13.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.63 -53.67 3.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 58.68 -114.28 0.74 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -164.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 55.94 -15.31 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -132.17 166.25 22.24 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.4 -0.813 . . . . 0.0 109.233 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -98.28 105.51 17.67 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.417 ' HB2' HG22 ' A' ' 50' ' ' VAL . 57.9 m-85 -75.26 139.69 42.71 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.8 t -131.05 140.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.373 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 tp -130.0 156.96 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 75' ' ' VAL . 25.7 p -91.64 169.03 11.07 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.171 0.51 . . . . 0.0 111.779 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -41.68 95.16 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.279 1.032 . . . . 0.0 110.176 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.216 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 -52.06 19.57 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.404 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 36' ' ' ILE . 32.1 m -58.58 -38.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.434 0.617 . . . . 0.0 112.001 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 p -75.78 -22.46 56.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.046 0.451 . . . . 0.0 111.34 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -69.1 -40.88 78.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' ILE . . . -66.45 -43.11 86.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.0 mm -57.72 -52.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.736 0.648 . . . . 0.0 111.391 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -65.51 -25.05 67.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -100.34 -28.39 12.98 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.334 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.68 41.57 3.1 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.91 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -100.45 147.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.44 97.89 0.45 Allowed 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.896 0.379 . . . . 0.0 111.511 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.6 tp -108.12 -34.29 2.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.622 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.23 -48.35 80.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.842 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 t -62.56 -37.25 85.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.839 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.5 69.72 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 87.4 mt -57.67 -45.86 85.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.68 -41.54 97.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.93 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HB2' HD21 ' A' ' 17' ' ' LEU . 61.7 mtt180 -74.06 -8.03 54.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.27 23.18 1.78 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.151 -1.499 . . . . 0.0 115.154 175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 62.6 t -98.39 119.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -99.45 155.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 110.991 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.91 135.29 33.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' HG2' HG13 ' A' ' 75' ' ' VAL . 2.9 tpm_? -122.32 125.08 45.19 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.82 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 120.355 0.121 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 158.05 55.98 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 122.72 2.28 . . . . 0.0 111.582 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -66.07 -27.91 68.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.985 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.262 5.1 p90 -62.01 -37.09 83.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.737 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -71.29 -38.68 71.77 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 74' ' ' MET . 18.8 m -63.17 -40.9 98.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.699 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -65.97 -35.37 80.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.21 91.8 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.15 -45.09 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.615 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' SER . 26.6 mmt -61.67 -45.16 95.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 53' ' ' ARG . 46.4 t -61.77 -40.66 87.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 120.876 0.37 . . . . 0.0 110.73 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.05 69.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -79.85 -27.61 40.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.323 0.582 . . . . 0.0 110.348 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.25 -48.79 21.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.09 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.69 -12.86 55.31 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.596 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 57.19 63.3 1.93 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.97 -179.92 3.8 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 113.455 -1.702 . . . . 0.0 112.308 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.34 130.83 36.39 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.1 tp -107.55 130.25 54.89 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.301 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -111.03 115.83 50.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.84 146.18 33.9 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.42 -29.0 15.2 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.634 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.37 123.15 24.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -73.17 -17.55 61.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.674 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 34.0 t70 -81.01 -33.18 33.83 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.8 t -60.45 -41.48 87.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.748 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 82.5 mt -59.59 -50.34 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.87 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.674 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.6 p-10 -68.6 -41.47 79.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.2 mmmt -59.23 -43.98 92.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.432 . . . . 0.0 111.542 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.56 96.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.236 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' ILE 0.312 17.4 ptpt -74.55 -18.51 60.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.8 mt-10 -67.4 -29.79 69.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.48 -7.5 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.487 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.07 -7.19 47.97 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.235 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.21 127.21 39.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.27 95.41 3.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.523 . . . . 0.0 110.147 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.35 132.53 44.61 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.232 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.27 153.97 78.44 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 123.566 0.542 . . . . 0.0 110.392 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.7 Cg_endo -76.25 166.99 26.69 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 121.962 1.775 . . . . 0.0 111.637 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 12' ' ' LYS . 41.7 mt -54.74 -44.72 72.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.014 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.54 -25.81 60.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.221 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.21 -44.67 68.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.26 -38.95 93.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.556 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -22.75 64.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.311 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.26 0.552 . . . . 0.0 109.912 177.803 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -87.37 149.17 24.67 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -136.55 114.09 10.98 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.1 t -98.79 132.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -99.67 131.79 46.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.108 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -92.91 148.58 36.13 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 85.2 Cg_exo -53.8 -23.19 26.04 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.502 2.801 . . . . 0.0 114.505 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 p -65.21 -24.27 67.31 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.109 -0.369 . . . . 0.0 111.683 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . . . -91.44 7.74 39.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.108 0.48 . . . . 0.0 111.46 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HB3' HG21 ' A' ' 40' ' ' ILE . 9.5 m-30 -66.81 157.55 32.67 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.81 -35.8 2.09 Favored Glycine 0 C--N 1.318 -0.449 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.208 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -93.59 12.29 25.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.344 1.068 . . . . 0.0 109.366 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.48 -38.66 81.43 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.834 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -58.74 -37.85 77.13 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.196 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -74.41 -59.45 2.72 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.722 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.9 pt -59.48 -43.84 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.4 tp -68.73 -43.9 74.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.831 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.08 -33.15 15.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.492 -0.861 . . . . 0.0 114.893 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 m -81.31 -34.46 31.9 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 117.321 0.56 . . . . 0.0 111.436 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.0 -60.39 2.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 22' ' ' ASN . 4.2 tmmm? 59.83 141.88 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 CA-C-O 122.336 1.065 . . . . 0.0 112.537 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 21' ' ' LYS 0.31 14.4 t-20 81.58 63.84 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 125.509 1.523 . . . . 0.0 114.342 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -146.11 150.27 35.59 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 164.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -87.88 92.89 9.29 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.7 m-85 -74.33 126.43 30.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.131 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.87 133.17 67.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.974 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 tp -117.08 156.93 18.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.626 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.2 p -94.12 165.22 12.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -39.35 93.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.914 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.64 -33.28 66.51 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.48 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.5 -52.4 53.36 Favored Glycine 0 N--CA 1.446 -0.661 0 O-C-N 123.869 0.73 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.7 m -63.04 -39.97 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -65.34 -40.36 93.55 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.101 0.477 . . . . 0.0 110.271 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.52 -49.08 74.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.46 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.25 73.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.799 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.0 mm -59.71 -57.25 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.273 0.358 . . . . 0.0 110.934 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -26.31 63.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -81.37 -18.66 44.8 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.423 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.21 37.24 25.28 Favored Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.525 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.4 mt -101.35 140.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.7 98.54 0.07 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.574 0.75 . . . . 0.0 111.446 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.49 -30.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.14 -49.46 77.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 23.0 t -62.91 -34.39 77.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.709 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.9 63.02 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.4 mt -60.99 -39.89 91.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.955 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.24 -39.39 92.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.308 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.544 ' HB2' HD21 ' A' ' 17' ' ' LEU . 63.2 mtt180 -79.22 -7.22 58.08 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.35 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.06 12.09 4.06 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.995 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 90.2 t -82.58 131.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 pt -108.43 148.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 p -101.89 127.98 54.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 120.885 0.374 . . . . 0.0 111.257 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -118.52 154.24 32.87 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.322 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -174.499 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 76.7 mt . . . . . 0 C--O 1.243 0.757 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 8.3 Cg_exo -71.06 150.28 60.04 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.246 1.964 . . . . 0.0 109.874 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.89 -28.91 62.49 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -64.64 -33.16 75.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.632 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.55 -44.62 50.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.6 m -59.7 -38.09 80.63 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.993 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.626 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 35.7 tt0 -63.74 -40.65 97.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.89 87.83 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.13 -46.05 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.181 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.82 -37.59 88.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.15 -36.43 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.234 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.62 -33.35 73.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.237 0.541 . . . . 0.0 110.306 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.68 -35.93 70.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.605 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.48 -52.29 41.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.674 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.44 -15.12 53.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.811 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.78 62.85 1.8 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -170.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 177.82 4.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.813 -1.994 . . . . 0.0 111.368 -171.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.15 126.09 35.68 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.0 tp -103.02 125.74 49.9 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.499 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -107.25 118.98 56.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -147.76 159.17 44.11 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mt-10 -103.43 -25.93 13.07 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.152 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.39 126.61 31.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.076 -173.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.43 -42.09 63.82 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 124.423 1.077 . . . . 0.0 112.705 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.5 -35.27 58.45 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.586 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.77 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.99 -48.42 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -68.64 -37.49 79.74 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.474 ' N ' HD22 ' A' ' 92' ' ' ASN . 31.6 mmmt -67.19 -39.2 86.33 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.46 87.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -60.23 -42.39 95.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.341 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 52.9 mt-10 -55.82 -42.59 75.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.176 0.59 . . . . 0.0 111.097 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.72 -8.49 56.96 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.987 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.54 44.1 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.08 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.26 129.46 46.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.15 92.85 6.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.451 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -97.93 136.0 38.85 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.606 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.24 152.23 73.11 Favored Pre-proline 0 C--N 1.293 -1.885 0 O-C-N 123.376 0.423 . . . . 0.0 110.609 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 16.9 Cg_exo -68.73 160.27 50.24 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 121.968 1.779 . . . . 0.0 110.712 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.534 HG23 ' CG2' ' A' ' 16' ' ' ILE . 53.6 mt -54.78 -42.92 64.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 123.837 0.855 . . . . 0.0 111.728 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -63.07 -25.32 68.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.991 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.59 -34.84 46.51 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.828 0.346 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.88 -41.85 95.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.9 mt -64.14 -41.76 97.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.249 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.36 33.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.637 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.057 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.246 0.881 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.412 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 95.5 m-85 -87.8 152.93 21.74 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.91 108.28 7.81 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 26' ' ' VAL . 46.6 t -92.85 131.65 39.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -97.72 132.39 42.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.41 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -92.84 149.39 37.7 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 Cg_exo -57.07 -15.17 16.76 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 123.441 2.761 . . . . 0.0 114.961 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -75.14 -22.03 58.4 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.769 -0.582 . . . . 0.0 111.099 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.21 10.11 25.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.484 0.659 . . . . 0.0 110.995 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.459 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.9 m-30 -72.08 156.3 39.35 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.498 0.666 . . . . 0.0 111.749 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -33.7 4.88 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.741 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 57.8 mtpt -106.46 18.54 21.8 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 122.405 1.098 . . . . 0.0 109.539 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.94 -39.5 94.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.696 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -68.6 -35.21 77.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.15 -175.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 -54.57 19.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.676 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.5 pt -57.77 -39.81 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp -59.33 -55.05 39.64 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.764 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.93 -33.42 41.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.955 -1.117 . . . . 0.0 113.718 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -77.53 -15.49 59.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -122.42 -60.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.687 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 60.23 -171.45 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.308 0.643 . . . . 0.0 111.609 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.2 -14.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.677 1.991 . . . . 0.0 115.013 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -93.05 149.32 21.31 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -90.73 99.67 12.66 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.4 m-85 -74.71 131.42 40.84 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.636 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 4' ' ' VAL . 39.5 t -122.16 136.39 59.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.593 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.65 153.32 27.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.614 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 25.6 p -92.47 166.91 12.3 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.088 0.471 . . . . 0.0 112.007 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -41.09 99.03 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.443 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.45 -31.72 69.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -56.43 24.17 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.107 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -59.99 -40.74 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -63.77 -38.32 90.68 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.72 -39.6 76.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.671 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.06 -42.14 94.48 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.4 mm -56.34 -52.63 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 123.759 0.662 . . . . 0.0 110.951 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -21.79 61.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 m -88.74 -23.58 22.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.44 41.55 6.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.886 -1.15 . . . . 0.0 111.575 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.7 mt -103.22 153.53 5.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.85 83.25 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.118 0.485 . . . . 0.0 110.561 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -93.13 -27.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 -38.47 89.14 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.44 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.2 m -72.88 -24.45 60.85 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.421 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.77 -52.63 9.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.185 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.19 -40.35 81.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.689 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.48 -44.82 72.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.636 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 17' ' ' LEU . 53.5 mtt85 -81.65 -5.71 58.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.44 5.2 6.67 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 118.898 -1.62 . . . . 0.0 115.146 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.95 124.82 28.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.57 0.685 . . . . 0.0 109.167 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.79 149.82 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.931 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.03 120.39 45.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HG2' HG13 ' A' ' 75' ' ' VAL . 31.8 tpt180 -113.14 126.51 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.025 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.062 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 93' ' ' LYS . 84.8 mt . . . . . 0 CA--C 1.511 -0.555 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -59.03 148.11 86.92 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.738 2.292 . . . . 0.0 111.229 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.81 -44.37 77.8 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.204 1.002 . . . . 0.0 111.307 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -63.93 -34.69 78.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 73' ' ' ILE . 26.6 mm-40 -70.36 -39.92 74.34 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -63.15 -41.04 99.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.184 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.614 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -60.31 -39.6 87.56 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.33 83.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.48 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 69' ' ' GLU . 61.5 mt -58.18 -43.64 86.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.401 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.8 mmt -67.43 -38.68 84.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.093 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 53' ' ' ARG . 55.8 t -66.2 -39.62 84.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.358 0.599 . . . . 0.0 110.209 176.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.66 71.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.118 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.69 -47.03 64.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.184 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.13 -39.07 79.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 111.328 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.19 -11.43 57.87 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.332 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.46 59.26 3.38 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -117.76 177.11 4.89 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.148 -171.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.42 141.47 28.71 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.2 tp -105.72 124.66 49.93 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.815 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.08 110.77 25.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -138.96 147.48 42.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.06 -28.43 12.35 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 91' ' ' ILE . 19.6 t70 -76.06 122.47 24.29 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.02 -29.54 69.77 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.621 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 23.0 t70 -79.73 -39.27 31.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.5 -44.3 88.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.067 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 87' ' ' ASP . 96.7 mt -57.62 -49.91 79.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.621 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.4 p-10 -69.57 -42.94 73.83 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.223 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 65' ' ' LEU . 32.2 mmmt -60.52 -41.99 95.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.425 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.54 92.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 5.2 ptmm? -71.33 -25.5 62.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.035 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 44.0 mt-10 -74.02 -30.34 62.39 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 174.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 95.2 mt -79.89 -12.45 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.248 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 12.78 16.43 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.601 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 44.6 t -108.48 132.14 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.98 97.47 6.07 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 118.904 -1.118 . . . . 0.0 109.727 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.3 129.3 41.02 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.781 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 106' ' ' GLU . 2.6 pp -130.14 143.49 49.35 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.034 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 33.2 Cg_exo -61.28 158.36 35.79 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.363 2.042 . . . . 0.0 110.947 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 9.5 mt -54.06 -40.47 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.39 -20.43 65.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 102' ' ' ILE . 53.0 mm-40 -76.68 -31.8 57.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.886 0.85 . . . . 0.0 109.125 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.48 -32.72 66.44 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.018 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.3 mt -79.64 -48.55 13.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.172 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.08 63.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.846 0.355 . . . . 0.0 111.788 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.796 -178.22 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.502 -0.899 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.39 153.65 21.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.65 107.69 9.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 83' ' ' LEU . 46.9 t -92.38 131.73 38.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.7 mt -97.26 128.77 48.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.328 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 m -88.51 149.58 44.66 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 49.1 Cg_exo -58.03 -21.75 51.9 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.105 2.537 . . . . 0.0 113.404 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 p -68.84 -19.35 64.26 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.93 16.44 19.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.264 0.554 . . . . 0.0 111.521 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.5 m-30 -75.5 156.45 35.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.95 -34.32 5.0 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.565 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.2 mmmp? -98.38 15.54 24.4 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.75 -38.83 86.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.129 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.62 -36.41 80.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.805 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.85 -56.08 5.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.329 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.482 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.5 pt -58.24 -41.22 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 48' ' ' ARG . 36.7 tp -72.25 -52.86 14.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.234 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.63 -31.15 58.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.84 -0.695 . . . . 0.0 114.3 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.8 m -83.3 -39.31 20.98 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 117.652 0.726 . . . . 0.0 112.231 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -91.26 -59.55 2.12 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.225 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.8 -152.53 0.37 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 t30 70.05 -14.28 0.39 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 125.013 1.325 . . . . 0.0 112.845 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -115.5 160.17 20.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 123.135 0.574 . . . . 0.0 109.63 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.6 102.07 13.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CB ' HG22 ' A' ' 50' ' ' VAL . 57.0 m-85 -75.41 136.66 40.73 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG22 ' A' ' 4' ' ' VAL . 54.9 t -128.71 139.62 51.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.442 -177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 10.2 tp -127.58 158.86 38.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -96.71 168.53 10.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 122.138 -0.351 . . . . 0.0 110.404 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.8 p -68.69 -39.06 80.72 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.09 -31.8 72.53 Favored 'General case' 0 C--O 1.214 -0.807 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.92 -54.06 36.15 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.496 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.562 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.6 m -62.93 -35.12 69.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.046 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -68.4 -38.75 81.58 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -63.06 -40.52 97.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.68 96.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.376 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.7 mm -60.07 -53.91 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -93.25 -9.87 37.57 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.502 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.82 37.81 60.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.655 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.91 140.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.06 108.94 1.66 Allowed 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.819 0.699 . . . . 0.0 112.367 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.3 tp -113.73 -9.38 12.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.494 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.21 -49.01 66.14 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.113 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -62.21 -26.5 68.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.703 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -69.58 -57.08 5.64 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.552 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.47 -39.74 80.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.906 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.97 -47.17 81.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.979 1.312 . . . . 0.0 112.804 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 17' ' ' LEU . 72.5 mtt85 -91.25 4.05 53.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 6.06 6.59 Favored Glycine 0 CA--C 1.505 -0.534 0 C-N-CA 118.67 -1.729 . . . . 0.0 115.813 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' CB ' ' A' ' 25' ' ' PHE . 57.8 t -81.03 120.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.653 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.4 p -98.02 128.28 49.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.186 0.517 . . . . 0.0 111.444 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -150.5 126.89 10.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.442 0 O-C-N 123.324 0.39 . . . . 0.0 110.617 -178.847 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 97.1 mt . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 119.714 -0.184 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 3.0 Cg_exo -78.62 169.82 19.18 Favored 'Trans proline' 0 C--O 1.265 1.839 0 C-N-CA 123.05 2.5 . . . . 0.0 109.489 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -60.03 -42.74 95.06 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -55.26 -38.98 69.25 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.9 -40.92 71.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 0.0 109.685 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 m -73.79 -24.31 59.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.699 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.67 -45.11 95.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.71 87.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.752 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.4 -44.41 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.155 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 3.4 mmt -60.71 -48.61 81.02 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.145 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.7 -38.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.907 0.384 . . . . 0.0 110.612 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.9 84.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.398 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -71.13 -40.73 71.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.23 0.538 . . . . 0.0 109.885 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -63.92 -45.1 90.79 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.982 0.913 . . . . 0.0 111.363 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.18 -15.13 44.73 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.044 -0.41 . . . . 0.0 111.695 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 57.8 60.16 2.89 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.913 1.34 . . . . 0.0 107.661 -169.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.46 175.43 5.47 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.272 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.46 135.28 33.69 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 4' ' ' VAL . 41.5 tp -110.83 125.19 53.34 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.713 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -98.1 110.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.25 146.55 35.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.307 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -108.78 -20.53 13.03 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.103 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 10.5 t70 -79.2 132.79 36.63 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -63.04 -35.43 80.22 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.28 -28.41 34.69 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.658 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 87' ' ' ASP . 91.4 t -63.64 -49.89 80.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.0 mt -57.58 -47.21 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.982 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.0 t30 -63.12 -54.74 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 84.5 tttt -55.79 -51.26 68.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.52 1.128 . . . . 0.0 111.367 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.4 93.72 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.603 0.565 . . . . 0.0 111.258 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 21.2 ttmm -65.27 -38.77 91.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.112 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.1 mt-10 -62.7 -38.72 91.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.221 0.534 . . . . 0.0 109.762 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 81.8 mt -72.68 -13.2 61.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.437 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.14 5.39 37.81 Favored Glycine 0 CA--C 1.501 -0.803 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.358 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.3 t -92.83 137.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.59 96.34 10.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.092 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.81 127.02 42.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.83 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.24 152.83 78.92 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 26.3 Cg_exo -66.53 163.44 32.59 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.353 2.035 . . . . 0.0 112.181 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 12' ' ' LYS . 72.3 mt -52.74 -43.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.543 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -65.64 -27.96 68.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.12 -32.13 56.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.135 0.493 . . . . 0.0 110.411 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.88 -40.81 75.45 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.98 -43.28 96.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.059 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.64 94.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.394 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.186 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -86.98 150.21 24.22 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -131.35 107.65 9.09 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 40.8 t -93.24 130.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.74 125.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.601 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -87.04 147.54 43.04 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 59.4 Cg_exo -53.17 -28.22 40.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.071 2.514 . . . . 0.0 113.971 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.3 m -60.53 -22.23 63.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.89 13.52 32.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.97 0.414 . . . . 0.0 111.382 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.8 m-30 -70.12 162.85 27.5 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.798 0.809 . . . . 0.0 112.604 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -33.88 3.63 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.153 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -95.98 14.24 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.671 0.789 . . . . 0.0 110.215 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -38.74 75.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.569 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -74.49 -26.98 60.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.141 0.496 . . . . 0.0 110.918 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.0 -46.67 20.38 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.728 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.6 pt -66.21 -39.65 84.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.301 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 48' ' ' ARG . 5.4 mp -65.24 -54.62 26.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.805 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.91 -31.3 75.21 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.635 -0.711 . . . . 0.0 114.147 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -88.63 -29.96 19.56 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -106.38 -59.24 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 118.34 -1.344 . . . . 0.0 113.64 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 56.07 -152.96 0.36 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -167.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 69.3 -15.0 0.29 Allowed 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 124.791 1.236 . . . . 0.0 113.566 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.73 149.09 32.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -86.85 98.08 11.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -75.0 129.6 37.92 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.065 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 52.0 t -125.01 138.0 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.172 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -130.87 142.38 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.498 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 23.2 p -82.7 165.12 20.23 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -38.24 78.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.8 -29.61 66.95 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.81 -54.09 33.44 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.399 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.0 m -60.82 -35.72 66.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.0 m -65.73 -42.24 91.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.74 -37.37 86.32 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.67 76.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.479 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.2 mm -59.33 -49.93 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.821 0.448 . . . . 0.0 111.201 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -98.12 -14.56 20.36 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 120.809 0.338 . . . . 0.0 111.607 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.55 35.31 20.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.155 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -92.32 146.54 6.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.74 88.3 5.21 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.889 1.328 . . . . 0.0 111.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 tp -88.72 -19.22 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.724 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.34 -49.36 76.4 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 125.908 1.683 . . . . 0.0 109.437 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -59.78 -30.92 69.22 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 111.226 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -75.21 -52.75 10.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.016 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.44 -39.33 79.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.95 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.01 -40.31 76.37 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.321 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.594 ' HB2' HD23 ' A' ' 17' ' ' LEU . 45.5 mtt85 -82.98 -10.02 58.99 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.86 15.63 3.15 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.322 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.28 123.92 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -96.83 143.78 11.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.024 0.44 . . . . 0.0 110.871 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.9 t -87.9 136.81 22.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.69 126.59 43.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.809 176.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.534 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.555 ' HG ' ' OD2' ' A' ' 89' ' ' ASP . 59.4 mt . . . . . 0 C--O 1.235 0.338 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.71 166.12 28.95 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.389 2.059 . . . . 0.0 110.376 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -56.64 -36.03 69.02 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -62.83 -38.33 90.32 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.494 ' OE2' ' HB2' ' A' ' 7' ' ' PRO . 69.9 mm-40 -71.03 -36.16 72.27 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -62.04 -41.96 98.67 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.77 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.498 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -62.55 -36.85 83.94 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.16 78.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.109 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.78 -44.71 98.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.064 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.7 mmt -59.12 -45.96 89.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.19 -39.08 83.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-O 121.153 0.502 . . . . 0.0 110.131 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.03 66.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -75.2 -36.75 61.37 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.091 0.556 . . . . 0.0 110.477 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.58 -44.44 74.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.319 0.581 . . . . 0.0 111.536 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.84 -19.03 31.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.733 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.44 67.74 0.94 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -171.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.7 3.99 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.87 -170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 2.3 tm? -90.51 126.77 36.03 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -108.33 120.72 43.2 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.821 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.0 mt -94.21 112.14 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -145.02 139.71 27.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.878 0.37 . . . . 0.0 111.581 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.73 -22.69 16.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.606 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' HG23 ' A' ' 90' ' ' VAL . 12.6 t70 -87.67 132.95 33.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -51.17 -48.25 61.94 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 124.184 0.927 . . . . 0.0 113.07 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.607 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.4 t70 -69.4 -27.7 65.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 123.549 0.531 . . . . 0.0 111.374 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 87' ' ' ASP . 40.5 t -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.03 -50.01 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.866 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.0 p-10 -70.57 -36.64 73.72 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 43.6 tptt -66.43 -40.97 89.83 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.468 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -67.89 -36.49 80.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.062 0.458 . . . . 0.0 109.827 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.78 -40.88 89.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.838 0.855 . . . . 0.0 109.233 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 62.6 mt-10 -63.18 -35.92 81.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.804 0.812 . . . . 0.0 110.787 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.12 -5.87 59.32 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.045 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.52 21.11 41.79 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.645 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 64.5 t -106.03 137.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -84.69 95.34 8.89 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.429 0.633 . . . . 0.0 110.966 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.68 131.23 45.01 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.882 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.95 155.45 76.3 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 122.686 0.394 . . . . 0.0 110.683 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.5 Cg_exo -71.7 162.03 43.37 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.151 1.901 . . . . 0.0 110.656 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.4 mt -54.21 -38.16 38.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 123.652 0.781 . . . . 0.0 112.71 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.23 -34.1 76.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.594 0.235 . . . . 0.0 110.945 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.85 -30.45 62.67 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.276 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.88 -38.79 89.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.76 -43.51 83.9 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.971 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.56 65.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.245 0.866 0 CA-C-O 121.637 0.732 . . . . 0.0 110.593 178.465 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.245 0.831 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -87.68 146.8 25.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.03 13.93 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 83' ' ' LEU . 55.2 t -91.85 126.2 44.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt -93.12 125.7 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.885 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -89.48 152.22 47.08 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 82.6 Cg_exo -50.65 -27.95 21.06 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.461 2.774 . . . . 0.0 111.681 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -51.78 -36.42 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.864 1.266 . . . . 0.0 111.651 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 6.61 41.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.366 0.603 . . . . 0.0 111.625 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 10.0 m-85 -79.38 134.49 36.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.274 0.559 . . . . 0.0 111.323 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.14 -36.28 3.79 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HB2' HD13 ' A' ' 104' ' ' ILE . 27.5 mtpp -110.36 15.74 22.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.92 -39.14 62.55 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.938 1.695 . . . . 0.0 110.877 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.94 -35.95 82.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.801 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.95 -53.39 21.07 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.648 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CG2' HG23 ' A' ' 104' ' ' ILE . 25.9 pt -60.87 -41.13 87.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.2 tp -69.35 -55.08 11.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.598 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.45 -34.12 12.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.743 -1.218 . . . . 0.0 114.694 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 m -84.4 -25.84 28.76 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 117.683 0.741 . . . . 0.0 112.015 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -97.55 -59.63 1.74 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.852 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 58.31 -140.82 0.74 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.07 -14.79 0.29 Allowed 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -135.5 162.23 33.24 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -93.47 108.42 20.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' HG22 ' A' ' 50' ' ' VAL . 99.2 m-85 -79.06 125.97 30.1 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.852 -176.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.63 134.64 60.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.114 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.5 tp -121.19 153.58 24.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 47.2 p -97.19 176.77 5.8 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.996 0.427 . . . . 0.0 111.929 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -42.57 85.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 123.686 0.794 . . . . 0.0 112.11 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.61 -24.47 56.52 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.59 -49.52 59.64 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.376 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.9 m -66.89 -32.07 56.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 m -65.96 -40.52 91.38 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.59 -44.54 93.34 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.732 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' VAL . 48.3 mm -64.14 -48.32 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.296 0.372 . . . . 0.0 111.039 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.65 -30.12 65.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.3 t -84.41 -28.2 27.08 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.976 0.417 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.43 34.64 6.93 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.154 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.4 mt -97.27 149.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.09 87.77 0.78 Allowed 'General case' 0 C--O 1.241 0.63 0 O-C-N 123.315 0.384 . . . . 0.0 111.406 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -86.11 -27.13 6.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.31 -45.32 93.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -66.37 -29.8 70.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.796 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -67.88 -51.29 49.85 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.51 -40.12 81.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.085 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.9 -38.83 89.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.17 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.5 mtt180 -87.85 2.9 50.27 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.89 -2.5 7.96 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.43 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 25' ' ' PHE . 73.1 t -72.61 132.79 32.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 117.79 0.795 . . . . 0.0 109.645 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.7 pt -111.39 142.91 22.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.267 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.46 116.41 41.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-O 121.332 0.587 . . . . 0.0 110.689 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -118.64 126.27 51.57 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.196 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 -176.191 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.5 145.75 92.33 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.077 1.851 . . . . 0.0 110.647 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.718 0.407 . . . . 0.0 111.602 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -64.4 -33.31 75.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.878 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.35 -37.19 63.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.2 m -64.46 -39.92 94.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.535 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.4 tt0 -63.42 -40.5 97.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -61.1 -45.46 94.62 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 90' ' ' VAL . 73.4 mt -59.58 -45.45 94.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.207 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.413 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmt -60.79 -47.35 86.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.61 -37.97 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.031 0.443 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.44 -29.59 69.1 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.43 -34.06 36.38 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.13 0.572 . . . . 0.0 110.583 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -46.21 68.05 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.467 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.24 -20.81 43.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.794 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 56.93 64.39 1.66 Allowed 'General case' 0 C--O 1.247 0.924 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.61 -176.81 3.07 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.805 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.29 126.76 35.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 4' ' ' VAL . 43.5 tp -107.73 127.5 53.74 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.534 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mt -106.39 114.95 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -148.13 155.17 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.84 -35.5 9.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.78 118.88 12.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.545 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -74.57 -17.56 60.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.182 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.63 -39.18 24.84 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 73' ' ' ILE . 79.3 t -59.78 -51.68 70.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.588 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.9 mt -54.1 -44.93 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.437 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.3 t30 -54.29 -52.21 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.752 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.79 -43.71 95.5 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.555 0.535 . . . . 0.0 110.752 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.55 97.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.035 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -70.71 -28.43 64.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.2 mt-10 -68.45 -28.98 67.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.14 0.495 . . . . 0.0 109.811 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.86 -11.83 58.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.655 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.85 14.17 35.05 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.51 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -86.83 90.89 8.47 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.91 132.85 49.77 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.362 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.74 157.82 64.03 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 123.972 0.795 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.3 Cg_exo -70.45 164.7 34.26 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.505 HG23 ' CG2' ' A' ' 16' ' ' ILE . 33.9 mt -58.35 -46.93 89.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.327 53.7 mt-10 -76.03 -16.0 60.03 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.87 -35.03 38.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 16' ' ' ILE . 3.3 tm? -60.83 -43.01 98.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.895 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.87 -34.66 78.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.164 0.507 . . . . 0.0 110.523 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.8 -4.42 43.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.363 0.602 . . . . 0.0 111.067 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.435 -1.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 177.404 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.248 0.977 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.43 147.04 25.6 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.56 110.93 11.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.1 t -94.6 133.11 36.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.06 129.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -85.91 144.39 39.19 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 84.6 Cg_exo -52.52 -18.03 7.69 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.786 2.991 . . . . 0.0 113.879 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 p -73.99 -20.13 60.43 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.04 0.448 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.96 12.04 33.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.524 . . . . 0.0 111.224 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-85 -73.11 153.97 40.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.36 -34.22 3.31 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -92.66 1.6 57.18 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 124.577 1.151 . . . . 0.0 109.713 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -51.4 -39.97 58.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.038 1.335 . . . . 0.0 111.949 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.88 -33.59 76.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.861 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.41 -49.13 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.997 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.405 ' CG2' HG23 ' A' ' 104' ' ' ILE . 26.5 pt -68.26 -43.44 84.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.891 0.377 . . . . 0.0 111.935 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 52.6 tp -70.31 -48.56 56.05 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.83 -33.16 74.8 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.181 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 m -90.43 -15.1 31.55 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.439 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -114.64 -59.17 2.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 55.57 -155.21 0.28 Allowed 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 70.7 -13.97 0.45 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.99 148.33 34.03 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -85.87 96.47 9.79 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.2 m-85 -74.38 129.8 38.46 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.064 -176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.0 t -127.4 138.65 54.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.87 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 8.4 tp -123.7 160.21 27.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.575 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.8 p -99.62 165.48 11.59 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 120.835 0.35 . . . . 0.0 111.647 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.44 -36.66 84.89 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.919 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.96 -18.46 60.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.062 0.458 . . . . 0.0 110.014 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.24 -44.68 17.02 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 36' ' ' ILE . 20.2 m -66.64 -36.44 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.8 p -72.41 -31.96 65.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.535 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.63 -42.34 92.51 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -65.05 -47.68 76.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.57 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.0 mm -59.15 -45.85 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.581 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.23 -26.53 62.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -103.46 4.08 35.65 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.52 37.92 85.88 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.354 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.09 155.92 4.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.41 129.6 35.12 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.69 -40.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.802 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.76 -31.52 72.21 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 122.159 -0.338 . . . . 0.0 111.01 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 m -57.72 -40.64 80.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 123.774 0.671 . . . . 0.0 109.922 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.15 60.08 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.808 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.6 mt -57.72 -45.11 86.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.058 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.37 -39.83 92.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.564 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 78.6 mtt180 -77.23 -3.79 41.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.85 7.43 5.59 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.017 -1.563 . . . . 0.0 115.862 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 63.6 t -86.78 138.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 pt -113.1 167.41 6.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 14.4 p -120.16 144.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.456 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' THR . 49.4 mtt180 -132.86 157.45 45.02 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.146 0.578 . . . . 0.0 110.241 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.162 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.666 -177.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' ' OE2' ' A' ' 69' ' ' GLU . 80.7 mt . . . . . 0 C--O 1.241 0.615 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.24 144.86 13.35 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.509 2.806 . . . . 0.0 113.588 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -46.91 -35.22 6.21 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.138 1.375 . . . . 0.0 114.106 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -58.62 -43.2 89.55 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' OE2' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -85.45 -26.66 26.21 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.973 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 m -63.45 -34.9 78.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.685 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.575 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.6 tt0 -64.47 -40.89 96.56 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -45.0 95.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.38 -45.76 97.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.751 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.4 mmt -65.82 -39.42 90.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 28' ' ' THR . 70.7 t -66.46 -36.28 76.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-O 121.196 0.522 . . . . 0.0 109.848 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.74 72.2 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.52 -44.61 82.03 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.384 1.074 . . . . 0.0 110.219 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.83 -57.06 14.41 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.103 0.961 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.84 -13.6 57.42 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.087 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.47 64.74 1.4 Allowed 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -170.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.77 177.15 4.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.91 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.23 127.21 36.58 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 48.1 tp -108.23 122.83 47.75 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.635 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.8 115.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.08 144.0 32.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.648 0.261 . . . . 0.0 110.668 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -93.37 -25.58 17.63 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.81 123.82 29.71 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -73.33 -18.9 61.14 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -81.59 -33.25 31.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OE1' ' A' ' 69' ' ' GLU . 95.8 t -61.18 -48.47 88.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 88.0 mt -56.65 -48.58 80.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.96 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 23.6 t30 -51.43 -58.85 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.622 1.169 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 mmmp? -65.87 -40.08 91.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.45 89.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 14.2 tppt? -57.77 -42.08 83.35 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.698 0.799 . . . . 0.0 109.655 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 41.0 mt-10 -67.3 -34.62 77.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.728 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.4 mt -79.38 2.67 20.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.252 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.84 18.7 46.53 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.988 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 61.9 t -106.35 142.87 18.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -97.84 94.47 6.93 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.149 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -94.04 132.53 38.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.929 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.51 152.33 77.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 123.488 0.492 . . . . 0.0 110.691 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.0 Cg_exo -71.97 160.13 48.45 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.034 1.823 . . . . 0.0 110.27 175.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.405 HG23 ' CG2' ' A' ' 16' ' ' ILE . 43.2 mt -57.24 -36.88 53.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.02 -25.73 66.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.07 -30.8 62.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.464 0.649 . . . . 0.0 109.947 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.68 -42.39 67.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.16 -33.64 76.25 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.675 0.75 . . . . 0.0 110.786 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.33 69.34 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.831 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.304 -1.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.028 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 C--O 1.248 1.018 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.15 152.28 22.47 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.12 107.2 8.47 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.5 t -92.35 132.68 36.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -175.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.1 mt -98.32 131.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.573 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.18 149.82 42.1 Favored Pre-proline 0 C--N 1.311 -1.105 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -54.45 -26.29 44.03 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 123.268 2.646 . . . . 0.0 113.483 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.5 m -63.31 -14.97 55.66 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -98.08 5.49 48.61 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 0.0 111.535 -176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 6.5 m-30 -68.09 149.91 49.05 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -33.17 5.2 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HE2' HG21 ' A' ' 104' ' ' ILE . 60.2 mtpt -105.66 19.93 19.74 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.915 0.864 . . . . 0.0 109.603 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.9 mt -67.71 -30.41 69.91 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.796 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -71.92 -41.28 68.06 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.845 0.831 . . . . 0.0 109.035 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' OE1' ' HA ' ' A' ' 12' ' ' LYS . 17.8 mp0 -58.62 -57.27 13.72 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 113.253 -1.794 . . . . 0.0 111.824 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 104' ' ' ILE . 15.7 pt -63.04 -43.74 99.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.99 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.8 mp -61.46 -54.31 45.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.637 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.14 -29.65 64.23 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 123.522 0.514 . . . . 0.0 114.14 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.3 t -81.79 -61.25 1.97 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.175 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -77.84 -53.39 7.54 Favored 'General case' 0 C--O 1.253 1.268 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.424 -170.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 8.1 mtmp? 59.65 -162.17 0.25 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 66.91 -15.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -97.79 163.8 12.66 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.43 -0.794 . . . . 0.0 109.432 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -97.82 95.78 7.77 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 172.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.8 m-85 -74.8 135.32 41.67 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.3 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.09 138.85 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.616 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.68 159.29 33.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.609 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 23.0 p -100.03 171.46 7.82 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -45.51 84.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.283 1.033 . . . . 0.0 110.995 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.12 -26.55 61.27 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.75 -57.2 17.12 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.176 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.0 m -60.38 -34.96 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.988 0.394 . . . . 0.0 111.096 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.7 m -65.6 -33.52 76.09 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.056 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -65.79 -40.2 91.72 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -67.28 -42.55 83.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.1 mm -62.62 -47.87 90.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.256 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -39.48 87.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 t -81.69 -28.5 33.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.888 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.54 41.04 4.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.207 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.42 HG21 ' HB3' ' A' ' 10' ' ' PHE . 62.8 mt -101.64 151.64 5.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.84 92.95 5.54 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.442 1.115 . . . . 0.0 111.489 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -89.57 -17.68 8.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.317 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.59 -33.72 76.57 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.223 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.5 m -61.72 -30.12 70.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.233 0.54 . . . . 0.0 110.955 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.96 -50.17 13.81 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.68 -38.38 84.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.915 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.44 -39.17 75.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.712 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB2' HD23 ' A' ' 17' ' ' LEU . 94.9 mtt180 -89.42 -14.81 34.64 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.208 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 123.77 16.64 3.3 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.735 -1.221 . . . . 0.0 115.106 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 25' ' ' PHE . 60.7 t -73.03 123.41 27.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.1 pt -93.99 150.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.75 118.78 47.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -116.09 126.47 53.78 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.357 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -118.83 132.61 56.12 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -87.56 158.9 18.79 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -69.33 -56.32 7.84 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -167.47 120.48 0.93 Allowed 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.949 1.3 . . . . 0.0 110.053 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -133.83 130.67 20.72 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 23.9 Cg_exo -65.95 121.94 9.4 Favored 'Trans proline' 0 C--O 1.241 0.65 0 CA-C-N 120.252 1.126 . . . . 0.0 110.888 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 59' ' ' PRO . 6.1 Cg_endo -91.07 132.73 1.54 Allowed 'Trans proline' 0 N--CA 1.442 -1.524 0 C-N-CA 122.869 2.379 . . . . 0.0 111.52 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -114.09 107.97 16.37 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.554 -0.859 . . . . 0.0 108.694 176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 m -156.13 144.43 11.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.82 -37.16 1.3 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 119.807 -1.187 . . . . 0.0 111.924 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.28 -34.9 12.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.53 0.681 . . . . 0.0 111.1 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -84.24 143.29 41.95 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.932 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -79.36 161.67 25.57 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.759 2.306 . . . . 0.0 111.853 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 13.2 mm100 -53.32 -40.65 64.97 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.326 1.6 p90 -63.35 -38.4 91.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.56 -38.26 62.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 32.2 t -58.12 -48.04 81.43 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.075 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.609 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.8 tt0 -60.92 -38.13 84.69 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.563 0.345 . . . . 0.0 110.167 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.62 74.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.946 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -58.61 -45.22 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.451 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 mmt -60.96 -45.16 95.84 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.39 -35.94 76.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-O 120.827 0.346 . . . . 0.0 110.972 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.51 -33.61 74.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.898 0.38 . . . . 0.0 110.539 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -69.52 -46.57 66.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -49.2 -56.8 8.13 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.08 1.352 . . . . 0.0 111.431 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.51 -16.64 36.33 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.392 -172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 60.65 68.44 0.75 Allowed 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.74 179.26 4.02 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.674 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.11 129.96 36.33 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 4' ' ' VAL . 42.5 tp -108.34 123.78 49.35 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.267 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.1 mt -98.13 110.04 24.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.57 139.29 38.58 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -96.01 -29.3 14.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.206 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.71 130.16 39.41 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.93 0.395 . . . . 0.0 110.674 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -55.18 -42.51 73.31 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 124.94 1.296 . . . . 0.0 112.644 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.48 -34.12 31.55 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.156 -175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.3 t -57.39 -45.71 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.0 mt -59.24 -51.64 70.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.897 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -71.07 -31.86 68.38 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -175.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' N ' HD22 ' A' ' 92' ' ' ASN . 49.2 tptt -71.94 -42.87 66.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.094 0.473 . . . . 0.0 110.388 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.66 74.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.998 0.427 . . . . 0.0 110.209 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -62.79 -38.35 90.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.554 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 50.3 mt-10 -57.39 -43.22 83.47 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.696 0.76 . . . . 0.0 110.409 176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.7 mt -73.84 -11.35 60.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.017 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.3 15.92 31.28 Favored Glycine 0 CA--C 1.5 -0.868 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.268 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t -100.1 131.43 47.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -80.82 89.98 5.85 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.503 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.3 128.1 38.02 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.325 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.68 157.05 78.09 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 123.578 0.549 . . . . 0.0 111.083 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.81 156.39 52.91 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.611 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 40.7 mt -55.8 -44.46 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.64 -24.29 65.43 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.93 -28.77 35.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.21 -35.22 79.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 86.0 mt -72.93 -31.66 64.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.046 175.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -26.94 62.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.877 0.37 . . . . 0.0 110.866 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.9 p -100.43 25.56 7.56 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.382 0.61 . . . . 0.0 110.611 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.5 t -74.38 1.48 11.59 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.018 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt 65.32 32.6 9.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.048 0.939 . . . . 0.0 111.303 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.68 -26.02 28.04 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.038 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 64.01 75.53 0.38 Allowed 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.228 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -100.45 131.42 46.38 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.644 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -68.19 143.77 55.22 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -57.7 110.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -118.37 159.55 23.22 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.8 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.8 m80 . . . . . 0 C--N 1.296 -1.725 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.193 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.246 0.912 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.2 156.38 19.26 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -133.73 110.31 9.74 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 26' ' ' VAL . 49.4 t -95.08 129.83 44.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.109 0.48 . . . . 0.0 110.068 -175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.8 mt -95.98 129.76 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.127 -176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.7 m -90.39 152.63 45.73 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.0 Cg_exo -57.58 -24.79 64.01 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 123.204 2.603 . . . . 0.0 114.068 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -70.16 -17.67 63.18 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.12 0.486 . . . . 0.0 111.505 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -95.95 9.08 41.88 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.5 m-30 -66.7 144.34 56.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.884 0.373 . . . . 0.0 111.709 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.8 -36.08 2.49 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.929 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -87.91 -12.63 44.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.511 HD12 ' HG3' ' A' ' 14' ' ' LYS . 2.9 pp -62.34 -24.3 67.26 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.109 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' HD12 ' A' ' 13' ' ' LEU . 48.7 mtmt -75.02 -25.8 59.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.284 0.564 . . . . 0.0 110.029 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -76.08 -45.64 33.01 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.658 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 104' ' ' ILE . 12.7 pt -64.27 -37.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.205 0.526 . . . . 0.0 110.391 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 48' ' ' ARG . 47.9 tp -65.69 -55.16 18.89 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.252 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.53 -19.22 78.32 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.004 0.762 . . . . 0.0 115.004 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.1 m -105.42 -3.5 22.51 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.717 -0.872 . . . . 0.0 113.05 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 111' ' ' SER . 23.3 t-20 -125.94 -59.36 1.34 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.009 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 61.92 178.72 0.12 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.634 1.174 . . . . 0.0 114.088 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 16.6 m120 74.34 -15.01 0.65 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 125.945 1.698 . . . . 0.0 114.814 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -80.43 152.9 28.57 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tpmt? -93.0 96.83 10.33 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 173.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HB2' HG22 ' A' ' 50' ' ' VAL . 93.0 m-85 -74.83 127.85 34.16 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.722 -176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 4' ' ' VAL . 72.3 t -120.42 130.43 74.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.562 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -116.98 144.77 23.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.589 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 22.8 p -81.85 169.68 16.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.1 p -72.27 -39.92 68.01 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.839 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.1 mt -70.09 -28.76 65.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.075 175.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.11 -53.01 36.05 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.806 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.0 m -61.25 -41.65 90.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 120.288 -0.565 . . . . 0.0 112.097 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 m -63.58 -37.59 87.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -66.53 -39.33 88.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.98 -46.55 77.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.487 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.9 mm -57.46 -51.9 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.07 0.548 . . . . 0.0 111.4 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.8 -23.4 63.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.5 m -90.72 -23.03 20.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.046 0.451 . . . . 0.0 111.217 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.31 31.48 11.7 Favored Glycine 0 C--O 1.243 0.68 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.761 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 77.8 mt -92.14 138.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.55 88.25 0.93 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.743 1.258 . . . . 0.0 111.883 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.5 tp -86.96 -19.76 7.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.907 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.9 -41.29 91.3 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.945 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 m -57.71 -35.57 70.83 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.656 0.782 . . . . 0.0 110.952 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.11 -50.2 13.57 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.332 0.586 . . . . 0.0 109.765 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.9 mt -58.51 -41.71 86.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.865 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.04 -48.53 81.28 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.705 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.4 mtt180 -74.57 -8.56 56.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -175.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.61 13.27 3.85 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 118.776 -1.678 . . . . 0.0 114.676 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 25' ' ' PHE . 72.7 t -82.95 122.44 37.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -101.55 154.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.454 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 t -100.35 128.63 52.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -133.33 141.86 48.15 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.935 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.79 157.03 17.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 57' ' ' HIS . 29.2 t80 -80.63 117.1 21.04 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 m -93.51 -23.41 18.36 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.316 0.579 . . . . 0.0 112.061 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.597 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 20.4 t60 -80.37 169.29 17.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -80.98 130.91 61.38 Favored Pre-proline 0 C--N 1.318 -0.761 0 O-C-N 122.025 -0.422 . . . . 0.0 110.872 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 73.3 Cg_endo -76.33 124.22 7.64 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.828 2.352 . . . . 0.0 114.392 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 59' ' ' PRO . 16.6 Cg_exo -75.24 172.57 16.08 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.606 2.87 . . . . 0.0 111.702 172.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -85.09 136.66 33.46 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.837 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 m -137.88 145.06 29.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.1 -52.37 0.29 Allowed Glycine 0 C--N 1.304 -1.222 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.609 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.52 -45.52 93.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.868 0.867 . . . . 0.0 111.919 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 78.1 mt -95.14 142.5 24.69 Favored Pre-proline 0 N--CA 1.427 -1.598 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.658 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 31.7 Cg_exo -64.93 155.59 67.07 Favored 'Trans proline' 0 C--O 1.254 1.314 0 C-N-CA 122.664 2.243 . . . . 0.0 110.037 172.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -62.4 -33.0 73.91 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.256 6.3 p90 -62.35 -39.27 92.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.99 -42.4 73.11 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.0 m -67.08 -29.86 69.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.522 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.589 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.1 tt0 -66.55 -40.37 89.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.36 -47.39 84.39 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.8 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' HA ' HD22 ' A' ' 83' ' ' LEU . 67.2 mt -54.75 -50.64 58.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.646 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.583 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 11.8 mmt -71.66 -31.65 67.05 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.4 t -68.33 -35.02 69.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.62 72.95 Favored 'General case' 0 C--O 1.208 -1.079 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.508 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -70.25 -48.22 57.84 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.33 -44.15 92.65 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.5 mt -85.23 -17.9 35.63 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.203 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 61.1 66.89 0.84 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-O 123.028 1.394 . . . . 0.0 107.4 -171.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.56 178.16 4.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 113.156 -1.838 . . . . 0.0 111.229 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -89.53 121.13 31.45 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 101' ' ' ALA . 51.0 tp -97.11 127.09 42.74 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.177 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.3 mt -111.91 117.44 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.896 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.7 153.48 43.41 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.413 ' OE1' ' HB ' ' A' ' 104' ' ' ILE . 6.7 mm-40 -101.04 -17.63 16.63 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.17 127.91 40.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -69.43 -24.61 63.84 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -81.09 -35.27 31.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.03 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.54 -49.95 81.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.9 -47.82 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.689 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -62.22 -50.43 71.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.577 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' HA ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tmtt? -60.26 -43.84 95.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.333 0.587 . . . . 0.0 109.443 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.58 98.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.021 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 35.7 ttmt -69.98 -31.2 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.602 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt-10 -63.54 -34.58 78.11 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 109.52 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 86.5 mt -80.35 -11.14 59.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.179 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.34 12.48 26.92 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.887 177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 40.4 t -98.54 127.75 50.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -79.17 91.03 4.91 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.663 0.744 . . . . 0.0 109.545 177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 83' ' ' LEU . . . -100.32 137.42 38.77 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.574 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -140.99 153.58 67.43 Favored Pre-proline 0 C--N 1.296 -1.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.182 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 27.5 Cg_exo -63.59 155.45 62.85 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.443 2.095 . . . . 0.0 111.112 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.606 HG23 HG23 ' A' ' 16' ' ' ILE . 7.4 mt -55.7 -43.52 73.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.93 -19.33 61.28 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.87 -177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.44 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 12.6 mm-40 -77.34 -33.48 55.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.4 -41.79 88.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.3 -46.5 88.39 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.663 ' HA ' ' O ' ' A' ' 112' ' ' LEU . . . -62.3 -22.39 66.0 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.546 0.738 . . . . 0.0 112.68 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.2 m -74.71 -7.77 54.34 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.526 0.679 . . . . 0.0 110.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.408 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 31.3 t -122.62 -35.99 2.99 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.663 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 31.5 mt -128.21 94.09 3.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.784 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -75.48 -32.75 60.68 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -99.59 122.34 42.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 167.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -70.38 79.18 0.55 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.628 0.771 . . . . 0.0 112.247 -171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -77.45 -42.51 35.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.854 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.42 ' H ' HD13 ' A' ' 112' ' ' LEU . 26.2 m-70 -75.94 119.02 19.33 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -103.63 128.57 50.91 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 177.04 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 C--O 1.245 0.837 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -87.75 147.56 25.13 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.39 110.2 10.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HD12 ' A' ' 83' ' ' LEU . 47.0 t -92.57 132.65 36.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 13' ' ' LEU . 40.9 mm -95.41 130.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.329 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.6 m -90.22 152.5 45.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -57.04 -12.39 9.57 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 123.528 2.819 . . . . 0.0 113.977 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -81.97 -9.39 59.59 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 122.924 0.49 . . . . 0.0 111.172 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.4 13.66 33.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.039 0.447 . . . . 0.0 111.801 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.437 ' HB3' HG21 ' A' ' 40' ' ' ILE . 23.2 m-30 -76.67 152.43 35.78 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.489 0.661 . . . . 0.0 111.071 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.94 -36.01 3.55 Favored Glycine 0 C--N 1.313 -0.709 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -96.36 -1.57 47.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.723 0.773 . . . . 0.0 109.295 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 5' ' ' ILE . 43.4 tp -53.62 -38.64 64.24 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.669 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.36 -41.43 63.43 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.135 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.42 -50.87 61.94 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.278 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 16.2 pt -59.18 -40.51 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-O 121.156 0.503 . . . . 0.0 111.434 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.5 tp -66.25 -48.42 70.57 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.297 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.55 -33.17 25.79 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 114.251 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.4 t -76.38 -46.33 27.85 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 116.925 0.362 . . . . 0.0 110.972 -176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -92.0 -47.58 7.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.909 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? 58.55 -142.46 0.66 Allowed 'General case' 0 C--N 1.362 1.137 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.3 t30 68.68 -14.2 0.29 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 166.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -123.9 157.55 34.0 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.315 -0.866 . . . . 0.0 110.49 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -92.93 98.4 11.34 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' HB2' HG22 ' A' ' 50' ' ' VAL . 97.0 m-85 -75.37 130.61 39.29 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.568 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.6 t -123.77 134.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.106 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -117.9 152.35 19.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.486 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.3 p -91.28 170.58 9.87 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 120.959 0.409 . . . . 0.0 111.779 -176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -37.99 87.57 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.886 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.15 -20.39 55.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.158 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.93 -51.41 19.1 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.8 m -63.14 -39.28 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.1 p -70.4 -34.94 73.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.446 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -65.01 -38.19 90.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.67 75.24 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.548 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' VAL . 37.1 mm -58.31 -49.93 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.89 0.476 . . . . 0.0 111.808 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -27.06 65.66 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -91.78 -5.9 52.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.8 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.72 40.95 57.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.304 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 10' ' ' PHE . 69.3 mt -100.88 146.83 8.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -71.96 85.69 0.99 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.036 0.446 . . . . 0.0 111.288 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.1 tp -90.38 -24.42 5.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -61.83 -41.19 97.48 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.736 -1.574 . . . . 0.0 111.131 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 8.4 t -72.52 -26.41 61.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.207 0.527 . . . . 0.0 109.74 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.77 -47.63 29.9 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 84.7 mt -57.77 -44.05 85.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.044 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -53.76 -47.77 70.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.031 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.678 ' HB2' HD21 ' A' ' 17' ' ' LEU . 68.4 mtt180 -84.53 1.62 44.92 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -174.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.96 7.37 6.04 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 118.786 -1.673 . . . . 0.0 116.324 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.4 t -81.44 127.73 39.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 118.148 0.974 . . . . 0.0 108.722 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -102.48 159.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.4 p -114.88 137.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -141.05 139.82 34.16 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.31 152.15 21.7 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 57' ' ' HIS . 22.7 t80 -84.52 108.6 17.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -60.25 -34.85 74.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.353 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . 13.0 m-70 -79.76 154.26 28.64 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 11.3 mptt -95.65 111.14 54.64 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.75 157.39 24.54 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.798 2.332 . . . . 0.0 112.459 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -82.52 171.72 12.0 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 121.936 1.757 . . . . 0.0 110.97 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -83.65 122.64 28.88 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -82.39 125.16 39.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.515 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.76 62.76 4.35 Favored Glycine 0 N--CA 1.44 -1.081 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.753 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.6 t30 178.81 -55.34 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 124.766 1.226 . . . . 0.0 108.542 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.1 mt -107.59 141.14 22.38 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.494 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.05 170.24 12.09 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 123.098 2.532 . . . . 0.0 111.762 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.439 HE21 ' HA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -66.08 -24.76 66.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -173.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.269 42.1 p90 -72.75 -43.77 62.47 Favored 'General case' 0 C--O 1.255 1.391 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.33 -33.07 55.58 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.607 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.3 m -66.38 -28.2 68.45 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.299 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.4 tt0 -66.13 -40.02 90.32 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.23 87.26 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.901 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.2 -46.09 84.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.783 176.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mmt -63.46 -42.75 98.63 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG21 HG22 ' A' ' 28' ' ' THR . 96.7 t -69.41 -35.06 65.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.477 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.85 88.46 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -66.22 -42.02 89.28 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.23 0.612 . . . . 0.0 109.899 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -64.91 -42.53 94.66 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 123.977 0.911 . . . . 0.0 111.251 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.35 -10.65 51.61 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.599 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.95 39.63 19.93 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -175.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.17 178.65 5.93 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 113.574 -1.648 . . . . 0.0 112.689 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.99 125.62 35.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 47.0 tp -102.49 123.25 45.9 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.046 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.49 113.69 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.07 160.07 40.75 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.754 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.52 -29.48 7.16 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.5 138.78 37.65 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.775 -0.77 . . . . 0.0 113.021 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -46.19 -55.49 7.03 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 126.833 2.053 . . . . 0.0 110.931 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.92 -37.58 64.58 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.964 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.81 -51.4 73.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 O-C-N 123.47 0.481 . . . . 0.0 110.399 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -45.31 96.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.124 0.488 . . . . 0.0 109.857 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -64.56 -40.24 95.2 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.797 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 96' ' ' GLU . 2.5 tmtm? -68.68 -39.28 80.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.322 0.582 . . . . 0.0 109.684 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.64 85.77 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.69 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -66.4 -35.07 79.4 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.405 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.6 mt-10 -58.13 -40.91 82.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.463 0.705 . . . . 0.0 110.187 175.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.06 -11.05 59.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.639 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.68 16.79 47.47 Favored Glycine 0 C--N 1.31 -0.864 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.468 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -90.11 139.15 18.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -81.5 90.3 6.23 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.632 0.73 . . . . 0.0 110.694 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -103.6 131.17 50.98 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.498 176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.6 154.95 79.9 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 123.458 0.474 . . . . 0.0 111.309 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.9 Cg_exo -70.07 160.5 49.41 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.664 2.243 . . . . 0.0 111.373 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 44.8 mt -58.9 -43.69 89.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.7 -24.95 67.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.59 -45.4 62.29 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.08 -43.53 95.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.301 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 95.1 mt -61.46 -40.22 93.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.899 0.48 . . . . 0.0 111.205 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 -21.73 63.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.3 m -92.16 12.17 23.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.783 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -80.06 91.1 5.45 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.8 pp -158.04 162.18 38.1 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.256 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HB2' ' CD2' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -89.14 -20.19 24.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 75.1 t60 74.36 12.21 4.01 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.457 1.103 . . . . 0.0 113.315 172.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 113' ' ' GLU . 21.1 p80 -117.0 -37.39 3.59 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.824 -1.172 . . . . 0.0 113.289 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 66.5 m80 69.38 -67.28 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.965 1.306 . . . . 0.0 109.962 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -152.56 135.44 15.51 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -88.34 -32.81 18.22 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 . . . . . 0 N--CA 1.421 -1.893 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 174.129 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 C--O 1.239 0.506 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.57 154.46 20.6 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-O 120.891 0.377 . . . . 0.0 110.755 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -135.69 111.2 9.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.419 HG22 ' HB ' ' A' ' 26' ' ' VAL . 48.9 t -92.57 130.27 41.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.5 mt -95.29 127.73 47.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.104 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -93.7 153.44 41.14 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -52.87 -20.78 13.82 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 C-N-CA 123.521 2.814 . . . . 0.0 114.571 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -64.0 -29.86 70.98 Favored 'General case' 0 C--O 1.202 -1.42 0 CA-C-O 120.621 0.248 . . . . 0.0 110.684 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.87 11.28 16.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.48 ' HB3' HD13 ' A' ' 40' ' ' ILE . 18.0 m-30 -74.26 148.68 41.28 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.169 0.509 . . . . 0.0 111.128 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 -35.65 3.29 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -90.0 -7.43 54.0 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.1 tp -45.15 -39.4 6.07 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 128.281 2.632 . . . . 0.0 112.36 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -74.82 -28.98 60.92 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -71.7 -48.82 44.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-O 120.565 0.221 . . . . 0.0 110.914 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.498 ' CG2' HG23 ' A' ' 104' ' ' ILE . 21.5 pt -64.32 -38.83 83.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.498 0.666 . . . . 0.0 111.133 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' A' ' 48' ' ' ARG . 41.7 tp -73.7 -49.68 24.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.209 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 118' ' ' HIS . . . -81.71 -33.05 28.53 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 114.596 0.599 . . . . 0.0 114.596 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m -86.12 -30.65 22.37 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.791 0.796 . . . . 0.0 112.256 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.472 HD22 HD13 ' A' ' 107' ' ' LEU . 45.5 t-20 -103.83 -57.73 1.99 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.103 -1.039 . . . . 0.0 112.193 -176.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 21' ' ' LYS . 5.0 mmpt? 56.95 -137.1 1.04 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -168.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.5 t30 70.19 -14.95 0.36 Allowed 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.906 0.882 . . . . 0.0 112.991 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -129.84 159.8 35.46 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -96.01 102.98 14.84 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 92.4 m-85 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.571 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HB ' HG22 ' A' ' 4' ' ' VAL . 45.4 t -123.67 139.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.514 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -128.4 153.8 38.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.506 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 22.8 p -100.07 175.71 5.66 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.41 ' HA ' HG22 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -66.84 -39.24 87.56 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.32 -20.5 60.78 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.373 0.606 . . . . 0.0 110.064 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.46 -54.9 5.83 Favored Glycine 0 N--CA 1.431 -1.661 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.842 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -60.54 -38.81 79.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 p -66.51 -36.49 82.85 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.446 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -69.27 -39.85 78.13 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.75 -36.29 83.15 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.88 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.3 mm -65.5 -52.86 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.884 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.06 -27.85 67.71 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -90.45 -0.36 57.62 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.77 38.44 95.95 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.443 -0.408 . . . . 0.0 112.837 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 10' ' ' PHE . 62.7 mt -94.52 148.09 5.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -70.93 83.1 0.66 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.738 0.78 . . . . 0.0 111.076 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.22 -23.09 4.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.561 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -66.67 -37.86 85.64 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.4 t -65.85 -33.83 76.76 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.45 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.34 -51.42 44.72 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 91.8 mt -54.88 -46.93 74.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.855 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -60.38 -43.43 96.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.702 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.61 ' HB2' HD21 ' A' ' 17' ' ' LEU . 98.7 mtt180 -78.89 0.51 27.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.82 3.19 7.74 Favored Glycine 0 N--CA 1.458 0.144 0 C-N-CA 119.24 -1.457 . . . . 0.0 115.665 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 60.2 t -82.22 127.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 117.827 0.814 . . . . 0.0 109.438 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.4 pt -104.49 144.76 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 6.3 p -97.42 120.98 47.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -122.92 126.36 47.11 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -117.6 141.72 48.05 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.355 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.31 147.75 37.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.7 m -73.71 -40.93 63.23 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -158.03 100.63 1.73 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.346 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -136.46 101.59 9.92 Favored Pre-proline 0 C--N 1.292 -1.904 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.4 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.24 125.69 18.16 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 121.7 1.6 . . . . 0.0 108.938 172.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.64 137.17 67.17 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 123.067 2.511 . . . . 0.0 113.356 -174.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -95.35 109.11 21.31 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.43 159.97 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.507 0.67 . . . . 0.0 112.139 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.16 88.99 0.08 OUTLIER Glycine 0 C--N 1.29 -2.01 0 N-CA-C 107.44 -2.264 . . . . 0.0 107.44 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.5 t30 80.05 -21.27 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.815 1.246 . . . . 0.0 111.183 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.0 mt -103.38 146.94 33.41 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.011 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.74 161.39 24.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.409 2.739 . . . . 0.0 114.578 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.43 -33.04 69.24 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.129 -0.941 . . . . 0.0 113.432 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.273 6.7 p90 -61.52 -32.48 72.53 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -79.35 -36.65 39.07 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.505 176.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 74' ' ' MET . 14.6 m -54.72 -51.73 64.66 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.722 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.506 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.7 tt0 -61.38 -43.53 98.72 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.185 0.303 . . . . 0.0 110.595 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.83 -51.4 69.48 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.338 0.59 . . . . 0.0 110.286 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' CD1' ' HD2' ' A' ' 93' ' ' LYS . 71.5 mt -63.55 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.417 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 70' ' ' SER . 6.5 mmt -68.25 -38.44 81.81 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.868 -0.52 . . . . 0.0 111.196 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.33 -38.06 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 121.614 0.721 . . . . 0.0 109.71 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.81 -31.76 73.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.115 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -71.87 -43.46 65.43 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.703 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -69.94 -30.53 67.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.652 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.91 -15.01 26.84 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 t30 55.2 61.97 2.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.99 -177.57 3.4 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.662 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.3 mt -90.0 147.82 23.45 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.62 133.73 55.67 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.359 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.1 mt -111.21 117.87 56.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.89 154.51 40.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.912 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.94 -37.26 12.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.328 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -77.16 130.67 37.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.196 -173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -62.59 -35.42 79.46 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.826 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -76.6 -36.6 57.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.124 0.42 . . . . 0.0 109.969 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.5 t -62.36 -44.85 99.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.96 -45.1 95.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.111 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.439 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.6 t30 -57.73 -52.88 63.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.346 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.435 ' HZ3' ' CD ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER -56.76 -43.08 80.41 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.696 0.799 . . . . 0.0 110.756 -178.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.3 -47.53 76.3 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.114 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -69.81 -27.61 65.03 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.513 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.1 mt-10 -70.6 -23.27 62.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 110.472 176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 98.3 mt -85.59 -18.39 33.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.523 175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.2 11.99 18.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.104 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.79 131.32 46.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -78.17 95.91 5.06 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.288 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.78 130.01 42.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.387 -0.824 . . . . 0.0 108.892 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.45 153.55 80.47 Favored Pre-proline 0 C--N 1.29 -2.0 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.147 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -66.76 164.27 29.97 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.21 1.94 . . . . 0.0 111.711 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.498 HG23 ' CG2' ' A' ' 16' ' ' ILE . 64.1 mt -65.75 -43.93 93.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.65 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -66.49 -25.29 66.63 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.841 0.353 . . . . 0.0 111.448 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -41.78 66.76 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.254 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 20' ' ' ASN . 3.4 tm? -64.21 -39.22 93.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 92.7 mt -65.23 -45.25 85.4 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.512 177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.12 71.37 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 123.686 0.794 . . . . 0.0 112.547 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.6 m -62.85 -26.85 68.96 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.441 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . 9.1 m -103.25 99.15 8.99 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.629 0.728 . . . . 0.0 111.165 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.1 pt? -126.78 -41.0 1.86 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -28.93 68.19 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.493 172.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 111' ' ' SER . 35.0 m80 -81.72 74.12 8.73 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -105.98 151.62 24.39 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.5 t60 63.89 50.1 2.67 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -92.56 -75.75 0.48 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.878 -172.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 12.6 t-80 -85.92 -28.59 24.21 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 . . . . . 0 CA--C 1.479 -1.766 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 170.603 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 C--O 1.248 0.993 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -89.51 154.72 19.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 120.901 0.381 . . . . 0.0 110.003 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.55 110.43 9.34 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.5 t -91.92 129.33 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 13' ' ' LEU . 65.0 mt -93.1 128.01 44.84 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 t -93.15 138.5 23.16 Favored Pre-proline 0 N--CA 1.419 -2.023 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 22.7 Cg_exo -39.03 -31.7 0.28 Allowed 'Trans proline' 0 CA--C 1.555 1.554 0 C-N-CA 125.047 3.832 . . . . 0.0 117.003 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.6 p -65.96 -22.49 66.48 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.606 0.639 . . . . 0.0 112.238 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -88.79 10.27 21.62 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.517 0.727 . . . . 0.0 112.069 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-30 -68.44 152.67 45.08 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.397 0.618 . . . . 0.0 112.605 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.17 -34.11 4.07 Favored Glycine 0 N--CA 1.46 0.284 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.783 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -100.21 7.07 44.75 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.015 0.912 . . . . 0.0 109.322 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.429 ' CD2' HG21 ' A' ' 5' ' ' ILE . 76.1 mt -51.51 -49.44 61.9 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.346 1.458 . . . . 0.0 110.636 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.07 -20.47 63.22 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.654 -175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.19 -55.65 6.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG2' HG23 ' A' ' 104' ' ' ILE . 17.5 pt -60.53 -42.39 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 48' ' ' ARG . 3.4 mp -54.82 -51.92 64.31 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.577 0.751 . . . . 0.0 111.702 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.36 -33.13 29.32 Favored Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.882 -0.675 . . . . 0.0 114.057 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 m -71.89 -38.24 70.0 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 120.451 -0.499 . . . . 0.0 111.709 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' CG ' ' HA ' ' A' ' 111' ' ' SER . 27.1 t-20 -102.65 -59.35 1.72 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.623 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 62.46 -168.13 0.2 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -168.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 71.36 -13.39 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -107.14 143.95 34.57 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -88.83 103.91 16.43 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.438 ' CB ' HG22 ' A' ' 50' ' ' VAL . 94.5 m-85 -74.94 138.55 42.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.706 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.84 135.43 63.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.04 153.9 32.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.478 HG22 HG21 ' A' ' 75' ' ' VAL . 48.3 p -94.98 172.02 8.4 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 120.934 0.397 . . . . 0.0 111.466 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -65.81 -44.22 86.3 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 123.361 0.664 . . . . 0.0 110.267 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -70.38 -25.24 63.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.62 -52.6 28.99 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.9 m -61.5 -36.17 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.977 0.389 . . . . 0.0 110.835 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.5 m -67.37 -38.87 85.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -64.99 -38.5 91.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.952 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.43 -51.1 68.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.181 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 32' ' ' VAL . 50.3 mm -55.82 -50.5 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.607 0.567 . . . . 0.0 111.763 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -71.2 -21.51 62.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -95.05 -4.44 46.43 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.365 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.68 31.21 54.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.109 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.7 mt -103.24 133.15 47.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -76.01 108.25 8.78 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.23 1.014 . . . . 0.0 111.58 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.418 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.9 tp -98.8 -22.47 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.47 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -67.75 -27.44 66.79 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.391 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.2 t -70.38 -31.79 69.18 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -47.7 38.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 81.9 mt -54.7 -43.55 72.63 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.315 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.43 -33.94 74.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.443 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 44' ' ' SER . 33.7 mtt180 -85.49 -4.16 59.08 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.864 -0.735 . . . . 0.0 112.201 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.81 17.74 2.77 Favored Glycine 0 CA--C 1.504 -0.606 0 C-N-CA 119.437 -1.364 . . . . 0.0 114.447 172.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 25' ' ' PHE . 59.3 t -89.24 124.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.3 pt -99.11 161.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.4 127.19 61.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tpm_? -132.44 125.31 30.43 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.98 141.72 29.06 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.634 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 57' ' ' HIS . 40.0 t80 -79.26 108.73 12.98 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 m -65.56 -25.0 67.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 111.588 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 55' ' ' PHE . 59.6 m80 -80.21 166.09 21.76 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -93.24 118.35 67.68 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.63 141.46 31.07 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.966 2.444 . . . . 0.0 112.229 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.56 153.7 60.14 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.165 1.91 . . . . 0.0 110.768 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -85.74 119.42 26.05 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 65' ' ' LEU . 17.0 m -89.79 159.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.554 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.82 -69.44 1.39 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.949 -0.644 . . . . 0.0 114.236 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.06 -32.37 26.86 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 62' ' ' VAL . 72.2 mt -79.89 153.24 75.17 Favored Pre-proline 0 C--N 1.308 -1.211 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -82.54 151.35 15.11 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.086 1.858 . . . . 0.0 111.505 175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -62.98 -30.09 71.32 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -63.12 -32.71 74.15 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.495 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.3 mt-10 -89.6 -24.96 21.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.736 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.9 t -62.3 -40.05 95.01 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -57.23 -47.46 81.27 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.136 0.974 . . . . 0.0 108.598 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.12 87.13 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.219 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 69' ' ' GLU . 65.5 mt -59.98 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.2 mmt -63.95 -40.55 96.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.051 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 28' ' ' THR . 77.8 t -67.56 -40.59 84.57 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 CA-C-O 120.849 0.356 . . . . 0.0 110.668 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.68 70.56 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -77.22 -42.36 37.67 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.729 0.811 . . . . 0.0 110.212 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.48 -49.04 79.34 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.423 1.089 . . . . 0.0 110.102 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.73 -18.96 28.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.917 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 t30 59.08 68.96 0.76 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.85 -177.21 3.35 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 113.283 -1.781 . . . . 0.0 110.468 -173.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.1 mt -84.01 137.75 33.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.9 tp -108.66 116.12 31.38 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.136 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 58.1 mt -95.43 110.29 23.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -137.49 146.83 44.7 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.223 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -98.1 -22.79 16.03 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.08 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.52 124.71 31.7 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 12.7 mptt -74.36 -16.45 60.9 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -81.19 -35.42 31.4 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.946 -1.102 . . . . 0.0 108.447 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.79 -44.34 97.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.709 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.8 mt -58.79 -51.83 67.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.459 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.567 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 10.0 t30 -59.29 -46.13 89.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.176 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -58.35 -49.67 76.39 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 124.393 1.077 . . . . 0.0 110.202 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.16 79.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.051 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 38.0 ttmt -64.95 -34.98 79.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.9 mt-10 -61.61 -34.31 75.43 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.502 0.668 . . . . 0.0 109.811 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.8 -1.53 52.0 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.554 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.09 11.84 58.25 Favored Glycine 0 C--N 1.319 -0.376 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.45 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 65.2 t -96.96 141.95 14.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -89.16 97.93 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.115 -1.034 . . . . 0.0 109.293 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.9 131.27 46.86 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.78 151.27 65.48 Favored Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 123.567 0.542 . . . . 0.0 111.013 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 6.8 Cg_exo -71.86 166.04 30.73 Favored 'Trans proline' 0 C--O 1.253 1.274 0 C-N-CA 122.226 1.951 . . . . 0.0 111.095 174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.444 HD11 ' HB1' ' A' ' 9' ' ' ALA . 45.5 mt -58.46 -40.52 78.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -63.55 -23.04 67.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.871 0.367 . . . . 0.0 111.785 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 34.2 mm-40 -78.1 -35.15 49.61 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.18 -37.22 75.08 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.1 mt -64.52 -40.56 95.85 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 109.8 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.89 -18.45 62.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.395 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.0 m -105.82 16.31 25.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.554 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.508 ' HA ' ' CG ' ' A' ' 20' ' ' ASN . 69.7 m -67.39 149.86 49.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.548 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt 75.99 66.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.754 1.221 . . . . 0.0 109.801 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.9 -28.34 36.0 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.87 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.3 m80 73.64 96.04 0.07 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.037 0.935 . . . . 0.0 111.459 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -135.06 112.15 10.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.745 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -83.49 80.27 9.16 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 122.114 0.959 . . . . 0.0 108.54 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -128.14 142.92 51.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 -176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -65.62 -32.11 73.5 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.653 0.661 . . . . 0.0 112.014 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 174.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.82 144.72 26.45 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.752 0.31 . . . . 0.0 110.236 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -129.73 109.88 11.32 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 41.0 t -92.61 133.88 32.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.85 121.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.78 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -82.63 149.3 60.29 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 52.0 Cg_exo -56.47 -15.75 16.33 Favored 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.604 2.869 . . . . 0.0 114.861 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 p -71.92 -20.78 61.72 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.981 0.419 . . . . 0.0 111.261 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.67 11.82 31.98 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.637 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 8.7 m-30 -65.94 147.61 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.86 -34.69 3.83 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.973 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.0 mmmt -90.07 -1.09 57.9 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.583 0.353 . . . . 0.0 111.29 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 10' ' ' PHE . 7.9 mp -54.25 -35.77 62.85 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.429 0.633 . . . . 0.0 111.401 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -61.8 -38.52 88.4 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.836 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.33 -38.95 33.96 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 -176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.4 pt -67.02 -35.26 74.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 13' ' ' LEU . 5.0 mp -57.23 -55.52 33.73 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.747 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.38 -33.35 53.42 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -76.98 -40.28 47.38 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.089 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -100.87 -52.67 3.25 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.545 -1.262 . . . . 0.0 111.803 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 59.51 -178.97 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 73.01 -14.64 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.59 1.556 . . . . 0.0 112.869 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -89.42 148.35 23.52 Favored 'General case' 0 CA--C 1.492 -1.281 0 O-C-N 121.75 -0.594 . . . . 0.0 109.398 177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -91.94 98.29 11.49 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 96.6 m-85 -74.81 125.35 28.61 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.897 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.6 t -118.94 136.28 56.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -129.07 144.04 39.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.439 ' H ' HD13 ' A' ' 27' ' ' ILE . 39.8 p -81.62 169.58 16.86 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.395 0.617 . . . . 0.0 112.565 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 p -67.62 -36.47 80.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.79 -31.0 70.57 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -67.54 -50.55 42.62 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.247 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 36' ' ' ILE . 28.3 m -61.74 -40.53 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 117.369 0.585 . . . . 0.0 112.007 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 p -69.89 -39.26 76.36 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 120.51 0.195 . . . . 0.0 110.617 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -59.05 -42.3 89.98 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.04 61.52 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.7 mm -53.85 -51.37 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 122.968 0.507 . . . . 0.0 112.085 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -67.86 -22.15 65.14 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 m -95.89 -3.9 44.52 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.807 0.337 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.84 34.97 55.34 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.877 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.17 137.18 27.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.08 94.07 1.87 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.214 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 10.2 tp -101.86 -20.34 5.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.82 -41.83 97.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.268 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 14.5 m -71.02 -24.91 62.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.999 0.428 . . . . 0.0 111.058 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.98 -47.36 59.34 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 85.3 mt -56.32 -40.27 74.14 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.234 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.58 -39.42 87.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.803 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 44' ' ' SER . 95.8 mtt180 -83.34 -1.9 54.44 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.96 2.54 7.19 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 114.714 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 65.5 t -76.05 120.33 25.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 174.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 40.4 pt -97.95 140.42 18.03 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.233 0.54 . . . . 0.0 110.55 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -91.44 119.23 38.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -148.08 138.8 23.06 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 120.99 0.424 . . . . 0.0 109.875 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.57 151.37 51.95 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.54 162.31 24.38 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 14.8 m -53.83 -56.81 14.25 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 56' ' ' SER . 7.8 t-80 156.75 136.49 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.979 1.312 . . . . 0.0 110.697 164.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -134.21 145.17 54.39 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 170.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -68.09 124.0 11.27 Favored 'Trans proline' 0 C--O 1.246 0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 111.048 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -80.82 130.32 7.54 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.822 1.682 . . . . 0.0 112.469 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 61.7 tttp -96.66 109.47 22.1 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 m -150.87 162.79 3.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 123.888 0.875 . . . . 0.0 108.875 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -123.31 -54.71 0.2 Allowed Glycine 0 N--CA 1.429 -1.813 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.92 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -97.61 1.35 48.67 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.653 0.74 . . . . 0.0 110.82 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' A' ' 89' ' ' ASP . 90.0 mt -104.99 140.56 21.2 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 15.3 Cg_exo -70.99 159.03 53.77 Favored 'Trans proline' 0 C--O 1.252 1.205 0 C-N-CA 122.71 2.273 . . . . 0.0 109.888 173.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -62.7 -40.14 96.2 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -58.68 -37.62 76.43 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -71.03 -40.17 71.88 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 74' ' ' MET . 19.2 m -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.544 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.61 -37.81 87.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.02 -45.37 89.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.555 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -58.27 -45.43 89.15 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.8 mmt -60.83 -45.54 94.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.699 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.39 -39.65 84.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.15 0.5 . . . . 0.0 110.27 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.97 -30.47 71.55 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.93 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -75.42 -27.07 58.85 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.596 0.758 . . . . 0.0 110.537 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' MET . 31.9 mm-40 -77.04 -42.85 36.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.132 0.491 . . . . 0.0 110.479 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -92.26 -9.23 42.86 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.23 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 t30 55.73 57.25 5.38 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.12 175.01 6.25 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 113.57 -1.65 . . . . 0.0 112.747 -170.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.06 121.63 30.69 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 tp -101.9 121.11 41.5 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.072 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.4 mt -101.84 110.25 28.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.5 147.66 34.84 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.252 -176.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -95.97 -26.24 15.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.254 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.89 131.22 37.4 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.069 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -68.54 -33.75 74.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HB3' HD21 ' A' ' 65' ' ' LEU . 13.2 t70 -76.39 -30.75 57.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -177.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.11 -49.9 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.301 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 94.3 mt -57.69 -47.14 86.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.13 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 6.4 t30 -58.07 -54.75 43.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.251 178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 61' ' ' LYS . 1.3 tmtm? -61.24 -44.93 96.46 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.593 -173.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.7 98.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 37.9 ttmt -68.94 -28.09 66.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.9 mt-10 -64.4 -33.52 76.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.39 -3.86 57.94 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.092 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.16 0.36 59.92 Favored Glycine 0 C--N 1.316 -0.569 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.537 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.6 t -81.64 135.08 25.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -84.03 96.17 8.8 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.322 0.582 . . . . 0.0 109.672 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 133.7 51.33 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.502 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.74 156.48 62.79 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.333 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 10.4 Cg_exo -72.93 162.4 41.12 Favored 'Trans proline' 0 C--O 1.256 1.382 0 C-N-CA 122.366 2.044 . . . . 0.0 111.322 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 12' ' ' LYS . 69.3 mt -55.98 -44.68 79.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -72.0 -16.53 62.07 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.786 -0.766 . . . . 0.0 112.83 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.28 -27.63 27.73 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.743 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.86 -38.2 79.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.5 -14.57 60.84 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.517 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.79 -35.44 14.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.491 0.663 . . . . 0.0 109.248 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.7 m -91.45 11.47 23.81 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.587 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.8 p -80.98 -25.01 37.62 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 116' ' ' HIS . 86.4 mt 60.37 83.1 0.14 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.859 -1.519 . . . . 0.0 113.608 174.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -26.97 50.92 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.02 0.914 . . . . 0.0 109.153 173.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -92.87 106.94 18.83 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -58.04 103.83 0.16 Allowed 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.637 0.585 . . . . 0.0 110.669 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.409 ' HA ' HD13 ' A' ' 112' ' ' LEU . 9.3 m170 66.64 118.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.537 1.135 . . . . 0.0 111.7 -173.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -65.59 -35.92 82.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 70.77 -46.55 0.63 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.53 1.532 . . . . 0.0 113.537 173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -177.198 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 92.2 m-85 -87.89 155.58 19.79 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.275 0.56 . . . . 0.0 110.816 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -138.1 110.4 7.4 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.2 t -92.84 128.95 44.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.92 126.44 48.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 t -91.74 145.7 31.64 Favored Pre-proline 0 C--N 1.298 -1.658 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.618 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 84.5 Cg_exo -50.85 -28.22 22.86 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 123.954 3.102 . . . . 0.0 115.103 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 p -60.56 -34.45 74.18 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.23 12.15 7.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.508 0.723 . . . . 0.0 112.825 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.618 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 10.5 m-30 -67.99 165.83 17.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.726 0.774 . . . . 0.0 112.754 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.73 -35.3 3.07 Favored Glycine 0 C--O 1.215 -1.081 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.214 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -113.13 14.78 19.55 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.659 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.29 -35.17 79.45 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 113.077 -1.874 . . . . 0.0 108.314 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -67.05 -40.68 87.19 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.7 -51.5 64.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.633 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.3 pt -60.31 -39.48 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.9 0.381 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -65.71 -48.32 72.4 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.065 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.19 -33.75 43.71 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 114.64 0.616 . . . . 0.0 114.64 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -86.21 -36.23 19.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 117.488 0.644 . . . . 0.0 111.627 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.5 -53.96 4.68 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.945 -173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 59.16 -174.48 0.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.364 0.602 . . . . 0.0 111.364 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 -13.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.809 1.244 . . . . 0.0 114.011 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -103.8 154.57 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.3 tpmt? -91.66 97.97 11.35 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 50' ' ' VAL . 96.3 m-85 -74.81 129.36 37.55 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -119.49 138.06 51.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.973 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.4 tp -126.46 152.47 34.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' ARG . 41.9 p -90.88 169.32 11.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 122.108 -0.37 . . . . 0.0 111.246 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 54' ' ' ALA . 19.3 p -67.83 -41.84 82.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.482 0.658 . . . . 0.0 109.687 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.61 -34.43 78.24 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.139 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.7 -57.66 16.65 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.998 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 36' ' ' ILE . 29.3 m -59.73 -39.34 79.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 27.0 m -66.11 -36.22 82.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.76 0.314 . . . . 0.0 111.118 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -69.21 -40.13 78.2 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.65 84.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.773 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.2 mm -57.37 -57.68 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 123.223 0.327 . . . . 0.0 111.207 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 33' ' ' SER . 6.7 ptpp? -65.07 -24.37 67.44 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 t -93.96 -8.2 40.74 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.371 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.84 34.34 43.33 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.665 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.2 mt -91.54 143.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.76 95.02 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 111.195 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -126.05 -28.95 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.32 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.07 -39.82 94.91 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 47' ' ' ASP . 5.5 m -67.67 -30.88 70.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.292 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.1 -51.05 42.59 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.1 -38.11 85.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.96 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 44' ' ' SER . 10.6 t70 -52.77 -45.51 67.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.631 1.172 . . . . 0.0 112.051 176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -82.78 -9.81 59.17 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.416 -177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.11 19.09 4.42 Favored Glycine 0 C--N 1.311 -0.86 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.257 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 25' ' ' PHE . 93.9 t -73.13 132.18 33.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.66 145.88 12.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.639 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 34.0 t -96.11 132.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 28' ' ' THR . 23.3 ttm180 -153.25 138.65 17.61 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 29' ' ' THR . . . -152.93 157.87 41.27 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 11.4 m-85 -71.84 147.07 47.54 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -74.15 -39.08 63.52 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -165.86 100.12 0.66 Allowed 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.605 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.567 ' HB2' ' CD1' ' A' ' 55' ' ' PHE . 5.7 tmtm? -137.43 110.71 8.96 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 171.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.47 121.76 2.67 Favored 'Trans proline' 0 N--CA 1.436 -1.878 0 CA-C-N 119.978 1.028 . . . . 0.0 111.463 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -91.6 132.12 1.35 Allowed 'Trans proline' 0 N--CA 1.438 -1.735 0 C-N-CA 122.998 2.465 . . . . 0.0 110.337 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -84.97 107.16 16.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.097 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 m -145.79 148.32 17.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.055 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.77 38.5 0.86 Allowed Glycine 0 C--N 1.283 -2.392 0 N-CA-C 106.658 -2.577 . . . . 0.0 106.658 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -158.0 -56.07 0.07 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 113.838 -1.181 . . . . 0.0 110.027 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt -83.72 141.85 41.88 Favored Pre-proline 0 C--N 1.307 -1.27 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.163 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -64.07 147.25 91.63 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 122.527 2.152 . . . . 0.0 110.174 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.59 -34.7 77.53 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.76 -0.2 . . . . 0.0 111.296 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.252 10.4 p90 -64.08 -35.85 82.08 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.705 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' ILE . 72.0 mm-40 -71.97 -40.3 68.71 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' MET . 35.8 m -61.5 -38.19 86.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.922 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -58.78 -44.39 90.68 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.92 -42.82 97.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.722 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.459 HD11 HG13 ' A' ' 90' ' ' VAL . 64.2 mt -59.63 -46.21 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.03 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 13.4 mmt -62.86 -45.17 93.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.625 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.42 -40.44 89.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 120.848 0.356 . . . . 0.0 110.606 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.28 -32.69 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.203 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.52 -38.45 68.06 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.628 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.24 -49.77 46.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.827 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.08 -14.11 58.09 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.021 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.6 m120 60.44 65.83 1.01 Allowed 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.871 1.32 . . . . 0.0 108.48 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -119.56 171.43 8.37 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 113.206 -1.815 . . . . 0.0 110.04 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -84.54 133.33 34.45 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -101.94 116.38 32.57 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.015 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.4 mt -96.34 110.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -134.49 154.99 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -101.59 -31.0 11.05 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.04 122.34 25.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.148 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 10.8 mptt -69.42 -25.96 64.39 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -173.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.63 -29.82 33.05 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.6 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.459 HG13 HD11 ' A' ' 73' ' ' ILE . 74.8 t -63.24 -49.16 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.77 -44.32 81.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.208 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -55.33 -56.0 25.05 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.354 1.462 . . . . 0.0 111.412 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -69.01 -40.88 78.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.373 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.45 -41.96 86.33 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 18.0 ptpt -76.54 -18.61 58.6 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.154 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.97 -28.24 68.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.58 -18.48 33.22 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.93 13.64 15.51 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.969 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -94.74 127.97 46.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -76.41 89.89 3.23 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.726 0.774 . . . . 0.0 109.484 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.99 129.31 43.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.174 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 pp -135.22 148.74 67.67 Favored Pre-proline 0 C--N 1.291 -1.96 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.14 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.3 Cg_exo -68.84 167.76 22.25 Favored 'Trans proline' 0 C--O 1.254 1.281 0 C-N-CA 122.72 2.28 . . . . 0.0 111.68 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.64 -50.05 62.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.097 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -57.76 -36.58 72.3 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' CG ' ' HD2' ' A' ' 103' ' ' PRO . 56.6 mm-40 -69.51 -37.82 77.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.429 . . . . 0.0 110.524 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.92 -44.54 84.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.37 -43.44 92.86 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.31 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.74 -27.42 69.19 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.138 0.575 . . . . 0.0 111.78 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.6 m -93.63 29.19 2.08 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.303 0.573 . . . . 0.0 110.632 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -106.19 99.76 9.33 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.3 mt 65.47 27.76 11.66 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.873 0.869 . . . . 0.0 110.386 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -46.45 71.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.893 1.277 . . . . 0.0 111.299 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -145.41 -26.01 0.47 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.723 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 119' ' ' HIS . 89.8 m-70 -80.19 66.7 5.77 Favored 'General case' 0 CA--C 1.495 -1.141 0 CA-C-O 122.031 0.919 . . . . 0.0 112.062 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -163.9 16.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.967 -1.924 . . . . 0.0 107.523 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -98.75 -75.31 0.56 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -92.41 -36.66 13.01 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.573 ' O ' ' HA ' ' A' ' 115' ' ' HIS . 5.6 t60 . . . . . 0 N--CA 1.422 -1.87 0 N-CA-C 100.993 -3.706 . . . . 0.0 100.993 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -87.75 160.14 18.19 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.947 0.403 . . . . 0.0 110.406 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -137.28 114.95 11.25 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.15 131.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.185 0.517 . . . . 0.0 109.778 -175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 57.1 mt -97.49 130.24 46.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.762 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 m -94.57 149.02 35.89 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 88.2 Cg_exo -50.96 -27.37 20.89 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.657 2.905 . . . . 0.0 114.94 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.8 p -64.25 -24.53 67.7 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 120.975 0.417 . . . . 0.0 112.061 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.51 6.52 43.2 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 122.643 0.377 . . . . 0.0 111.688 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 15.1 m-30 -68.76 154.33 42.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -34.47 3.48 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.016 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 104' ' ' ILE . 59.2 mtpt -98.95 11.87 37.64 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.004 0.907 . . . . 0.0 109.662 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.71 -36.37 74.15 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.296 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.22 -38.42 79.9 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.741 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.17 -59.2 2.82 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.578 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.422 HG23 HG23 ' A' ' 104' ' ' ILE . 29.6 pt -57.18 -45.59 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 61.3 tp -66.97 -42.6 84.88 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.331 -177.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.89 -33.16 34.28 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.593 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 m -77.27 -45.89 24.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 120.883 0.373 . . . . 0.0 111.507 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 111' ' ' SER . 43.7 t-20 -93.9 -58.41 2.26 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.254 -174.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 57.69 -146.32 0.55 Allowed 'General case' 0 C--N 1.359 1.021 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 -167.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.0 -14.02 0.25 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -117.77 157.48 26.47 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.8 tpmt? -90.63 102.67 15.42 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -75.06 120.38 20.5 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.843 0.83 . . . . 0.0 110.545 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.31 133.14 65.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.653 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 tt -123.39 153.6 28.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.571 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 24.7 p -90.75 170.55 10.03 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -67.96 -38.64 83.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.943 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.9 mt -73.04 -29.74 63.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.31 -56.18 25.0 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.578 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.9 m -60.82 -38.39 78.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.735 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 44.3 t -64.45 -40.33 95.51 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 120.811 0.339 . . . . 0.0 110.627 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -66.88 -38.92 87.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.91 86.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.379 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.2 mm -55.3 -56.81 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.6 0.562 . . . . 0.0 111.337 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 33' ' ' SER . 14.4 pttm -66.49 -30.27 70.57 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -87.41 -0.73 57.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.545 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.58 95.49 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 112.099 -0.401 . . . . 0.0 112.099 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 10' ' ' PHE . 81.1 mt -92.07 147.8 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 123.566 0.746 . . . . 0.0 109.18 -177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -70.2 89.25 0.64 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.153 0.502 . . . . 0.0 110.922 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -102.84 -32.65 3.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.774 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -60.56 -39.29 87.43 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -30.62 71.07 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.274 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.95 -48.6 23.6 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.57 -41.93 95.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.249 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.68 -21.73 64.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.609 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.8 mtt180 -92.9 -7.95 44.7 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.94 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.74 5.82 6.82 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 115.248 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.63 129.72 36.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 118.149 0.974 . . . . 0.0 108.848 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.1 pt -104.88 152.56 6.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.24 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.18 124.35 52.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.9 tpm_? -122.41 124.76 44.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.18 146.27 24.11 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.82 108.35 5.07 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.4 m -80.21 9.75 5.3 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.52 -173.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -126.02 157.9 36.72 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -61.02 113.5 7.98 Favored Pre-proline 0 C--O 1.25 1.105 0 O-C-N 123.783 0.677 . . . . 0.0 111.285 -176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.15 125.07 12.49 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.892 2.395 . . . . 0.0 112.002 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.24 171.95 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.251 1.968 . . . . 0.0 110.064 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -96.13 147.42 23.75 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.966 -0.693 . . . . 0.0 110.476 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 65' ' ' LEU . 57.3 t -126.12 118.06 50.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 174.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.77 -12.92 65.7 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.985 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' ND2' ' HG ' ' A' ' 65' ' ' LEU . 3.0 p-10 -94.34 -33.04 13.35 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.626 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' HG ' ' ND2' ' A' ' 64' ' ' ASN . 96.2 mt -108.49 153.22 42.22 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 116.871 -0.149 . . . . 0.0 111.195 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -64.84 153.66 76.84 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.981 1.788 . . . . 0.0 109.601 173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.85 -32.92 74.84 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -60.36 -40.46 90.86 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.58 -40.99 69.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 176.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -63.66 -37.88 89.03 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.325 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 34.7 tt0 -61.75 -40.83 96.5 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.95 -46.06 89.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.511 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.19 -44.32 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.404 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.6 mmt -64.51 -40.05 94.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -67.67 -38.03 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.088 0.47 . . . . 0.0 110.067 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.18 -32.52 74.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -73.67 -35.96 65.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.313 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.95 -46.71 67.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.672 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.3 mt -83.87 -17.77 39.75 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.03 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.54 69.19 0.7 Allowed 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -126.21 176.18 7.25 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.721 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -85.86 134.49 33.9 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -101.97 122.62 44.4 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.459 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.36 113.47 36.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.22 159.54 42.49 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -107.95 -24.54 11.58 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -86.65 135.71 33.3 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.594 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 88' ' ' LYS . 2.7 mppt? -59.49 -38.52 81.11 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.078 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.38 -34.11 67.71 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 65' ' ' LEU . 51.5 t -67.95 -53.08 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.625 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.3 -43.13 85.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.098 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -70.73 -41.65 71.58 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.505 ' HD2' ' OE1' ' A' ' 96' ' ' GLU . 40.3 tptt -65.87 -39.78 91.03 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.094 0.473 . . . . 0.0 110.311 -176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.53 -41.47 98.89 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.08 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -71.74 -20.44 61.9 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' OE1' ' HD2' ' A' ' 93' ' ' LYS . 42.3 mt-10 -72.93 -31.8 64.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.27 -14.53 57.31 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.535 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.05 4.26 44.82 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.954 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.97 133.81 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -79.85 93.47 5.64 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.45 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.61 130.14 41.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.578 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 102' ' ' ILE . 2.5 pp -132.21 139.2 34.16 Favored Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.479 -178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 25.6 Cg_exo -61.28 159.98 28.8 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.321 2.014 . . . . 0.0 110.453 172.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 12' ' ' LYS . 45.6 mt -56.09 -40.54 64.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -62.47 -30.07 70.99 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.806 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HG3' ' HD2' ' A' ' 103' ' ' PRO . 26.9 mm-40 -75.89 -33.57 59.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.782 0.325 . . . . 0.0 110.486 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.51 -43.39 80.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 85.7 mt -63.43 -42.59 98.7 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.01 177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.11 -38.14 85.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.0 110.877 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -65.81 -47.04 76.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.467 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.457 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 68.7 m -154.65 99.25 2.15 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.911 0.386 . . . . 0.0 111.228 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pp -97.31 -27.66 14.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.644 0.735 . . . . 0.0 110.655 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.54 -30.51 9.0 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.18 170.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 72.85 -43.23 0.56 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.95 1.3 . . . . 0.0 110.023 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -147.31 121.57 9.57 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -67.73 -21.8 65.27 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 72.77 -57.6 0.63 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.901 1.28 . . . . 0.0 112.498 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -158.26 -55.77 0.07 Allowed 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 122.967 0.507 . . . . 0.0 110.465 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 CA--C 1.511 -0.555 0 C-N-CA 126.781 2.033 . . . . 0.0 108.029 177.49 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -86.77 146.04 26.4 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -130.91 113.55 14.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.74 134.57 30.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.2 mt -95.97 128.61 47.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.446 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 85' ' ' ALA . 1.4 t -82.47 144.4 49.46 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.355 176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 49.4 Cg_exo -58.07 -26.76 76.94 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.91 2.407 . . . . 0.0 112.452 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.0 m -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.151 0.5 . . . . 0.0 110.547 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 104' ' ' ILE . . . -83.82 -0.1 49.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.802 . . . . 0.0 112.615 -174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 7' ' ' PRO . 16.3 m-30 -63.2 153.01 35.89 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.426 0.631 . . . . 0.0 112.362 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.59 -35.38 3.5 Favored Glycine 0 C--N 1.31 -0.915 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.166 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -99.05 3.67 46.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 122.76 1.267 . . . . 0.0 108.397 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.1 tt -63.4 -34.92 78.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.038 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -61.66 -34.35 75.57 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.232 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -71.82 -62.66 1.34 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.822 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.463 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.9 pt -53.43 -40.37 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 48' ' ' ARG . 49.2 tp -62.5 -54.88 33.45 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.152 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.77 -30.47 13.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.175 -1.012 . . . . 0.0 114.134 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.7 t -78.54 -29.62 46.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 122.429 -0.454 . . . . 0.0 110.911 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -114.81 -55.04 2.52 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.913 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 51.6 tttp 58.01 -140.19 0.79 Allowed 'General case' 0 CA--C 1.562 1.437 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -172.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.513 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 66.4 t30 69.93 -13.36 0.42 Allowed 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 124.793 1.237 . . . . 0.0 113.949 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -114.54 161.22 18.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.695 -0.628 . . . . 0.0 109.737 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -92.95 102.35 14.71 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -75.49 124.04 26.48 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.359 0.6 . . . . 0.0 111.446 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.86 134.61 61.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.025 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.3 tp -121.14 149.47 24.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.469 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 24.1 p -85.86 168.63 14.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 121.584 0.707 . . . . 0.0 112.506 -177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -40.76 95.8 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.291 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.93 -30.52 58.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.93 -54.65 35.77 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.947 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.2 m -60.56 -42.42 91.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.475 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.0 m -63.16 -41.79 99.32 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 120.859 0.362 . . . . 0.0 111.378 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -63.02 -43.43 98.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.307 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.95 84.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.199 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 32' ' ' VAL . 31.8 mm -59.25 -52.53 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.805 0.442 . . . . 0.0 111.088 177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -12.89 60.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -98.48 -16.01 19.37 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.716 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.19 41.36 13.96 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.192 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.4 mt -100.41 157.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -66.86 83.74 0.11 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.905 0.482 . . . . 0.0 111.364 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 8.3 tp -107.13 -31.61 2.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -71.09 -37.44 72.42 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.882 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.9 m -65.29 -28.92 69.67 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.934 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HB1' HG21 ' A' ' 50' ' ' VAL . . . -76.99 -50.08 13.97 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.75 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 80.5 mt -57.88 -40.74 80.98 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.806 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.89 -49.61 65.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.883 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.436 ' HB2' HD21 ' A' ' 17' ' ' LEU . 66.4 mtt180 -82.09 -0.62 45.48 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -173.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.04 0.68 8.17 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 118.609 -1.757 . . . . 0.0 115.026 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG21 ' HB1' ' A' ' 45' ' ' ALA . 97.2 t -72.48 126.89 33.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 pt -104.53 148.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.616 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.8 t -96.03 137.98 22.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' NE ' HD21 ' A' ' 79' ' ' LEU . 37.8 ttt85 -147.91 136.11 21.34 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.266 0.555 . . . . 0.0 111.499 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.26 153.76 34.51 Favored 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.88 158.89 21.46 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 17.8 m -58.77 -56.96 15.42 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.118 0.261 . . . . 0.0 110.393 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 56' ' ' SER . 13.9 t-80 172.72 104.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.314 0.384 . . . . 0.0 110.199 175.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -134.74 153.29 78.75 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -74.27 123.85 8.55 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.098 1.199 . . . . 0.0 109.258 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HA ' ' SD ' ' A' ' 74' ' ' MET . 16.8 Cg_exo -70.48 128.96 16.07 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 121.123 1.215 . . . . 0.0 109.305 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -116.44 109.43 17.3 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 m -150.25 161.82 4.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.07 43.91 1.2 Allowed Glycine 0 C--N 1.3 -1.422 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.122 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -178.44 -43.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 111.062 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 97.6 mt -76.37 149.17 81.41 Favored Pre-proline 0 C--N 1.308 -1.214 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 17.0 Cg_exo -70.53 161.25 46.69 Favored 'Trans proline' 0 C--O 1.251 1.136 0 C-N-CA 122.396 2.064 . . . . 0.0 111.042 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -56.46 -40.18 74.41 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.746 0.818 . . . . 0.0 112.623 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -62.68 -36.59 83.39 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -75.4 -37.62 60.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t -59.93 -44.8 94.14 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 39.3 tt0 -61.94 -37.88 86.38 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.826 -0.17 . . . . 0.0 110.88 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -42.87 97.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.019 0.438 . . . . 0.0 110.089 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.32 -44.1 83.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.901 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.385 177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 60' ' ' PRO . 23.2 mmt -60.92 -42.5 98.24 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.55 -40.53 82.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.134 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.02 74.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.295 0.569 . . . . 0.0 110.136 177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -68.66 -44.07 74.88 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.439 1.096 . . . . 0.0 110.62 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -74.19 -27.22 60.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.072 -177.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD21 ' NE ' ' A' ' 53' ' ' ARG . 93.1 mt -88.75 -19.13 26.44 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 61.06 48.86 6.08 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -170.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.98 176.92 5.93 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.819 -1.537 . . . . 0.0 112.243 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.8 tm? -89.94 128.03 36.14 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.2 tp -103.57 119.06 38.15 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.483 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.9 mt -94.58 110.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.77 -1.566 . . . . 0.0 106.77 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -126.11 173.45 9.2 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.0 -60.33 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.44 136.19 57.44 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.34 0.59 . . . . 0.0 111.232 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 45.9 mtmt -58.34 -35.37 71.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.151 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -77.25 -31.07 54.76 Favored 'General case' 0 CA--C 1.504 -0.809 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.111 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 65' ' ' LEU . 46.5 t -63.39 -43.45 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 175.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.43 -49.52 82.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.739 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -58.16 -52.72 64.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -64.62 -33.23 75.45 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.85 -46.78 77.21 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.436 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.43 -20.94 61.33 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.82 -39.1 93.42 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.696 0.76 . . . . 0.0 109.176 170.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.57 -3.57 57.79 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.265 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 93.14 10.81 59.3 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.916 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.23 126.1 44.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.39 95.3 3.21 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.176 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.44 143.93 29.13 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.027 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -141.0 152.27 64.69 Favored Pre-proline 0 C--N 1.294 -1.821 0 O-C-N 123.728 0.643 . . . . 0.0 110.445 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.6 Cg_endo -69.94 159.45 53.23 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.54 1.493 . . . . 0.0 109.848 172.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.463 HG23 ' CG2' ' A' ' 16' ' ' ILE . 75.4 mt -54.89 -43.65 69.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.88 -23.56 67.39 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.51 -32.38 54.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 120.954 0.406 . . . . 0.0 110.186 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.52 -37.9 71.16 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.2 -35.64 81.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.673 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 -9.22 58.35 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.249 0.547 . . . . 0.0 111.094 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.0 m -95.0 4.24 54.03 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.444 0.64 . . . . 0.0 109.735 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.6 t -87.14 165.29 15.85 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 171.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.6 mt 63.32 28.46 15.65 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -39.37 78.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -80.6 -3.94 52.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.615 0.721 . . . . 0.0 110.293 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.264 72.4 m80 52.37 -96.4 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 126.313 1.845 . . . . 0.0 115.896 176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -120.53 128.69 53.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.734 0.302 . . . . 0.0 110.33 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -146.74 110.9 5.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -70.4 112.56 6.79 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.183 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.08 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 C--O 1.244 0.767 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -87.42 155.67 19.92 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.79 109.15 9.45 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' O ' HD12 ' A' ' 83' ' ' LEU . 59.2 t -92.37 129.23 43.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.8 mt -96.96 133.99 36.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.573 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -91.7 147.13 34.46 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.523 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 45.5 Cg_exo -56.16 -21.45 35.48 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.219 2.613 . . . . 0.0 114.561 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -67.81 -25.67 65.69 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 122.094 -0.379 . . . . 0.0 111.729 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 19.57 8.83 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.025 0.53 . . . . 0.0 111.866 -175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.523 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 12.1 m-30 -72.33 168.09 19.1 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 -34.87 3.38 Favored Glycine 0 C--O 1.217 -0.943 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.357 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' ILE . 13.4 mmmm -100.12 21.22 13.17 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.414 0.626 . . . . 0.0 110.098 -178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.33 -27.32 68.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.711 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -79.52 -43.54 22.92 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -177.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -66.26 -46.24 77.73 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.831 -1.531 . . . . 0.0 111.457 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 12' ' ' LYS . 30.6 pt -64.88 -34.48 70.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.398 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 48' ' ' ARG . 9.5 tp -66.65 -55.04 17.05 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 121.167 0.508 . . . . 0.0 109.671 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.4 -33.17 61.59 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.3 m -82.81 -48.1 11.17 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 117.358 0.579 . . . . 0.0 111.214 -176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 111' ' ' SER . 52.1 t30 -90.21 -59.07 2.29 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.668 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 22' ' ' ASN . 75.1 tttt 59.7 -162.21 0.26 Allowed 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' H ' ' HG2' ' A' ' 21' ' ' LYS . 43.1 m-80 73.86 -0.51 3.34 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 170.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -123.18 152.42 41.23 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -87.13 104.34 16.26 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.6 m-85 -74.69 131.27 40.73 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.689 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 58.6 t -127.76 138.23 55.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.331 -176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.3 tp -125.27 150.59 30.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.6 p -84.01 163.15 20.1 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.14 0.495 . . . . 0.0 111.415 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -62.56 -34.37 76.8 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.351 177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.06 -32.64 63.38 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.03 67.51 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.108 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.9 m -61.35 -39.34 82.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.717 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -65.32 -37.54 87.41 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.693 0.282 . . . . 0.0 111.085 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -66.23 -42.23 88.96 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.446 0.641 . . . . 0.0 109.471 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.64 90.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.774 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 32' ' ' VAL . 40.8 mm -61.27 -50.58 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.572 0.349 . . . . 0.0 111.043 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -64.73 -35.78 82.18 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.3 t -80.45 -28.33 37.68 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.112 0.482 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.59 40.91 6.62 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG21 ' HB3' ' A' ' 10' ' ' PHE . 79.6 mt -95.77 149.04 4.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.14 91.72 0.23 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.725 0.774 . . . . 0.0 111.725 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.2 tp -109.59 -27.55 2.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.186 175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.96 -48.21 77.35 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.332 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.592 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 3.1 m -72.77 -27.8 62.22 Favored 'General case' 0 C--O 1.204 -1.303 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.26 -44.89 90.38 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 82.1 mt -60.1 -44.14 95.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.641 176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.94 -38.01 84.33 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.749 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 44' ' ' SER . 72.5 mtt85 -67.27 -19.8 65.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.71 4.11 6.88 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.85 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 61.9 t -75.98 119.75 24.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.6 pt -98.29 150.24 4.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.876 0.369 . . . . 0.0 111.647 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.45 135.47 27.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.511 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -132.56 135.61 46.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.71 143.58 32.9 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -72.08 122.26 20.64 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.2 t -63.38 -39.86 95.66 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 123.42 0.45 . . . . 0.0 110.679 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -100.82 -179.46 4.07 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -109.38 105.34 57.07 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.2 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.91 157.13 15.56 Favored 'Trans proline' 0 C--O 1.249 1.031 0 C-N-CA 122.403 2.069 . . . . 0.0 111.193 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 130.75 32.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.865 1.71 . . . . 0.0 109.819 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -80.17 148.19 31.01 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 63' ' ' GLY . 21.1 t -76.57 130.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' O ' HG12 ' A' ' 62' ' ' VAL . . . -77.53 161.45 50.05 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 108.676 -1.769 . . . . 0.0 108.676 174.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 t30 76.27 -40.12 0.38 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.91 0.884 . . . . 0.0 112.073 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.85 155.97 42.97 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 121.994 -0.441 . . . . 0.0 110.665 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -66.43 145.15 76.23 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.245 1.963 . . . . 0.0 109.958 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.51 -38.94 89.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -33.49 75.74 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -73.98 -40.77 62.74 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.9 m -60.96 -40.41 93.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.646 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.67 -38.22 90.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.768 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.78 -46.44 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 123.662 0.601 . . . . 0.0 110.092 176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.7 mmt -61.77 -49.55 75.93 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.77 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.57 -41.49 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.18 -41.55 98.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.552 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -65.36 -46.31 80.68 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.696 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -60.75 -43.88 97.4 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.218 0.607 . . . . 0.0 109.517 -178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.0 -15.99 54.67 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.343 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 64.34 43.61 4.64 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.58 178.93 5.02 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 113.237 -1.801 . . . . 0.0 112.288 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD11 HD11 ' A' ' 102' ' ' ILE . 1.9 tm? -87.0 135.21 33.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 4' ' ' VAL . 45.0 tp -111.09 122.29 47.52 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.495 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mt -103.13 110.21 29.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -138.72 155.17 48.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -108.47 -25.4 10.97 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -75.76 129.55 37.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.755 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -50.85 -50.32 57.07 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 124.683 1.24 . . . . 0.0 112.611 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.47 -27.49 34.57 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.562 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.21 -47.77 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.1 mt -61.06 -43.86 97.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.785 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 4.4 t30 -61.56 -47.77 84.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.873 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.411 ' HG2' HG11 ' A' ' 62' ' ' VAL . 50.4 tptt -66.41 -36.54 83.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.124 0.487 . . . . 0.0 111.1 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.31 84.36 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.498 0.666 . . . . 0.0 109.871 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -72.76 -26.26 61.48 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 51.6 mt-10 -63.8 -36.72 84.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.101 0.56 . . . . 0.0 110.23 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 89.8 mt -81.49 -18.96 43.33 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.748 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.97 27.54 6.57 Favored Glycine 0 N--CA 1.439 -1.139 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.033 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.0 t -98.27 141.17 16.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -81.17 90.75 6.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.72 0.771 . . . . 0.0 109.5 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.0 131.04 54.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.124 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 82' ' ' LEU . 2.3 pp -143.09 157.16 61.12 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 123.782 0.677 . . . . 0.0 110.268 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -73.17 167.33 27.62 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.661 2.241 . . . . 0.0 111.981 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 79.4 mt -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.223 1.009 . . . . 0.0 113.274 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.44 -38.05 89.64 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.015 0.436 . . . . 0.0 111.462 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.6 -31.19 64.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.476 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.44 -39.7 94.22 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 79.5 mt -68.26 -19.29 64.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.21 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.63 2.41 25.92 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -106.49 26.03 10.41 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.921 -0.487 . . . . 0.0 112.007 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.502 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 48.8 m -56.81 126.17 25.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.596 HD23 ' H ' ' A' ' 112' ' ' LEU . 2.4 pt? -109.44 28.9 8.07 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.576 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -56.12 -57.54 11.74 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.935 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -135.22 -43.89 0.71 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 69.06 -38.59 0.4 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.887 1.675 . . . . 0.0 114.014 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -78.13 123.94 27.46 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.9 0.48 . . . . 0.0 111.152 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -78.06 -7.01 56.37 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.88 0.847 . . . . 0.0 111.078 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 175.44 -48.86 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 102.239 -3.245 . . . . 0.0 102.239 174.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 . . . . . 0 N--CA 1.416 -2.138 0 N-CA-C 102.622 -3.103 . . . . 0.0 102.622 165.275 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -87.71 149.29 24.32 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.23 111.28 10.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 61.8 t -92.67 129.85 42.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mt -95.3 125.77 47.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.884 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -92.42 141.21 24.54 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -38.84 -32.2 0.28 Allowed 'Trans proline' 0 CA--C 1.554 1.476 0 C-N-CA 125.074 3.849 . . . . 0.0 116.98 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.6 p -64.75 -22.97 67.1 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.754 0.706 . . . . 0.0 112.053 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.44 11.51 25.94 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.381 0.672 . . . . 0.0 111.411 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.3 m-30 -76.28 159.63 30.4 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.359 0.6 . . . . 0.0 112.238 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.3 -34.97 2.2 Favored Glycine 0 C--O 1.223 -0.57 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.403 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HE2' HG21 ' A' ' 104' ' ' ILE . 58.7 mtpt -96.3 13.12 28.66 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.939 0.876 . . . . 0.0 109.433 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.9 mt -54.73 -39.21 68.03 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.216 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -73.13 -21.0 60.81 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.98 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -74.53 -58.39 3.32 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 104' ' ' ILE . 23.1 pt -59.34 -48.91 85.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 48' ' ' ARG . 57.6 tp -66.72 -45.96 77.01 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.941 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.16 48.75 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.292 -0.956 . . . . 0.0 114.061 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -84.79 -27.22 27.0 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.179 -0.609 . . . . 0.0 112.384 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.405 ' CG ' ' HB2' ' A' ' 111' ' ' SER . 43.1 t-20 -109.07 -59.1 1.94 Allowed 'General case' 0 C--O 1.243 0.718 0 C-N-CA 119.629 -0.828 . . . . 0.0 112.089 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 59.06 -155.86 0.35 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 70.7 -15.32 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 124.847 1.259 . . . . 0.0 113.896 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -104.98 153.6 21.22 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -91.82 97.5 11.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 173.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.458 ' HB2' HG22 ' A' ' 50' ' ' VAL . 90.2 m-85 -74.6 125.66 29.14 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.509 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 53.1 t -121.26 135.19 62.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.438 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 13.1 tt -123.45 154.38 29.44 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.528 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 20.4 p -89.86 167.93 12.45 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -45.57 92.45 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.719 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.1 mt -71.67 -21.87 61.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.95 -56.68 8.75 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.691 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.7 m -58.58 -38.33 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 117.323 0.561 . . . . 0.0 111.156 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 m -67.21 -35.05 78.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.523 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.91 -40.1 87.57 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.79 -49.07 78.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.456 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 32' ' ' VAL . 42.7 mm -55.4 -51.15 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.999 178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -12.35 61.44 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -106.78 -0.56 23.36 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.02 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.59 29.2 68.11 Favored Glycine 0 C--O 1.242 0.601 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.221 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.93 129.91 37.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.97 111.75 6.6 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.077 0.942 . . . . 0.0 111.049 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -116.77 -16.98 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.73 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.31 -43.62 96.19 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 122.314 -0.241 . . . . 0.0 111.222 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -63.22 -32.18 73.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.107 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.14 58.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.39 -43.17 99.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.465 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.26 -43.18 74.41 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.695 1.198 . . . . 0.0 111.978 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.524 ' HB2' HD21 ' A' ' 17' ' ' LEU . 81.6 mtt180 -77.12 -13.59 59.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.26 13.38 3.56 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 118.828 -1.653 . . . . 0.0 115.265 177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 25' ' ' PHE . 84.2 t -81.3 133.13 29.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.2 pt -110.52 154.57 12.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 120.676 0.274 . . . . 0.0 110.593 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 5.2 p -107.92 136.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -127.34 133.18 50.11 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.01 130.86 41.51 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.293 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -90.15 137.68 32.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 57' ' ' HIS . 49.5 m -85.9 -57.59 2.98 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -171.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' SER . 6.9 t60 176.81 99.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.731 0.696 . . . . 0.0 112.166 177.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -137.37 149.2 64.81 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 166.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 16.1 Cg_exo -71.36 123.82 9.87 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 N-CA-C 108.545 -1.367 . . . . 0.0 108.545 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 59' ' ' PRO . 5.6 Cg_exo -75.75 131.11 13.11 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.962 1.774 . . . . 0.0 111.419 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 63.0 mttm -89.63 109.17 20.16 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.76 162.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.21 -77.13 0.77 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.79 70.96 1.34 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.503 1.144 . . . . 0.0 111.107 175.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.4 mt -108.09 148.7 38.0 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.164 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.93 140.29 37.95 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.465 2.11 . . . . 0.0 110.688 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -45.38 -45.39 12.6 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.804 1.241 . . . . 0.0 113.139 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -61.17 -34.57 75.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -87.83 -28.23 21.76 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -64.08 -38.69 91.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.929 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.528 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 37.5 tt0 -62.0 -40.82 96.96 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.424 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -59.44 -48.7 80.62 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.917 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.416 HD11 HG13 ' A' ' 90' ' ' VAL . 61.9 mt -59.99 -45.28 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.907 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.497 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 3.7 mmt -62.55 -44.48 96.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 -177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.72 -38.4 82.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-O 120.939 0.399 . . . . 0.0 110.746 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.43 80.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.589 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -69.84 -39.43 76.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.482 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 74' ' ' MET . 12.8 mm-40 -60.09 -49.89 75.87 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.485 0.659 . . . . 0.0 111.208 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.1 mt -82.61 -16.83 46.94 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.343 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 60.73 56.09 3.08 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.05 177.76 4.85 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.031 -1.895 . . . . 0.0 111.649 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.38 134.69 34.4 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 34.5 tp -109.19 128.71 55.25 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.452 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.1 mt -106.89 113.09 42.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.56 146.57 32.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -98.63 -23.52 15.44 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.13 123.94 27.47 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.768 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.56 -38.12 80.28 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.805 -173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.57 -31.29 47.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.515 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 73' ' ' ILE . 81.5 t -62.9 -46.53 96.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -58.26 -49.56 81.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.01 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.9 t30 -56.14 -48.74 75.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.258 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.52 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 2.2 tmtm? -65.55 -45.9 81.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.013 0.435 . . . . 0.0 110.351 -175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.06 82.84 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.664 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -57.82 -42.64 84.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.439 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 39.9 mt-10 -60.39 -35.57 76.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.76 0.824 . . . . 0.0 111.091 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 81.6 mt -77.54 -5.61 50.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.523 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.77 7.22 63.11 Favored Glycine 0 CA--C 1.495 -1.193 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.4 t -93.04 128.22 44.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -82.45 97.95 8.65 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 118.616 -1.233 . . . . 0.0 110.307 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -92.44 127.46 37.94 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.227 174.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.61 146.65 62.32 Favored Pre-proline 0 C--N 1.28 -2.449 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.293 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 40.3 Cg_endo -71.42 167.65 25.73 Favored 'Trans proline' 0 C--O 1.254 1.305 0 C-N-CA 122.421 2.081 . . . . 0.0 111.065 175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.533 HG23 HG23 ' A' ' 16' ' ' ILE . 63.2 mt -60.18 -40.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.11 -29.56 69.9 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.283 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.2 -32.59 63.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.968 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.39 -34.88 76.82 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 93.2 mt -65.9 -40.73 91.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.185 0.517 . . . . 0.0 109.948 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.57 -25.42 63.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.317 0.579 . . . . 0.0 110.811 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 t -67.5 -15.36 63.62 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.751 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 20' ' ' ASN . 31.1 t -116.65 99.35 7.08 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 91.8 mt 55.32 89.24 0.04 OUTLIER 'General case' 0 C--O 1.244 0.799 0 C-N-CA 124.542 1.137 . . . . 0.0 113.961 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -75.41 -19.94 59.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.9 t60 82.64 86.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.878 2.071 . . . . 0.0 107.902 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.308 72.6 m-70 94.06 -90.8 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 127.122 2.169 . . . . 0.0 112.914 -174.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -168.83 89.94 0.23 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 66.49 151.89 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.221 1.009 . . . . 0.0 110.314 -168.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -150.3 154.4 37.79 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 109.813 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 . . . . . 0 C--N 1.305 -1.35 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 174.292 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.505 -0.762 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -87.88 150.2 23.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -127.77 108.56 10.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.1 t -92.12 128.44 43.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.219 0.533 . . . . 0.0 109.705 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.0 mt -93.94 124.13 46.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.716 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -87.2 149.01 46.28 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.476 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 50.9 Cg_exo -59.05 -19.34 48.19 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.355 2.703 . . . . 0.0 114.4 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 p -69.1 -19.25 64.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.979 0.418 . . . . 0.0 110.941 173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 104' ' ' ILE . . . -99.49 13.52 33.06 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.282 0.633 . . . . 0.0 110.963 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 12.2 m-30 -71.44 153.87 41.94 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.18 -33.1 4.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.057 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.42 11.99 35.83 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.078 0.466 . . . . 0.0 111.653 -175.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' H ' HD12 ' A' ' 13' ' ' LEU . 4.8 mp -59.47 -32.01 69.85 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.773 0.796 . . . . 0.0 108.864 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -60.11 -39.68 87.06 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.319 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.46 -56.29 8.91 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 104' ' ' ILE . 22.0 pt -58.62 -37.63 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.0 tp -72.94 -47.62 43.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.222 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.99 -31.57 31.67 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.551 -0.833 . . . . 0.0 114.34 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 m -87.72 -22.51 24.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -114.84 -55.77 2.45 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.501 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.78 -142.04 0.52 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -171.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 70.77 -13.86 0.46 Allowed 'General case' 0 N--CA 1.518 2.933 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.98 156.4 43.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.9 tpmt? -89.02 102.4 15.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.477 ' HB2' HG22 ' A' ' 50' ' ' VAL . 95.9 m-85 -74.71 126.9 31.87 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.344 0.592 . . . . 0.0 110.027 -177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.3 t -115.69 126.66 73.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.263 -177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -113.89 145.53 19.63 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.246 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 ' H ' HD13 ' A' ' 27' ' ' ILE . 26.9 p -84.79 160.44 20.24 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -44.22 97.43 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.968 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.78 -32.21 73.62 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.634 177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.02 -48.8 77.4 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.705 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.7 m -62.82 -41.56 92.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.599 0.699 . . . . 0.0 111.659 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -64.72 -36.4 84.17 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 76.8 t80 -67.75 -43.16 80.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.64 85.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 44.2 mm -64.75 -52.67 51.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.789 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -67.64 -32.53 73.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -175.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -88.54 -11.77 44.72 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.09 18.02 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.86 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.4 HG21 ' HB3' ' A' ' 10' ' ' PHE . 66.3 mt -97.0 142.27 14.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -67.73 112.66 4.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.046 0.45 . . . . 0.0 110.705 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -124.62 -26.3 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.516 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.13 -35.62 78.4 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.659 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.7 p -65.28 -38.86 91.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.485 0.66 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -52.09 63.95 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.596 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.67 -39.78 85.6 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 121.466 0.65 . . . . 0.0 110.624 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.5 -38.42 84.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.467 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.701 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.6 mtt180 -87.04 3.48 45.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -176.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.36 2.24 7.64 Favored Glycine 0 C--O 1.237 0.335 0 C-N-CA 118.73 -1.7 . . . . 0.0 115.771 171.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 25' ' ' PHE . 92.6 t -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.4 pt -105.62 157.34 6.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 7.2 p -105.86 128.13 60.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.129 0.49 . . . . 0.0 110.768 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.89 137.4 52.83 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.24 126.3 51.24 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 31.4 t80 -80.83 104.25 11.22 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.6 p -75.16 -16.98 60.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.107 0.963 . . . . 0.0 113.158 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 49.2 t60 -90.68 159.21 16.5 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 58' ' ' LYS . 53.4 mtpt -75.89 119.44 77.19 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.893 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -86.5 124.92 2.4 Favored 'Trans proline' 0 N--CA 1.44 -1.65 0 C-N-CA 121.829 1.686 . . . . 0.0 111.086 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.492 ' HD2' ' SD ' ' A' ' 74' ' ' MET . 30.7 Cg_endo -66.78 134.11 33.84 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.746 1.631 . . . . 0.0 110.69 176.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -72.39 111.59 7.71 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 65' ' ' LEU . 61.3 t -69.12 134.72 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.23 -61.87 3.81 Favored Glycine 0 N--CA 1.465 0.627 0 O-C-N 123.622 0.576 . . . . 0.0 114.475 -174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -75.19 -37.47 61.2 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.156 0.503 . . . . 0.0 112.002 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 60.3 mt -86.7 132.98 40.76 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -169.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 45.1 Cg_exo -60.05 169.1 5.13 Favored 'Trans proline' 0 C--O 1.256 1.385 0 C-N-CA 122.96 2.44 . . . . 0.0 112.238 176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.21 -48.53 70.92 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.501 0.72 . . . . 0.0 111.72 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.447 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 3.5 p90 -63.22 -31.21 72.3 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -75.71 -42.39 50.97 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -61.57 -39.98 93.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.123 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -54.03 -50.2 67.22 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.572 1.149 . . . . 0.0 109.234 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.01 -48.97 77.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.611 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.05 -45.56 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.934 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.492 ' SD ' ' HD2' ' A' ' 60' ' ' PRO . 29.8 mmt -65.09 -38.31 90.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -64.68 -43.37 96.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.41 77.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.016 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.67 -39.25 80.7 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.631 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.64 -48.83 36.19 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.289 -176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.09 -21.55 50.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.284 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 65.56 69.08 0.47 Allowed 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.05 170.7 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.492 -172.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 1.7 tm? -85.27 122.86 30.06 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 36.8 tp -99.59 125.75 45.45 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.18 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.7 mt -105.54 113.86 43.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -140.85 145.54 36.35 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.896 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -95.77 -29.32 14.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.439 ' HB3' HG23 ' A' ' 90' ' ' VAL . 14.1 t70 -83.71 124.09 30.51 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.384 -0.927 . . . . 0.0 110.858 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -46.51 -36.53 6.81 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 125.892 1.677 . . . . 0.0 114.402 179.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 23.9 t70 -79.72 -33.82 40.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.363 -176.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 87' ' ' ASP . 59.2 t -62.93 -46.04 97.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.66 -46.46 93.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.916 177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 7.3 t30 -59.54 -51.6 69.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.672 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.1 mmmt -63.01 -41.68 99.64 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -46.03 88.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.464 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 19.5 ptpt -68.53 -26.18 65.3 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.026 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 48.2 mt-10 -69.3 -28.74 66.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.189 0.519 . . . . 0.0 109.852 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.44 0.03 56.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.703 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.77 8.76 65.01 Favored Glycine 0 C--O 1.241 0.54 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.4 t -92.66 128.92 43.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -81.25 92.69 6.38 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.157 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.56 132.41 44.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.759 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.96 155.95 76.05 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.303 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.8 Cg_exo -70.76 160.65 48.73 Favored 'Trans proline' 0 C--O 1.256 1.409 0 C-N-CA 121.999 1.799 . . . . 0.0 110.868 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 16' ' ' ILE . 39.8 mt -54.76 -42.9 64.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 C-N-CA 123.651 0.78 . . . . 0.0 111.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -63.13 -36.72 84.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -71.13 -33.06 69.75 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.975 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.95 -47.95 75.8 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.8 mt -63.0 -33.33 75.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.056 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.16 -10.64 59.61 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.538 ' HA ' ' OE1' ' A' ' 113' ' ' GLU . 50.2 m -109.29 20.98 17.67 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.328 0.585 . . . . 0.0 110.885 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -89.25 -17.63 28.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.87 -27.23 3.35 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -169.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.538 ' OE1' ' HA ' ' A' ' 110' ' ' SER . 1.1 mp0 -62.67 -41.46 99.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -172.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.1 m80 63.92 -166.88 0.22 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 59.8 -89.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.859 0.864 . . . . 0.0 111.294 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -114.11 113.87 25.31 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.49 0.662 . . . . 0.0 110.437 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -151.58 28.73 0.63 Allowed 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 170.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -179.49 102.56 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 129.971 3.308 . . . . 0.0 105.89 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 C--N 1.287 -2.12 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.502 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 C--O 1.245 0.863 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.64 153.0 21.72 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.0 109.69 10.22 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 57.9 t -92.61 128.54 44.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.61 123.48 43.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.99 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 m -83.93 148.59 54.33 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 77.3 Cg_exo -53.32 -11.25 1.71 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 124.13 3.22 . . . . 0.0 114.679 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.438 ' HB2' ' H ' ' A' ' 86' ' ' GLU . 1.2 m -64.25 -47.36 79.91 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.7 20.33 0.95 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.54 -171.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 4.3 m-30 -70.6 147.77 48.86 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.084 0.469 . . . . 0.0 111.175 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -34.32 3.53 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -90.58 -0.77 57.8 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.606 1.162 . . . . 0.0 109.605 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.5 mt -47.52 -48.68 27.36 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.493 1.517 . . . . 0.0 111.999 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -75.12 -22.78 57.98 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.434 -173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -75.38 -52.37 10.92 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 104' ' ' ILE . 23.7 pt -63.57 -41.45 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.459 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 48' ' ' ARG . 59.9 tp -65.38 -54.97 21.06 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.518 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.1 -33.6 56.78 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.538 -0.839 . . . . 0.0 114.225 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -79.35 -55.64 4.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.849 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.593 ' OD1' ' HA ' ' A' ' 111' ' ' SER . 52.1 t30 -75.67 -59.06 2.92 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.017 -173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 60.09 -156.73 0.34 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 t30 73.11 -13.97 0.65 Allowed 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 124.257 1.023 . . . . 0.0 113.38 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -116.35 155.16 28.94 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.549 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -90.85 101.92 14.68 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' HB2' HG22 ' A' ' 50' ' ' VAL . 87.1 m-85 -74.66 133.72 42.09 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.63 140.03 49.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.304 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 9.7 tp -126.42 154.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 72' ' ' ALA . 81.7 p -99.92 177.9 4.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -47.46 79.54 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 124.685 1.194 . . . . 0.0 112.133 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.61 -24.05 56.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.92 -56.42 22.67 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.044 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 36' ' ' ILE . 35.2 m -61.42 -34.59 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 117.049 0.425 . . . . 0.0 111.379 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 m -67.93 -37.34 81.51 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.114 0.483 . . . . 0.0 110.665 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -69.24 -35.07 75.75 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.88 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.16 88.22 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.4 mm -58.81 -53.13 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.047 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -29.48 70.29 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.3 m -86.13 -2.74 58.62 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.628 0.252 . . . . 0.0 111.558 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.3 41.23 53.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.667 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -108.66 137.97 37.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -76.43 88.63 3.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.259 1.028 . . . . 0.0 111.134 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -81.8 -22.72 9.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.333 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.87 -32.38 72.74 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.143 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 m -65.42 -33.44 75.96 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.267 0.556 . . . . 0.0 110.875 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.58 -47.86 16.34 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.3 -42.83 82.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.38 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.52 -41.95 86.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.717 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' HD21 ' A' ' 17' ' ' LEU . 80.7 mtt85 -79.64 -2.6 43.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.64 24.08 4.48 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.923 -1.132 . . . . 0.0 114.771 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 25' ' ' PHE . 95.6 t -86.4 126.7 40.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.5 pt -100.47 151.02 5.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.378 -177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.1 t -99.52 123.25 52.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -121.3 125.59 47.42 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.1 149.08 22.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 28.7 t80 -85.22 113.02 21.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.6 m -69.68 -22.92 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.711 0.804 . . . . 0.0 112.712 -174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 61.4 t-80 -88.17 160.61 17.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.67 145.97 94.87 Favored Pre-proline 0 C--O 1.251 1.147 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.463 173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.97 143.5 96.02 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 123.145 2.563 . . . . 0.0 112.726 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.51 171.61 16.54 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.538 2.158 . . . . 0.0 111.311 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -100.87 110.49 22.56 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.95 162.56 11.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.24 -68.5 0.56 Allowed Glycine 0 C--N 1.292 -1.903 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.147 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -79.39 -38.83 33.97 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 83.3 mt -73.97 141.31 78.15 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 29.3 Cg_exo -64.68 148.38 90.24 Favored 'Trans proline' 0 C--O 1.253 1.235 0 C-N-CA 122.398 2.066 . . . . 0.0 110.068 174.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -58.06 -42.22 85.03 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.94 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -61.77 -35.3 77.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 48.4 mt-10 -81.11 -27.26 35.65 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.221 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -70.51 -32.12 69.49 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.617 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.77 -46.81 86.27 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -55.08 -48.14 73.95 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.7 0.625 . . . . 0.0 111.181 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.8 mt -57.03 -47.67 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.918 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.451 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 1.9 mmt -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.058 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.1 t -66.81 -39.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 120.731 0.301 . . . . 0.0 110.664 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.86 -30.8 70.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.042 0.449 . . . . 0.0 110.532 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -71.21 -43.74 66.77 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.88 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.68 -50.89 65.22 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 109.787 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.6 mt -76.7 -20.34 56.7 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.361 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.89 68.47 0.57 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -173.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 179.74 4.02 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.629 -172.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.93 133.15 36.39 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 30.8 tp -108.91 127.76 54.34 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.391 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.8 mt -105.72 115.65 47.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -144.2 157.55 44.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.626 0.25 . . . . 0.0 110.424 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' H ' ' HB2' ' A' ' 8' ' ' SER . 49.0 mt-10 -97.92 -43.71 6.98 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.957 0.408 . . . . 0.0 110.074 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.47 126.84 31.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.474 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -62.49 -28.0 69.52 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.714 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -75.54 -39.48 58.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.18 -51.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 171.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.21 -49.9 73.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.664 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.603 ' O ' ' HG3' ' A' ' 96' ' ' GLU 0.264 0.2 OUTLIER -64.9 -42.99 94.3 Favored 'General case' 0 C--O 1.205 -1.255 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.221 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.574 ' N ' HD22 ' A' ' 92' ' ' ASN . 10.0 mtpp -63.22 -41.54 99.14 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.72 99.87 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.26 0.552 . . . . 0.0 109.764 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -72.77 -26.13 61.43 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.698 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.8 mt-10 -64.62 -37.19 86.72 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.1 mt -80.82 -15.71 55.66 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.656 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.31 5.49 28.27 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.083 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.5 t -94.36 130.34 43.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.9 96.7 5.76 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.086 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -99.41 133.69 43.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.44 155.26 72.05 Favored Pre-proline 0 C--N 1.298 -1.65 0 O-C-N 123.49 0.493 . . . . 0.0 111.171 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 23.6 Cg_exo -67.91 162.87 37.86 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.519 2.146 . . . . 0.0 112.066 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.431 HG23 ' CG2' ' A' ' 16' ' ' ILE . 84.3 mt -57.66 -46.4 86.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 123.859 0.864 . . . . 0.0 111.597 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.31 -37.71 78.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.85 -39.58 87.63 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.37 -46.8 81.81 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.2 mt -59.81 -39.59 85.56 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.197 0.599 . . . . 0.0 110.646 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.57 -16.29 60.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.724 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.9 m -99.02 15.06 27.01 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.909 0.385 . . . . 0.0 110.274 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.593 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 23.3 t -71.4 108.76 5.0 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.82 83.73 2.09 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.385 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.05 -35.56 78.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 36.6 m80 73.22 169.8 0.31 Allowed 'General case' 0 C--O 1.24 0.572 0 C-N-CA 125.414 1.486 . . . . 0.0 112.847 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -65.82 -21.75 66.5 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.5 m80 66.51 -177.49 0.2 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.453 0.701 . . . . 0.0 111.546 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -131.91 107.82 8.97 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -102.12 144.07 31.14 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.6 t60 . . . . . 0 C--N 1.287 -2.144 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 C--O 1.24 0.581 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.86 154.49 20.49 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.5 108.99 9.95 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 28.7 t -93.54 134.41 31.36 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -176.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 13' ' ' LEU . 37.9 mt -104.56 134.24 46.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 m -89.08 146.9 37.35 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.58 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 70.6 Cg_exo -52.65 -28.08 35.83 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.545 2.83 . . . . 0.0 114.328 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 p -61.75 -22.86 65.76 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.97 13.23 31.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.166 0.507 . . . . 0.0 111.445 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 3.6 m-30 -69.88 160.52 31.65 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.23 -34.33 3.65 Favored Glycine 0 C--O 1.221 -0.664 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.687 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.527 ' HB2' HD13 ' A' ' 104' ' ' ILE . 28.6 mtpp -102.18 13.85 33.56 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.781 0.801 . . . . 0.0 110.382 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' CD2' HG21 ' A' ' 5' ' ' ILE . 61.4 mt -56.93 -40.74 76.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.42 -1.263 . . . . 0.0 109.572 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -65.92 -26.2 67.49 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.024 -1.443 . . . . 0.0 111.33 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.53 -49.15 9.52 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.74 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.438 ' CG2' HG23 ' A' ' 104' ' ' ILE . 19.0 pt -63.38 -46.55 95.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 CA-C-O 121.171 0.51 . . . . 0.0 111.368 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.7 tp -67.97 -43.18 79.59 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.853 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.36 -33.19 64.52 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.196 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.1 m -83.79 -45.32 13.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.411 ' HA ' ' OG ' ' A' ' 111' ' ' SER . 61.4 t30 -96.63 -53.67 3.49 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 58.68 -114.28 0.74 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -164.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 55.94 -15.31 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -132.17 166.25 22.24 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.4 -0.813 . . . . 0.0 109.233 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.6 tpmt? -98.28 105.51 17.67 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.417 ' HB2' HG22 ' A' ' 50' ' ' VAL . 57.9 m-85 -75.26 139.69 42.71 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -174.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 55.8 t -131.05 140.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.373 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.1 tp -130.0 156.96 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 75' ' ' VAL . 25.7 p -91.64 169.03 11.07 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.171 0.51 . . . . 0.0 111.779 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.0 -41.68 95.16 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 124.279 1.032 . . . . 0.0 110.176 175.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.216 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.23 -52.06 19.57 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.404 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 36' ' ' ILE . 32.1 m -58.58 -38.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.434 0.617 . . . . 0.0 112.001 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.3 p -75.78 -22.46 56.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.046 0.451 . . . . 0.0 111.34 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -69.1 -40.88 78.12 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 42' ' ' ILE . . . -66.45 -43.11 86.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.258 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 32' ' ' VAL . 47.0 mm -57.72 -52.53 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.736 0.648 . . . . 0.0 111.391 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -65.51 -25.05 67.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.9 t -100.34 -28.39 12.98 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 119.268 -0.973 . . . . 0.0 112.334 -179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.68 41.57 3.1 Favored Glycine 0 C--N 1.316 -0.529 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.91 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.7 mt -100.45 147.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.44 97.89 0.45 Allowed 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.896 0.379 . . . . 0.0 111.511 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.6 tp -108.12 -34.29 2.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.622 177.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.23 -48.35 80.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.842 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 t -62.56 -37.25 85.42 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.839 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.5 69.72 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 42' ' ' ILE . 87.4 mt -57.67 -45.86 85.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.054 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.68 -41.54 97.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.93 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HB2' HD21 ' A' ' 17' ' ' LEU . 61.7 mtt180 -74.06 -8.03 54.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.27 23.18 1.78 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.151 -1.499 . . . . 0.0 115.154 175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 62.6 t -98.39 119.57 46.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -99.45 155.82 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-O 120.792 0.329 . . . . 0.0 110.991 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.1 t -97.91 135.29 33.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' HG2' HG13 ' A' ' 75' ' ' VAL . 2.9 tpm_? -122.32 125.08 45.19 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.62 111.86 24.72 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 58' ' ' LYS . 1.4 t80 -78.48 139.11 38.71 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 m -82.81 -57.24 3.39 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.67 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -173.49 101.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 6.6 tmtt? -135.8 117.22 11.85 Favored Pre-proline 0 C--N 1.309 -1.191 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.64 124.16 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.7 1.6 . . . . 0.0 110.781 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -90.4 168.45 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.306 2.004 . . . . 0.0 112.77 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -113.72 108.15 16.72 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -158.35 160.47 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 124.012 0.925 . . . . 0.0 108.923 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.27 -59.04 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -93.35 -1.27 56.12 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.785 0.434 . . . . 0.0 111.197 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.5 mt -99.44 134.03 21.5 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 122.164 -0.335 . . . . 0.0 111.118 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -65.88 158.05 55.98 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 122.72 2.28 . . . . 0.0 111.582 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -66.07 -27.91 68.44 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.985 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . 0.262 5.1 p90 -62.01 -37.09 83.57 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.737 176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -71.29 -38.68 71.77 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 74' ' ' MET . 18.8 m -63.17 -40.9 98.86 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.699 -177.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -65.97 -35.37 80.41 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.21 91.8 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.1 mt -60.15 -45.09 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.615 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 70' ' ' SER . 26.6 mmt -61.67 -45.16 95.21 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.668 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG13 ' HG2' ' A' ' 53' ' ' ARG . 46.4 t -61.77 -40.66 87.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 120.876 0.37 . . . . 0.0 110.73 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.05 69.62 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -79.85 -27.61 40.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.323 0.582 . . . . 0.0 110.348 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.25 -48.79 21.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.09 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.69 -12.86 55.31 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.596 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 57.19 63.3 1.93 Allowed 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -173.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.97 -179.92 3.8 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 113.455 -1.702 . . . . 0.0 112.308 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -90.34 130.83 36.39 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.1 tp -107.55 130.25 54.89 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.301 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -111.03 115.83 50.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.84 146.18 33.9 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -94.42 -29.0 15.2 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.634 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -74.37 123.15 24.11 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -73.17 -17.55 61.36 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.674 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 34.0 t70 -81.01 -33.18 33.83 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.8 t -60.45 -41.48 87.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.748 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.459 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 82.5 mt -59.59 -50.34 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.87 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.674 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.6 p-10 -68.6 -41.47 79.52 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 89' ' ' ASP . 28.2 mmmt -59.23 -43.98 92.34 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.008 0.432 . . . . 0.0 111.542 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.57 -43.56 96.66 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.236 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 91' ' ' ILE 0.312 17.4 ptpt -74.55 -18.51 60.57 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 45.8 mt-10 -67.4 -29.79 69.39 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.48 -7.5 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.487 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 104.07 -7.19 47.97 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.235 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.21 127.21 39.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.27 95.41 3.74 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.523 . . . . 0.0 110.147 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.35 132.53 44.61 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.232 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.27 153.97 78.44 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 123.566 0.542 . . . . 0.0 110.392 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.7 Cg_endo -76.25 166.99 26.69 Favored 'Trans proline' 0 C--O 1.253 1.226 0 C-N-CA 121.962 1.775 . . . . 0.0 111.637 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 12' ' ' LYS . 41.7 mt -54.74 -44.72 72.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.014 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -73.54 -25.81 60.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.221 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.21 -44.67 68.16 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.26 -38.95 93.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.556 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -22.75 64.37 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.311 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.9 m -84.92 -10.27 57.25 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.26 0.552 . . . . 0.0 109.912 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 20' ' ' ASN . 10.1 t -89.73 94.15 9.73 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.94 8.33 8.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.392 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.23 -34.17 71.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.526 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -101.0 24.6 9.09 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.466 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -9.53 32.36 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.109 0.48 . . . . 0.0 112.267 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -115.23 74.47 0.88 Allowed 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -81.84 79.78 8.3 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.194 -176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -161.98 151.55 16.23 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 . . . . . 0 C--N 1.29 -2.001 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.434 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -87.37 149.17 24.67 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -136.55 114.09 10.98 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' HD12 ' A' ' 83' ' ' LEU . 43.1 t -98.79 132.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.7 mt -99.67 131.79 46.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.108 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -92.91 148.58 36.13 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 85.2 Cg_exo -53.8 -23.19 26.04 Favored 'Trans proline' 0 CA--C 1.547 1.135 0 C-N-CA 123.502 2.801 . . . . 0.0 114.505 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 p -65.21 -24.27 67.31 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 122.109 -0.369 . . . . 0.0 111.683 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 86' ' ' GLU . . . -91.44 7.74 39.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.108 0.48 . . . . 0.0 111.46 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HB3' HG21 ' A' ' 40' ' ' ILE . 9.5 m-30 -66.81 157.55 32.67 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.81 -35.8 2.09 Favored Glycine 0 C--N 1.318 -0.449 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.208 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -93.59 12.29 25.81 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.344 1.068 . . . . 0.0 109.366 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.7 mt -59.48 -38.66 81.43 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 113.66 -1.609 . . . . 0.0 109.834 177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -58.74 -37.85 77.13 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.196 -178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -74.41 -59.45 2.72 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.722 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.534 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.9 pt -59.48 -43.84 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 48' ' ' ARG . 51.4 tp -68.73 -43.9 74.95 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.831 -175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.08 -33.15 15.52 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.492 -0.861 . . . . 0.0 114.893 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.6 m -81.31 -34.46 31.9 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 117.321 0.56 . . . . 0.0 111.436 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -86.0 -60.39 2.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.086 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 22' ' ' ASN . 4.2 tmmm? 59.83 141.88 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.07 0 CA-C-O 122.336 1.065 . . . . 0.0 112.537 -178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.447 ' N ' ' HD2' ' A' ' 21' ' ' LYS 0.31 14.4 t-20 81.58 63.84 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 125.509 1.523 . . . . 0.0 114.342 177.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -146.11 150.27 35.59 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 164.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -87.88 92.89 9.29 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.7 m-85 -74.33 126.43 30.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.131 -176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.87 133.17 67.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.974 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 tp -117.08 156.93 18.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.626 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 21.2 p -94.12 165.22 12.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -39.35 93.96 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.914 176.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -72.64 -33.28 66.51 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.48 175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.5 -52.4 53.36 Favored Glycine 0 N--CA 1.446 -0.661 0 O-C-N 123.869 0.73 . . . . 0.0 112.298 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.7 m -63.04 -39.97 87.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -65.34 -40.36 93.55 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-O 121.101 0.477 . . . . 0.0 110.271 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -63.52 -49.08 74.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.46 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.53 -39.25 73.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.799 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 32' ' ' VAL . 45.0 mm -59.71 -57.25 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 123.273 0.358 . . . . 0.0 110.934 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -26.31 63.7 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.6 m -81.37 -18.66 44.8 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.423 177.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.21 37.24 25.28 Favored Glycine 0 CA--C 1.509 -0.308 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.525 HG21 ' HB3' ' A' ' 10' ' ' PHE . 84.4 mt -101.35 140.04 21.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -60.7 98.54 0.07 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.574 0.75 . . . . 0.0 111.446 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tp -109.49 -30.72 2.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -60.14 -49.46 77.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.477 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 23.0 t -62.91 -34.39 77.33 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.709 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.8 -50.9 63.02 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.4 mt -60.99 -39.89 91.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.955 178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.24 -39.39 92.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.308 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.544 ' HB2' HD21 ' A' ' 17' ' ' LEU . 63.2 mtt180 -79.22 -7.22 58.08 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.35 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.06 12.09 4.06 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.431 -1.366 . . . . 0.0 115.995 174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 90.2 t -82.58 131.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.8 pt -108.43 148.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 p -101.89 127.98 54.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 120.885 0.374 . . . . 0.0 111.257 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtt180 -118.52 154.24 32.87 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.322 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.32 116.63 30.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.527 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -90.73 98.05 11.55 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.4 t -70.49 -29.36 65.87 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.547 1.139 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -76.63 148.1 37.14 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -92.41 121.4 66.46 Favored Pre-proline 0 C--N 1.294 -1.834 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.611 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.5 148.55 20.0 Favored 'Trans proline' 0 C--O 1.257 1.434 0 C-N-CA 124.062 3.175 . . . . 0.0 114.101 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 149.6 55.43 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.966 2.444 . . . . 0.0 110.246 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 3.3 mptp? -81.3 110.28 16.61 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.509 0.671 . . . . 0.0 111.539 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -98.75 106.83 19.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 172.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.89 66.26 0.85 Allowed Glycine 0 C--N 1.321 -0.299 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.713 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -176.94 -44.52 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 124.058 0.943 . . . . 0.0 108.893 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 76.7 mt -93.52 138.78 22.82 Favored Pre-proline 0 C--O 1.243 0.757 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.512 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 8.3 Cg_exo -71.06 150.28 60.04 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 122.246 1.964 . . . . 0.0 109.874 175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.89 -28.91 62.49 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -64.64 -33.16 75.28 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.632 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -74.55 -44.62 50.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.6 m -59.7 -38.09 80.63 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.993 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.626 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 35.7 tt0 -63.74 -40.65 97.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.74 -45.89 87.83 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.272 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.1 mt -57.13 -46.05 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.181 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.6 mmt -64.82 -37.59 88.12 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -70.15 -36.43 67.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.234 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.62 -33.35 73.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.237 0.541 . . . . 0.0 110.306 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -71.68 -35.93 70.44 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.605 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -67.48 -52.29 41.09 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.674 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.2 mt -82.44 -15.12 53.75 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.811 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.78 62.85 1.8 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -170.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.91 177.82 4.6 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.813 -1.994 . . . . 0.0 111.368 -171.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -90.15 126.09 35.68 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 4' ' ' VAL . 44.0 tp -103.02 125.74 49.9 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.499 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.2 mt -107.25 118.98 56.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -147.76 159.17 44.11 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mt-10 -103.43 -25.93 13.07 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.337 -0.545 . . . . 0.0 112.152 178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.39 126.61 31.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.076 -173.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.43 -42.09 63.82 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 124.423 1.077 . . . . 0.0 112.705 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.5 -35.27 58.45 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.586 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.77 -45.8 97.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 98.9 mt -60.99 -48.42 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.856 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -68.64 -37.49 79.74 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' N ' HD22 ' A' ' 92' ' ' ASN . 31.6 mmmt -67.19 -39.2 86.33 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.037 178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.46 87.58 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -60.23 -42.39 95.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.341 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' OE2' ' HD2' ' A' ' 93' ' ' LYS . 52.9 mt-10 -55.82 -42.59 75.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.176 0.59 . . . . 0.0 111.097 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.72 -8.49 56.96 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.987 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.54 44.1 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.08 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.26 129.46 46.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.15 92.85 6.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.451 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -97.93 136.0 38.85 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.606 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.24 152.23 73.11 Favored Pre-proline 0 C--N 1.293 -1.885 0 O-C-N 123.376 0.423 . . . . 0.0 110.609 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 16.9 Cg_exo -68.73 160.27 50.24 Favored 'Trans proline' 0 C--O 1.248 0.981 0 C-N-CA 121.968 1.779 . . . . 0.0 110.712 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.534 HG23 ' CG2' ' A' ' 16' ' ' ILE . 53.6 mt -54.78 -42.92 64.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 123.837 0.855 . . . . 0.0 111.728 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -63.07 -25.32 68.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.991 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -78.59 -34.84 46.51 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 120.828 0.346 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.88 -41.85 95.29 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 83.9 mt -64.14 -41.76 97.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.249 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 -5.36 33.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.637 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 t -113.02 3.48 16.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 m -87.56 65.57 8.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 0.0 110.48 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.584 ' HG ' ' H ' ' A' ' 114' ' ' HIS . 1.8 pt? -171.63 -172.4 1.04 Allowed 'General case' 0 C--O 1.247 0.944 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.885 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -15.07 61.15 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.093 0.246 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.584 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 69.6 t60 80.51 14.07 0.8 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.096 1.358 . . . . 0.0 110.127 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 57.37 -79.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.389 1.475 . . . . 0.0 113.178 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -133.4 119.91 20.26 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -78.42 -31.61 48.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 172.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -157.48 -44.22 0.07 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 126.625 1.97 . . . . 0.0 107.312 171.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 . . . . . 0 CA--C 1.491 -1.292 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 175.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.246 0.881 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.412 ' HB2' ' HB2' ' A' ' 81' ' ' ALA . 95.5 m-85 -87.8 152.93 21.74 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -134.91 108.28 7.81 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 26' ' ' VAL . 46.6 t -92.85 131.65 39.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -175.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -97.72 132.39 42.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.41 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -92.84 149.39 37.7 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 Cg_exo -57.07 -15.17 16.76 Favored 'Trans proline' 0 CA--C 1.55 1.316 0 C-N-CA 123.441 2.761 . . . . 0.0 114.961 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.2 p -75.14 -22.03 58.4 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.769 -0.582 . . . . 0.0 111.099 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.21 10.11 25.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.484 0.659 . . . . 0.0 110.995 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.459 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.9 m-30 -72.08 156.3 39.35 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.498 0.666 . . . . 0.0 111.749 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -33.7 4.88 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.741 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 57.8 mtpt -106.46 18.54 21.8 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 122.405 1.098 . . . . 0.0 109.539 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.94 -39.5 94.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.757 -1.565 . . . . 0.0 111.696 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -68.6 -35.21 77.03 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.15 -175.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.19 -54.57 19.89 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.676 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG2' HG23 ' A' ' 104' ' ' ILE . 24.5 pt -57.77 -39.81 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp -59.33 -55.05 39.64 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.764 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.93 -33.42 41.49 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.955 -1.117 . . . . 0.0 113.718 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -77.53 -15.49 59.24 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' OD1' ' HG ' ' A' ' 112' ' ' LEU . 54.1 t30 -122.42 -60.09 1.58 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.687 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 60.23 -171.45 0.13 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.308 0.643 . . . . 0.0 111.609 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 65.2 -14.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 126.677 1.991 . . . . 0.0 115.013 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -93.05 149.32 21.31 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -90.73 99.67 12.66 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 95.4 m-85 -74.71 131.42 40.84 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.636 -176.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 4' ' ' VAL . 39.5 t -122.16 136.39 59.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.593 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 tp -122.65 153.32 27.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.614 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 25.6 p -92.47 166.91 12.3 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.088 0.471 . . . . 0.0 112.007 -177.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.24 -41.09 99.03 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.443 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.45 -31.72 69.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.9 -56.43 24.17 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.107 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 36' ' ' ILE . 27.4 m -59.99 -40.74 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -63.77 -38.32 90.68 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 120.916 0.388 . . . . 0.0 110.844 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.72 -39.6 76.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.671 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.06 -42.14 94.48 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.759 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.4 mm -56.34 -52.63 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 O-C-N 123.759 0.662 . . . . 0.0 110.951 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.98 -21.79 61.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.4 m -88.74 -23.58 22.9 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.44 41.55 6.08 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 119.886 -1.15 . . . . 0.0 111.575 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.7 mt -103.22 153.53 5.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -72.85 83.25 1.2 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.118 0.485 . . . . 0.0 110.561 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -93.13 -27.36 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.16 -38.47 89.14 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.44 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.2 m -72.88 -24.45 60.85 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.421 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' HA ' HD21 ' A' ' 17' ' ' LEU . . . -76.77 -52.63 9.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.185 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.5 mt -58.19 -40.35 81.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.689 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -54.48 -44.82 72.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.636 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 17' ' ' LEU . 53.5 mtt85 -81.65 -5.71 58.33 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.44 5.2 6.67 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 118.898 -1.62 . . . . 0.0 115.146 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.5 t -70.95 124.82 28.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 117.57 0.685 . . . . 0.0 109.167 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.5 pt -99.79 149.82 5.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.931 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -96.03 120.39 45.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HG2' HG13 ' A' ' 75' ' ' VAL . 31.8 tpt180 -113.14 126.51 55.53 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.54 125.32 40.93 Favored 'General case' 0 N--CA 1.419 -2.025 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 74' ' ' MET . 13.4 t80 -73.68 100.42 3.37 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -66.05 -30.76 71.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.106 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -77.12 145.7 37.62 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.72 126.62 92.84 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.46 124.34 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 113.236 -174.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -60.3 142.62 98.61 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.422 2.081 . . . . 0.0 110.003 172.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -85.59 110.37 19.2 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.076 0.465 . . . . 0.0 111.598 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.8 t -86.2 97.18 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.86 69.19 1.55 Allowed Glycine 0 CA--C 1.506 -0.527 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.161 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.484 HD22 ' HG ' ' A' ' 65' ' ' LEU . 7.4 t30 -176.36 -40.14 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 124.095 0.958 . . . . 0.0 109.57 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HG ' HD22 ' A' ' 64' ' ' ASN . 84.8 mt -107.56 154.73 40.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.658 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -59.03 148.11 86.92 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.738 2.292 . . . . 0.0 111.229 173.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -55.81 -44.37 77.8 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.204 1.002 . . . . 0.0 111.307 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -63.93 -34.69 78.54 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 73' ' ' ILE . 26.6 mm-40 -70.36 -39.92 74.34 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -63.15 -41.04 99.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.184 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.614 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -60.31 -39.6 87.56 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.33 83.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.48 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 69' ' ' GLU . 61.5 mt -58.18 -43.64 86.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.401 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 55' ' ' PHE . 19.8 mmt -67.43 -38.68 84.95 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.093 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG13 ' HG2' ' A' ' 53' ' ' ARG . 55.8 t -66.2 -39.62 84.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.358 0.599 . . . . 0.0 110.209 176.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.51 -30.66 71.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.118 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.69 -47.03 64.67 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.184 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.13 -39.07 79.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 111.328 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.19 -11.43 57.87 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.332 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.46 59.26 3.38 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' A' ' 2' ' ' PHE . . . -117.76 177.11 4.89 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.148 -171.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.42 141.47 28.71 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.2 tp -105.72 124.66 49.93 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.815 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.08 110.77 25.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -138.96 147.48 42.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -102.06 -28.43 12.35 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 91' ' ' ILE . 19.6 t70 -76.06 122.47 24.29 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -61.02 -29.54 69.77 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.621 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 23.0 t70 -79.73 -39.27 31.48 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.5 -44.3 88.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.067 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 87' ' ' ASP . 96.7 mt -57.62 -49.91 79.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.621 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.4 p-10 -69.57 -42.94 73.83 Favored 'General case' 0 C--O 1.21 -0.977 0 C-N-CA 118.982 -1.087 . . . . 0.0 112.223 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 65' ' ' LEU . 32.2 mmmt -60.52 -41.99 95.52 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.425 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.86 -43.54 92.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.993 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 5.2 ptmm? -71.33 -25.5 62.44 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.035 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 44.0 mt-10 -74.02 -30.34 62.39 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 174.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 95.2 mt -79.89 -12.45 59.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.889 0.376 . . . . 0.0 111.248 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 110.39 12.78 16.43 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.601 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 44.6 t -108.48 132.14 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.98 97.47 6.07 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 118.904 -1.118 . . . . 0.0 109.727 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.3 129.3 41.02 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.781 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 106' ' ' GLU . 2.6 pp -130.14 143.49 49.35 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.034 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 33.2 Cg_exo -61.28 158.36 35.79 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.363 2.042 . . . . 0.0 110.947 174.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 9.5 mt -54.06 -40.47 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.39 -20.43 65.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 102' ' ' ILE . 53.0 mm-40 -76.68 -31.8 57.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.886 0.85 . . . . 0.0 109.125 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.48 -32.72 66.44 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.612 -1.177 . . . . 0.0 108.018 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 104' ' ' ILE . 88.3 mt -79.64 -48.55 13.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.172 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.08 63.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.846 0.355 . . . . 0.0 111.788 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m -97.14 35.91 1.52 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.796 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.0 p -62.23 96.19 0.07 Allowed 'General case' 0 C--O 1.255 1.383 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 20' ' ' ASN . 85.9 mt 71.06 108.8 0.06 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 125.057 1.343 . . . . 0.0 113.766 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 -41.78 39.08 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.787 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.518 ' CE1' HD13 ' A' ' 112' ' ' LEU . 13.0 m170 63.94 173.58 0.18 Allowed 'General case' 0 C--O 1.246 0.879 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 66.77 172.72 0.25 Allowed 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.99 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -140.8 144.16 35.25 Favored 'General case' 0 C--N 1.287 -2.132 0 C-N-CA 119.596 -0.842 . . . . 0.0 108.87 175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -44.33 121.91 2.78 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 124.529 1.143 . . . . 0.0 113.916 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -68.43 -34.75 76.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.233 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.1 m170 . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 175.149 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.502 -0.899 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -87.39 153.65 21.28 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.65 107.69 9.0 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 83' ' ' LEU . 46.9 t -92.38 131.73 38.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -176.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.7 mt -97.26 128.77 48.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.328 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 m -88.51 149.58 44.66 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 49.1 Cg_exo -58.03 -21.75 51.9 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.105 2.537 . . . . 0.0 113.404 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.1 p -68.84 -19.35 64.26 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.93 16.44 19.39 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.264 0.554 . . . . 0.0 111.521 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 8.5 m-30 -75.5 156.45 35.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.95 -34.32 5.0 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.565 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 1.2 mmmp? -98.38 15.54 24.4 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.75 -38.83 86.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.129 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -61.62 -36.41 80.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.805 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -74.85 -56.08 5.14 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.329 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.482 ' CG2' HG23 ' A' ' 104' ' ' ILE . 29.5 pt -58.24 -41.22 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 48' ' ' ARG . 36.7 tp -72.25 -52.86 14.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.234 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.63 -31.15 58.94 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.84 -0.695 . . . . 0.0 114.3 -175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.8 m -83.3 -39.31 20.98 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 117.652 0.726 . . . . 0.0 112.231 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -91.26 -59.55 2.12 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.225 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.5 mttt 55.8 -152.53 0.37 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.5 t30 70.05 -14.28 0.39 Allowed 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 125.013 1.325 . . . . 0.0 112.845 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -115.5 160.17 20.26 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 123.135 0.574 . . . . 0.0 109.63 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -98.6 102.07 13.69 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CB ' HG22 ' A' ' 50' ' ' VAL . 57.0 m-85 -75.41 136.66 40.73 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.368 -174.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG22 ' A' ' 4' ' ' VAL . 54.9 t -128.71 139.62 51.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.442 -177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 10.2 tp -127.58 158.86 38.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -96.71 168.53 10.45 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 122.138 -0.351 . . . . 0.0 110.404 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.8 p -68.69 -39.06 80.72 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.7 mt -67.09 -31.8 72.53 Favored 'General case' 0 C--O 1.214 -0.807 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.92 -54.06 36.15 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.496 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.562 ' O ' HG12 ' A' ' 36' ' ' ILE . 26.6 m -62.93 -35.12 69.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.046 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.7 t -68.4 -38.75 81.58 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -63.06 -40.52 97.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.68 96.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.376 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 32' ' ' VAL . 46.7 mm -60.07 -53.91 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 123.301 0.376 . . . . 0.0 110.69 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.89 -23.76 65.15 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.4 m -93.25 -9.87 37.57 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.502 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.82 37.81 60.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.655 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.91 140.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.06 108.94 1.66 Allowed 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 123.819 0.699 . . . . 0.0 112.367 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.3 tp -113.73 -9.38 12.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.494 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.21 -49.01 66.14 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.113 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 m -62.21 -26.5 68.4 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.703 -178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -69.58 -57.08 5.64 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.552 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.47 -39.74 80.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.906 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -56.97 -47.17 81.37 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.979 1.312 . . . . 0.0 112.804 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.63 ' HB2' HD21 ' A' ' 17' ' ' LEU . 72.5 mtt85 -91.25 4.05 53.28 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -174.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.95 6.06 6.59 Favored Glycine 0 CA--C 1.505 -0.534 0 C-N-CA 118.67 -1.729 . . . . 0.0 115.813 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' CB ' ' A' ' 25' ' ' PHE . 57.8 t -81.03 120.19 32.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.4 pt -102.86 151.74 6.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.653 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 9.4 p -98.02 128.28 49.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.186 0.517 . . . . 0.0 111.444 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -150.5 126.89 10.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.7 158.68 39.96 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.324 0.39 . . . . 0.0 110.617 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -85.03 138.0 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 123.844 0.715 . . . . 0.0 110.254 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.2 t -92.75 -31.7 14.96 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.27 100.38 5.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.739 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HD2' ' O ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -137.15 147.98 60.69 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 165.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -69.26 123.2 10.02 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 172.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -88.76 128.87 2.06 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 120.503 0.802 . . . . 0.0 113.091 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -116.01 109.51 17.64 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 172.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 65' ' ' LEU . 29.8 m -135.43 133.42 52.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-O 120.937 0.399 . . . . 0.0 110.65 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.65 -71.03 0.28 Allowed Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -14.68 22.4 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.611 ' O ' ' HB ' ' A' ' 62' ' ' VAL . 97.1 mt -107.01 148.24 36.61 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.409 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 65' ' ' LEU . 3.0 Cg_exo -78.62 169.82 19.18 Favored 'Trans proline' 0 C--O 1.265 1.839 0 C-N-CA 123.05 2.5 . . . . 0.0 109.489 170.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -60.03 -42.74 95.06 Favored 'General case' 0 C--O 1.209 -1.052 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -55.26 -38.98 69.25 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -70.9 -40.92 71.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 0.0 109.685 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 m -73.79 -24.31 59.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.699 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -61.67 -45.11 95.42 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.71 87.51 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.752 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.7 mt -56.4 -44.41 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.155 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 3.4 mmt -60.71 -48.61 81.02 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.145 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.8 t -64.7 -38.06 81.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.907 0.384 . . . . 0.0 110.612 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.05 -36.9 84.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.398 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -71.13 -40.73 71.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.23 0.538 . . . . 0.0 109.885 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -63.92 -45.1 90.79 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.982 0.913 . . . . 0.0 111.363 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.8 mt -85.18 -15.13 44.73 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.044 -0.41 . . . . 0.0 111.695 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 57.8 60.16 2.89 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 122.913 1.34 . . . . 0.0 107.661 -169.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.46 175.43 5.47 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 113.293 -1.776 . . . . 0.0 111.272 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.46 135.28 33.69 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 4' ' ' VAL . 41.5 tp -110.83 125.19 53.34 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.594 -0.843 . . . . 0.0 110.713 -178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -98.1 110.38 25.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -142.25 146.55 35.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.307 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -108.78 -20.53 13.03 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.103 177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 90' ' ' VAL . 10.5 t70 -79.2 132.79 36.63 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -63.04 -35.43 80.22 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -81.28 -28.41 34.69 Favored 'General case' 0 C--O 1.212 -0.895 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.658 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 87' ' ' ASP . 91.4 t -63.64 -49.89 80.39 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 90.0 mt -57.58 -47.21 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.982 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.517 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.0 t30 -63.12 -54.74 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.661 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 84.5 tttt -55.79 -51.26 68.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.52 1.128 . . . . 0.0 111.367 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.4 93.72 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.603 0.565 . . . . 0.0 111.258 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 21.2 ttmm -65.27 -38.77 91.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.112 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 46.1 mt-10 -62.7 -38.72 91.56 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.221 0.534 . . . . 0.0 109.762 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 81.8 mt -72.68 -13.2 61.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.437 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.14 5.39 37.81 Favored Glycine 0 CA--C 1.501 -0.803 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.358 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 59.3 t -92.83 137.49 22.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -86.59 96.34 10.06 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.092 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.81 127.02 42.38 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.83 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.24 152.83 78.92 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 26.3 Cg_exo -66.53 163.44 32.59 Favored 'Trans proline' 0 C--O 1.247 0.963 0 C-N-CA 122.353 2.035 . . . . 0.0 112.181 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 12' ' ' LYS . 72.3 mt -52.74 -43.85 45.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.543 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -65.64 -27.96 68.76 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -77.12 -32.13 56.24 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.135 0.493 . . . . 0.0 110.411 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.88 -40.81 75.45 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.98 -43.28 96.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.059 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.64 94.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.394 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.7 p -63.92 -10.24 19.91 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.7 t -76.3 -22.22 55.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.3 mt -109.05 95.52 5.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -81.59 -58.28 3.09 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -165.61 167.22 17.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 103.797 -2.668 . . . . 0.0 103.797 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -77.84 114.16 16.43 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.969 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -85.57 169.58 13.4 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.347 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -66.68 139.05 57.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 123.411 0.445 . . . . 0.0 110.298 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -59.9 119.56 7.96 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.217 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.409 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -86.98 150.21 24.22 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' LEU . . . -131.35 107.65 9.09 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 40.8 t -93.24 130.69 41.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.0 mt -94.74 125.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.601 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -87.04 147.54 43.04 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.494 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 59.4 Cg_exo -53.17 -28.22 40.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.071 2.514 . . . . 0.0 113.971 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.3 m -60.53 -22.23 63.38 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 174.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.89 13.52 32.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.97 0.414 . . . . 0.0 111.382 -177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 7' ' ' PRO . 13.8 m-30 -70.12 162.85 27.5 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.798 0.809 . . . . 0.0 112.604 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.69 -33.88 3.63 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.153 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -95.98 14.24 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.671 0.789 . . . . 0.0 110.215 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.2 mt -57.76 -38.74 75.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.569 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -74.49 -26.98 60.35 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.141 0.496 . . . . 0.0 110.918 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -78.0 -46.67 20.38 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.728 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.6 pt -66.21 -39.65 84.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.381 -0.527 . . . . 0.0 111.301 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 HD23 ' HB2' ' A' ' 48' ' ' ARG . 5.4 mp -65.24 -54.62 26.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.805 176.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.91 -31.3 75.21 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 115.635 -0.711 . . . . 0.0 114.147 -174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -88.63 -29.96 19.56 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.302 -0.959 . . . . 0.0 112.709 -176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -106.38 -59.24 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 118.34 -1.344 . . . . 0.0 113.64 -173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 mptt 56.07 -152.96 0.36 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -167.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 69.3 -15.0 0.29 Allowed 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 124.791 1.236 . . . . 0.0 113.566 171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -111.73 149.09 32.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -86.85 98.08 11.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.019 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -75.0 129.6 37.92 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.065 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 52.0 t -125.01 138.0 55.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.172 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -130.87 142.38 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.498 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 23.2 p -82.7 165.12 20.23 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -69.29 -38.24 78.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.404 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.8 -29.61 66.95 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.81 -54.09 33.44 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.399 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 36' ' ' ILE . 25.0 m -60.82 -35.72 66.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.873 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.0 m -65.73 -42.24 91.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.858 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.74 -37.37 86.32 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.67 76.68 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.479 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.2 mm -59.33 -49.93 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 122.821 0.448 . . . . 0.0 111.201 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -66.35 -24.95 66.6 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -98.12 -14.56 20.36 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 120.809 0.338 . . . . 0.0 111.607 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.55 35.31 20.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.155 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -92.32 146.54 6.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.74 88.3 5.21 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.889 1.328 . . . . 0.0 111.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.8 tp -88.72 -19.22 7.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.724 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.34 -49.36 76.4 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 125.908 1.683 . . . . 0.0 109.437 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -59.78 -30.92 69.22 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 124.375 1.07 . . . . 0.0 111.226 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -75.21 -52.75 10.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.016 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.44 -39.33 79.53 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.95 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.01 -40.31 76.37 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.321 178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.594 ' HB2' HD23 ' A' ' 17' ' ' LEU . 45.5 mtt85 -82.98 -10.02 58.99 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.86 15.63 3.15 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.003 -1.57 . . . . 0.0 114.322 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.28 123.92 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 pt -96.83 143.78 11.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.024 0.44 . . . . 0.0 110.871 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 39.9 t -87.9 136.81 22.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.69 126.59 43.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.809 176.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.73 114.82 26.5 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 44.0 t80 -70.58 141.8 51.78 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 m -68.69 -58.43 4.24 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 175.28 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -136.29 142.59 40.3 Favored Pre-proline 0 C--N 1.306 -1.29 0 C-N-CA 124.079 0.952 . . . . 0.0 109.144 169.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.34 142.1 84.3 Favored 'Trans proline' 0 C--O 1.247 0.929 0 C-N-CA 121.805 1.67 . . . . 0.0 108.622 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.53 130.61 36.3 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.549 2.166 . . . . 0.0 113.394 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -110.82 109.82 20.18 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 65' ' ' LEU . 27.3 m -148.12 162.32 6.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.647 -169.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.76 -67.13 1.18 Allowed Glycine 0 N--CA 1.437 -1.294 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 168.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -127.68 -4.64 5.86 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 122.285 1.04 . . . . 0.0 109.697 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.555 ' HG ' ' OD2' ' A' ' 89' ' ' ASP . 59.4 mt -58.73 144.31 80.71 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 114.471 -1.24 . . . . 0.0 113.716 -176.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -75.71 166.12 28.95 Favored 'Trans proline' 0 C--O 1.252 1.223 0 C-N-CA 122.389 2.059 . . . . 0.0 110.376 170.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -56.64 -36.03 69.02 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -62.83 -38.33 90.32 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' OE2' ' HB2' ' A' ' 7' ' ' PRO . 69.9 mm-40 -71.03 -36.16 72.27 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -62.04 -41.96 98.67 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.77 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.498 ' OE2' ' HB ' ' A' ' 28' ' ' THR . 36.5 tt0 -62.55 -36.85 83.94 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.16 78.38 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.109 177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.78 -44.71 98.02 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.064 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.401 ' HB3' ' CE1' ' A' ' 55' ' ' PHE . 18.7 mmt -59.12 -45.96 89.56 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.19 -39.08 83.39 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-O 121.153 0.502 . . . . 0.0 110.131 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.61 -27.03 66.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.098 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -75.2 -36.75 61.37 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 123.091 0.556 . . . . 0.0 110.477 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.58 -44.44 74.39 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.319 0.581 . . . . 0.0 111.536 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.84 -19.03 31.24 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.733 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 57.44 67.74 0.94 Allowed 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -171.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.68 179.7 3.99 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 112.402 -2.181 . . . . 0.0 111.87 -170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 3' ' ' ALA . 2.3 tm? -90.51 126.77 36.03 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -108.33 120.72 43.2 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.821 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 54.0 mt -94.21 112.14 26.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -145.02 139.71 27.63 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 120.878 0.37 . . . . 0.0 111.581 -176.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.73 -22.69 16.82 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.606 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' HG23 ' A' ' 90' ' ' VAL . 12.6 t70 -87.67 132.95 33.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -51.17 -48.25 61.94 Favored 'General case' 0 C--O 1.24 0.597 0 O-C-N 124.184 0.927 . . . . 0.0 113.07 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.607 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.4 t70 -69.4 -27.7 65.53 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 123.549 0.531 . . . . 0.0 111.374 -170.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 87' ' ' ASP . 40.5 t -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.8 mt -62.03 -50.01 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.866 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 89' ' ' ASP . 2.0 p-10 -70.57 -36.64 73.72 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' LYS . 43.6 tptt -66.43 -40.97 89.83 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.468 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -67.89 -36.49 80.31 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.062 0.458 . . . . 0.0 109.827 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -59.78 -40.88 89.75 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.838 0.855 . . . . 0.0 109.233 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 62.6 mt-10 -63.18 -35.92 81.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.804 0.812 . . . . 0.0 110.787 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.12 -5.87 59.32 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.045 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.52 21.11 41.79 Favored Glycine 0 C--N 1.318 -0.449 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.645 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 94' ' ' ALA . 64.5 t -106.03 137.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -84.69 95.34 8.89 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.429 0.633 . . . . 0.0 110.966 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.68 131.23 45.01 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.882 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.95 155.45 76.3 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 122.686 0.394 . . . . 0.0 110.683 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 15.5 Cg_exo -71.7 162.03 43.37 Favored 'Trans proline' 0 C--O 1.252 1.177 0 C-N-CA 122.151 1.901 . . . . 0.0 110.656 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 60.4 mt -54.21 -38.16 38.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 123.652 0.781 . . . . 0.0 112.71 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -63.23 -34.1 76.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.594 0.235 . . . . 0.0 110.945 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.85 -30.45 62.67 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.276 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.88 -38.79 89.71 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.76 -43.51 83.9 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.971 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.56 65.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.874 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.6 m -76.03 -12.22 60.09 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-O 121.637 0.732 . . . . 0.0 110.593 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 m -87.38 152.74 22.0 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 112' ' ' LEU 0.275 2.2 pt? -83.57 86.66 7.07 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.542 -1.663 . . . . 0.0 110.636 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.32 -47.9 77.65 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 116' ' ' HIS . 18.6 p-80 -94.05 121.76 35.87 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.97 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -95.07 -16.06 22.96 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 114' ' ' HIS . 37.2 m80 -142.15 -175.34 4.39 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -76.83 105.5 7.93 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.325 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -82.72 115.36 21.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.084 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.295 -0.859 . . . . 0.0 109.805 179.025 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 C--O 1.245 0.831 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -87.68 146.8 25.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.5 111.03 13.93 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' O ' HD12 ' A' ' 83' ' ' LEU . 55.2 t -91.85 126.2 44.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt -93.12 125.7 45.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.885 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -89.48 152.22 47.08 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 82.6 Cg_exo -50.65 -27.95 21.06 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.461 2.774 . . . . 0.0 111.681 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 t -51.78 -36.42 47.51 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.864 1.266 . . . . 0.0 111.651 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.1 6.61 41.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.366 0.603 . . . . 0.0 111.625 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 10.0 m-85 -79.38 134.49 36.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.274 0.559 . . . . 0.0 111.323 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.14 -36.28 3.79 Favored Glycine 0 C--N 1.296 -1.674 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HB2' HD13 ' A' ' 104' ' ' ILE . 27.5 mtpp -110.36 15.74 22.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 tp -52.92 -39.14 62.55 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.938 1.695 . . . . 0.0 110.877 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -64.94 -35.95 82.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.801 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.95 -53.39 21.07 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.648 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' CG2' HG23 ' A' ' 104' ' ' ILE . 25.9 pt -60.87 -41.13 87.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 48' ' ' ARG . 55.2 tp -69.35 -55.08 11.46 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.598 -177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.45 -34.12 12.59 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.743 -1.218 . . . . 0.0 114.694 -173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.3 m -84.4 -25.84 28.76 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 117.683 0.741 . . . . 0.0 112.015 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.586 ' OD1' ' HB2' ' A' ' 111' ' ' SER . 35.3 t30 -97.55 -59.63 1.74 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 119.219 -0.993 . . . . 0.0 111.852 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 mttp 58.31 -140.82 0.74 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -169.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.07 -14.79 0.29 Allowed 'General case' 0 N--CA 1.512 2.63 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -135.5 162.23 33.24 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -93.47 108.42 20.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' HG22 ' A' ' 50' ' ' VAL . 99.2 m-85 -79.06 125.97 30.1 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.852 -176.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.63 134.64 60.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.114 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.5 tp -121.19 153.58 24.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 47.2 p -97.19 176.77 5.8 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.996 0.427 . . . . 0.0 111.929 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -42.57 85.45 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 123.686 0.794 . . . . 0.0 112.11 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.61 -24.47 56.52 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.59 -49.52 59.64 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.376 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 36' ' ' ILE . 34.9 m -66.89 -32.07 56.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.004 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.0 m -65.96 -40.52 91.38 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -59.59 -44.54 93.34 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.732 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.19 98.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' VAL . 48.3 mm -64.14 -48.32 86.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 123.296 0.372 . . . . 0.0 111.039 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -71.65 -30.12 65.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.3 t -84.41 -28.2 27.08 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 120.976 0.417 . . . . 0.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.43 34.64 6.93 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.154 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 10' ' ' PHE . 57.4 mt -97.27 149.84 4.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -71.09 87.77 0.78 Allowed 'General case' 0 C--O 1.241 0.63 0 O-C-N 123.315 0.384 . . . . 0.0 111.406 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -86.11 -27.13 6.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -62.31 -45.32 93.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -66.37 -29.8 70.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.796 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 17' ' ' LEU . . . -67.88 -51.29 49.85 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.4 mt -58.51 -40.12 81.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.085 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.9 -38.83 89.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.17 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HB2' HD21 ' A' ' 17' ' ' LEU . 74.5 mtt180 -87.85 2.9 50.27 Favored 'General case' 0 C--O 1.249 1.05 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.89 -2.5 7.96 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.312 -1.423 . . . . 0.0 115.43 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 25' ' ' PHE . 73.1 t -72.61 132.79 32.91 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 117.79 0.795 . . . . 0.0 109.645 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.7 pt -111.39 142.91 22.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.267 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.46 116.41 41.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-O 121.332 0.587 . . . . 0.0 110.689 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -118.64 126.27 51.57 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -91.4 150.76 21.12 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 57' ' ' HIS . 45.1 t80 -81.48 109.29 15.81 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 175.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.6 m -74.09 9.72 1.49 Allowed 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.292 1.037 . . . . 0.0 113.181 -173.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 55' ' ' PHE . 64.2 m-70 -122.86 176.12 6.17 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -68.58 116.31 39.08 Favored Pre-proline 0 C--N 1.31 -1.118 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.69 124.15 12.38 Favored 'Trans proline' 0 C--O 1.249 1.051 0 C-N-CA 121.561 1.507 . . . . 0.0 110.943 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -84.39 163.89 12.81 Favored 'Trans proline' 0 N--CA 1.439 -1.686 0 C-N-CA 122.272 1.981 . . . . 0.0 112.369 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HE2' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -111.71 121.93 46.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 174.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.7 123.6 37.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 173.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.7 66.62 1.36 Allowed Glycine 0 C--O 1.238 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.733 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.9 t30 175.69 -39.8 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 125.815 1.646 . . . . 0.0 108.697 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -107.72 149.38 38.88 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.332 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -63.5 145.75 92.33 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 122.077 1.851 . . . . 0.0 110.647 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.467 ' NE2' ' HE2' ' A' ' 61' ' ' LYS . 58.0 tt0 -59.98 -37.0 78.36 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.718 0.407 . . . . 0.0 111.602 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -64.4 -33.31 75.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.878 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.35 -37.19 63.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.2 m -64.46 -39.92 94.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.535 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.4 tt0 -63.42 -40.5 97.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -61.1 -45.46 94.62 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.485 HD11 HG13 ' A' ' 90' ' ' VAL . 73.4 mt -59.58 -45.45 94.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.207 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.413 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 4.3 mmt -60.79 -47.35 86.72 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.61 -37.97 80.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.031 0.443 . . . . 0.0 110.401 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.44 -29.59 69.1 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.43 -34.06 36.38 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 123.13 0.572 . . . . 0.0 110.583 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -46.21 68.05 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.467 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.24 -20.81 43.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.794 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 t30 56.93 64.39 1.66 Allowed 'General case' 0 C--O 1.247 0.924 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -110.61 -176.81 3.07 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.134 -1.848 . . . . 0.0 111.805 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -87.29 126.76 35.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 4' ' ' VAL . 43.5 tp -107.73 127.5 53.74 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.931 -0.707 . . . . 0.0 110.534 -178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.7 mt -106.39 114.95 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -148.13 155.17 41.11 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -101.84 -35.5 9.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.291 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.78 118.88 12.32 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.545 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -74.57 -17.56 60.71 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.182 -172.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -81.63 -39.18 24.84 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 73' ' ' ILE . 79.3 t -59.78 -51.68 70.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.588 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 91.9 mt -54.1 -44.93 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.437 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 8.3 t30 -54.29 -52.21 62.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.752 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -63.79 -43.71 95.5 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.555 0.535 . . . . 0.0 110.752 -177.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.55 97.27 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.035 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -70.71 -28.43 64.73 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 53.2 mt-10 -68.45 -28.98 67.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.14 0.495 . . . . 0.0 109.811 176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.86 -11.83 58.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.655 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.85 14.17 35.05 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.51 140.98 15.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -86.83 90.89 8.47 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.91 132.85 49.77 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.362 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pp -141.74 157.82 64.03 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 123.972 0.795 . . . . 0.0 110.836 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 19.3 Cg_exo -70.45 164.7 34.26 Favored 'Trans proline' 0 C--O 1.255 1.334 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 176.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.505 HG23 ' CG2' ' A' ' 16' ' ' ILE . 33.9 mt -58.35 -46.93 89.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.327 53.7 mt-10 -76.03 -16.0 60.03 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.87 -35.03 38.73 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 169.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 16' ' ' ILE . 3.3 tm? -60.83 -43.01 98.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.895 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.87 -34.66 78.64 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.164 0.507 . . . . 0.0 110.523 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.8 -4.42 43.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.363 0.602 . . . . 0.0 111.067 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.3 m -85.17 -4.03 59.02 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.586 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . 36.1 t -113.21 107.48 15.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -143.45 -16.58 0.64 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.345 0.593 . . . . 0.0 111.98 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 117' ' ' HIS . 0.2 OUTLIER -100.32 -15.51 17.99 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.515 178.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -80.9 84.88 6.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -134.4 -64.52 0.68 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -119.26 17.71 13.07 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' A' ' 113' ' ' GLU . 39.5 t60 -129.5 136.1 49.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -118.7 -52.58 2.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.836 0.35 . . . . 0.0 110.957 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 . . . . . 0 C--N 1.296 -1.747 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.821 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 C--O 1.248 0.977 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -87.43 147.04 25.6 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 25' ' ' PHE . . . -131.56 110.93 11.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.1 t -94.6 133.11 36.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.06 129.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -85.91 144.39 39.19 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.627 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 84.6 Cg_exo -52.52 -18.03 7.69 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.786 2.991 . . . . 0.0 113.879 176.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.1 p -73.99 -20.13 60.43 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.04 0.448 . . . . 0.0 110.904 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.96 12.04 33.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.199 0.524 . . . . 0.0 111.224 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' ' HA ' ' A' ' 7' ' ' PRO . 8.1 m-85 -73.11 153.97 40.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.36 -34.22 3.31 Favored Glycine 0 C--O 1.226 -0.373 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -92.66 1.6 57.18 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 124.577 1.151 . . . . 0.0 109.713 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -51.4 -39.97 58.33 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.038 1.335 . . . . 0.0 111.949 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -65.88 -33.59 76.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.861 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.41 -49.13 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.997 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.405 ' CG2' HG23 ' A' ' 104' ' ' ILE . 26.5 pt -68.26 -43.44 84.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.891 0.377 . . . . 0.0 111.935 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 48' ' ' ARG . 52.6 tp -70.31 -48.56 56.05 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 -177.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.83 -33.16 74.8 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 116.106 -0.497 . . . . 0.0 114.181 -176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 m -90.43 -15.1 31.55 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.881 -0.728 . . . . 0.0 112.439 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -114.64 -59.17 2.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 55.57 -155.21 0.28 Allowed 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 70.7 -13.97 0.45 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.99 148.33 34.03 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -85.87 96.47 9.79 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 176.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 3' ' ' ALA . 98.2 m-85 -74.38 129.8 38.46 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.064 -176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 4' ' ' VAL . 42.0 t -127.4 138.65 54.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.87 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 8.4 tp -123.7 160.21 27.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.575 ' HB ' ' OE1' ' A' ' 71' ' ' GLU . 25.8 p -99.62 165.48 11.59 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 120.835 0.35 . . . . 0.0 111.647 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.44 -36.66 84.89 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.919 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.96 -18.46 60.38 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.062 0.458 . . . . 0.0 110.014 176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.24 -44.68 17.02 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 36' ' ' ILE . 20.2 m -66.64 -36.44 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.017 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.8 p -72.41 -31.96 65.95 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.535 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.63 -42.34 92.51 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.403 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . . . -65.05 -47.68 76.5 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.57 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 32' ' ' VAL . 49.0 mm -59.15 -45.85 92.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.581 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -72.23 -26.53 62.06 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -103.46 4.08 35.65 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.52 37.92 85.88 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.354 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.4 mt -102.09 155.92 4.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -78.41 129.6 35.12 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -128.69 -40.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.802 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -66.76 -31.52 72.21 Favored 'General case' 0 CA--C 1.487 -1.461 0 O-C-N 122.159 -0.338 . . . . 0.0 111.01 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 m -57.72 -40.64 80.06 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 123.774 0.671 . . . . 0.0 109.922 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.77 -45.15 60.08 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.808 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 50' ' ' VAL . 87.6 mt -57.72 -45.11 86.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.058 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.37 -39.83 92.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.564 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HB2' HD21 ' A' ' 17' ' ' LEU . 78.6 mtt180 -77.23 -3.79 41.46 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.85 7.43 5.59 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.017 -1.563 . . . . 0.0 115.862 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' LEU . 63.6 t -86.78 138.52 18.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.4 pt -113.1 167.41 6.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' ILE . 14.4 p -120.16 144.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.456 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' THR . 49.4 mtt180 -132.86 157.45 45.02 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 123.146 0.578 . . . . 0.0 110.241 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.01 133.02 35.08 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.666 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.1 144.05 31.16 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 173.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.9 m -97.62 -50.53 4.45 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.602 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.94 99.0 3.27 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.644 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -137.32 106.51 8.58 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.19 121.86 2.79 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 CA-C-N 119.94 1.014 . . . . 0.0 111.359 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -91.62 139.82 2.36 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 123.164 2.576 . . . . 0.0 110.354 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -85.83 108.22 18.02 Favored 'General case' 0 N--CA 1.423 -1.78 0 C-N-CA 117.97 -1.492 . . . . 0.0 109.076 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 m -153.3 162.06 2.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 C-N-CA 125.255 1.422 . . . . 0.0 107.312 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.3 11.68 5.0 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.382 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -148.05 -36.72 0.2 Allowed 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.574 ' HB3' ' OE2' ' A' ' 69' ' ' GLU . 80.7 mt -61.82 132.96 93.56 Favored Pre-proline 0 C--O 1.241 0.615 0 C-N-CA 122.614 0.365 . . . . 0.0 111.937 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.24 144.86 13.35 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.509 2.806 . . . . 0.0 113.588 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -46.91 -35.22 6.21 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.138 1.375 . . . . 0.0 114.106 -174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -58.62 -43.2 89.55 Favored 'General case' 0 C--O 1.26 1.609 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' OE2' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -85.45 -26.66 26.21 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.973 -179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 m -63.45 -34.9 78.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.685 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.575 ' OE1' ' HB ' ' A' ' 28' ' ' THR . 40.6 tt0 -64.47 -40.89 96.56 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HA ' HG21 ' A' ' 28' ' ' THR . . . -60.46 -45.0 95.29 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.157 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.9 mt -61.38 -45.76 97.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.815 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.751 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.4 mmt -65.82 -39.42 90.85 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 28' ' ' THR . 70.7 t -66.46 -36.28 76.93 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 CA-C-O 121.196 0.522 . . . . 0.0 109.848 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.12 -33.74 72.2 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -66.52 -44.61 82.03 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 124.384 1.074 . . . . 0.0 110.219 177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.83 -57.06 14.41 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.103 0.961 . . . . 0.0 110.635 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.84 -13.6 57.42 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.087 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.47 64.74 1.4 Allowed 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -170.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.77 177.15 4.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.91 -173.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.23 127.21 36.58 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 48.1 tp -108.23 122.83 47.75 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.635 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 53.7 mt -97.8 115.49 37.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . -143.08 144.0 32.08 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.648 0.261 . . . . 0.0 110.668 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -93.37 -25.58 17.63 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.81 123.82 29.71 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -73.33 -18.9 61.14 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -81.59 -33.25 31.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.435 HG22 ' OE1' ' A' ' 69' ' ' GLU . 95.8 t -61.18 -48.47 88.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 88.0 mt -56.65 -48.58 80.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.96 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 96' ' ' GLU . 23.6 t30 -51.43 -58.85 5.12 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.622 1.169 . . . . 0.0 111.681 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 2.4 mmmp? -65.87 -40.08 91.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.73 -38.45 89.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 99' ' ' VAL . 14.2 tppt? -57.77 -42.08 83.35 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.698 0.799 . . . . 0.0 109.655 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 92' ' ' ASN . 41.0 mt-10 -67.3 -34.62 77.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.728 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 93' ' ' LYS . 90.4 mt -79.38 2.67 20.8 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.252 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 90.84 18.7 46.53 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.988 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 95' ' ' LYS . 61.9 t -106.35 142.87 18.27 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -97.84 94.47 6.93 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.149 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 83' ' ' LEU . . . -94.04 132.53 38.43 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.929 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.51 152.33 77.67 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 123.488 0.492 . . . . 0.0 110.691 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 11.0 Cg_exo -71.97 160.13 48.45 Favored 'Trans proline' 0 C--O 1.251 1.172 0 C-N-CA 122.034 1.823 . . . . 0.0 110.27 175.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.405 HG23 ' CG2' ' A' ' 16' ' ' ILE . 43.2 mt -57.24 -36.88 53.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.02 -25.73 66.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -74.07 -30.8 62.55 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.464 0.649 . . . . 0.0 109.947 176.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.68 -42.39 67.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.4 mt -64.16 -33.64 76.25 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.675 0.75 . . . . 0.0 110.786 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.26 -30.33 69.34 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.831 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.1 m -103.63 13.03 34.1 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.2 p -110.33 178.53 4.36 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 122.028 -0.42 . . . . 0.0 111.268 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . 0.274 0.6 OUTLIER -112.79 102.05 10.1 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -176.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.17 -49.09 8.0 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -158.72 86.82 0.86 Allowed 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 112.907 -1.951 . . . . 0.0 107.833 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -157.7 83.96 0.89 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.684 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -132.19 164.26 26.75 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -100.27 125.44 46.46 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -84.72 -42.39 15.3 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 167.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.101 . . . . . . . . 0 0 . 1 stop_ save_